<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34603720</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>70</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Perioperative management of patients with asthma during elective surgery: A systematic review.</ArticleTitle><Pagination><StartPage>102874</StartPage><MedlinePgn>102874</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amsu.2021.102874</ELocationID><Abstract><AbstractText>Asthma is one of the commonest respiratory illnesses among elderly patients undergoing surgery. Detailed preoperative assessment, pharmacotherapy and safe anaesthetic measures throughout perioperative period are the keys to decrease complications. Resistance to expiratory airflow results in positive alveolar pressures at the end of expiration, which causes air-trapping and hyperinflation of the lungs and thorax, increased work of breathing, and alteration of respiratory muscle function. This systematic review was conducted according to the Preferred Reporting Items for systematic review and metanalysis (PRISMA) statement. Search engines like PubMed through HINARI, Cochrane database and Google Scholars were used to find evidences. Low-dose IV ketamine, midazolam, IV lidocaine or combined with salbutamol are recommended to be used as premedication before induction. Propofol, ketamine, halothane, isoflurane and sevoflurane are best induction agents and maintenance for asthmatic surgical patients respectively. Among the muscle relaxants, vecuronium is safe for use in asthmatics. In addition, Succinylcholine and pancronium which releases low levels of histamine has been used safely in asthmatics with little morbidity.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bayable</LastName><ForeName>Samuel Debas</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Medicine and Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melesse</LastName><ForeName>Debas Yaregal</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lema</LastName><ForeName>Girmay Fitiwi</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Seid Adem</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Endotracheal intubation</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Laryngospasm</Keyword><Keyword MajorTopicYN="N">Perioperative respiratory adverse events</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34603720</ArticleId><ArticleId IdType="pmc">PMC8473668</ArticleId><ArticleId IdType="doi">10.1016/j.amsu.2021.102874</ArticleId><ArticleId IdType="pii">S2049-0801(21)00824-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Woods B., Sladen R. Perioperative considerations for the patient with asthma and bronchospasm. Br. J. Anaesth. 2009;103(suppl_1):i57&#x2013;i65.</Citation><ArticleIdList><ArticleId IdType="pubmed">20007991</ArticleId></ArticleIdList></Reference><Reference><Citation>Applegate R. The perioperative management of asthma. J. Allergy Ther. S. 2013;11:2.</Citation></Reference><Reference><Citation>Dones F., Foresta G., Russotto V. Update on perioperative management of the child with asthma. Pediatr. Rep. 2012;4(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3395977</ArticleId><ArticleId IdType="pubmed">22802997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirumalasetty J., Grammer L.C. Asthma, surgery, and general anesthesia: a review. J. Asthma. 2006;43(4):251&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">16809236</ArticleId></ArticleIdList></Reference><Reference><Citation>Burburan S., Xisto D., Rocco P. Anaesthetic management in asthma. Minerva Anestesiol. 2007;73(6):357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17115010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-S. Postoperative adverse outcomes in patients with asthma: a nationwide population-based cohort study. Medicine. 2016;95(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998277</ArticleId><ArticleId IdType="pubmed">26817903</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalfaro P. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth. Analg. 2001;93(4):898&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">11574353</ArticleId></ArticleIdList></Reference><Reference><Citation>Homer R.J., Elias J.A. Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology. 2005;20(1):28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">15653837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F.H. Airway remodeling: a comparison between fatal and nonfatal asthma. J. Asthma. 2004;41(6):631&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">15584312</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int. J. Surg. 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakage M., Iwasaki S., Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J. Anesth. 2008;22(4):412&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">19011781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lommatzsch M., Virchow C.J. Severe asthma: definition, diagnosis and treatment. Deutsches &#xc4;rzteblatt International. 2014;111(50):847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4357024</ArticleId><ArticleId IdType="pubmed">25585581</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulet L.-P. Asthma and chronic obstructive pulmonary disease guideline implementation: lessons learned on recruitment of primary care physicians to a knowledge translation study. Can. Respir. J. J. Can. Thorac. Soc. 2013;20(4):275&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3956338</ArticleId><ArticleId IdType="pubmed">23936886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman E.D. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008;31(1):143&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18166595</ArticleId></ArticleIdList></Reference><Reference><Citation>Liccardi G. Bronchial asthma. Curr. Opin. Anaesthesiol. 2012;25(1):30&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">22157191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh C.-C. Premedication with intravenous low-dose ketamine suppresses fentanyl-induced cough. J. Clin. Anesth. 2007;19(1):53&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17321928</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright A. Bronchospastic disease and emergency surgery. Middle East J. Anesthesiol. 2004;17:927&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pubmed">15449749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kil H.-K. Effect of prophylactic bronchodilator treatment on lung resistance after tracheal intubation. Anesthesiology. 1994;81(1):43&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">8042809</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamzik M. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth. Analg. 2007;104(1):168&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zervas E. An algorithmic approach for the treatment of severe uncontrolled asthma. ERJ Open Res. 2018;4(1) 00125-2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838355</ArticleId><ArticleId IdType="pubmed">29531957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R.S. Comparative effects of thiopentone and propofol on respiratory resistance after tracheal intubation. Br. J. Anaesth. 1996;77(6):735&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">9014625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizov R. Wheezing during induction of general anesthesia in patients with and without asthma a randomized, blinded trial. Anesthesiology. 1995;82(5):1111&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Eames W.O. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology. 1996;84(6):1307&#x2013;1311.</Citation><ArticleIdList><ArticleId IdType="pubmed">8669670</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Wagner E.M. Mechanisms of bronchoprotection by anesthetic induction agents propofol versus ketamine. Anesthesiology. 1999;90(3):822&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">10078684</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen C.M., Thirstrup S., Nielsen-Kudsk J.E. Smooth muscle relaxant effects of propofol and ketamine in isolated Guinea-pig trachea. Eur. J. Pharmacol. 1993;238(1):75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">8405085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirshman C.A. Mechanism of action of inhalational anesthesia on airways. Anesthesiology. 1982;56(2):107&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">7055323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooke G.A., Choi J.H., Bishop M.J. The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology. 1997;86(6):1294&#x2013;1299.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyktari V. Respiratory resistance during anaesthesia with isoflurane, sevoflurane, and desflurane: a randomized clinical trial. Br. J. Anaesth. 2011;107(3):454&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">21665899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyktari V.G. Effect of the physical properties of isoflurane, sevoflurane, and desflurane on pulmonary resistance in a laboratory lung model. Anesthesiology. 2006;104(6):1202&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16732091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikmen Y. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia. 2003;58(8):745&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">12859465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepner D.L., Castells M.C. Anaphylaxis during the perioperative period. Anesth. Analg. 2003;97(5):1381&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Bishop M.J. Endotracheal intubation, but not laryngeal mask airway insertion, produces reversible bronchoconstriction. Anesthesiology. 1999;90(2):391&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">9952142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagihira S. [Preoperative management of patients with bronchial asthma or chronic bronchitis] Masui. 2015;64(9):934&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">26466493</ArticleId></ArticleIdList></Reference><Reference><Citation>Quon B.S. Increased vs stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Chest. 2010;138(4):771A.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32870298</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>848</StartPage><EndPage>858</EndPage><MedlinePgn>848-858</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2020.12866</ELocationID><Abstract><AbstractText Label="IMPORTANCE">In patients who undergo mechanical ventilation during surgery, the ideal tidal volume is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether low-tidal-volume ventilation compared with conventional ventilation during major surgery decreases postoperative pulmonary complications.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Single-center, assessor-blinded, randomized clinical trial of 1236 patients older than 40 years undergoing major noncardiothoracic, nonintracranial surgery under general anesthesia lasting more than 2 hours in a tertiary hospital in Melbourne, Australia, from February 2015 to February 2019. The last date of follow-up was February 17, 2019.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomized to receive a tidal volume of 6 mL/kg predicted body weight (n&#x2009;=&#x2009;614; low tidal volume group) or a tidal volume of 10 mL/kg predicted body weight (n&#x2009;=&#x2009;592; conventional tidal volume group). All patients received positive end-expiratory pressure (PEEP) at 5 cm H2O.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was a composite of postoperative pulmonary complications within the first 7 postoperative days, including pneumonia, bronchospasm, atelectasis, pulmonary congestion, respiratory failure, pleural effusion, pneumothorax, or unplanned requirement for postoperative invasive or noninvasive ventilation. Secondary outcomes were postoperative pulmonary complications including development of pulmonary embolism, acute respiratory distress syndrome, systemic inflammatory response syndrome, sepsis, acute kidney injury, wound infection (superficial and deep), rate of intraoperative need for vasopressor, incidence of unplanned intensive care unit admission, rate of need for rapid response team call, intensive care unit length of stay, hospital length of stay, and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">Among 1236 patients who were randomized, 1206 (98.9%) completed the trial (mean age, 63.5 years; 494 [40.9%] women; 681 [56.4%] undergoing abdominal surgery). The primary outcome occurred in 231 of 608 patients (38%) in the low tidal volume group compared with 232 of 590 patients (39%) in the conventional tidal volume group (difference, -1.3% [95% CI, -6.8% to 4.2%]; risk ratio, 0.97 [95% CI, 0.84-1.11]; P&#x2009;=&#x2009;.64). There were no significant differences in any of the secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adult patients undergoing major surgery, intraoperative ventilation with low tidal volume compared with conventional tidal volume, with PEEP applied equally between groups, did not significantly reduce pulmonary complications within the first 7 postoperative days.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ANZCTR Identifier: ACTRN12614000790640.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karalapillai</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong O</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oughton</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galtieri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Amsterdam University Medical Centres, Location AMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306. doi: 10.1001/jama.2020.22627.</RefSource><PMID Version="1">33464328</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):307. doi: 10.1001/jama.2020.22630.</RefSource><PMID Version="1">33464329</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Jan 19;325(3):306-307. doi: 10.1001/jama.2020.22633.</RefSource><PMID Version="1">33464330</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Peyton reported receipt of personal fees from Maquet Critical Care. Dr Wilson reported receipt of personal fees from Fisher Paykel. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32870298</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pii">2770010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meara JG, Leather AJM, Hagander L, et al. . Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569-624. doi:10.1016/S0140-6736(15)60160-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60160-X</ArticleId><ArticleId IdType="pubmed">25924834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, et al. . Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166. doi:10.1001/jamasurg.2016.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317-334. doi:10.1093/bja/aex002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex002</ArticleId><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CC, Harris EM, Vacchiano C, et al. . Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth. 2019;123(6):898-913. doi:10.1016/j.bja.2019.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.08.017</ArticleId><ArticleId IdType="pubmed">31587835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendixen HH, Hedley-Whyte J, Laver MB. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation: a concept of atelectasis. N Engl J Med. 1963;269:991-996. doi:10.1056/NEJM196311072691901</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196311072691901</ArticleId><ArticleId IdType="pubmed">14059732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308. doi:10.1056/NEJM200005043421801</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Cardoso SO, Manetta JA, et al. . Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012;308(16):1651-1659. doi:10.1001/jama.2012.13730</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13730</ArticleId><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupancich E, Paparella D, Turani F, et al. . Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2005;130(2):378-383. doi:10.1016/j.jtcvs.2004.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2004.11.061</ArticleId><ArticleId IdType="pubmed">16077402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrigge H, Uhlig U, Baumgarten G, et al. . Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005;31(10):1379-1387. doi:10.1007/s00134-005-2767-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2767-1</ArticleId><ArticleId IdType="pubmed">16132888</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Miranda D, Gommers D, Struijs A, et al. . Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg. 2005;28(6):889-895. doi:10.1016/j.ejcts.2005.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.10.007</ArticleId><ArticleId IdType="pubmed">16271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al. ; IMPROVE Study Group . A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428-437. doi:10.1056/NEJMoa1301082</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanderer JP, Blum JM, Ehrenfeld JM. Intraoperative low-tidal-volume ventilation. N Engl J Med. 2013;369(19):1861. doi:10.1056/NEJMc1311316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1311316</ArticleId><ArticleId IdType="pubmed">24195560</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu054</ArticleId><ArticleId IdType="pmc">PMC9585620</ArticleId><ArticleId IdType="pubmed">24623057</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Galtieri J, et al. . Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, Australia. BMC Anesthesiol. 2014;14:85. doi:10.1186/1471-2253-14-85</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-85</ArticleId><ArticleId IdType="pmc">PMC4190393</ArticleId><ArticleId IdType="pubmed">25302048</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, et al. . Low tidal volume ventilation during anaesthesia for major surgery: protocol and statistical analysis plan. Crit Care Resusc. 2019;21(4):243-250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31778630</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg L, Li M, Churilov L, et al. . Associations of fluid amount, type, and balance and acute kidney injury in patients undergoing major surgery. Anaesth Intensive Care. 2018;46(1):79-87. doi:10.1177/0310057X1804600112</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1804600112</ArticleId><ArticleId IdType="pubmed">29361260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ; PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology . High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495-503. doi:10.1016/S0140-6736(14)60416-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, et al. ; Writing Committee for the PROBESE Collaborative Group of the Protective Ventilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology; PROBESE Collaborative Group . Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321(23):2292-2305. doi:10.1001/jama.2019.7505</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="pubmed">31157366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti AB, Suzumura &#xc9;A, Laranjeira LN, et al. ; Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial Investigators . Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335-1345. doi:10.1001/jama.2017.14171</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14171</ArticleId><ArticleId IdType="pmc">PMC5710484</ArticleId><ArticleId IdType="pubmed">28973363</ArticleId></ArticleIdList></Reference><Reference><Citation>LAS VEGAS Investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS&#x2014;an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492-507. doi:10.1097/EJA.0000000000000646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31157366</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>321</Volume><Issue>23</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) With Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications in Obese Patients: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>2292</StartPage><EndPage>2305</EndPage><MedlinePgn>2292-2305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2019.7505</ELocationID><Abstract><AbstractText Label="IMPORTANCE">An intraoperative higher level of positive end-expiratory positive pressure (PEEP) with alveolar recruitment maneuvers improves respiratory function in obese patients undergoing surgery, but the effect on clinical outcomes is uncertain.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether a higher level of PEEP with alveolar recruitment maneuvers decreases postoperative pulmonary complications in obese patients undergoing surgery compared with a lower level of PEEP.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Randomized clinical trial of 2013 adults with body mass indices of 35 or greater and substantial risk for postoperative pulmonary complications who were undergoing noncardiac, nonneurological surgery under general anesthesia. The trial was conducted at 77 sites in 23 countries from July 2014-February 2018; final follow-up: May 2018.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomized to the high level of PEEP group (n&#x2009;=&#x2009;989), consisting of a PEEP level of 12 cm H2O with alveolar recruitment maneuvers (a stepwise increase of tidal volume and eventually PEEP) or to the low level of PEEP group (n&#x2009;=&#x2009;987), consisting of a PEEP level of 4 cm H2O. All patients received volume-controlled ventilation with a tidal volume of 7 mL/kg of predicted body weight.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was a composite of pulmonary complications within the first 5 postoperative days, including respiratory failure, acute respiratory distress syndrome, bronchospasm, new pulmonary infiltrates, pulmonary infection, aspiration pneumonitis, pleural effusion, atelectasis, cardiopulmonary edema, and pneumothorax. Among the 9 prespecified secondary outcomes, 3 were intraoperative complications, including hypoxemia (oxygen desaturation with Spo2 &#x2264;92% for &gt;1 minute).</AbstractText><AbstractText Label="RESULTS">Among 2013 adults who were randomized, 1976 (98.2%) completed the trial (mean age, 48.8 years; 1381 [69.9%] women; 1778 [90.1%] underwent abdominal operations). In the intention-to-treat analysis, the primary outcome occurred in 211 of 989 patients (21.3%) in the high level of PEEP group compared with 233 of 987 patients (23.6%) in the low level of PEEP group (difference, -2.3% [95% CI, -5.9% to 1.4%]; risk ratio, 0.93 [95% CI, 0.83 to 1.04]; P&#x2009;=&#x2009;.23). Among the 9 prespecified secondary outcomes, 6 were not significantly different between the high and low level of PEEP groups, and 3 were significantly different, including fewer patients with hypoxemia (5.0% in the high level of PEEP group vs 13.6% in the low level of PEEP group; difference, -8.6% [95% CI, -11.1% to 6.1%]; P&#x2009;&lt;&#x2009;.001).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among obese patients undergoing surgery under general anesthesia, an intraoperative mechanical ventilation strategy with a higher level of PEEP and alveolar recruitment maneuvers, compared with a strategy with a lower level of PEEP, did not reduce postoperative pulmonary complications.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov Identifier: NCT02148692.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>Writing Committee for the PROBESE Collaborative Group of the PROtective VEntilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology</CollectiveName></Author><Author ValidYN="Y"><LastName>Bluth</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROBESE Collaborative Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Bluth</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bobek</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Canet</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Cinnella</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>de Baerdemaeker</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gregoretti</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hedenstierna</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hemmes</LastName><ForeName>S N T</ForeName><Initials>SNT</Initials></Author><Author ValidYN="Y"><LastName>Hiesmayr</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>M W</ForeName><Initials>MW</Initials></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Laffey</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Licker</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Markstaller</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Matot</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G H</ForeName><Initials>GH</Initials></Author><Author ValidYN="Y"><LastName>Mulier</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Senturk</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Severgnini</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02148692</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Jun 18;321(23):2285-2287. doi: 10.1001/jama.2019.7540.</RefSource><PMID Version="1">31157358</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesth Crit Care Pain Med. 2019 Oct;38(5):435-437. doi: 10.1016/j.accpm.2019.09.006.</RefSource><PMID Version="1">31585762</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA. 2019 Nov 12;322(18):1829-1830. doi: 10.1001/jama.2019.16415.</RefSource><PMID Version="1">31714970</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Nov 12;322(18):1828. doi: 10.1001/jama.2019.14394.</RefSource><PMID Version="1">31714980</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="Y">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010995" MajorTopicYN="N">Pleural Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="N">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Bluth reported receiving personal fees from Comen Eletronics Technology Co Ltd. Dr Serpa Neto reported receiving personal fees from Drager. Dr Gama de Abreu reported receiving grants and personal fees from Dr&#xe4;gerwerk AG and GlaxoSmithKline and receiving personal fees from GE Healthcare. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Abelha</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abita&#x11f;ao&#x11f;lu</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Achilles</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adebesin</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adriaensens</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahene</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akbar</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al Harbi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al Khoury al Kallab</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albanel</LastName><ForeName>X</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aldenkortt</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alfouzan</LastName><ForeName>R A S</ForeName><Initials>RAS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alruqaie</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altermatt</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Araujo</LastName><ForeName>B L C</ForeName><Initials>BLC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arbes&#xfa;</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artsi</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aurilio</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayanoglu</LastName><ForeName>O H</ForeName><Initials>OH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacuzzi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baig</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baird</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balonov</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balust</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Banks</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bao</LastName><ForeName>X</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baumgartner</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belda Tortosa</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergamaschi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergmann</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bigatello</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biosca P&#xe9;rez</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birr</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bluth</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bobek</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bojaxhi</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonenti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonney</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bos</LastName><ForeName>E M E</ForeName><Initials>EME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowman</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Braz</LastName><ForeName>L G</ForeName><Initials>LG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brugnoni</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brull</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunetti</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruni</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buenvenida</LastName><ForeName>S L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Busch</LastName><ForeName>C J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camerini</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capatti</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carmona</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carungcong</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carvalho</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cattan</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cavaleiro</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiumello</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciardo</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cinella</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coburn</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colella</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Contreras</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corman Dincer</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cotter</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crovetto</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darrah</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davies</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Baerdemaeker</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Hert</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Cojo Peces</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delphin</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diaper</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>do Nascimento Junior</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donatiello</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dong</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dourado</LastName><ForeName>M D S</ForeName><Initials>MDS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dullenkopf</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebner</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elgendy</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellenberger</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erdo&#x11f;an Ar&#x131;</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ermert</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farah</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez-Bustamante</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferreira</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiore</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fonte</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forti&#xe0; Palah&#xed;</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galimberti</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garofano</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giaccari</LastName><ForeName>L G</ForeName><Initials>LG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gilsanz</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girrbach</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gobbi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godfried</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goettel</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstein</LastName><ForeName>P A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goren</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorlin</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Granell Gil</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gratarola</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graterol</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gregoretti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guyon</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haire</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harou</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hedenstierna</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helf</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hemmes</LastName><ForeName>S N T</ForeName><Initials>SNT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hempel</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hern&#xe1;ndez C&#xe1;diz</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyse</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hiesmayr</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollmann</LastName><ForeName>M W</ForeName><Initials>MW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huercio</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ilievska</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaber</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jakus</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jeganath</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jelting</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jung</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabon</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kacha</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karaman Ili&#x107;</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karuppiah</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kavas</LastName><ForeName>A D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keli Barcelos</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kellogg</LastName><ForeName>T A</ForeName><Initials>TA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemper</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerbrat</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khodr</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kienbaum</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kir</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiss</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kivrak</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klari&#x107;</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koch</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>K&#xf6;ksal</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kranke</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuvaki</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuzmanovska</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laffey</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lange</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lemos</LastName><ForeName>M F D</ForeName><Initials>MFD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Licker</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Baamonde</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Hern&#xe1;ndez</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez-Martinez</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luise</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacGregor</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machado</LastName><ForeName>H S</ForeName><Initials>HS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magalh&#xe3;es</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maillard</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malerbi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manimekalai</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Margarson</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Markstaller</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>D P</ForeName><Initials>DP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Y N</ForeName><Initials>YN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez-Ocon</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin-Loeches</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maseda</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matot</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>McAuliffe</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKenzie</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medina</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meersch</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menzen</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mertens</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meurer</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyer-Treschan</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miao</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Micalizzi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mili&#x107;</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>G H</ForeName><Initials>GH</Initials></Investigator><Investigator ValidYN="Y"><LastName>M&#xf3;dolo</LastName><ForeName>N S P</ForeName><Initials>NSP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moine</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>M&#xf6;lders</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montero-Feijoo</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moret</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulier</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muller</LastName><ForeName>M K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nalwaya</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naumovski</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navalesi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navarro e Lima</LastName><ForeName>L H</ForeName><Initials>LH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nesek</LastName><ForeName>Adam V</ForeName><Initials>AV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newell</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nisnevitch</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nizamuddin</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novazzi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nunes</LastName><ForeName>C S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connor</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oprea</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orhan Sungur</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>&#xd6;zbilgin</LastName><ForeName>&#x15e;</ForeName><Initials>&#x15e;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pacheco</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Packianathaswamy</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palma Gonzalez</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papaspyros</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paredes</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Passavanti</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedemonte</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peremin</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Philipsenburg</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinho</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinho</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Posthuma</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pota</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Preckel</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Priani</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Putensen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rached</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Radoeshki</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ragazzi</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rajamanickam</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rajamohan</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rangarajan</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiterer</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Renew</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynaud</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rhys</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivas</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robitzky</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossaint</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rubulotta</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabbatini</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samuels</LastName><ForeName>J D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanahuja</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sansone</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sayedalahl</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaefer</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scharffenberg</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiffer</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schliewe</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmitt</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schorer</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schumann</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Selmo</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sendra</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senturk</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Severgnini</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shosholcheva</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sibai</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simon</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simonassi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sinno</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sivrikoz</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skandalou</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soares</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Socorro Artiles</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sousa Castro</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sousa</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spadaro</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sprung</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stamatakis</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steiner</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevenazzi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suarez-de-la-Rica</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suppan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teichmann</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tena Guerrero</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiel</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tol&#xf3;s</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tore Altun</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tucci</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Z A</ForeName><Initials>ZA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turudi&#x107;</LastName><ForeName>&#x17d;</ForeName><Initials>&#x17d;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unterberg</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Limmen</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Nieuwenhove</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Waesberghe</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vitkovi&#x107;</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vivona</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vizcaychipi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volta</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weber</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weingarten</LastName><ForeName>T N</ForeName><Initials>TN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittenstein</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wrigge</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wyffels</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yag&#xfc;e</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yates</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yavru</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zac</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhong</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31157366</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pii">2735541</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ball L, Hemmes SNT, Serpa Neto A, et al. ; Las Vegas Investigators; PROVE Network; Clinical Trial Network of the European Society of Anaesthesiology . Intraoperative ventilation settings and their associations with postoperative pulmonary complications in obese patients. Br J Anaesth. 2018;121(4):899-908. doi:10.1016/j.bja.2018.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.04.021</ArticleId><ArticleId IdType="pubmed">30236252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazo V, Sabat&#xe9; S, Canet J, et al. . Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121(2):219-231. doi:10.1097/ALN.0000000000000334</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000334</ArticleId><ArticleId IdType="pubmed">24901240</ArticleId></ArticleIdList></Reference><Reference><Citation>Las Vegas Investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: Las Vegas&#x2014;an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492-507. doi:10.1097/EJA.0000000000000646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, et al. . Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the Perioperative Research Network Investigators. JAMA Surg. 2017;152(2):157-166. doi:10.1001/jamasurg.2016.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser TG, Haynes AB, Molina G, et al. . Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(suppl 2):S11. doi:10.1016/S0140-6736(15)60806-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60806-6</ArticleId><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference><Reference><Citation>NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128&#xb7;9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. doi:10.1016/S0140-6736(17)32129-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32129-3</ArticleId><ArticleId IdType="pmc">PMC5735219</ArticleId><ArticleId IdType="pubmed">29029897</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshin A, Forouzanfar MH, Reitsma MB, et al. ; GBD 2015 Obesity Collaborators . Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1614362</ArticleId><ArticleId IdType="pmc">PMC5477817</ArticleId><ArticleId IdType="pubmed">28604169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, et al. . Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ. 2015;351:h3646. doi:10.1136/bmj.h3646</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h3646</ArticleId><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, da Costa LGV, Hemmes SNT, et al. ; Las Vegas . The Las Vegas risk score for prediction of postoperative pulmonary complications: an observational study. Eur J Anaesthesiol. 2018;35(9):691-701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450515</ArticleId><ArticleId IdType="pubmed">29916860</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, et al. ; IMPROVE Study Group . A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428-437. doi:10.1056/NEJMoa1301082</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ; PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology . High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495-503. doi:10.1016/S0140-6736(14)60416-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Soro M, Unzueta C, et al. ; Individualized PeRioperative Open-lung VEntilation (iPROVE) Network . Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial. Lancet Respir Med. 2018;6(3):193-203. doi:10.1016/S2213-2600(18)30024-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30024-9</ArticleId><ArticleId IdType="pubmed">29371130</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;pin JL, Timsit JF, Tamisier R, Borel JC, L&#xe9;vy P, Jaber S. Prevention and care of respiratory failure in obese patients. Lancet Respir Med. 2016;4(5):407-418. doi:10.1016/S2213-2600(16)00054-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00054-0</ArticleId><ArticleId IdType="pubmed">27304558</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Pelosi P, et al. . Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study. Anesthesiology. 2011;114(6):1354-1363. doi:10.1097/ALN.0b013e31821811ba</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31821811ba</ArticleId><ArticleId IdType="pubmed">21478734</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestler C, Simon P, Petroff D, et al. . Individualized positive end-expiratory pressure in obese patients during general anaesthesia: a randomized controlled clinical trial using electrical impedance tomography. Br J Anaesth. 2017;119(6):1194-1205. doi:10.1093/bja/aex192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex192</ArticleId><ArticleId IdType="pubmed">29045567</ArticleId></ArticleIdList></Reference><Reference><Citation>Imber DA, Pirrone M, Zhang C, Fisher DF, Kacmarek RM, Berra L. Respiratory management of perioperative obese patients. Respir Care. 2016;61(12):1681-1692. doi:10.4187/respcare.04732</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.04732</ArticleId><ArticleId IdType="pubmed">27624632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Teichmann R, Kiss T, et al. ; PROBESE Investigators; PROtective VEntilation Network (PROVEnet); Clinical Trial Network of the European Society of Anaesthesiology (ESA) . Protective intraoperative ventilation with higher versus lower levels of Positive End-Expiratory Pressure in Obese Patients (PROBESE): study protocol for a randomized controlled trial. Trials. 2017;18(1):202. doi:10.1186/s13063-017-1929-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-1929-0</ArticleId><ArticleId IdType="pmc">PMC5410049</ArticleId><ArticleId IdType="pubmed">28454590</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet J, Gallart L, Gomar C, et al. ; ARISCAT Group . Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338-1350. doi:10.1097/ALN.0b013e3181fc6e0a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181fc6e0a</ArticleId><ArticleId IdType="pubmed">21045639</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308. doi:10.1056/NEJM200005043421801</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Talab HF, Zabani IA, Abdelrahman HS, et al. . Intraoperative ventilatory strategies for prevention of pulmonary atelectasis in obese patients undergoing laparoscopic bariatric surgery. Anesth Analg. 2009;109(5):1511-1516. doi:10.1213/ANE.0b013e3181ba7945</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181ba7945</ArticleId><ArticleId IdType="pubmed">19843790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould AL. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Stat Med. 1992;11(1):55-66. doi:10.1002/sim.4780110107</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780110107</ArticleId><ArticleId IdType="pubmed">1557576</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinius H, Jonsson L, Gustafsson S, et al. . Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009;111(5):979-987. doi:10.1097/ALN.0b013e3181b87edb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181b87edb</ArticleId><ArticleId IdType="pubmed">19809292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Suarez-Sipmann F, Tusman G, et al. . Open lung approach versus standard protective strategies: effects on driving pressure and ventilatory efficiency during anesthesia&#x2014;a pilot, randomized controlled trial. PLoS One. 2017;12(5):e0177399. doi:10.1371/journal.pone.0177399</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177399</ArticleId><ArticleId IdType="pmc">PMC5426745</ArticleId><ArticleId IdType="pubmed">28493943</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838-854. doi:10.1097/00000542-200504000-00021</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200504000-00021</ArticleId><ArticleId IdType="pubmed">15791115</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ldner A, Kiss T, Serpa Neto A, et al. . Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology. 2015;123(3):692-713. doi:10.1097/ALN.0000000000000754</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000754</ArticleId><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ldner A, Braune A, Ball L, et al. . Comparative effects of volutrauma and atelectrauma on lung inflammation in experimental acute respiratory distress syndrome. Crit Care Med. 2016;44(9):e854-e865. doi:10.1097/CCM.0000000000001721</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001721</ArticleId><ArticleId IdType="pmc">PMC5105831</ArticleId><ArticleId IdType="pubmed">27035236</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Rocco PRM, Gama de Abreu M. Close down the lungs and keep them resting to minimize ventilator-induced lung injury. Crit Care. 2018;22(1):72. doi:10.1186/s13054-018-1991-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-1991-3</ArticleId><ArticleId IdType="pmc">PMC5861643</ArticleId><ArticleId IdType="pubmed">29558993</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MB, Meade MO, Slutsky AS, et al. . Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755. doi:10.1056/NEJMsa1410639</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1410639</ArticleId><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, et al. ; PROVE Network Investigators . Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4(4):272-280. doi:10.1016/S2213-2600(16)00057-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni N, Williams P. Positive pressure ventilation: what is the real cost? Br J Anaesth. 2008;101(4):446-457. doi:10.1093/bja/aen240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen240</ArticleId><ArticleId IdType="pubmed">18782885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira SM, Tucci MR, Morais CCA, et al. . Individual positive end-expiratory pressure settings optimize intraoperative mechanical ventilation and reduce postoperative atelectasis. Anesthesiology. 2018;129(6):1070-1081. doi:10.1097/ALN.0000000000002435</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002435</ArticleId><ArticleId IdType="pubmed">30260897</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35094928</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>8 Pt A</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative Pulmonary Complications After Cardiac Surgery: The VENICE International Cohort Study.</ArticleTitle><Pagination><StartPage>2344</StartPage><EndPage>2351</EndPage><MedlinePgn>2344-2351</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2021.12.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(21)01108-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Postoperative pulmonary complications (PPC) remain a main issue after cardiac surgery. The objective was to report the incidence and identify risk factors of PPC after cardiac surgery.</AbstractText><AbstractText Label="DESIGN">An international multicenter prospective study (42 international centers in 9 countries).</AbstractText><AbstractText Label="PARTICIPANTS">A total of 707 adult patients who underwent cardiac surgery under cardiopulmonary bypass.</AbstractText><AbstractText Label="INTERVENTIONS">None MEASUREMENTS AND MAIN RESULTS: During a study period of 2 weeks, the investigators included all patients in their respective centers and screened for PPCs. PPC was defined as the occurrence of at least 1 pulmonary complication among the following: atelectasis, pleural effusion, respiratory failure, respiratory infection, pneumothorax, bronchospasm, or aspiration pneumonitis. Among 676 analyzed patients, 373 patients presented with a PPC (55%). The presence of PPC was significantly associated with a longer intensive care length of stay and hospital length of stay. One hundred ninety (64%) patients were not intraoperatively ventilated during cardiopulmonary bypass. Ventilation settings were similar regarding tidal volume, respiratory rate, inspired oxygen. In the regression model, age, the Euroscore II, chronic obstructive pulmonary disease, preoxygenation modality, intraoperative positive end-expiratory pressure, the absence of pre- cardiopulmonary bypass ventilation, the absence of lung recruitment, and the neuromuscular blockade were associated with PPC occurrence.</AbstractText><AbstractText Label="CONCLUSION">Both individual risk factors and ventilatory settings were shown to explain the high level of PPCs. These findings require further investigations to assess a bundle strategy for optimal ventilation strategy to decrease PPC incidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Marc-Olivier</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesth&#xe9;sie R&#xe9;animation, Caen, France. Electronic address: fischer-mo@chu-caen.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotons</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Caen University Hospital, CAEN, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briant</LastName><ForeName>Anais R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Caen University Hospital, CAEN, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suehiro</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka City, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gozdzik</LastName><ForeName>Waldemar</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Therapy, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sponholz</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkeby-Garstad</LastName><ForeName>Idar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, St. Olav University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joosten</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigro Neto</LastName><ForeName>Caetano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunstyr</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University in Prague, and General University Hospital in Prague, Prague, The Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parienti</LastName><ForeName>Jean-Jacques</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Caen University Hospital, CAEN, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou-Arab</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care department, Amiens, Hospital University, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouattara</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care department, Amiens, Hospital University, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VENICE study group</CollectiveName><AffiliationInfo><Affiliation>CHU Bordeaux, Department of Anesthesia and Critical Care, Magellan Medico-Surgical Centre, Bordeaux, France; Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesth&#xe9;sie R&#xe9;animation, Caen, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">open-lung ventilation</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">postoperative pulmonary complication</Keyword></KeywordList><CoiStatement>Conflict of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35094928</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2021.12.024</ArticleId><ArticleId IdType="pii">S1053-0770(21)01108-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38195081</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Effect of Volatile Anesthesia Versus Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>571</StartPage><EndPage>580</EndPage><MedlinePgn>571-580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006814</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of intraoperative anesthetic regimen on pulmonary outcome after minimally invasive esophagectomy for esophageal cancer is yet undetermined. The aim of this study was to determine the effect of volatile anesthesia (sevoflurane or desflurane) compared with propofol-based intravenous anesthesia on pulmonary complications after minimally invasive esophagectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients scheduled for minimally invasive esophagectomy were randomly assigned to 1 of 3 general anesthetic regimens (sevoflurane, desflurane, or propofol). The primary outcome was the incidence of pulmonary complications within the 7 days postoperatively, which was a collapsed composite end point, including respiratory infection, pleural effusion, pneumothorax, atelectasis, respiratory failure, bronchospasm, pulmonary embolism, and aspiration pneumonitis. The severity of pulmonary complications, surgery-related complications, and other secondary outcomes were also assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 647 patients assessed for eligibility, 558 were randomized, and 553 were analyzed. A total of 185 patients were assigned to the sevoflurane group, 185 in the desflurane, and 183 in the propofol group. Patients receiving a volatile anesthetic (sevoflurane or desflurane) had a significantly lower incidence (36.5% vs 47.5%; odds ratio, 0.63; 95% confidence interval, 0.44-0.91; P = .013) and lower severity grade of pulmonary complications ( P = .035) compared to the patients receiving propofol. There were no statistically significant differences in other secondary outcomes between the 2 groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients undergoing minimally invasive esophagectomy, the use of volatile anesthesia (sevoflurane or desflurane) resulted in the reduced risk and severity of pulmonary complications within the first 7 postoperative days as compared to propofol-based intravenous anesthesia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu-Tong</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital of Integrated Traditional Chinese and Western Medicine of Liangshan Prefecture, Xichang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Kai-Xi</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue-Fei</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>CRS35BZ94Q</RegistryNumber><NameOfSubstance UI="D000077335">Desflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000771" MajorTopicYN="N">Anesthesia, Intravenous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="Y">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077335" MajorTopicYN="Y">Desflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="Y">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38195081</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006814</ArticleId><ArticleId IdType="pii">00000539-202409000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Klevebro F, Elliott JA, Slaman A, et al. Cardiorespiratory comorbidity and postoperative complications following esophagectomy: a European multicenter cohort study. Ann Surg Oncol. 2019;26:2864&#x2013;2873.</Citation></Reference><Reference><Citation>Booka E, Takeuchi H, Suda K, et al. Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer. BJS Open. 2018;2:276&#x2013;284.</Citation></Reference><Reference><Citation>Seesing MFJ, Gisbertz SS, Goense L, et al. A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Ann Surg. 2017;266:839&#x2013;846.</Citation></Reference><Reference><Citation>Tsunoda S, Obama K, Hisamori S, et al. Lower incidence of postoperative pulmonary complications following robot-assisted minimally invasive esophagectomy for esophageal cancer: propensity score-matched comparison to conventional minimally invasive esophagectomy. Ann Surg Oncol. 2021;28:639&#x2013;647.</Citation></Reference><Reference><Citation>Bhayani NH, Gupta A, Dunst CM, Kurian AA, Reavis KM, Swanstrom LL. Esophagectomies with thoracic incisions carry increased pulmonary morbidity. JAMA Surg. 2013;148:733&#x2013;738.</Citation></Reference><Reference><Citation>Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS (R) ) Society Recommendations. World J Surg. 2019;43:299&#x2013;330.</Citation></Reference><Reference><Citation>Singh P, Gossage J, Markar S, et al. Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/Perioperative Quality Initiative (POQI) consensus statement on intraoperative and postoperative interventions to reduce pulmonary complications after oesophagectomy. Br J Surg. 2022;109:1096&#x2013;1106.</Citation></Reference><Reference><Citation>Durkin C, Schisler T, Lohser J. Current trends in anesthesia for esophagectomy. Curr Opin Anaesthesiol. 2017;30:30&#x2013;35.</Citation></Reference><Reference><Citation>Kaufmann K, Heinrich S. Minimizing postoperative pulmonary complications in thoracic surgery patients. Curr Opin Anaesthesiol. 2021;34:13&#x2013;19.</Citation></Reference><Reference><Citation>Beck-Schimmer B, Bonvini JM, Braun J, et al. Which anesthesia regimen is best to reduce morbidity and mortality in lung surgery?: a multicenter randomized controlled trial. Anesthesiology. 2016;125:313&#x2013;321.</Citation></Reference><Reference><Citation>de la Gala F, Pineiro P, Reyes A, et al. Postoperative pulmonary complications, pulmonary and systemic inflammatory responses after lung resection surgery with prolonged one-lung ventilation Randomized controlled trial comparing intravenous and inhalational anaesthesia. Br J Anaesth. 2017;119:655&#x2013;663.</Citation></Reference><Reference><Citation>Li XF, Hu JR, Wu Y, Chen Y, Zhang MQ, Yu H. Comparative effect of propofol and volatile anesthetics on postoperative pulmonary complications after lung resection surgery: a randomized clinical trial. Anesth Analg. 2021;133:949&#x2013;957.</Citation></Reference><Reference><Citation>Zhang GH, Wang W. Effects of sevoflurane and propofol on the development of pneumonia after esophagectomy: a retrospective cohort study. BMC Anesthesiol. 2017;17:164.</Citation></Reference><Reference><Citation>Lee JJ, Kim GH, Kim JA, et al. Comparison of pulmonary morbidity using sevoflurane or propofol-remifentanil anesthesia in an Ivor Lewis operation. J Cardiothorac Vasc Anesth. 2012;26:857&#x2013;862.</Citation></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332&#x2013;c332.</Citation></Reference><Reference><Citation>Zhang R, Liu S, Sun H, et al. The application of single-lumen endotracheal tube anaesthesia with artificial pneumothorax in thoracolaparoscopic oesophagectomy. Interact Cardiovasc Thorac Surg. 2014;19:308&#x2013;310.</Citation></Reference><Reference><Citation>van Workum F, Slaman AE, van Berge Henegouwen MI, et al. Propensity score-matched analysis comparing minimally invasive Ivor Lewis versus minimally invasive mckeown esophagectomy. Ann Surg. 2020;271:128&#x2013;133.</Citation></Reference><Reference><Citation>Ye H, Wang X, Li X, et al. Effect of single-port inflatable mediastinoscopy simultaneous laparoscopic-assisted radical esophagectomy on respiration and circulation. J Cardiothorac Surg. 2021;16:288.</Citation></Reference><Reference><Citation>Yu H, Tian W, Xu Z, et al. Patient-controlled intravenous analgesia with opioids after thoracoscopic lung surgery: a randomized clinical trial. BMC Anesthesiol. 2022;22:253.</Citation></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, et al.; Writing Committee for the PROBESE Collaborative Group of the PROtective VEntilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology. Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low peep on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321:2292&#x2013;2305.</Citation></Reference><Reference><Citation>Li XF, Jiang D, Jiang YL, et al. Comparison of low and high inspiratory oxygen fraction added to lung-protective ventilation on postoperative pulmonary complications after abdominal surgery: a randomized controlled trial. J Clin Anesth. 2020;67:110009.</Citation></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205&#x2013;213.</Citation></Reference><Reference><Citation>Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013;118:1332&#x2013;1340.</Citation></Reference><Reference><Citation>Shi W, Chen Y, Zhang MQ, Che GW, Yu H. Effects of methylprednisolone on early postoperative pain and recovery in patients undergoing thoracoscopic lung surgery: a randomized controlled trial. J Clin Anesth. 2021;75:110526.</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;3107.</Citation></Reference><Reference><Citation>Walsh M, Srinathan SK, McAuley DF, et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol. 2014;67:622&#x2013;628.</Citation></Reference><Reference><Citation>Canet J, Gallart L, Gomar C, et al.; ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113:1338&#x2013;1350.</Citation></Reference><Reference><Citation>Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286&#x2013;294.</Citation></Reference><Reference><Citation>Schilling T, Kozian A, Senturk M, et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology. 2011;115:65&#x2013;74.</Citation></Reference><Reference><Citation>Schilling T, Kozian A, Kretzschmar M, et al. Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth. 2007;99:368&#x2013;375.</Citation></Reference><Reference><Citation>Demarquette A, Perrault T, Alapetite T, et al. Spin and fragility in randomised controlled trials in the anaesthesia literature: a systematic review. Br J Anaesth. 2023;130:528&#x2013;535.</Citation></Reference><Reference><Citation>Wagner J, Strosing KM, Spassov SG, et al. Sevoflurane posttreatment prevents oxidative and inflammatory injury in ventilator-induced lung injury. PLoS One. 2018;13:e0192896.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36008492</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1041</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of clinical pharmacology</Title><ISOAbbreviation>Eur J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies.</ArticleTitle><Pagination><StartPage>1613</StartPage><EndPage>1622</EndPage><MedlinePgn>1613-1622</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00228-022-03374-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Asthma is a heterogeneous disease with a wide range of symptoms. Severe asthma exacerbations (SAEs) are characterized by worsening symptoms and bronchospasm requiring emergency department visits. In addition to conventional strategies for SAEs (inhaled &#x3b2;-agonists, anticholinergics, and systemic corticosteroids), another pharmacological option is represented by ketamine. We performed a systematic review to explore the role of ketamine in refractory SAEs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic search on PubMed and EMBASE up to August 12th, 2021. We selected prospective studies only, and outcomes of interest were oxygenation/respiratory parameters, clinical status, need for invasive ventilation and effects on weaning.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included a total of seven studies, five being randomized controlled trials (RCTs, population range 44-92 patients). The two small prospective studies (n&#x2009;=&#x2009;10 and n&#x2009;=&#x2009;11) did not have a control group. Four studies focused on adults, and three enrolled a pediatric population. We found a large heterogeneity regarding sample size, age and gender distribution, inclusion criteria (different severity scores, if any) and ketamine dosing (bolus and/or continuous infusion). Of the five RCTs, three compared ketamine to placebo, while one used fentanyl and the other aminophylline. The outcomes evaluated by the included studies were highly variable. Despite paucity of data and large heterogeneity, an overview of the included studies suggests absence of clear benefit produced by ketamine in patients with refractory SAE, and some signals towards side effects.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our systematic review does not support the use of ketamine in refractory SAE. A limited number of prospective studies with large heterogeneity was found. Well-designed multicenter RCTs are desirable.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>La Via</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy. luigilavia7@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy. luigilavia7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuttone</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dezio</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University "Magna Graecia", Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brancati</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crimi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pneumology, AOU "Policlinico - San Marco", Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astuto</LastName><ForeName>Marinella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Pharmacol</MedlineTA><NlmUniqueID>1256165</NlmUniqueID><ISSNLinking>0031-6970</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>27Y3KJK423</RegistryNumber><NameOfSubstance UI="D000628">Aminophylline</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000628" MajorTopicYN="N">Aminophylline</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="Y">Anti-Asthmatic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018680" MajorTopicYN="N">Cholinergic Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminophylline</Keyword><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Fentanyl</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008492</ArticleId><ArticleId IdType="pmc">PMC9482594</ArticleId><ArticleId IdType="doi">10.1007/s00228-022-03374-3</ArticleId><ArticleId IdType="pii">10.1007/s00228-022-03374-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet (London, England) 2018;391(10122):783&#x2013;800. doi: 10.1016/s0140-6736(17)33311-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(17)33311-1</ArticleId><ArticleId IdType="pubmed">29273246</ArticleId></ArticleIdList></Reference><Reference><Citation>To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet LP. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi: 10.1186/1471-2458-12-204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-204</ArticleId><ArticleId IdType="pmc">PMC3353191</ArticleId><ArticleId IdType="pubmed">22429515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102&#x2013;1112. doi: 10.1164/rccm.201901-0016OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201901-0016OC</ArticleId><ArticleId IdType="pmc">PMC6888652</ArticleId><ArticleId IdType="pubmed">31166782</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Bas&#xe1;&#xf1;ez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernab&#xe9; E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, F&#xe8;vre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Le&#xf2;n FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England) 2012;380(9859):2163&#x2013;2196. doi: 10.1016/s0140-6736(12)61729-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(12)61729-2</ArticleId><ArticleId IdType="pmc">PMC6350784</ArticleId><ArticleId IdType="pubmed">23245607</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021 doi: 10.1016/j.jaip.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.001</ArticleId><ArticleId IdType="pubmed">34718211</ArticleId></ArticleIdList></Reference><Reference><Citation>Donner CF, Amaducci S, Bacci E, Baldacci S, Bartoli ML, Beghi GM, Benfante A, Brighindi S, Casali L, Castiglia D, Cazzola M, Celi A, Cianchetti S, Colombo G, Crimi C, Dente FL, Di Maria G, Di Maria A, Latorre M, Lavorini F, Maio S, Mannini C, Messina R, Paggiaro PL, Pignatti P, Price D, Scichilone N, Simoni M, Spanevello A, Stagno d'Alcontres M, Tan S, Torchio R, Viegi G, Visca D, Wouters EFM, Yu Hui Xin S (2018) Inhalation therapy in the next decade: determinants of adherence to treatment in asthma and COPD. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 88(1): 886. 10.4081/monaldi.2018.886</Citation><ArticleIdList><ArticleId IdType="pubmed">29557582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelaia C, Crimi C. Indacaterol/Glycopyrronium/Mometasone fixed dose combination for uncontrolled asthma. Expert Rev Respir Med. 2021 doi: 10.1080/17476348.2021.2011222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2021.2011222</ArticleId><ArticleId IdType="pubmed">34845963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular targets for biological therapies of severe asthma. Front Immunol. 2020;11:603312. doi: 10.3389/fimmu.2020.603312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603312</ArticleId><ArticleId IdType="pmc">PMC7734054</ArticleId><ArticleId IdType="pubmed">33329598</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffler E, Terranova G, Chessari C, Frazzetto V, Crimi C, Fichera S, Picardi G, Nicolosi G, Porto M, Intravaia R, Crimi N. Point-of-care blood eosinophil count in a severe asthma clinic setting. Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology. 2017;119(1):16&#x2013;20. doi: 10.3389/fimmu.2020.603312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603312</ArticleId><ArticleId IdType="pubmed">28668237</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46&#x2013;52. doi: 10.1097/aci.0000000000000492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aci.0000000000000492</ArticleId><ArticleId IdType="pubmed">30516546</ArticleId></ArticleIdList></Reference><Reference><Citation>Caminati M, Vaia R. Uncontrolled asthma: unmet needs in the management of patients. 2021;14:457&#x2013;466. doi: 10.2147/jaa.s260604.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jaa.s260604</ArticleId><ArticleId IdType="pmc">PMC8104981</ArticleId><ArticleId IdType="pubmed">33976555</ArticleId></ArticleIdList></Reference><Reference><Citation>Furci F, Guarnieri G, Senna G, Crimi C, Campisi R, Noto A, Genco S, Cacopardo G, Nolasco S, Crimi N. Comparability of asthma control test scores between self and physician-administered test. Journal of asthma and allergy. 2020;170:106015. doi: 10.2147/jaa.s260604.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jaa.s260604</ArticleId><ArticleId IdType="pubmed">32843163</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma (2021) Global strategy for asthma management and prevention. Available at: http://www.ginasthma.org</Citation></Reference><Reference><Citation>Stefan MS, Nathanson BH, Lagu T, Priya A, Pekow PS, Steingrub JS, Hill NS, Goldberg RJ, Kent DM, Lindenauer PK. Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation. Ann Am Thorac Soc. 2016;13(7):1096&#x2013;1104. doi: 10.1513/AnnalsATS.201510-701OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201510-701OC</ArticleId><ArticleId IdType="pmc">PMC5015747</ArticleId><ArticleId IdType="pubmed">27070493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Roberts C, McLaughlin T. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology. 2004;93(1):29&#x2013;35. doi: 10.1016/s1081-1206(10)61444-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1081-1206(10)61444-5</ArticleId><ArticleId IdType="pubmed">15281469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016;37(7):865&#x2013;872. doi: 10.1038/aps.2016.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2016.5</ArticleId><ArticleId IdType="pmc">PMC4933765</ArticleId><ArticleId IdType="pubmed">27018176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowacka A, Borczyk M. Ketamine applications beyond anesthesia - a literature review. Eur J Pharmacol. 2019;860:172547. doi: 10.1016/j.ejphar.2019.172547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172547</ArticleId><ArticleId IdType="pubmed">31348905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol. 2008;182:313&#x2013;333. doi: 10.1007/978-3-540-74806-9_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-74806-9_15</ArticleId><ArticleId IdType="pubmed">18175098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA, Jr, Gould TD. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621&#x2013;660. doi: 10.1124/pr.117.015198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.015198</ArticleId><ArticleId IdType="pmc">PMC6020109</ArticleId><ArticleId IdType="pubmed">29945898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihaljevi&#x107; S, Pavlovi&#x107; M, Reiner K, &#x106;a&#x107;i&#x107; M. Therapeutic mechanisms of ketamine. Psychiatr Danub. 2020;32(3&#x2013;4):325&#x2013;333. doi: 10.24869/psyd.2020.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.24869/psyd.2020.325</ArticleId><ArticleId IdType="pubmed">33370729</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmingsen C, Nielsen PK, Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med. 1994;12(4):417&#x2013;420. doi: 10.1016/0735-6757(94)90051-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-6757(94)90051-5</ArticleId><ArticleId IdType="pubmed">8031424</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46(1):43&#x2013;50. doi: 10.1016/j.annemergmed.2005.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2005.02.024</ArticleId><ArticleId IdType="pubmed">15988425</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmailian M, Koushkian Esfahani M, Heydari F. The effect of low-dose ketamine in treating acute asthma attack; a randomized clinical trial. Emergency (Tehran, Iran) 2018;6(1):e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6036522</ArticleId><ArticleId IdType="pubmed">30009223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Guglani V, Jat KR. Ketamine versus aminophylline for acute asthma in children: a randomized, controlled trial. Annals of thoracic medicine. 2016;11(4):283&#x2013;288. doi: 10.4103/1817-1737.191874.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1817-1737.191874</ArticleId><ArticleId IdType="pmc">PMC5070438</ArticleId><ArticleId IdType="pubmed">27803755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedel W, Costa R, Mendez G, Marin L, Vargas T, Marques L. Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. Anaesthesiology intensive therapy. 2020;52(3):215&#x2013;218. doi: 10.5114/ait.2020.97765.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2020.97765</ArticleId><ArticleId IdType="pmc">PMC10172964</ArticleId><ArticleId IdType="pubmed">32876408</ArticleId></ArticleIdList></Reference><Reference><Citation>Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27(2):170&#x2013;175. doi: 10.1016/s0196-0644(96)70319-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0196-0644(96)70319-0</ArticleId><ArticleId IdType="pubmed">8629747</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo TM, Fortenberry JD, Linzer JF, Simon HK. Emergency department use of ketamine in pediatric status asthmaticus. The Journal of asthma : official journal of the Association for the Care of Asthma. 2001;38(8):657&#x2013;664. doi: 10.1081/jas-100107543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/jas-100107543</ArticleId><ArticleId IdType="pubmed">11758894</ArticleId></ArticleIdList></Reference><Reference><Citation>Heshmati F, Zeinali MB, Noroozinia H, Abbacivash R, Mahoori A. Use of ketamine in severe status asthmaticus in intensive care unit. Iran J Allergy Asthma Immunol. 2003;2(4):175&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">17301376</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AP, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG, Clarke G. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT. J Affect Disord. 2015;186:306&#x2013;311. doi: 10.1016/j.jad.2015.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2015.06.033</ArticleId><ArticleId IdType="pubmed">26275358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73(2):323&#x2013;345. doi: 10.1007/s43440-021-00232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00232-4</ArticleId><ArticleId IdType="pmc">PMC7994242</ArticleId><ArticleId IdType="pubmed">33609274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pabelick CM, Jones KA, Street K, Lorenz RR, Warner DO. Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle. Anesthesiology. 1997;86(5):1104&#x2013;1111. doi: 10.1097/00000542-199705000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199705000-00014</ArticleId><ArticleId IdType="pubmed">9158360</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal S, Agrawal A. Ketamine in status asthmaticus: a review. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2013;17(3):154&#x2013;161. doi: 10.4103/0972-5229.117048.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-5229.117048</ArticleId><ArticleId IdType="pmc">PMC3777369</ArticleId><ArticleId IdType="pubmed">24082612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Hirota K, Matsuki A, Zsigmond EK, Rabito SF. The role of the N-methyl-D-aspartic acid receptor in the relaxant effect of ketamine on tracheal smooth muscle. Anesth Analg. 1998;87(6):1383&#x2013;1388. doi: 10.1097/00000539-199812000-00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-199812000-00033</ArticleId><ArticleId IdType="pubmed">9842833</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol. 2005;204(1):27&#x2013;35. doi: 10.1016/j.taap.2004.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2004.08.011</ArticleId><ArticleId IdType="pubmed">15781291</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera AM, Brand P, Cavada G, Koppmann A, Rivas M, Mackenney J, Sep&#xfa;lveda H, Wevar ME, Cruzat L, Soto S, P&#xe9;rez MA, Le&#xf3;n A, Contreras I, Alvarez C, Walker B, Flores C, Lezana V, Garrido C, Herrera ME, Rojas A, Andrades C, Chala E, Mart&#xed;nez RA, Vega M, Perill&#xe1;n JA, Seguel H, Przybyzsweski I. Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study. Allergol Immunopathol. 2019;47(3):282&#x2013;288. doi: 10.1016/j.aller.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC7125869</ArticleId><ArticleId IdType="pubmed">30595390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27273556</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>The bronchodilator response in preschool children: A systematic review.</ArticleTitle><Pagination><StartPage>1242</StartPage><EndPage>1250</EndPage><MedlinePgn>1242-1250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.23459</ELocationID><Abstract><AbstractText Label="BACKGROUND">The bronchodilator response (BDR) is frequently used to support diagnostic and therapeutic decision-making for children who wheeze. However, there is little evidence-based guidance describing the role of BDR testing in preschool children and it is unclear whether published cut-off values, which are derived from adult data, can be applied to this population.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, EMBASE, Web of Science, and Cochrane databases (inception-September 2015) for studies reporting response to a bronchodilator in healthy preschool children, response following placebo inhalation, and the diagnostic efficacy of BDR compared with a clinical diagnosis of asthma/recurrent wheezing.</AbstractText><AbstractText Label="FINDINGS">We included 14 studies. Thirteen studies provided BDR data from healthy preschool children. Two studies reported response to placebo in preschool children with asthma/recurrent wheezing. Twelve studies compared BDR measurements from preschool children with asthma/recurrent wheeze to those from healthy children and seven of these studies reported diagnostic efficacy. Significant differences between the BDR measured in healthy preschool children compared with that in children with asthma/recurrent wheeze were demonstrated in some, but not all studies. Techniques such as interrupter resistance, oscillometry, and plethysmography were more consistently successfully completed than spirometry. Between study heterogeneity precluded determination of an optimum technique.</AbstractText><AbstractText Label="INTERPRETATION">There is little evidence to suggest spirometry-based BDR can be used in the clinical assessment of preschool children who wheeze. Further evaluation of simple alternative techniques is required. Future studies should recruit children in whom airways disease is suspected and should evaluate the ability of BDR testing to predict treatment response. Pediatr Pulmonol. 2016;51:1242-1250. &#xa9; 2016 Wiley Periodicals, Inc.</AbstractText><CopyrightInformation>&#xa9; 2016 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raywood</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lum</LastName><ForeName>Sooky</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aurora</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pike</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom. k.pike@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. k.pike@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="Y">Bronchodilator Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009991" MajorTopicYN="N">Oscillometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma and early wheeze</Keyword><Keyword MajorTopicYN="N">bronchodilator response</Keyword><Keyword MajorTopicYN="N">preschool child</Keyword><Keyword MajorTopicYN="N">pulmonary function testing (PFT)</Keyword><Keyword MajorTopicYN="N">spirometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27273556</ArticleId><ArticleId IdType="doi">10.1002/ppul.23459</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35226725</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Prophylactic Penehyclidine Inhalation for Prevention of Postoperative Pulmonary Complications in High-risk Patients: A Double-blind Randomized Trial.</ArticleTitle><Pagination><StartPage>551</StartPage><EndPage>566</EndPage><MedlinePgn>551-566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004159</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postoperative pulmonary complications are common. Aging and respiratory disease provoke airway hyperresponsiveness, high-risk surgery induces diaphragmatic dysfunction, and general anesthesia contributes to atelectasis and peripheral airway injury. This study therefore tested the hypothesis that inhalation of penehyclidine, a long-acting muscarinic antagonist, reduces the incidence of pulmonary complications in high-risk patients over the initial 30 postoperative days.</AbstractText><AbstractText Label="METHODS">This single-center double-blind trial enrolled 864 patients age over 50 yr who were scheduled for major upper-abdominal or noncardiac thoracic surgery lasting 2 h or more and who had an Assess Respiratory Risk in Surgical Patients in Catalonia score of 45 or higher. The patients were randomly assigned to placebo or prophylactic penehyclidine inhalation from the night before surgery through postoperative day 2 at 12-h intervals. The primary outcome was the incidence of a composite of pulmonary complications within 30 postoperative days, including respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, and aspiration pneumonitis.</AbstractText><AbstractText Label="RESULTS">A total of 826 patients (mean age, 64 yr; 63% male) were included in the intention-to-treat analysis. A composite of pulmonary complications was less common in patients assigned to penehyclidine (18.9% [79 of 417]) than those receiving the placebo (26.4% [108 of 409]; relative risk, 0.72; 95% CI, 0.56 to 0.93; P = 0.010; number needed to treat, 13). Bronchospasm was less common in penehyclidine than placebo patients: 1.4% (6 of 417) versus 4.4% (18 of 409; relative risk, 0.327; 95% CI, 0.131 to 0.82; P = 0.011). None of the other individual pulmonary complications differed significantly. Peak airway pressures greater than 40 cm H2O were also less common in patients given penehyclidine: 1.9% (8 of 432) versus 4.9% (21 of 432; relative risk, 0.381; 95% CI, 0.171 to 0.85; P = 0.014). The incidence of other adverse events, including dry mouth and delirium, that were potentially related to penehyclidine inhalation did not differ between the groups.</AbstractText><AbstractText Label="CONCLUSIONS">In high-risk patients having major upper-abdominal or noncardiac thoracic surgery, prophylactic penehyclidine inhalation reduced the incidence of pulmonary complications without provoking complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xin-Quan</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guo-Jun</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China; the Department of Anesthesiology, Aerospace Central Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei-Ou</ForeName><Initials>WO</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China; the Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China; the Department of Anesthesiology, Beijing Fangshan Liangxiang Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Liang-Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China; the Department of Anesthesiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Kun-Yao</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Sai-Nan</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Biostatistics, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong-Xin</ForeName><Initials>DX</Initials><Identifier Source="ORCID">0000-0002-3205-1836</Identifier><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China; the Outcomes Research Consortium, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>the Outcomes Research Consortium, Cleveland, Ohio; the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011812">Quinuclidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>353CX8CSHD</RegistryNumber><NameOfSubstance UI="C486140">penehyclidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesthesiology. 2023 Feb 1;138(2):232. doi: 10.1097/ALN.0000000000004203.</RefSource><PMID Version="1">35404994</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="Y">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="Y">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011812" MajorTopicYN="N">Quinuclidines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>28</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35226725</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004159</ArticleId><ArticleId IdType="pii">135653</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37780107</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-8293</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The journal of allergy and clinical immunology. Global</Title><ISOAbbreviation>J Allergy Clin Immunol Glob</ISOAbbreviation></Journal><ArticleTitle>Incidence of perioperative hypersensitivity reactions: A&#xa0;single-center, prospective, US cohort experience.</ArticleTitle><Pagination><StartPage>88</StartPage><EndPage>92</EndPage><MedlinePgn>88-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacig.2022.09.010</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A previous study, using administrative data, reported an incidence of perioperative anaphylaxis (POA) of 1:6537 procedures in the United States.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">We sought to determine the incidence of POA in a prospective US cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Adult participants undergoing a procedure at a single tertiary care center were studied prospectively between April 2018 and January 2022. Subinvestigators recorded vital signs and skin checks preoperatively, 15 minutes into induction, and hourly thereafter until 1 hour into the postoperative period. If participants developed an adverse reaction, additional variables were documented: causal agent(s) exposure, type of nonallergic adverse reaction, Sixth National Audit Project severity score, evidence of mast cell activation by serum acute and baseline tryptase pairing, Allergy consult, and causal agent identification.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 939 procedures (mean age, 59.25&#xa0;&#xb1; 14.78 years; 58% females; 87% White), there were 12 (1.3%) cases with an identified adverse reaction. Nine cases were classified as nonhypersensitivity adverse reactions (1%) and 3 as possible hypersensitivity reactions (0.3%); 1 case was classified as suspected perioperative hypersensitivity and 2 as POA (0.2%). Both POA cases were males, had previous procedures, had evidence of mast cell activation, had a Sixth National Audit Project score of 3, and were referred to Allergy for further evaluation. There were 9 participants who developed a nonhypersensitivity adverse reaction: relative overdose of anesthetic (n&#xa0;= 6), transient rash (n&#xa0;= 2), and isolated bronchospasm (n&#xa0;= 1). All transient rashes were observed during undraping protocol.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In our prospective study, the incidence of POA is 1:470 procedures. Our study suggests that the incidence of POA may be higher than previously reported.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonzalez-Estrada</LastName><ForeName>Alexei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avila-Castano</LastName><ForeName>Karol</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irizarry-Alvarado</LastName><ForeName>Joan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pai</LastName><ForeName>Sher-Lu</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volcheck</LastName><ForeName>Gerald W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Deparment of Allergic Diseases, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol Glob</MedlineTA><NlmUniqueID>9918453488706676</NlmUniqueID><ISSNLinking>2772-8293</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">POA</Keyword><Keyword MajorTopicYN="N">POH</Keyword><Keyword MajorTopicYN="N">anaphylaxis</Keyword><Keyword MajorTopicYN="N">hypersensitivity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37780107</ArticleId><ArticleId IdType="pmc">PMC10509856</ArticleId><ArticleId IdType="doi">10.1016/j.jacig.2022.09.010</ArticleId><ArticleId IdType="pii">S2772-8293(22)00090-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mertes P.M., Ebo D.G., Garcez T., Rose M., Sabato V., Takazawa T., et al. Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth. 2019;123:e16&#x2013;e28.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Estrada A., Carrillo-Martin I., Renew J.R., Rank M.A., Campbell R.L., Volcheck G.W. Incidence of and risk factors for perioperative or periprocedural anaphylaxis in the United States from 2005 to 2014. Ann Allergy Asthma Immunol. 2021;126:180&#x2013;186.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">33068738</ArticleId></ArticleIdList></Reference><Reference><Citation>Savic L.C., Kaura V., Yusaf M., Hammond-Jones A.M., Jackson R., Howell S., et al. Incidence of suspected perioperative anaphylaxis: a multicenter snapshot study. J Allergy Clin Immunol Pract. 2015;3:454&#x2013;455.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">25687288</ArticleId></ArticleIdList></Reference><Reference><Citation>Berroa F., Lafuente A., Javaloyes G., Cabrera-Freitag P., de la Borbolla J.M., Moncada R., et al. The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study. Anesth Analg. 2015;121:117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">25902325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook T.M., Harper N.J.N., Farmer L., Garcez T., Floss K., Marinho S., et al. Anaesthesia, surgery, and life-threatening allergic reactions: protocol and methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists. Br J Anaesth. 2018;121:124&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">29935564</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitte J., Amadei L., Gouitaa M., Mezouar S., Zieleskiewicz L., Albanese J., et al. Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: an observational study. Allergy. 2019;74:1157&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">30793322</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey L. In: Drug allergy testing. DA Khan A.B., editor. Elsevier; New York, NY: 2018. Perioperative anaphylaxis; pp. 223&#x2013;238.</Citation></Reference><Reference><Citation>Lieberman P., Nicklas R.A., Randolph C., Oppenheimer J., Bernstein D., Bernstein J., et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">26505932</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper N.J., Dixon T., Dugu&#xe9; P., Edgar D.M., Fay A., Gooi H.C., et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia. 2009;64:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3082210</ArticleId><ArticleId IdType="pubmed">19143700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33947626</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0828</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of internal medicine</Title><ISOAbbreviation>Eur J Intern Med</ISOAbbreviation></Journal><ArticleTitle>Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>88</EndPage><MedlinePgn>77-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejim.2021.04.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0953-6205(21)00124-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Inhaled antibiotics (IA) in non-cystic fibrosis bronchiectasis (NCFB) are recommended by some clinical practice guidelines for prevention or treatment of NCFB exacerbations.</AbstractText><AbstractText Label="METHODS">We performed a systematic review and meta-analysis to evaluate the efficacy and safety of IA use for treatment of adults with NCFB and Pseudomonas aeruginosa chronic bronchial infection. The search was performed in the Cochrane Library, PubMed, and Web of Science databases from 2000 to 2019. Studies of IA for treatment of stable or exacerbated NCFB adults (&#x2265;18 years) with P. aeruginosa infection were considered eligible. PROSPERO Registration number: CRD42019136154.</AbstractText><AbstractText Label="RESULTS">Twelve trials (2476 participants) were included. IA therapy increased P. aeruginosa eradication from sputum in patients with exacerbations (OR: 3.19, 95%CI: 1.70-5.99) with similar effects on stable patients (OR: 7.22, 95%CI: 2.81-18.59), and a trend to reduced emergence of new respiratory pathogens (OR: 0.58, 95%CI: 0.28-1.18). IA achieved significant reduced exacerbation rates (RR: 0.90; 95%CI: 0.82-0.98) in stable patients, with a number needed to treat (NNT) of 59, but no significant changes in FEV<sub>1</sub>, mortality, hospitalizations or quality of life were identified. In stable patients, IA use increased antimicrobial resistance (RR: 2.10, 95%CI: 1.35-3.27) at the end of therapy, with a number needed to treat of 6.</AbstractText><AbstractText Label="CONCLUSIONS">IA therapy achieved a statistically significant eradication of P. aeruginosa from sputum, with a 10% reduction of exacerbations in stable patients. This effect has to be balanced with significant increases in antimicrobial resistance. Our meta-analysis failed to show a significant benefit in terms of patient-centered outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tejada</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Clinical Research/Epidemiology&#xa0;in Pneumonia &amp; Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain. Electronic address: stmagraner@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campogiani</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sol&#xe9;-Lleonart</LastName><ForeName>Candela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitari de Vic, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez</LastName><ForeName>Aroa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Donor &amp; Transplant Coordination, Vall d'Hebron University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallego</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Respiratory Department, Parc Taul&#xed; University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vendrell</LastName><ForeName>Monserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Clinical Research/Epidemiology&#xa0;in Pneumonia &amp; Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain; Respiratory Department, Dr. Josep Trueta University Hospital, Girona, Spain; Insitut d'Investigaci&#xf3; Biom&#xe8;dica de Girona (IDIBGI), Universitat de Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soriano</LastName><ForeName>Joan B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitario La Princesa, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rello</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Clinical Research/Epidemiology&#xa0;in Pneumonia &amp; Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain; Clinical Research in the ICU, Anesthesia Department, CHU Nimes, Universite de Nimes-Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Intern Med</MedlineTA><NlmUniqueID>9003220</NlmUniqueID><ISSNLinking>0953-6205</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001987" MajorTopicYN="Y">Bronchiectasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003550" MajorTopicYN="Y">Cystic Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011552" MajorTopicYN="Y">Pseudomonas Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aerosolized antibiotics</Keyword><Keyword MajorTopicYN="N">Bronchiectasis</Keyword><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Chronic respiratory tract infection</Keyword><Keyword MajorTopicYN="N">Non-cystic fibrosis</Keyword><Keyword MajorTopicYN="N">P. aeruginosa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33947626</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2021.04.009</ArticleId><ArticleId IdType="pii">S0953-6205(21)00124-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39587607</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Inhaled antibiotics for treating pneumonia in invasively ventilated patients in intensive care unit: a meta-analysis of randomized clinical trials with trial sequential analysis.</ArticleTitle><Pagination><StartPage>387</StartPage><MedlinePgn>387</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">387</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05159-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">The use of inhaled antibiotics for treating pneumonia in invasively ventilated patients offers a direct approach, allowing for high local concentrations of the drug in the lower respiratory tract while simultaneously reducing systemic toxicity. However, the real efficacy and safety of nebulized antibiotics remain unclear. The aim of the present is to assess among critically adult patients with pneumonia and invasive ventilation, whether receiving adjuvant inhaled antibiotics improves the rate of microbiological eradication.</AbstractText><AbstractText Label="METHODS">A comprehensive literature search of randomized clinical trials (RCTs) was conducted (from inception until September 20, 2024, PROSPERO-CRD592906) across Medline, Embase, and Scopus. Randomized controlled trials, enrolling intensive care units (ICU) patients with pneumonia and comparing nebulized antimicrobial therapy (inhaled group) with intravenous antimicrobial treatment or intravenous antimicrobial therapy plus inhaled placebo (control group), were included. The primary outcome was the rate of microbiological eradication after treatment. Secondary outcomes were the rate of clinical recovery, the incidence of drug-related adverse events, ICU and hospital mortality. A qualitative analysis was conducted according to the GRADE framework. Data were pooled using an odds-ratio analysis. The heterogeneity and reliability of our results were evaluated using the I<sup>2</sup>-statistic and trial sequential analysis (TSA), respectively.</AbstractText><AbstractText Label="RESULTS">A total of 11 RCTs (1472 patients) met the inclusion criteria. Compared to controls, the use of adjuvant inhaled antibiotics determined a greater rate of microbiological eradication (OR 2.63, 95% CI 1.36-5.09; low certainty of evidence). The TSA confirmed the reliability of our primary outcome. Moreover, nebulized antibiotics increased the risk of bronchospasm (OR 3.15, 95% CI 1.33-7.47; high evidence), while nephrotoxicity, clinical recovery, ICU and hospital survival (either in the case of pneumonia caused by MDR bacteria or not) were not different between groups.</AbstractText><AbstractText Label="CONCLUSIONS">In conclusion, compared to the sole intravenous therapy, the use of adjuvant inhaled antibiotics for treatment of pneumonia in invasively ventilated critically ill patients was associated with a greater incidence of microbiological eradication (low GRADE and high risk of publication bias), but not with clinical recovery and survival.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sella</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pettenuzzo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cassai</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Section of Anaesthesiology and Intensive Care, University of Padua, 13, Vincenzo Gallucci Street, 35125, Padua, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarantonello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Congedi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Section of Anaesthesiology and Intensive Care, University of Padua, 13, Vincenzo Gallucci Street, 35125, Padua, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocagli</LastName><ForeName>Honoria</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregori</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, Padua University Hospital, Padua, Italy. paolo.navalesi@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Section of Anaesthesiology and Intensive Care, University of Padua, 13, Vincenzo Gallucci Street, 35125, Padua, PD, Italy. paolo.navalesi@unipd.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Section of Anaesthesiology and Intensive Care, University of Padua, 13, Vincenzo Gallucci Street, 35125, Padua, PD, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PADOVA ICU Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Inhaled</Keyword><Keyword MajorTopicYN="N">Multi-drug resistant</Keyword><Keyword MajorTopicYN="N">Multi-drug resistant organism</Keyword><Keyword MajorTopicYN="N">Nebulized</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Bertoncello</LastName><ForeName>Carlo Albero</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franchetti</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiavolin</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carofiglio</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guidotto</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Lorenzi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Legnaro</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nardelli</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pistollato</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mormando</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peralta</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petranzan</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muraro</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Persona</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pacchiarini</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>1</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39587607</ArticleId><ArticleId IdType="pmc">PMC11587605</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05159-9</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05159-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fernando SM, Tran A, Cheng W, Klompas M, Kyeremanteng K, Mehta S, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive Care Med. 2020;46(6):1170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223448</ArticleId><ArticleId IdType="pubmed">32306086</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragoza R, Vidal-Cort&#xe9;s P, Aguilar G, Borges M, Diaz E, Ferrer R, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care Lond Engl. 2020;24(1):383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322703</ArticleId><ArticleId IdType="pubmed">32600375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudeck MA, Weiner LM, Allen-Bridson K, Malpiedi PJ, Peterson KD, Pollock DA, et al. National healthcare safety network (NHSN) report, data summary for 2012 Device-associated module. Am J Infect Control. 2013;41(12):1148&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4629786</ArticleId><ArticleId IdType="pubmed">24274911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta AB, Syeda SN, Wiener RS, Walkey AJ. Epidemiological trends in invasive mechanical ventilation in the United States: a population-based study. J Crit Care. 2015;30(6):1217&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628853</ArticleId><ArticleId IdType="pubmed">26271686</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44:S27-72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107997</ArticleId><ArticleId IdType="pubmed">17278083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;63(5):e61-111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981759</ArticleId><ArticleId IdType="pubmed">27418577</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci&#xf3;n Latinoamericana del T&#xf3;rax (ALAT). Eur Respir J. 2017;50(3):1700582.</Citation><ArticleIdList><ArticleId IdType="pubmed">28890434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med. 2008;36(4):1089&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">18379232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, et al. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care Lond Engl. 2012;16(6):R218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672596</ArticleId><ArticleId IdType="pubmed">23148736</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad SS, Rodriguez AH, Chuang YC, Marjanek Z, Pareigis AJ, Reis G, et al. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59(1):51&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305133</ArticleId><ArticleId IdType="pubmed">24723282</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti M, Rinaldi M, Bonazzetti C, Gaibani P, Giannella M, Viale P, Pea F. Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? Antimicrob Agents Chemother. 2023;67(11): e0096923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10648963</ArticleId><ArticleId IdType="pubmed">37843260</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo A, Sella N, Pettenuzzo T, De Cassai A, Crociani S, Schiavolin C, et al. Multidrug-resistant and extended-spectrum &#x3b2;-lactamase gram-negative bacteria in bilateral lung transplant recipients: incidence, risk factors, and in-hospital mortality. Chest. 2022;162(6):1255&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">35850288</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30156569</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4181663</ArticleId><ArticleId IdType="pubmed">24768475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodvold KA, George JM, Yoo L. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents. Clin Pharmacokinet. 2011;50(10):637&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">21895037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, Luyt CE, Nicolau DP, Pugin J. Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Ann Intensive Care. 2016;6(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835402</ArticleId><ArticleId IdType="pubmed">27090532</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederman MS, Alder J, Bassetti M, Boateng F, Cao B, Corkery K, et al. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial. Lancet Infect Dis. 2020;20(3):330&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">31866328</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen RA, Howes D, Maslove DM. Is mortality a useful primary end point for critical care trials? Chest. 2020;158(1):206&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">31790654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Maan L, Anand N, Yadav G, Mishra M, Gupta MK. The efficacy and safety of intravenous colistin plus aerosolized colistin versus intravenous colistin alone in critically Ill trauma patients with multi-drug resistant gram-negative bacilli infection. Cureus. 2023;15(11): e49314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10748797</ArticleId><ArticleId IdType="pubmed">38143689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiseo G, Brigante G, Giacobbe DR, Maraolo AE, Gona F, Falcone M, et al. Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM). Int J Antimicrob Agents. 2022;60(2): 106611.</Citation><ArticleIdList><ArticleId IdType="pubmed">35697179</ArticleId></ArticleIdList></Reference><Reference><Citation>Angermair S, Deja M, Thronicke A, Grehn C, Akbari N, Uhrig A, et al. A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP). Anaesth Crit Care Pain Med. 2023;42(5): 101249.</Citation><ArticleIdList><ArticleId IdType="pubmed">37217019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cassai A, Boscolo A, Zarantonello F, Pettenuzzo T, Sella N, Geraldini F, et al. Enhancing study quality assessment: an in-depth review of risk of bias tools for meta-analysis-a comprehensive guide for anesthesiologists. J Anesth Analg Crit Care. 2023;3(1):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10626791</ArticleId><ArticleId IdType="pubmed">37932825</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar MA, Abdalla W. Effect of extended infusion of meropenem and nebulized amikacin on gram-negative multidrug-resistant ventilator-associated pneumonia. Saudi J Anaesth. 2018;12(1):89&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789513</ArticleId><ArticleId IdType="pubmed">29416463</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cassai A, Pasin L, Boscolo A, Salvagno M, Navalesi P. Trial sequential analysis: plain and simple. Korean J Anesthesiol. 2021;74(4):363&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342843</ArticleId><ArticleId IdType="pubmed">33333708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo A, Spiezia L, De Cassai A, Pasin L, Pesenti E, Zatta M, et al. Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis. J Crit Care. 2021;61:5&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33049490</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. Am J Respir Crit Care Med. 2014;189(10):1225&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">24646034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar YS, Saber-Ayad M, Shash RY. Combined microbiological and clinical outcomes of short-term inhaled colistin adjunctive therapy in ventilator-associated pneumonia. Egypt J Chest Dis Tuberc. 2018;67(4):376.</Citation></Reference><Reference><Citation>Liu C, Zhang YT, Peng ZY, Zhou Q, Hu B, Zhou H, et al. Aerosolized amikacin as adjunctive therapy of ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: a single-center randomized controlled trial. Chin Med J (Engl). 2017;130(10):1196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443026</ArticleId><ArticleId IdType="pubmed">28485320</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan MJ, Rabbani R, Anam AM, Santini A, Huq SMR. The Susceptibility of MDR-K. Pneumoniae to polymyxin B plus its nebulised form versus polymyxin B alone in critically Ill South Asian Patients. J Crit Care Med Univ Med Si Farm Din Targu-Mures. 2021;7(1):28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8519379</ArticleId><ArticleId IdType="pubmed">34722901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S. Polymyxin B plus aerosolized colistin vs polymyxin B alone in hospital-acquired pneumonia (&#x201c;AEROCOL&#x201d; Study): a feasibility study. Indian J Crit Care Med. 2024;28(8):792&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11372667</ArticleId><ArticleId IdType="pubmed">39239172</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael S, Niederman MS, Chastre J, Corkery K, Fink JB, Luyt CE, Garc&#xed;a MS. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. Intensive Care Med. 2012;38(2):263&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">22147112</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Bu W, Guo T, Geng Z, Shao M. Development and validation of an in-hospital mortality risk prediction model for patients with severe community-acquired pneumonia in the intensive care unit. BMC Pulm Med. 2023;23(1):303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436447</ArticleId><ArticleId IdType="pubmed">37592285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wang Z, Liu Z, Wang J, Ma L. Association between time of discharge from ICU and hospital mortality: a systematic review and meta-analysis. Crit Care Lond Engl. 2016;20(1):390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131545</ArticleId><ArticleId IdType="pubmed">27903270</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL. Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? No Intensive Care Med. 2016;42(11):1778&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">27620286</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederman MS. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;51(Suppl 1):S12-17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20597660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe9;-Lleonart C, Rouby JJ, Blot S, Poulakou G, Chastre J, Palmer LB, et al. Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anesthesiology. 2017;126(5):890&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">28248714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, He LL, Che LQ, Li W, Ying SM, Chen ZH, et al. Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Crit Care Lond Engl. 2018;22(1):301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238320</ArticleId><ArticleId IdType="pubmed">30442203</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med. 2008;36(7):2008&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">18552684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ. Nebulized antibiotics study group: nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by pseudomonas aeruginosa. Am J Respir Crit Care Med. 2011;184:106&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21474643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorham J, Taccone FS, Hites M. How to use nebulized antibiotics in severe respiratory infections. Antibiot Basel Switz. 2023;12(2):267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952454</ArticleId><ArticleId IdType="pubmed">36830177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko J, Pawar S, Seppelt I, Brar G. Is it the end of the road for inhaled antibiotic therapy in ventilator-associated pneumonia? In: Chacko J, Pawar S, Seppelt I, Brar G, editors. Controversies in critical care. Springer Nature: Singapore; 2023. p. 373&#x2013;80. 10.1007/978-981-19-9940-6_43.</Citation></Reference><Reference><Citation>Daniels LM, Juliano J, Marx A, Weber DJ. Inhaled antibiotics for hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64(3):386&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27803096</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lyu S, Luo J, Liu P, Albuainain FA, Alamoudi OA, Rochette V, Ehrmann S. Prophylactic antibiotics delivered via the respiratory tract to reduce ventilator-associated pneumonia: a systematic review, network meta-analysis, and trial sequential analysis of randomized controlled trials. Crit Care Med. 2024;52(10):1612&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">38722206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampieri FG, Nassar AP, Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT. Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Lond Engl. 2015;19(1):150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4403838</ArticleId><ArticleId IdType="pubmed">25887226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurjar M. Colistin for lung infection: an update. J Intensive Care. 2015;3(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4336271</ArticleId><ArticleId IdType="pubmed">25705428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii. Anesthesiology. 2012;117(6):1335&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">23132092</ArticleId></ArticleIdList></Reference><Reference><Citation>Luque S, Grau S, Valle M, Sorl&#xed; L, Horcajada JP, Segura C, et al. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2013;42(2):178&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">23769664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39402635</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>A systematic review on the use of sevoflurane in the management of status asthmaticus in adults.</ArticleTitle><Pagination><StartPage>334</StartPage><MedlinePgn>334</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05122-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">To conduct a systematic review looking into the use of sevoflurane in the management of status asthmaticus (SA) in adults.</AbstractText><AbstractText Label="METHODS">We performed a systematic search on PubMed, EMBASE, and The Cochrane Library - CENTRAL through 23rd August 2023, restricting to studies reported in English. We included studies reporting use of sevoflurane in asthmatics beyond its use as an anaesthetic agent in surgeries i.e. in the emergency department (ED) and critical care setting, and focused on patient's clinical parameters, ventilation pressures and weaning of invasive ventilation.</AbstractText><AbstractText Label="RESULTS">A total of 13 publications fulfilled the inclusion criteria, comprising of 18 cases. All publications were of case reports/ series and conference abstracts, and no randomised trials were available. Most patients required intubation despite best medical management before sevoflurane administration, and high airway pressures and respiratory acidosis were apparent. There was significant heterogeneity regarding severity of asthma, treatment instituted, and the delivery, duration and concentration of sevoflurane administered. Many of the studies also did not quantify the changes in parameters pre- and post-sevoflurane. Sixteen patients experienced improvements in clinical status with sevoflurane administration-one required escalation to extracorporeal membrane oxygenation (ECMO), and another did not survive.</AbstractText><AbstractText Label="CONCLUSION">The systematic review suggests sevoflurane can be a valuable treatment option in SA. As these cases are rare and heterogenous, further prospective case series are needed to support this.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Gerald Wai Kit</ForeName><Initials>GWK</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, National University Hospital, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore. gerald.ho@mohh.com.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thaarun</LastName><ForeName>Thirumeninathan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ee</LastName><ForeName>Neo Jean</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Teo Chong</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Medicine, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Koh Zheng</ForeName><Initials>KZ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, National University Hospital, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cove</LastName><ForeName>Matthew Edward</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loh</LastName><ForeName>Will Ne-Hooi</ForeName><Initials>WN</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, National University Hospital, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="Y">Sevoflurane</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013224" MajorTopicYN="Y">Status Asthmaticus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Intubation</Keyword><Keyword MajorTopicYN="N">Respiratory acidosis</Keyword><Keyword MajorTopicYN="N">Sevoflurane</Keyword><Keyword MajorTopicYN="N">Status asthmaticus</Keyword><Keyword MajorTopicYN="N">Volatile agent</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402635</ArticleId><ArticleId IdType="pmc">PMC11476279</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05122-8</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05122-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty RK, Basnet S. Status asthmaticus. StatPearls Publishing. 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK526070/</Citation><ArticleIdList><ArticleId IdType="pubmed">30252326</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergraft TB, Stanford RH, Beasley R, et al. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol. 2004;93(1):29&#x2013;35. 10.1016/S1081-1206(10)61444-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15281469</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood P, Rathmell JP, Urman RD. Stoelting&#x2019;s Pharmacology &amp; Physiology in Anaesthetic Practice, 5th Ed. Wolters Kluwer, 2015.</Citation></Reference><Reference><Citation>Habre W, Pet&#xe1;k F, Sly PD, et al. Protective effects of volatile agents against methacholine-induced bronchoconstriction in rats. Anesthesiology. 2001;94(2):348&#x2013;53. 10.1097/00000542-200102000-00026.</Citation><ArticleIdList><ArticleId IdType="pubmed">11176101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz N, Pet&#xe1;k F, Barazzone-Argiroffo C, et al. Effects of volatile anaesthetic agents on enhanced airway tone in sensitized guinea pigs. Br J Anaesth. 2004;92(2):254&#x2013;60. 10.1093/bja/aeh049.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722179</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G , Shea B , O&#x2019;Connell D et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa, Ontario: The Ottawa Health Research Institute, 2011.</Citation></Reference><Reference><Citation>Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60&#x2013;3. 10.1136/bmjebm-2017-110853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234235</ArticleId><ArticleId IdType="pubmed">29420178</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmel B, Patel K, Fox D, et al. An unexpected trial: Sevoflurane in status asthmaticus. Obstructive Lung Diseases, Chest J. 2021;160(4):A1769. 10.1016/j.chest.2021.07.1612.</Citation></Reference><Reference><Citation>Munusamy S, Monfared SSN, Iqbal P, Abdussalam ALM. Challenging case of severe acute asthma in a mechanically ventilated patient managed with sevoflurane. Clin Case Rep. 2023;11(2):e6571. 10.1002/ccr3.6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9949361</ArticleId><ArticleId IdType="pubmed">36846180</ArticleId></ArticleIdList></Reference><Reference><Citation>Maqsood U, Patel N. Extracorporeal membrane oxygenation (ECMO) for near-fatal asthma refractory to conventional ventilation. BMJ Case Rep. 2018;2018:bcr2017223276. 10.1136/bcr-2017-223276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5878337</ArticleId><ArticleId IdType="pubmed">29559484</ArticleId></ArticleIdList></Reference><Reference><Citation>Adi O, Apoo FN, Fong CP, et al. Inhaled volatile anesthetic gas for severe bronchospasm in the emergency department. Am J Emerg Med. 2023;68:213.e5-213.e9. 10.1016/j.ajem.2023.04.032.</Citation><ArticleIdList><ArticleId IdType="pubmed">37120400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori N, Nagata H, Ohta S, Suzuki M. Prolonged sevoflurane inhalation was not nephrotoxic in two patients with refractory status asthmaticus. Anesth Analg. 1996;83(1):189&#x2013;91. 10.1097/00000539-199607000-00035.</Citation><ArticleIdList><ArticleId IdType="pubmed">8659736</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan LM, Hoffman TL. Refractory status asthmaticus: treatment with sevoflurane. Fed Pract. 2019;36(10):476&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6837338</ArticleId><ArticleId IdType="pubmed">31768099</ArticleId></ArticleIdList></Reference><Reference><Citation>Najout H, Moutawakil M, Elkoundi A, et al. Salbutamol-induced severe lactic acidosis in acute asthma. SAGE Open Med Case Rep. 2020;8:63. 10.1177/2050313X20969027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826258</ArticleId><ArticleId IdType="pubmed">35154769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng D, Fahimi J, Hern HG. Sevoflurane administration initiated out of the ED for life-threatening status asthmaticus. Am J Emerg Med. 2015;33(8):1110.e3-6. 10.1016/j.ajem.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">25662208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruszkai Z, Bokr&#xe9;t&#xe1;s GP, Bartha PT. Sevoflurane therapy for life-threatening acute severe asthma: a case report. Can J Anaesth. 2014;61(10):943&#x2013;50. 10.1007/s12630-014-0213-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">25069782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorour K, Vyas PA, Raval DS, et al. Successful treatment of severe asthma exacerbation with sevoflurane inhalation in the intensive care unit. J Anesth Crit Care Open Access. 2015;3(2):00092. 10.15406/jaccoa.2015.03.00092.</Citation></Reference><Reference><Citation>Littlefield L, Donaldson R, Kagunye S, et al. Successful use of inhaled sevoflurane in refractory adult status asthmaticus: a case series. Allergy Airway Chest J. 2020;158(4):A53-54. 10.1016/j.chest.2020.08.083.</Citation></Reference><Reference><Citation>Sinniah R, Ahmed MU, Makki I, Khan MMHS. Terminal refractory intubated status asthmaticus: challenges posed in the treatment of a pregnant patient refractory to inhaled sevoflurane and VV-ECMO. Am J Respiratory Critical Care Med. 2021;5:203.</Citation></Reference><Reference><Citation>Baigel G. Volatile agents to avoid ventilating asthmatics. Anaesth Intensive Care. 2003;31(2):208&#x2013;10. 10.1177/0310057X0303100213.</Citation><ArticleIdList><ArticleId IdType="pubmed">12712788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesnil M, Capdevila X, Bringuier S, et al. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med. 2011;37(6):933&#x2013;41. 10.1007/s00134-011-2187-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">21445642</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen QY, Fang L, Wu HM, et al. Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation. Respirology. 2015;20(2):258&#x2013;63. 10.1111/resp.12439.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakage M, Hirshman CA, Croxton TL. Volatile anesthetics inhibit voltage-dependent Ca2+ channels in porcine tracheal smooth muscle cells. Am J Physiol. 1995;268(2 Pt 1):L187&#x2013;91. 10.1152/ajplung.1995.268.2.L187.</Citation><ArticleIdList><ArticleId IdType="pubmed">7864139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakage M. Editorial II: effects of anaesthetic agents on airway smooth muscles. BJA. 2002;88(5):624&#x2013;7. 10.1093/bja/88.5.624.</Citation><ArticleIdList><ArticleId IdType="pubmed">12066996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen XD, Yamakage M, Namiki A. Inhibitory effects of volatile anesthetics on K+ and Cl&#x2212; channel currents in porcine tracheal and bronchial smooth muscle. Anesthesiology. 2002;96:458&#x2013;66. 10.1097/00000542-200202000-00035.</Citation><ArticleIdList><ArticleId IdType="pubmed">11818782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooke GA, Choi JH, Bishop MJ. The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology. 1997;86:1294&#x2013;9. 10.1097/00000542-199706000-00010.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197298</ArticleId></ArticleIdList></Reference><Reference><Citation>Swenson ER, Robertson HT, Polissar NL, et al. Conducting airway gas exchange: diffusion-related differences in inert gas elimination. J Appl Physiol. 1985;72(4):1581&#x2013;8. 10.1152/jappl.1992.72.4.1581.</Citation><ArticleIdList><ArticleId IdType="pubmed">1317375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiklund CU, Lim S, Lindsten U, Lindahl SG. Relaxation by sevoflurane, desflurane and halothane in the isolated guinea-pig trachea via inhibition of cholinergic neurotransmission. Br J Anaesth. 1999;83(3):422&#x2013;9. 10.1093/bja/83.3.422.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly L, Kolbe J, Mitzner W, et al. Bronchial blood flow affects recovery from constriction in dog lung periphery. J Appl Physiol. 1986;60(6):1954&#x2013;9. 10.1152/jappl.1986.60.6.1954.</Citation><ArticleIdList><ArticleId IdType="pubmed">3722062</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler J. The bronchial circulation. News Physiol Sci. 1991;6:21&#x2013;5. 10.1152/physiologyonline.1991.6.1.21.</Citation></Reference><Reference><Citation>Warner DO, Vettermann J, Brichant JF, Rehder K. Direct and neurally mediated effects of halothane on pulmonary resistance in vivo. Anesthesiology. 1990;72(6):1057&#x2013;63. 10.1097/00000542-199006000-00017.</Citation><ArticleIdList><ArticleId IdType="pubmed">2350021</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakage M. Effects of anaesthetic agents on airway smooth muscles. Br J Anaesth. 2002;88(5):624&#x2013;7. 10.1093/bja/88.5.624.</Citation><ArticleIdList><ArticleId IdType="pubmed">12066996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondo&#xf1;edo JR, McNeil JS, Amin SD, et al. Volatile anesthetics and the treatment of severe bronchospasm: a concept of targeted delivery. Drug Discov Today Dis Models. 2015;15:43&#x2013;50. 10.1016/j.ddmod.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4698912</ArticleId><ArticleId IdType="pubmed">26744597</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel DB, Debas YM, Girmay FL, et al. Perioperative management of patients with asthma during elective surgery: a systematic review. Ann Med Surg. 2021;70:102874. 10.1016/j.amsu.2021.102874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8473668</ArticleId><ArticleId IdType="pubmed">34603720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutte D, Zwitserloot AM, Houmes R, et al. Sevoflurane therapy for life-threatening asthma in children. Br J Anaesth. 2013;111(6):967&#x2013;70. 10.1093/bja/aet257.</Citation><ArticleIdList><ArticleId IdType="pubmed">23884875</ArticleId></ArticleIdList></Reference><Reference><Citation>Katherine R, Simon F. Sedation in the intensive care unit. Continu Educ Anaesthesia Critic Care Pain. 2008;8(2):50&#x2013;5. 10.1093/bjaceaccp/mkn005.</Citation></Reference><Reference><Citation>Soukup J, Michel P, Christel A, et al. Prolonged sedation with sevoflurane in comparison to intravenous sedation in critically ill patients-a randomized controlled trial. J Crit Care. 2023;74:154251. 10.1016/j.jcrc.2022.154251.</Citation><ArticleIdList><ArticleId IdType="pubmed">36640476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bito H, Ikeda K. Closed-circuit anesthesia with sevoflurane in humans. Effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit. Anesthesiology. 1994;80(1):71&#x2013;6. 10.1097/00000542-199401000-00014.</Citation><ArticleIdList><ArticleId IdType="pubmed">8291733</ArticleId></ArticleIdList></Reference><Reference><Citation>Conzen PF, Nuscheler M, Melotte A, et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg. 1995;81(3):569&#x2013;75. 10.1097/00000539-199509000-00026.</Citation><ArticleIdList><ArticleId IdType="pubmed">7653825</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x2019;Heud&#xe9; M, Poignant S, Elaroussi D, et al. Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit. BJA. 2019;122(5):E73&#x2013;5. 10.1016/j.bja.2019.02.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabibel R, Gerard L, Maiter D, et al. Complete nephrogenic diabetes insipidus after prolonged sevoflurane sedation: a case report of 3 cases. Int Anesthesia Res Soc. 2019;12(5):155&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30130280</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyldermans M, Jennes S, Morrison S, et al. Partial nephrogenic diabetes insipidus in a burned patient receiving sevoflurane sedation with an anesthetic conserving device-a case report. Crit Care Med. 2016;44(12):e1246&#x2013;50. 10.1097/CCM.0000000000001956.</Citation><ArticleIdList><ArticleId IdType="pubmed">27414478</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, Otsuka F, Ogura T, et al. Sevoflurane anaesthesia causes a transient decrease in aquaporin-2 and impairment of urine concentration. BJA. 1999;83(5):734&#x2013;9. 10.1093/bja/83.5.734.</Citation><ArticleIdList><ArticleId IdType="pubmed">10690135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneyd JR. Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead. BJA. 2022;129(1):7&#x2013;10. 10.1016/j.bja.2022.02.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">35331541</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner DA, Heitz D, Cooper MK, et al. Isoflurane for life-threatening bronchospasm: a 15-year single-center experience. Respir Care. 2012;57(11):1857&#x2013;64. 10.4187/respcare.01605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3825849</ArticleId><ArticleId IdType="pubmed">22417969</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med. 2006;32:927&#x2013;33. 10.1007/s00134-006-0163-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">16614808</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Prac Res Clin Anaesthesiol. 2005;19:523&#x2013;38. 10.1016/j.bpa.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">16013698</ArticleId></ArticleIdList></Reference><Reference><Citation>Canelli R, Spence N, Gonzalez M, et al. The ventilator management team: repurposing anesthesia workstations and personnel to combat COVID-19. J Intensive Care Med. 2020;35(9):927&#x2013;32. 10.1177/0885066620942097.</Citation><ArticleIdList><ArticleId IdType="pubmed">32677498</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickworth T, Jerath A, DeVine R, et al. The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report. Can J Anesth. 2013;60:38&#x2013;43. 10.1007/s12630-012-9814-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23132045</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell R, Oomen G, Carey P. A technical review of the history, development and performance of the anaesthetic conserving device &#x201c;AnaConDa&#x201d; for delivering volatile anaesthetic in intensive and post-operative critical care. J Clin Monit Comput. 2018;32(4):595&#x2013;604. 10.1007/s10877-017-0097-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6061082</ArticleId><ArticleId IdType="pubmed">29388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Rodr&#xed;guez R, Mu&#xf1;oz Mart&#xed;nez A, Galan Serrano J, Moral Garc&#xed;a MV. Health worker exposure risk during inhalation sedation with sevoflurane using the (AnaConDa&#xae;) anaesthetic conserving device. Rev Esp Anestesiol Reanim. 2014;61(3):133&#x2013;9. 10.1016/j.redar.2013.11.011.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein DH, Raval MV. Operating room efficiency. Semin Pediatr Surg. 2018;27(2):79&#x2013;85. 10.1053/j.sempedsurg.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">29548356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson K, Wands B. Review of anesthesia versus intensive care unit ventilators and ventilatory strategies: COVID-19 patient management implications. AANA J. 2021;89(1):62&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33501910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bristle TJ, Collins S, Hewer I, Hollifield K. Anesthesia and critical care ventilator modes: past, present, and future. AANA J. 2014;82(5):387&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">25842654</ArticleId></ArticleIdList></Reference><Reference><Citation>Stather DR, Stewart TE. Clinical review: mechanical ventilation in severe asthma. Crit Care. 2005;9(6):581&#x2013;7. 10.1186/cc3733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414026</ArticleId><ArticleId IdType="pubmed">16356242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackey P, Marting CR, Nise G, Radell P. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the anesthetic conserving device. Crit Care Med. 2005;33(3):585&#x2013;90. 10.1097/01.CCM.0000156294.92415.E2.</Citation><ArticleIdList><ArticleId IdType="pubmed">15753751</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliari M, Bellani G, Rona R, et al. Short-term evaluation of sedation with sevoflurane administered by anesthetic conserving device in critically ill patients. Intensiv Care Med. 2009;35:1240&#x2013;6. 10.1007/s00134-009-1414-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19189080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabanne R, Perbet S, Futier E, et al. Impact of the anesthetic conserving device on respiratory parameters and work of breathing in critically ill patients under light sedation with sevoflurane. Anesthesiology. 2014;121(4):808&#x2013;16. 10.1097/ALN.0000000000000394.</Citation><ArticleIdList><ArticleId IdType="pubmed">25111218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturesson LW, Bodelsson M, Johansson A, et al. Apparent dead space with the anesthetic conserving device, AnaConDa&#xae;: a clinical and laboratory investigation. Anesth Analg. 2013;117(6):1319&#x2013;24. 10.1213/ANE.0b013e3182a7778e.</Citation><ArticleIdList><ArticleId IdType="pubmed">24257381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturesson LW, Bodelsson M, Jonson B, Malmkvist G. Anaesthetic conserving device AnaConDa: dead space effect and significance for lung protective ventilation. Br J Anaesth. 2014;113(3):508&#x2013;14. 10.1093/bja/aeu102.</Citation><ArticleIdList><ArticleId IdType="pubmed">24871871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackey PV, Martling CR, Radell PJ. Three cases of PICU sedation with isoflurane delivered by the &#x201c;AnaConDa.&#x201d; Paediatr Anaesth. 2005;15(10):879&#x2013;85. 10.1111/j.1460-9592.2005.01704.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">16176317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25530053</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1735-9694</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>12</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Acta medica Iranica</Title><ISOAbbreviation>Acta Med Iran</ISOAbbreviation></Journal><ArticleTitle>Coincidence of asthma and bronchospasm during anesthesia in tympanomastoidectomy.</ArticleTitle><Pagination><StartPage>905</StartPage><EndPage>908</EndPage><MedlinePgn>905-8</MedlinePgn></Pagination><Abstract><AbstractText>High prevalence of asthma and bronchospasm was observed during induction of anesthesia in patients with chronic suppurative otitis mMedia (CSOM) who underwent tympanomastoidectomy. Although several studies have proposed association of allergic diseases with CSOM but no consensus about it has been established. Current study was designed to determine the coincidence of asthma in CSOM patients. In a cross-sectional study, authors investigated medical records of 106 CSOM patients underwent tympanomastoidectomy, aged 15 to 65 years, and 95 controls, which were matched by age and sex. Participants were admitted to Valiasr Hospital, Tehran, Iran, from April of 2011 to March of 2013. Required information, such as demographic characteristics and history of allergic rhinitis (AR) and asthma were obtained from patients' medical records. The prevalence of AR in the CSOM group was higher than controls' group (19.8% and 15.8%, respectively) (P&gt;0.05). Asthma prevalence was significantly higher in patients with CSOM (P=0.03) (OR=7.67, 95% CI: &#xa0;0.9-62.5). No significant association was found between history of AR and chronic ear infections. However, asthma was significantly more common in CSOM patients. Current study indicates that asthma and risk of bronchospasm need particular attention in patients with CSOM underwent tympanomastoidectomy before and during anesthesia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hosseinzadeh</LastName><ForeName>Nima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. nima_hd87@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadi</LastName><ForeName>Shahram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. sh_samadi@sina.tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amali</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. a_amali@sina.tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafari Javid</LastName><ForeName>Mihan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. mihanjavid@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Acta Med Iran</MedlineTA><NlmUniqueID>14540050R</NlmUniqueID><ISSNLinking>0044-6025</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010035" MajorTopicYN="N">Otitis Media, Suppurative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065631" MajorTopicYN="N">Rhinitis, Allergic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25530053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36660020</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1687-6962</ISSN><JournalIssue CitedMedium="Print"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Anesthesiology research and practice</Title><ISOAbbreviation>Anesthesiol Res Pract</ISOAbbreviation></Journal><ArticleTitle>Perioperative Respiratory Outcome of Patients with Eosinophilia: A Cohort Study in a Tertiary Care Hospital.</ArticleTitle><Pagination><StartPage>8514949</StartPage><MedlinePgn>8514949</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8514949</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/8514949</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A respiratory adverse event is one of the main causes of critical events in the perioperative period. Perioperative distress symptoms like cough and stridor have been reported to occur in patients with hyperreactive airways.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study was conducted to determine the relationship between blood eosinophil count and perioperative adverse respiratory events among different age groups of patients who require general anesthesia for different types of surgeries.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A cohort study was conducted on 197 patients of either gender, aged 3&#x2009;years and above, belonging to ASA classes I-II, who were scheduled to undergo surgery requiring general anesthesia and intubation. Patients were stratified according to absolute eosinophil count into two groups: Group A (AEC 0 to 499/mm<sup>3</sup>) and Group B (AEC 500 to 1000/mm<sup>3</sup>). Patients were monitored for 24&#x2009;hours in the perioperative period for adverse respiratory events such as bronchospasm, laryngospasm, a fall in SPO2&#x2009;&lt;&#x2009;95%, and cough and stridor.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 197 patients were evaluated, with a median age of 37&#x2009;&#xb1;&#x2009;14.4&#x2009;years. The percentage range of adverse respiratory events across different age groups was 35% in adults to 60% in children. Major complications noted were a fall in SPO2&#x2009;&lt;&#x2009;95% (62.5%) and cough (27.7%) as per CTCAE v5.0 (November 27, 2017). The Naranjo score of adverse respiratory events was categorized as possible with mild level 1 severity. Adverse respiratory events were managed with humidified oxygen, antitussives, and bronchodilators.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Eosinophilia is seen in one-third of the patients undergoing surgical interventions. Patients with a blood eosinophil count of &#x2265;400/mm<sup>3</sup> had an increased risk of exacerbations of respiratory adverse events in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Nari M. Lyngdoh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyngdoh</LastName><ForeName>Nari M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0002-6619-2987</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabah</LastName><ForeName>Rajani</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2397-4775</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Sunny</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7599-7077</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sailo</LastName><ForeName>Laltanpuii</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6177-4654</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakya</LastName><ForeName>Raju</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2408-2429</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahlang</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2918-8265</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shylla</LastName><ForeName>Badondor</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6737-8505</Identifier><AffiliationInfo><Affiliation>Nursing College, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naskar</LastName><ForeName>Chhandasi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0363-0422</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiol Res Pract</MedlineTA><NlmUniqueID>101532982</NlmUniqueID><ISSNLinking>1687-6962</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>2</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36660020</ArticleId><ArticleId IdType="pmc">PMC9845031</ArticleId><ArticleId IdType="doi">10.1155/2023/8514949</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Warner D. O., Warner M. A., Barnes R. D., et al. Perioperative respiratory complications in patients with asthma. Anesthesiology . 1996;85(3):460&#x2013;467. doi: 10.1097/00000542-199609000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199609000-00003</ArticleId><ArticleId IdType="pubmed">8853074</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswara G. Anesthetic concerns in patients with hyper-reactive airways. Karnataka Anaesthesia Journal . 2015 Jan 1;1(1):8&#x2013;16. doi: 10.4103/2394-6954.149714.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2394-6954.149714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shomali W., Gotlib J. World Health Organization&#x2010;defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology . 2019;94(10):1149&#x2013;1167. doi: 10.1002/ajh.25617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25617</ArticleId><ArticleId IdType="pubmed">31423623</ArticleId></ArticleIdList></Reference><Reference><Citation>Leru P. M. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clinical and Translational Allergy . 2019;9(1):36&#x2013;39. doi: 10.1186/s13601-019-0277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13601-019-0277-4</ArticleId><ArticleId IdType="pmc">PMC6657042</ArticleId><ArticleId IdType="pubmed">31367340</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers J., Rothenberg M. E. Eosinophils in mucosal immune responses. Mucosal Immunology . 2015;8(3):464&#x2013;475. doi: 10.1038/mi.2015.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.2</ArticleId><ArticleId IdType="pmc">PMC4476057</ArticleId><ArticleId IdType="pubmed">25807184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravin K. A., Loy M. The eosinophil in infection. Clinical Reviews in Allergy and Immunology . 2016;50(2):214&#x2013;227. doi: 10.1007/s12016-015-8525-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-015-8525-4</ArticleId><ArticleId IdType="pubmed">26690368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee L. Y., Gu Q., Lin A. H., Khosravi M., Gleich G. Airway hypersensitivity induced by eosinophil granule-derived cationic proteins. Pulmonary Pharmacology and Therapeutics . 2019;57 doi: 10.1016/j.pupt.2019.101804.101804</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2019.101804</ArticleId><ArticleId IdType="pubmed">31096035</ArticleId></ArticleIdList></Reference><Reference><Citation>Schleich F. N., Manise M., Sele J., Henket M., Seidel L., Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilicvsneutrophilic inflammation. BMC Pulmonary Medicine . 2013 Dec;13(1):11&#x2013;18. doi: 10.1186/1471-2466-13-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2466-13-11</ArticleId><ArticleId IdType="pmc">PMC3657295</ArticleId><ArticleId IdType="pubmed">23442497</ArticleId></ArticleIdList></Reference><Reference><Citation>Miravitlles M., Soler-Catalu&#xf1;a J. J., Soriano J. B., et al. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study. Respiratory Research . 2022;23(1):49&#x2013;50. doi: 10.1186/s12931-022-01965-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01965-3</ArticleId><ArticleId IdType="pmc">PMC8897916</ArticleId><ArticleId IdType="pubmed">35248041</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelmeier C. F., Kostikas K., Fang J., et al. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations. Respiratory Research . 2019;20(1):178&#x2013;180. doi: 10.1186/s12931-019-1130-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1130-y</ArticleId><ArticleId IdType="pmc">PMC6686508</ArticleId><ArticleId IdType="pubmed">31391053</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S., Brightling C. E. Eosinophilic airway inflammation in COPD. International Journal of COPD . 2006;1(1):39&#x2013;47. doi: 10.2147/copd.2006.1.1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/copd.2006.1.1.39</ArticleId><ArticleId IdType="pmc">PMC2706606</ArticleId><ArticleId IdType="pubmed">18046901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotlib J., Cross N. C., Gilliland D. G. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Practice and Research Clinical Haematology . 2006;19(3):535&#x2013;569. doi: 10.1016/j.beha.2005.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2005.07.013</ArticleId><ArticleId IdType="pubmed">16781488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Kaur A., Suri A. K., Kaur P., Bansal M., Kaur R. Incidence of eosinophilia in rural population in north India: a study at tertiary care hospital. Annals of Pathology and Laboratory Medicine . 2017;4(1):0&#x2013;4. doi: 10.21276/apalm.2017.1044.</Citation><ArticleIdList><ArticleId IdType="doi">10.21276/apalm.2017.1044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki S. Adverse drug reaction and causality assessment scales. Lung India . 2011;28(2):p. 152. doi: 10.4103/0970-2113.80343.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-2113.80343</ArticleId><ArticleId IdType="pmc">PMC3109846</ArticleId><ArticleId IdType="pubmed">21712934</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan R., Ramya G. Adverse drug reaction-causality assessment. International Journal of Research in Pharmacy and Chemistry . 2011;1(3):606&#x2013;612.</Citation></Reference><Reference><Citation>Louis R., Sele J., Henket M., et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy . 2002;57(10):907&#x2013;912. doi: 10.1034/j.1398-9995.2002.23608.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1398-9995.2002.23608.x</ArticleId><ArticleId IdType="pubmed">12269936</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella S., Massimino M., Manzella L., et al. Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes. International Journal of Molecular Sciences . 2021;22(2):p. 486. doi: 10.3390/ijms22020486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020486</ArticleId><ArticleId IdType="pmc">PMC7825323</ArticleId><ArticleId IdType="pubmed">33418988</ArticleId></ArticleIdList></Reference><Reference><Citation>Insiripong S., Siriyakorn N. Treatment of eosinophilia with albendazole. Southeast Asian Journal of Tropical Medicine and Public Health . 2008;39(3):p. 517.</Citation><ArticleIdList><ArticleId IdType="pubmed">18564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharanunni S., Varma N., Singh Sachdeva M. U., et al. The spectrum of hypereosinophilia and associated clonal disorders&#x2013;a real world data from a tropical setting. Mediterranean Journal of Hematology and Infectious Diseases . 2018;10(1) doi: 10.4084/mjhid.2018.052.e2018052</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2018.052</ArticleId><ArticleId IdType="pmc">PMC6131107</ArticleId><ArticleId IdType="pubmed">30210745</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhumitha S., Eswaran Y., Jayaganesh P. Study on peripheral eosinophilia among paediatric patients in a tertiary care hospital. Journal of Clinical and Diagnostic Research . 2019;13(9)</Citation></Reference><Reference><Citation>Gurrieri C., Weingarten T. N., Martin D. P., et al. Allergic reactions during anesthesia at a large United States referral center. Anesthesia and Analgesia . 2011;113(5):1202&#x2013;1212. doi: 10.1213/ane.0b013e31822d45ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31822d45ac</ArticleId><ArticleId IdType="pubmed">21865494</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S., McLeod M., Torchia D., Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The Journal of clinical and aesthetic dermatology . 2013;6(6):31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718748</ArticleId><ArticleId IdType="pubmed">23882307</ArticleId></ArticleIdList></Reference><Reference><Citation>Roufosse F., Weller P. F. Practical approach to the patient with hypereosinophilia. The Journal of Allergy and Clinical Immunology . 2010;126(1):39&#x2013;44. doi: 10.1016/j.jaci.2010.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.04.011</ArticleId><ArticleId IdType="pmc">PMC2902584</ArticleId><ArticleId IdType="pubmed">20538328</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38788748</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>535</StartPage><EndPage>543</EndPage><MedlinePgn>535-543</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(24)00115-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(24)00115-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tubeless upper airway surgery in children is a complex procedure in which surgeons and anaesthetists share the same operating field. These procedures are often interrupted for rescue oxygen therapy. The efficacy of nasal high-flow oxygen to decrease the frequency of rescue interruptions in children undergoing upper airway surgery is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multicentre randomised trial conducted in five tertiary hospitals in Australia, children aged 0-16 years who required tubeless upper airway surgery were randomised (1:1) by a web-based randomisation tool to either nasal high-flow oxygen delivery or standard oxygen therapy (oxygen flows of up to 6 L/min). Randomisation was stratified by site and age (&lt;1 year, 1-4 years, and 5-16 years). Subsequent tubeless upper airway surgery procedures in the same child could be included if there were more than 2 weeks between the procedures, and repeat surgical procedures meeting this condition were considered to be independent events. The oxygen therapy could not be masked, but the investigators remained blinded until outcome data were locked. The primary outcome was successful anaesthesia without interruption of the surgical procedure for rescue oxygenation. A rescue oxygenation event was defined as an interruption of the surgical procedure to deliver positive pressure ventilation using either bag mask technique, insertion of an endotracheal tube, or laryngeal mask to improve oxygenation. There were ten secondary outcomes, including the proportion of procedures with a hypoxaemic event (SpO<sub>2</sub> &lt;90%). Analyses were done on an intention-to-treat (ITT) basis. Safety was assessed in all enrolled participants. This trial is registered in the Australian New Zealand Clinical Trials Registry, ACTRN12618000949280, and is completed.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">From Sept 4, 2018, to April 12, 2021, 581 procedures in 487 children were randomly assigned to high-flow oxygen (297 procedures) or standard care (284 procedures); after exclusions, 528 procedures (267 assigned to high-flow oxygen and 261 assigned to standard care) in 483 children (293 male and 190 female) were included in the ITT analysis. The primary outcome of successful anaesthesia without interruption for tubeless airway surgery was achieved in 236 (88%) of 267 procedures on high-flow oxygen and in 229 (88%) of 261 procedures on standard care (adjusted risk ratio [RR] 1&#xb7;02, 95% CI 0&#xb7;96-1&#xb7;08, p=0&#xb7;82). There were 51 (19%) procedures with a hypoxaemic event in the high-flow oxygen group and 57 (22%) in the standard care group (RR 0&#xb7;86, 95% CI 0&#xb7;58-1&#xb7;24). Of the other prespecified secondary outcomes, none showed a significant difference between groups. Adverse events of epistaxis, laryngospasm, bronchospasm, hypoxaemia, bradycardia, cardiac arrest, hypotension, or death were similar in both study groups.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Nasal high-flow oxygen during tubeless upper airway surgery did not reduce the proportion of interruptions of the procedures for rescue oxygenation compared with standard care. There were no differences in adverse events between the intervention groups. These results suggest that both approaches, nasal high-flow or standard oxygen, are suitable alternatives to maintain oxygenation in children undergoing upper airway surgery.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Thrasher Research Fund, the Australian and New Zealand College of Anaesthetists, the Society for Paediatric Anaesthesia in New Zealand and Australia.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2024 Published by Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taverner</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Children's Hospital, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skowno</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Children's Hospital at Westmead, Sydney, NSW, Australia; School of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallett</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Children's Hospital, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spall</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Trang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkins</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Evidence-Based Healthcare, Bond University, Robina, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Evidence-Based Healthcare, Bond University, Robina, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgoyne</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayasekaran</LastName><ForeName>Shyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slee</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose, and Throat Surgery, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose, and Throat Surgery, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The University of Queensland, Brisbane, QLD, Australia; Children's Critical Care Research Collaborative Group, Griffith University, Gold Coast University Hospital, Southport, QLD, Australia; Wesley Research Institute, Brisbane, QLD, Australia; Menzies Health Institute Queensland, Southport, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Australia Catholic University, Department of Physiotherapy, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schibler</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, St Andrew's War Memorial Hospital, Wesley Research Institute, Brisbane, QLD, Australia; College of Medicine &amp; Dentistry, James Cook University, Townsville, QLD, Australia. Electronic address: andreas.schibler@wesleyresearch.org.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="Y">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="Y">Hypoxia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests AS reports consultancy fees from Fisher &amp; Paykel Healthcare, Auckland, New Zealand. SH reports support for travel and accommodation from Fisher &amp; Paykel Healthcare, Auckland, New Zealand. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38788748</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(24)00115-2</ArticleId><ArticleId IdType="pii">S2213-2600(24)00115-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40020692</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): a multicentre, randomised, controlled, phase 3 trial.</ArticleTitle><Pagination><StartPage>447</StartPage><EndPage>459</EndPage><MedlinePgn>447-459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(25)00040-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(25)00040-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative pulmonary complications (PPCs) are a leading cause of morbidity, death, and increased use of health-care resources. We aimed to determine whether a perioperative lung expansion bundle including individualised intraoperative management reduces PPC severity in patients undergoing major open abdominal surgery compared with usual care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multicentre, randomised controlled phase 3 trial (PRIME-AIR), we enrolled adult patients (age &#x2265;18 years) scheduled for an elective open abdominal surgery that would last at least 2 h, who were at intermediate or high risk for PPCs on the basis of their Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score (a score of &#x2265;26), and who had a BMI below 35 kg/m<sup>2</sup> at 17 academic hospitals across ten states in the USA. Participants were randomly assigned (1:1), using permuted block randomisation (a mixture of blocks sizes of 2 and 4; in a 1:2 ratio), stratified by centre, to either usual care or a lung expansion bundle. The bundle comprised preoperative education on PPCs, intraoperative protective ventilation with individualised positive end-expiratory pressure (PEEP) to maximise respiratory system compliance, intraoperative neuromuscular blockade administration and reversal based on patient's weight and neuromuscular transmission monitoring, and postoperative supervised incentive spirometry and mobilisation encouragement. Anaesthesiologists at each site were also randomly assigned to either the intervention bundle group or usual care group, and at each site, at least one unmasked and one masked investigator was designated for each participant. Assessors were masked to treatment assignment. The primary outcome was the highest severity (grade 0-4) of a composite of PPCs by postoperative day 7, including hypoxaemia, respiratory symptoms, atelectasis, bronchospasm, respiratory infection, hypercapnia, pneumonia, pleural effusion, pneumothorax, and ventilatory dependence. The primary endpoint and safety were assessed in the modified intention-to-treat (mITT) population (ie, all participants randomly assigned to treatment who received surgery, and did not withdraw consent or verbal agreement, and excluded those found to be ineligible after randomisation, or for whom consent was not obtained for other reasons). This study is registered with ClinicalTrials.gov, NCT04108130, and is now complete.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Between Jan 24, 2020, and April 5, 2023, we screened 1462 patients, of whom 794 were enrolled and randomly assigned to treatment. The mITT population included 751 participants, of whom 379 (50%) were in the intervention bundle group and 372 (50%) were in the usual care group. Mean age was 61&#xb7;8 years (SD 12&#xb7;8); 360 (48%) of 751 patients were female and 391 (52%) were male; 572 (76%) were White, 44 (6%) were Black, 35 (5%) were Asian, and ten (1%) were other races or more than one race. Adherence to bundle components was high (72-98%). Patients in the intervention bundle group received higher mean PEEP (7&#xb7;5 cmH<sub>2</sub>O [SD 2&#xb7;5] vs 5&#xb7;6 cmH<sub>2</sub>O [1&#xb7;4]) and more frequent per-protocol dosing of neuromuscular blockade (334 [88%] of 379 vs 214 [58%] of 372) and reversal (322 [86%] of 375 who received reversal medication vs 250 [70%] of 358) than did those in the usual care group. By postoperative day 7, the most common PPC severity was grade 2 (211 [56%] of 379 in intervention bundle group vs 225 [60%] of 372 in the usual care group). Mean PPC severity was similar in both groups (1&#xb7;60 [SD 0&#xb7;94] vs 1&#xb7;53 [0&#xb7;93]; mean difference 0&#xb7;07 [95% CI -0&#xb7;03 to 0&#xb7;18]; p=0&#xb7;19). Occurrence of serious adverse events was similar in both groups. At 7 days postoperatively, one (&lt;1%) patient in the intervention bundle group and two (1%) in the usual care group had died; at 30 days, cumulatively, one (&lt;1%) patient and four (1%) patients had died; and at 90 days, cumulatively, six (2%) patients and five (1%) patients had died, respectively. Adverse events occurred in 71 (19%) of 379 patients in the intervention bundle group and 54 (14%) of 372 in the usual care group, and 35 (9%) patients in each group had serious adverse events.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In patients with a BMI of less than 35 kg/m<sup>2</sup> who are at moderate-to-high risk of PPCs and undergoing prolonged major open abdominal surgery, a perioperative lung expansion bundle did not reduce PPC severity compared with usual care provided at US academic hospitals.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">US National Institutes for Health National Heart, Lung, and Blood Institute.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandez-Bustamante</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Biostatistics Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frendl</LastName><ForeName>Gyorgy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jae Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagrebetsky</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grecu</LastName><ForeName>Loreta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amar</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>Juraj</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ravindra A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Balachundhar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giquel</LastName><ForeName>Jadelis</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Miami, Palmetto Bay, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musch</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Massachusetts, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadler</LastName><ForeName>Jacob W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Intensive Care and Resuscitation and Outcomes Research Consortium, Department of Anesthesiology, Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Meera</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lee-Lynn</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparling</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douin</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weingarten</LastName><ForeName>Toby</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>B Taylor</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>Marcos F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, USA; Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: mfvidalm@utmb.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Perioperative Research Network (PRN) Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04108130</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL165107</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 HL140177</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 HL140177</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests AFB received investigator-initiated research grants paid to her institution from Merck Sharp &amp; Dohme and Tidal Medical Technologies. GF received royalties from Wolters-Kluwer for book publication. BS received consulting fees and honoraria from Masimo and investigator-initiated grants from Masimo and Merck. MGdA received consulting fees from Ambu for participation in a Data and Safety Monitoring Board. TW received consulting fees from Travena, Merck, and Takeda, and royalties from Elsevier for book publication. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Fernandez-Bustamante</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frendl</LastName><ForeName>Gyorgy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Jae Woo</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagrebetsky</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grecu</LastName><ForeName>Loreta</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amar</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sprung</LastName><ForeName>Juraj</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ravindra A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Balachundhar</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giquel</LastName><ForeName>Jadelis</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Musch</LastName><ForeName>Guido</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karan</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartels</LastName><ForeName>Karsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grover</LastName><ForeName>Meera</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Lee-Lynn</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sparling</LastName><ForeName>Jamie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douin</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weingarten</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vera-Arroyo</LastName><ForeName>Arnaldo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadler</LastName><ForeName>Jacob W</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiyatkin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desiderio</LastName><ForeName>Dawn</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrando-Ortola</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>B Taylor</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>Marcos F</ForeName><Initials>MF</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>1</Day><Hour>14</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>28</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40020692</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(25)00040-2</ArticleId><ArticleId IdType="pii">S2213-2600(25)00040-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28525411</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>266</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Beta-blockers and Traumatic Brain Injury: A Systematic Review, Meta-analysis, and Eastern Association for the Surgery of Trauma Guideline.</ArticleTitle><Pagination><StartPage>952</StartPage><EndPage>961</EndPage><MedlinePgn>952-961</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000002286</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine if beta-(&#x3b2;)-blockers improve outcomes after acute traumatic brain injury (TBI).</AbstractText><AbstractText Label="BACKGROUND">There have been no new inpatient pharmacologic therapies to improve TBI outcomes in a half-century. Treatment of TBI patients with &#x3b2;-blockers offers a potentially beneficial approach.</AbstractText><AbstractText Label="METHODS">Using MEDLINE, EMBASE, and CENTRAL databases, eligible articles for our systematic review and meta-analysis (PROSPERO CRD42016048547) included adult (age &#x2265; 16 years) blunt trauma patients admitted with TBI. The exposure of interest was &#x3b2;-blocker administration initiated during the hospitalization. Outcomes were mortality, functional measures, quality of life, cardiopulmonary morbidity (e.g., hypotension, bradycardia, bronchospasm, and/or congestive heart failure). Data were analyzed using a random-effects model, and represented by pooled odds ratio (OR) with 95% confidence intervals (CI) and statistical heterogeneity (I).</AbstractText><AbstractText Label="RESULTS">Data were extracted from 9 included studies encompassing 2005 unique TBI patients with &#x3b2;-blocker treatment and 6240 unique controls. Exposure to &#x3b2;-blockers after TBI was associated with a reduction of in-hospital mortality (pooled OR 0.39, 95% CI: 0.27-0.56; I = 65%, P &lt; 0.00001). None of the included studies examined functional outcome or quality of life measures, and cardiopulmonary adverse events were rarely reported. No clear evidence of reporting bias was identified.</AbstractText><AbstractText Label="CONCLUSIONS">In adults with acute TBI, observational studies reveal a significant mortality advantage with &#x3b2;-blockers; however, quality of evidence is very low. We conditionally recommend the use of in-hospital &#x3b2;-blockers. However, we recommend further high-quality trials to answer questions about the mechanisms of action, effectiveness on subgroups, dose-response, length of therapy, functional outcome, and quality of life after &#x3b2;-blocker use for TBI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alali</LastName><ForeName>Aziz S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>*Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada &#x2020;Division of Acute Care Surgery, Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA &#x2021;Eastern Association for the Surgery of Trauma, Chicago, IL &#xa7;Department of Critical Care, University Health Network, Toronto, ON, Canada &#xb6;Division of Critical Care and Department of Medicine, Mackenzie Health, Toronto, ON, Canada ||Department of Pediatrics, University of Toronto, Toronto, ON, Canada **Department of Surgery, West Virginia University, Morgantown, WV &#x2020;&#x2020;Department of Surgery, USC+LAC, Los Angeles, CA &#x2021;&#x2021;Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN &#xa7;&#xa7;Departments of Surgery, Anesthesiology/Critical Care Medicine, and Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD &#xb6;&#xb6;Division of Pulmonary and Critical Care Medicine and Center for Health Services Research, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN ||||Research Service, Nashville Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN ***Departments of Surgery and Critical Care Medicine, McGill University Health Centre, Montreal, QC, Canada &#x2020;&#x2020;&#x2020;Division of Trauma, Critical Care, and Burns, Department of Surgery, MetroHealth Medical Center, Cleveland, OH &#x2021;&#x2021;&#x2021;Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, AL, Canada &#xa7;&#xa7;&#xa7;Department of Communication Sciences and Disorders, Oxley College of Health Sciences, The University of Tulsa, Tulsa, OK &#xb6;&#xb6;&#xb6;Department of Hearing and Speech Sciences, Vanderbilt University School of Medicine, Nashville, TN ||||||Department of Surgery, University of Toronto, Toronto, ON, Canada ****Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada &#x2020;&#x2020;&#x2020;&#x2020;Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Departments of Surgery, Neurosurgery, and Hearing and Speech Sciences, Section of Surgical Sciences, Vanderbilt Brain Institute, Vanderbilt Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN &#x2021;&#x2021;&#x2021;&#x2021;Surgical Service, General Surgery Section, Nashville VA Medical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Kaushik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>McCredie</LastName><ForeName>Victoria A</ForeName><Initials>VA</Initials></Author><Author ValidYN="Y"><LastName>Golan</LastName><ForeName>Eyal</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Prakesh S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Bardes</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Hamblin</LastName><ForeName>Susan E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Haut</LastName><ForeName>Elliott R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Khwaja</LastName><ForeName>Kosar</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Nimitt J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Satish R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Laura D</ForeName><Initials>LD</Initials></Author><Author ValidYN="Y"><LastName>Nathens</LastName><ForeName>Avery B</ForeName><Initials>AB</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Mayur B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM120484</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL111111</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS024547</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="N">Brain Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>CONFLICT OF INTEREST WITH OTHER SOURCES OF SUPPORT:</b> Dr. Patel has been or is supported by the Vanderbilt Institute for Clinical and Translational Research awards (VR1584, VR5351, VR9276, VR12073) via CTSA grant UL1TR000011 (NCRR/NCATS/NIH), a 2013 EAST Trauma Foundation Research Scholarship, and speaker fees from Pfizer. Drs. Haut and Patel have served on the EAST Guidelines Section and Board of Directors. Dr. Haut is the primary investigator of a AHRQ grant (R01HS024547) of a PCORI contract (CE-12&#x2013;11&#x2013;4489). Dr. Haut receives book royalties from Lippincott, Williams, Wilkins (&#x201c;Avoiding Common ICU Errors&#x201d;), consultant and speaker fees from VHA/Vizient IMPERATIV&#xae; Advantage Performance Improvement Collaborative, and consultant and speaker fees for the Illinois Surgical Quality Improvement Collaborative. Dr. Haut was the paid author of a paper commissioned by the National Academies of Medicine.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28525411</ArticleId><ArticleId IdType="mid">NIHMS946298</ArticleId><ArticleId IdType="pmc">PMC5997270</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000002286</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menon DK, Zahed C. Prediction of outcome in severe traumatic brain injury. Current Opinion in Critical Care. 2009 Oct;15(5):437&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713837</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic Hyperactivity After Traumatic Brain Injury and the Role of Beta-Blocker Therapy. The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Dec;69(6):1602&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21045744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TY, Dunne IE, German JW. Beta blockers exposure and traumatic brain injury: a literature review. Neurosurgical Focus. 2008 Oct;25(4):E8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18828706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Berry C, Mirocha J, Salim A. Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury. Journal of Surgical Research. 2010 Sep;163(1):142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20599219</ArticleId></ArticleIdList></Reference><Reference><Citation>Radosevich JJ, Patanwala AE, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj. 2013 Nov 11;27(13&#x2013;14):1492&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24205899</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Ley EJ, Bukur M, Malinoski D, Margulies DR, Mirocha J, et al. Injury. 11. Vol. 43. Elsevier Ltd; 2012. Nov 1, Redefining hypotension in traumatic brain injury; pp. 1833&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21939970</ArticleId></ArticleIdList></Reference><Reference><Citation>POISE Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 May 31;371(9627):1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK, et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. Journal of the American College of Cardiology. 2009 Nov;54(22):2102&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">19926021</ArticleId></ArticleIdList></Reference><Reference><Citation>Alali AS, McCredie VA, Golan E, Shah PS, Nathens AB. Beta Blockers for Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis. Neurocrit Care. 2013 Sep 6;20(3):514&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24062229</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. BMJ. 7650. Vol. 336. British Medical Journal Publishing Group; 2008. Apr 26, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations; pp. 924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerwin AJ, Haut ER, Burns JB, Como JJ, Haider A, Stassen N, et al. The Eastern Association of the Surgery of Trauma approach to practice management guideline development using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Journal of Trauma and Acute Care Surgery. 73(5 Suppl 4):S283&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23114482</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. BMJ. 7652. Vol. 336. British Medical Journal Publishing Group; 2008. May 10, Going from evidence to recommendations; pp. 1049&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376019</ArticleId><ArticleId IdType="pubmed">18467413</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. BMJ. oct 18 2. Vol. 343. British Medical Journal Publishing Group; 2011. The Cochrane Collaboration&#x2019;r assessing risk of bias in randomised trials; pp. d5928&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. Springer Netherlands. 2010 Jul 22;25(9):603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Panczykowski DM, Puccio AM, Scruggs BJ, Bauer JS, Hricik AJ, Beers SR, et al. Prospective Independent Validation of IMPACT Modeling as a Prognostic Tool in Severe Traumatic Brain Injury. J Neurotrauma. 2012 Jan;29(1):47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">21933014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Berry C, Mirocha J, Salim A. Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury. Journal of Surgical Research. 2010 Sep;163(1):142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20599219</ArticleId></ArticleIdList></Reference><Reference><Citation>Neideen T, Lam M, Brasel KJ. Preinjury Beta Blockers are Associated With Increased Mortality in Geriatric Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 2008 Nov;65(5):1016&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19001968</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider EB, Efron DT, MacKenzie EJ, Rivara FP, Nathens AB, Jurkovich GJ. Premorbid Statin Use Is Associated With Improved Survival and Functional Outcomes in Older Head-Injured Individuals. The Journal of Trauma: Injury, Infection, and Critical Care. 2011 Oct;71(4):815&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21986733</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Valadka AB, Hannay HJ, Contant CF, Gopinath SP, Cormio M, et al. Prevention of secondary ischemic insults after severe head injury. Critical Care Medicine. 1999 Oct;27(10):2086&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">10548187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukur M, Lustenberger T, Cotton B, Arbabi S, Talving P, Salim A, et al. Beta-blocker exposure in the absence of significant head injuries is associated with reduced mortality in critically ill patients. The American Journal of Surgery. 2012 Nov;204(5):697&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">22578406</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D, Khoo K, Radulescu A, Cook C, Gerlach A, Papadimos T, et al. Journal of Emergencies, Trauma, and Shock. 4. Vol. 7. Medknow Publications; 2014. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients; pp. 305&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231268</ArticleId><ArticleId IdType="pubmed">25400393</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman A, Bar-Klein G, Serlin Y, Parmet Y, Heinemann U, Kaufer D. Should losartan be administered following brain injury? Expert Review of Neurotherapeutics. 2014 Nov 26;14(12):1365&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hend&#xe9;n PL, S&#xf6;ndergaard S, Rydenhag B, Reinsfelt B, Ricksten S-E, &#xc5;neman A. Can Baroreflex Sensitivity and Heart Rate Variability Predict Late Neurological Outcome in Patients With Traumatic Brain Injury? Journal of Neurosurgical Anesthesiology. 2014 Jan;26(1):50&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24064714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis PR, Dunne CE, Thompson KA, McDonald VS, Calvo RY, Badiee J, et al. Attenuation of cardiovascular stress with sympatholytics does not improve survival in patients with severe isolated traumatic brain injury. Journal of Trauma and Acute Care Surgery. 2016 Apr;80(4):643&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26713971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni S, Talving P, Wallin G, Ljungqvist O, Riddez L. Preinjury &#x3b2;-blockade is protective in isolated severe traumatic brain injury. Journal of Trauma and Acute Care Surgery. 2014 Mar;76(3):804&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24553552</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoup JP, Winkler J, Czap A, Staff I, Fortunato G, McCullough LD, et al. &#x3b2;-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage. Journal of the Neurological Sciences. 2014 Jan;336(1&#x2013;2):127&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956481</ArticleId><ArticleId IdType="pubmed">24183854</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayutham PK, Adhikary SD, Babu SK, Vedantam R, Korula G, Ramachandran A. Oxidative stress&#x2013;associated hypertension in surgically induced brain injury patients: Effects of &#x3b2;-blocker and angiotensin-converting enzyme inhibitor. Journal of Surgical Research. 2013 Jan;179(1):125&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">23020955</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb A, Semple J, Rothwell PM. Greater transmission of aortic pulsatility to the brain on propranolol versus amlodipine: Novel MRI method to measure concurrent beat-to-beat brachial and cerebral arterial pulsatility. Glasgow, UK: pp. 20150338&#x2013;9.</Citation></Reference><Reference><Citation>Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Gr&#xe4;nde PO, Koskinen LOD. Acta Anaesthesiol Scand. 4. Vol. 45. Munksgaard International Publishers; 2001. Apr, An outcome study of severe traumatic head injury using the &#x201c;Lund therapy&#x201d; with low-dose prostacyclin; pp. 402&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11300376</ArticleId></ArticleIdList></Reference><Reference><Citation>Naredi S, Ed&#xe9;n E, Z&#xe4;ll S, Stephensen H, Rydenhag B. Intensive Care Medicine. 5. Vol. 24. Springer-Verlag; 2014. Feb 26, A standardized neurosurgical/neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results; pp. 446&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">9660259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;nde PO, Nordstrom CH, Asgeirsson B. Current alternative therapy of post-traumatic brain edema. Nord Med. 1994;109(5):157&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7910683</ArticleId></ArticleIdList></Reference><Reference><Citation>Eker C, Asgeirsson B, Grande P-O, Schalen W, Nordstrom C-H. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Critical Care Medicine. 1998 Nov;26(11):1881&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9824083</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgeirsson B, Gr&#xe4;nde PO, Nordstrom CH. Intensive Care Medicine. 4. Vol. 20. Springer-Verlag; 1994. Apr, A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation; pp. 260&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8046119</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Clifton GL, Taylor AA, Grossman RG. Treatment of hypertension associated with head injury. J Neurosurg. 1983 Sep;59(3):455&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">6886759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs HJ, Herden HN, Welter J. Effect of metoprolol on the circulation after head trauma. Studies during continuous intravenous administration Deutsche Medizinische Wochenschrift. 105(44):1531&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7428661</ArticleId></ArticleIdList></Reference><Reference><Citation>Do D, Sheen VL, Bromfield E. Journal of Neurology, Neurosurgery &amp; Psychiatry. 6. Vol. 69. BMJ Publishing Group Ltd; 2000. Dec 1, Treatment of paroxysmal sympathetic storm with labetalol; pp. 832&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1737162</ArticleId><ArticleId IdType="pubmed">11185641</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgeirsson B, Gr&#xe4;nde PO, Nordstrom CH, Berntman L, Messeter K, Ryding E. Acta Anaesthesiol Scand. 3. Vol. 39. Blackwell Publishing Ltd; 1995. Apr, Effects of hypotensive treatment with &#x3b1; 2-agonist and &#x3b2; 1-antagonist on cerebral haemodynamics in severely head injured patients; pp. 347&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7793214</ArticleId></ArticleIdList></Reference><Reference><Citation>Radosevich JJ, Patanwala AE, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj. 2013 Nov 11;27(13&#x2013;14):1492&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24205899</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Zhang Y, Mahmood A, Chopp M. Investigational agents for treatment of traumatic brain injury. Expert Opinion on Investigational Drugs. 2015 Mar 25;24(6):743&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433440</ArticleId><ArticleId IdType="pubmed">25727893</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bergh WM. Pharmacotherapy of traumatic brain injury. Netherlands Journal of Critical Care. 24(1):6&#x2013;11.</Citation></Reference><Reference><Citation>Koskinen LOD, Olivecrona M, Gr&#xe4;nde PO. Severe traumatic brain injury management and clinical outcome using the Lund concept. Neuroscience. 2014 Dec;283:245&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24973658</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppola S, Froio S, Chiumello D. Annual Update in Intensive Care and Emergency Medicine 2015. Cham: Springer International Publishing; 2015. &#x3b2;-Blockers in Critically Ill Patients: From Physiology to Clinical Evidence; pp. 139&#x2013;52. (Annual Update in Intensive Care and Emergency Medicine; vol. 2015)</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin GD. Stroke, mTBI, infection, antibiotics and beta blockade: Connecting the dots. Medical Hypotheses. 2015 Aug;85(2):224&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26045369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, et al. In Vivo Effect of Propranolol Dose and Timing on Cerebral Perfusion After Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Feb;68(2):353&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, et al. The In Vivo Effect of Propranolol on Cerebral Perfusion and Hypoxia After Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2009 Jan;66(1):154&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131818</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D, Xu J, Du T, Yan E, Hertz L, Walz W, et al. Inhibition of Brain Swelling after Ischemia-Reperfusion by &#x3b2;-Adrenergic Antagonists: Correlation with Increased K +and Decreased Ca 2+Concentrations in Extracellular Fluid. BioMed Research International. 2014;2014(3):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247955</ArticleId><ArticleId IdType="pubmed">25478577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank J, Degaute J, Kuurne T, Vincent J, Neil-Dwyer G, Hayes Y, et al. Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade. The Lancet. 1987 Sep;330(8559):585&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2887885</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-Blocker Use is Associated With Improved Outcomes in Adult Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 2007 Jan;62(1):56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17215733</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-Blocker Exposure is Associated With Improved Survival After Severe Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2007 Jan;62(1):26&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">17215730</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaba K, Teixeira PGR, David J-S, Chan LS, Salim A, Brown C, et al. Beta-Blockers in Isolated Blunt Head Injury. Journal of the American College of Surgeons. 2008 Mar;206(3):432&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18308212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A, Harada MY, Barmparas G, Thomsen GM, Alban RF, Bloom M, et al. Early Propranolol after Traumatic Brain Injury is Associated with Lower Mortality. Journal of Trauma and Acute Care Surgery. 2016 Jan;:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26808028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni S, Talving P, Thelin EP, Wallin G, Ljungqvist O, Riddez L. World Journal of Surgery. Springer US; 2015. Apr 14, The Effect of &#x3b2;-blockade on Survival After Isolated Severe Traumatic Brain Injury; pp. 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25809062</ArticleId></ArticleIdList></Reference><Reference><Citation>Murry JS, Hoang DM, Barmparas G, Harada MY, Bukur M, Bloom MB, et al. Journal of Surgical Research. 1. Vol. 200. Elsevier Inc; 2016. Jan 1, Prospective evaluation of early propranolol after traumatic brain injury; pp. 221&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26188959</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeppel TJ, Fischer PE, Zarzaur BL, Magnotti LJ, Clement LP, Fabian TC, et al. Beta-Adrenergic Blockade and Traumatic Brain Injury: Protective? The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Oct;69(4):776&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">20938265</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeppel TJ, Sharpe JP, Magnotti LJ, Weinberg JA, Clement LP, Croce MA, et al. Traumatic brain injury and &#x3b2;-blockers. Journal of Trauma and Acute Care Surgery. 2014 Feb;76(2):504&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24458058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangbar B, Khalil M, Rhee P, Joseph B, Kulvatunyou N, Tang A, et al. Journal of Surgical Research. 2. Vol. 200. Elsevier Inc; 2016. Feb 1, Metoprolol improves survival in severe traumatic brain injury independent of heart rate control; pp. 586&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">26365164</ArticleId></ArticleIdList></Reference><Reference><Citation>Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PGR, Chan L, et al. Significance of Troponin Elevation After Severe Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2008 Jan;64(1):46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">18188098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjizacharia P, O&#x2019;Keeffe T, Brown CVR, Inaba K, Salim A, Chan LS, et al. Incidence, risk factors, and outcomes for atrial arrhythmias in trauma patients. The American Surgeon. 2011 May;77(5):634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21679600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukur M, Mohseni S, Mosheni S, Ley E, Salim A, Margulies D, et al. Efficacy of beta-blockade after isolated blunt head injury: does race matter? J Trauma Acute Care Surg. 2012 Apr;72(4):1013&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22491619</ArticleId></ArticleIdList></Reference><Reference><Citation>Riordan WP, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007 Sep;63(3) 503&#x2013;10&#x2013;discussion510&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">18073593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrick LE, Schroeppel TJ, Sharpe JP, Alsbrook D, Magnotti LJ, Weinberg JA, et al. Impact of Beta-Blockers on Nonhead Injured Trauma Patients. The American Surgeon. 2016 Jul;82(7):575&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27457854</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10&#x2008;008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. The Lancet. 2004 Oct;364(9442):1321&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15474134</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson P, Roberts I. BMJ. 7098. Vol. 314. BMJ Group; 1997. Jun 28, Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials; pp. 1855&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2126994</ArticleId><ArticleId IdType="pubmed">9224126</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregson B, Todd NV, Crawford D, Gerber CJ, Fulton B, Tacconi L, et al. CRASH trial is based on problematic meta-analysis. BMJ. 1999 Aug 28;319(7209):578&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1116452</ArticleId><ArticleId IdType="pubmed">10463914</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson P. Design of CRASH trial. Evidence shows that quality of trial by Faupel et al is good and therefore should not be excluded. BMJ. 1999 Oct 16;319(7216):1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1116856</ArticleId><ArticleId IdType="pubmed">10521212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension. N Engl J Med. 2016 Sep 22;375(12):1119&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27602507</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D&#x2019;Urso P, et al. Decompressive Craniectomy in Diffuse Traumatic Brain Injury. New England Journal of Medicine. 2011 Apr 21;364(16):1493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">21434843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol A, French C, Little L, Haddad S, Presneill J, Arabi Y, et al. Erythropoeitin in traumatic brain injury (EPO-TBI): A double-blind randomised controlled trial. Lancet. 2015 Dec 19;386(10012):2499&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">26452709</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2457&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303469</ArticleId><ArticleId IdType="pubmed">25493974</ArticleId></ArticleIdList></Reference><Reference><Citation>Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2467&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">25493978</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Hannay HJ, Yamal J-M, Gopinath S, Goodman JC, Tilley BC, et al. Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury. JAMA. 2014 Jul 2;312(1):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4113910</ArticleId><ArticleId IdType="pubmed">25058216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein D. Opinion: Why Most TBI Studies Fail [Internet] 2016 [cited 2016 Oct 9]. Available from:  http://www.the-scientist.com/?articles.view/articleNo/45434/title/Opinion&#x2013;why-most-tbi-studies-fail/</Citation></Reference><Reference><Citation>Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials. 2140 ed. BioMed Central. 2012 Sep 26;13(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517360</ArticleId><ArticleId IdType="pubmed">23013802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. JAMA: The Journal of the American Medical Association. 16. Vol. 310. American Medical Association; 2013. Oct 23, Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial; pp. 1683&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochanek PM, Bramlett HM, Dixon CE, Shear DA, Dietrich WD, Schmid KE, et al. Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium. J Neurotrauma. 2016 Mar 15;33(6):513&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26439468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40760863</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Bronchospasm and Future Asthma in Children: A Retrospective Matched Cohort Study.</ArticleTitle><Pagination><StartPage>856</StartPage><EndPage>863</EndPage><MedlinePgn>856-863</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.70029</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Asthma is the most common chronic disease in children. Difficulty in diagnosis can lead to decreased quality of life and increased morbidity and mortality. Children with asthma have increased intraoperative bronchospasm; however, it is unclear whether intraoperative bronchospasm predicts future asthma. We explored intraoperative bronchospasm and subsequent asthma diagnosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed 44,284 children aged 2-18&#x2009;years who underwent non-cardiac surgery under general anesthesia between 2014 and 2020. We collected demographic and peri-operative data, including the occurrence of bronchospasm. We then conducted a subgroup analysis of 35&#x2009;770 patients that received positive pressure ventilation, using logistic regression to assess the relationship between bronchospasm and airway pressures. The association of bronchospasm and subsequent asthma diagnosis was estimated using generalized estimating equations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Intraoperative bronchospasm occurred in 128 patients (0.3%) and was associated with increased risk of asthma (OR 2.29, 95% CI 1.10-4.74, p =&#x2009;0.03). Asthma was diagnosed in 1238 patients (2.8%); 8 had intraoperative bronchospasm (8 of 1238, 0.7%). After adjustment for confounders, male sex (OR 1.57, 95% CI 1.39-1.76, p &lt;&#x2009;0.001) and younger age (OR 0.96, 95% CI 0.94-0.97, p &lt;&#x2009;0.001) were also associated with future asthma diagnosis. In the subgroup analysis, Mean PIP (OR 1.50, 95% CI 1.30-1.74, p &lt;&#x2009;0.001) was associated with asthma.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows intraoperative bronchospasm is associated with an increased risk of future asthma in children. Enhanced collaboration between pediatric anesthesiologists and pediatricians, and further research, is essential to improve asthma detection, risk stratification, and overall care for pediatric patients.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Pediatric Anesthesia published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Anila B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0002-1958-2499</Identifier><AffiliationInfo><Affiliation>C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremper</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="Y">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">bronchospasm</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40760863</ArticleId><ArticleId IdType="pmc">PMC12416348</ArticleId><ArticleId IdType="doi">10.1111/pan.70029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Centers for Disease Control and Prevention
, &#x201c;Asthma CDC National Data,&#x201d;
https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.</Citation></Reference><Reference><Citation>Seol H. Y., Sohn S., Liu H., et&#xa0;al., &#x201c;Early Identification of Childhood Asthma: The Role of Informatics in an Era of Electronic Health Records,&#x201d; Frontiers in Pediatrics 7 (2019): 113, 10.3389/fped.2019.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00113</ArticleId><ArticleId IdType="pmc">PMC6454104</ArticleId><ArticleId IdType="pubmed">31001500</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron S. D., Boulet L. P., Reddel H. K., and Gershon A. S., &#x201c;Underdiagnosis and Overdiagnosis of Asthma,&#x201d; American Journal of Respiratory and Critical Care Medicine 198, no. 8 (2018): 1012&#x2013;1020, 10.1164/rccm.201804-0682ci.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201804-0682ci</ArticleId><ArticleId IdType="pubmed">29756989</ArticleId></ArticleIdList></Reference><Reference><Citation>Molis W. E., Bagniewski S., Weaver A. L., Jacobson R. M., and Juhn Y. J., &#x201c;Timeliness of Diagnosis of Asthma in Children and Its Predictors,&#x201d; Allergy 63, no. 11 (2008): 1529&#x2013;1535, 10.1111/j.1398-9995.2008.01749.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2008.01749.x</ArticleId><ArticleId IdType="pubmed">18925889</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez M. F. and Coutinho M. T., &#x201c;An Overview of Health Disparities in Asthma,&#x201d; Yale Journal of Biology and Medicine 94, no. 3 (2021): 497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461584</ArticleId><ArticleId IdType="pubmed">34602887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakirtas A., &#x201c;Diagnostic Challenges of Childhood Asthma,&#x201d; Current Opinion in Pulmonary Medicine 23, no. 1 (2017): 27&#x2013;33, 10.1097/mcp.0000000000000338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcp.0000000000000338</ArticleId><ArticleId IdType="pubmed">27801711</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaatmaca B., Sahiner U. M., Sekerel B. E., and Soyer O., &#x201c;Perioperative Hypersensitivity Reactions During Childhood and Outcomes of Subsequent Anesthesia,&#x201d; Paediatric Anaesthesia 31, no. 4 (2021): 436&#x2013;443, 10.1111/pan.14126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14126</ArticleId><ArticleId IdType="pubmed">33423333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizov R., Brown R. H., Weiss Y. S., et&#xa0;al., &#x201c;Wheezing During Induction of General Anesthesia in Patients With and Without Asthma. A Randomized, Blinded Trial,&#x201d; Anesthesiology 82, no. 5 (1995): 1111&#x2013;1116, 10.1097/00000542-199505000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199505000-00004</ArticleId><ArticleId IdType="pubmed">7741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E. S. and Bishop M. J., &#x201c;Endotracheal Intubation, but Not Laryngeal Mask Airway Insertion, Produces Reversible Bronchoconstriction,&#x201d; Anesthesiology 90, no. 2 (1999): 391&#x2013;394, 10.1097/00000542-199902000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199902000-00010</ArticleId><ArticleId IdType="pubmed">9952142</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern&#x2010;Sternberg B. S., Boda K., Chambers N. A., et&#xa0;al., &#x201c;Risk Assessment for Respiratory Complications in Paediatric Anaesthesia: A Prospective Cohort Study,&#x201d; Lancet 376, no. 9743 (2010): 773&#x2013;783, 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Dones F., Foresta G., and Russotto V., &#x201c;Update on Perioperative Management of the Child With Asthma,&#x201d; Pediatric Reports 4, no. 2 (2012): e19, 10.4081/pr.2012.e19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/pr.2012.e19</ArticleId><ArticleId IdType="pmc">PMC3395977</ArticleId><ArticleId IdType="pubmed">22802997</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C. S., Chang C. C., Yeh C. C., Chung C. L., Chen T. L., and Liao C. C., &#x201c;Postoperative Adverse Outcomes in Patients With Asthma: A Nationwide Population&#x2010;Based Cohort Study,&#x201d; Medicine 95, no. 3 (2016): e2548, 10.1097/MD.0000000000002548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002548</ArticleId><ArticleId IdType="pmc">PMC4998277</ArticleId><ArticleId IdType="pubmed">26817903</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson G. L., &#x201c;Bronchospasm During Anaesthesia. A Computer&#x2010;Aided Incidence Study of 136&#x2009;929 Patients,&#x201d; Acta Anaesthesiologica Scandinavica 31, no. 3 (1987): 244&#x2013;252, 10.1111/j.1399-6576.1987.tb02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1987.tb02560.x</ArticleId><ArticleId IdType="pubmed">3577646</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W., Disma N., Virag K., et&#xa0;al., &#x201c;Incidence of Severe Critical Events in Paediatric Anaesthesia (APRICOT): A Prospective Multicentre Observational Study in 261 Hospitals in Europe,&#x201d; Lancet Respiratory Medicine 5, no. 5 (2017): 412&#x2013;425, 10.1016/S2213-2600(17)30116-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30116-9</ArticleId><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods B. D. and Sladen R. N., &#x201c;Perioperative Considerations for the Patient With Asthma and Bronchospasm,&#x201d; British Journal of Anaesthesia 103, no. Suppl 1 (2009): i57&#x2013;i65, 10.1093/bja/aep271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep271</ArticleId><ArticleId IdType="pubmed">20007991</ArticleId></ArticleIdList></Reference><Reference><Citation>Murat I., Constant I., and Maud'huy H., &#x201c;Perioperative Anaesthetic Morbidity in Children: A Database of 24&#x2009;165 Anaesthetics Over a 30&#x2010;Month Period,&#x201d; Paediatric Anaesthesia 14, no. 2 (2004): 158&#x2013;166, 10.1111/j.1460-9592.2004.01167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01167.x</ArticleId><ArticleId IdType="pubmed">14962332</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson N. and Waterhouse P., &#x201c;Risk in Pediatric Anesthesia,&#x201d; Paediatric Anaesthesia 21, no. 8 (2011): 848&#x2013;857, 10.1111/j.1460-9592.2010.03366.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03366.x</ArticleId><ArticleId IdType="pubmed">20723093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgendorff A., Reiss I., Ehrhardt H., Eickelberg O., and Alvira C. M., &#x201c;Chronic Lung Disease in the Preterm Infant: Lessons Learned From Animal Models,&#x201d; American Journal of Respiratory Cell and Molecular Biology 50, no. 2 (2014): 233&#x2013;245, 10.1165/rcmb.2013-0014TR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0014TR</ArticleId><ArticleId IdType="pmc">PMC5455410</ArticleId><ArticleId IdType="pubmed">24024524</ArticleId></ArticleIdList></Reference><Reference><Citation>Emons J. A. and Gerth van Wijk R., &#x201c;Food Allergy and Asthma: Is There a Link? Curr Treat Options,&#x201d; Allergy 5, no. 4 (2018): 436&#x2013;444, 10.1007/s40521-018-0185-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-018-0185-1</ArticleId><ArticleId IdType="pmc">PMC6244552</ArticleId><ArticleId IdType="pubmed">30524933</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M., Srinathan S. K., McAuley D. F., et&#xa0;al., &#x201c;The Statistical Significance of Randomized Controlled Trial Results Is Frequently Fragile: A Case for a Fragility Index,&#x201d; Journal of Clinical Epidemiology 67 (2014): 622&#x2013;628, 10.1016/j.jclinepi.2013.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.10.019</ArticleId><ArticleId IdType="pubmed">24508144</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J. and Goadrich M., &#x201c;The Relationship Between Precision&#x2010;Recall and ROC Curves,&#x201d; in Proceedings of the 23rd International Conference on Machine Learning (Association for Computing Machinery, 2006).</Citation></Reference><Reference><Citation>Chowdhury N. U., Guntur V. P., Newcomb D. C., and Wechsler M. E., &#x201c;Sex and Gender in Asthma,&#x201d; European Respiratory Review 30, no. 162 (2021): 210067, 10.1183/16000617.0067-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0067-2021</ArticleId><ArticleId IdType="pmc">PMC8783601</ArticleId><ArticleId IdType="pubmed">34789462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakanthi N., Greally J. M., and Rastogi D., &#x201c;Pediatric Obesity&#x2010;Related Asthma: The Role of Metabolic Dysregulation,&#x201d; Pediatrics 137, no. 5 (2016): e20150812, 10.1542/peds.2015-0812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-0812</ArticleId><ArticleId IdType="pmc">PMC4845863</ArticleId><ArticleId IdType="pubmed">27244776</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake K. A., Galanter J. M., and Burchard E. G., &#x201c;Race, Ethnicity and Social Class and the Complex Etiologies of Asthma,&#x201d; Pharmacogenomics 9, no. 4 (2008): 453&#x2013;462, 10.2217/14622416.9.4.453.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/14622416.9.4.453</ArticleId><ArticleId IdType="pmc">PMC2746736</ArticleId><ArticleId IdType="pubmed">18384258</ArticleId></ArticleIdList></Reference><Reference><Citation>Malleske D., Bryant&#x2010;Stephens T. C., and Montoya&#x2010;Williams D., &#x201c;Childhood Asthma Disparities&#x2010;Race, Place, or Not Keeping Pace?,&#x201d; JAMA Pediatrics 176, no. 8 (2022): 739&#x2013;740, 10.1001/jamapediatrics.2022.1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.1457</ArticleId><ArticleId IdType="pmc">PMC9359892</ArticleId><ArticleId IdType="pubmed">35604670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21730929</PMID><DateCompleted><Year>2011</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Continuous intravenous infusion of ketamine for maintenance sedation.</ArticleTitle><Pagination><StartPage>812</StartPage><EndPage>820</EndPage><MedlinePgn>812-20</MedlinePgn></Pagination><Abstract><AbstractText>Ketamine HCl is a rapidly acting general anesthetic with sedative and analgesic properties that has been reported to have favorable effects on the cardiovascular and pulmonary systems. The goal of this review is to determine the hemodynamic and pulmonary effects of continuous intravenous (IV) ketamine infusion in mechanically ventilated patients, and to determine whether sufficient evidence exists to support its use as an agent for maintenance anesthesia. PubMed/Medline, EMBASE, and Index Medicus databases as well as relevant bibliographies were searched. Studies were independently evaluated for inclusion and exclusion criteria, as well as study parameters, by two evaluators. Any discrepancy was resolved by a third evaluator. Twenty studies (281 patients) met the inclusion criteria for this review including 11 prospective studies (250 patients). Data suggests that ketamine decreases airway resistance, improves dynamic compliance, and preserves functional residual capacity, minute ventilation and tidal volume, while retaining protective pharyngeal and laryngeal reflexes. In patients with refractory bronchospasm, continuous infusion of intravenous ketamine decreases audible wheeze, bronchodilator requirements, and hypercarbia. It also improves respiratory rate and oxygenation, and does not promote respiratory depression. Additionally, ketamine does not result in significant perturbations in blood pressure, heart rate, or vascular resistance. Ketamine may be a safe and effective tool for maintenance sedation of mechanically ventilated patients, however a large prospective clinical trial is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA. taqwa1@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamin</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Elamin</LastName><ForeName>E M</ForeName><Initials>EM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21730929</ArticleId><ArticleId IdType="pii">R02116307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39618204</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1750-8460</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>British journal of hospital medicine (London, England : 2005)</Title><ISOAbbreviation>Br J Hosp Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Impact of Propofol Administered before Extubation on Respiratory Adverse Events in Pediatric Patients Undergoing Tonsillectomy and Adenoidectomy: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>15</EndPage><MedlinePgn>1-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12968/hmed.2024.0431</ELocationID><Abstract><AbstractText><b>Aims/Background</b> Perioperative respiratory adverse events (PRAEs) are common in pediatric anesthesia, especially in otolaryngology procedures. In this randomized controlled trial, we investigated the impact of administering propofol before extubation on PRAEs in pediatric patients undergoing tonsillectomy and adenoidectomy. <b>Methods</b> We enrolled children aged 3 to 8 years old, of American Society of Anesthesiologists (ASA) classes I to III, scheduled for tonsillectomy, and randomly divided them into propofol and control groups. The subjects in the propofol group received multiple small doses of propofol (0.5 mg/kg per dose, total 1-2 mg/kg) until the patient resumed regular spontaneous breathing and exhibited no bodily movements. The subjects in the control group received 0.15 mL/kg of saline. The primary outcome was the rate of PRAEs, such as laryngospasm, bronchospasm, breath-holding spell, severe coughing, desaturation, and airway obstruction, post-extubation. The secondary outcomes were the extubation time, pre-extubation Richmond Agitation-Sedation Scale (RASS) score, end-tidal sevoflurane concentration at extubation, incidence of postoperative agitation, time to consciousness, and Face, Legs, Activity, Cry, and Consolability (FLACC) pain score in the recovery room. Results were reported with risk ratios (RR) and their 95% confidence intervals (CI), as well as the <i>p</i>-values indicating statistical significance. <b>Results</b> A total of 239 patients were included, including 119 in the propofol group and 120 in the control group. Our findings indicated no significant difference in the rate of PRAEs between the two groups (5.9% vs 10.8%, RR: 0.54, 95% CI: 0.23 to 1.31, <i>p</i> = 0.17). However, the propofol group showed a notable decrease in moderate to severe coughs (13.4% vs 60.0%, RR: 0.22, 95% CI: 0.14 to 0.36, <i>p</i> &lt; 0.001) and postoperative agitation (4.2% vs 60.8%, RR: 0.07, 95% CI: 0.03 to 0.17, <i>p</i> &lt; 0.001). <b>Conclusion</b> This trial demonstrated that while administering repeated small doses of propofol before extubation does not significantly reduce respiratory adverse events in children undergoing tonsillectomy and adenoidectomy, it does significantly reduce the incidence of severe coughing, improving postoperative recovery and clinical outcomes. Moreover, propofol helps reduce postoperative agitation, enhancing the safety and effectiveness of postoperative care, and maintaining its valuable clinical role in postoperative management. <b>Clinical Trial Registration</b> ClinicalTrials.gov (NCT05769842).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ruting</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Huiying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05769842</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Hosp Med (Lond)</MedlineTA><NlmUniqueID>101257109</NlmUniqueID><ISSNLinking>1750-8460</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="Y">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="Y">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">extubation</Keyword><Keyword MajorTopicYN="N">perioperative respiratory adverse events</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39618204</ArticleId><ArticleId IdType="doi">10.12968/hmed.2024.0431</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25605033</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1883</ISSN><JournalIssue CitedMedium="Internet"><Volume>209</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of surgery</Title><ISOAbbreviation>Am J Surg</ISOAbbreviation></Journal><ArticleTitle>Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems.</ArticleTitle><Pagination><StartPage>747</StartPage><EndPage>759</EndPage><MedlinePgn>747-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjsurg.2014.09.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9610(14)00576-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Esophageal atresia (EA) is a rare congenital anomaly with high infantile survival rates. The aim of this study was to outline the prevalence of common long-term problems associated with EA repair in patients older than 10 years of age.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Original papers were identified by systematic searching of MEDLINE and EMBASE databases from January 1993 to July 2014. Fifteen articles (907 EA patients) met inclusion criteria.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the first systematic review aiming to quantify the prevalence of the long-term problems associated with EA. The main active medical conditions (pooled estimated prevalence) identified were the following: dysphagia (50.3%), gastroesophageal reflux disease with (40.2%) or without (56.5%) histological esophagitis, recurrent respiratory tract infections (24.1%), doctor-diagnosed asthma (22.3%), persistent cough (14.6%), and wheeze (34.7%). The prevalence of Barrett's esophagus (6.4%) was 4 and 26 times higher than the adult (1.6%) and pediatric (.25%) general populations. Adult and pediatric practitioners should focus on how to develop effective long-term follow-up and transitional care for these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connor</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springford</LastName><ForeName>Laurie R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapetanakis</LastName><ForeName>Venediktos V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, St. George's University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK. Electronic address: stefano.giuliani@nhs.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Surg</MedlineTA><NlmUniqueID>0370473</NlmUniqueID><ISSNLinking>0002-9610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004933" MajorTopicYN="N">Esophageal Atresia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Barrett&#x2019;s esophagus</Keyword><Keyword MajorTopicYN="N">Esophageal atresia</Keyword><Keyword MajorTopicYN="N">Esophageal cancer</Keyword><Keyword MajorTopicYN="N">Gastroesophageal reflux</Keyword><Keyword MajorTopicYN="N">Long-term care</Keyword><Keyword MajorTopicYN="N">Review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25605033</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2014.09.019</ArticleId><ArticleId IdType="pii">S0002-9610(14)00576-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37080616</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Symptoms and signs of lung cancer prior to diagnosis: case-control study using electronic health records from ambulatory care within a large US-based tertiary care centre.</ArticleTitle><Pagination><StartPage>e068832</StartPage><MedlinePgn>e068832</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e068832</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-068832</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Lung cancer is the most common cause of cancer-related death in the USA. While most patients are diagnosed following symptomatic presentation, no studies have compared symptoms and physical examination signs at or prior to diagnosis from electronic health records (EHRs) in the USA. We aimed to identify symptoms and signs in patients prior to diagnosis in EHR data.</AbstractText><AbstractText Label="DESIGN">Case-control study.</AbstractText><AbstractText Label="SETTING">Ambulatory care clinics at a large tertiary care academic health centre in the USA.</AbstractText><AbstractText Label="PARTICIPANTS, OUTCOMES">We studied 698 primary lung cancer cases in adults diagnosed between 1 January 2012 and 31 December 2019, and 6841 controls matched by age, sex, smoking status and type of clinic. Coded and free-text data from the EHR were extracted from 2 years prior to diagnosis date for cases and index date for controls. Univariate and multivariable conditional logistic regression were used to identify symptoms and signs associated with lung cancer at time of diagnosis, and 1, 3, 6 and 12 months before the diagnosis/index dates.</AbstractText><AbstractText Label="RESULTS">Eleven symptoms and signs recorded during the study period were associated with a significantly higher chance of being a lung cancer case in multivariable analyses. Of these, seven were significantly associated with lung cancer 6&#x2009;months prior to diagnosis: haemoptysis (OR 3.2, 95%&#x2009;CI 1.9 to 5.3), cough (OR 3.1, 95%&#x2009;CI 2.4 to 4.0), chest crackles or wheeze (OR 3.1, 95%&#x2009;CI 2.3 to 4.1), bone pain (OR 2.7, 95%&#x2009;CI 2.1 to 3.6), back pain (OR 2.5, 95%&#x2009;CI 1.9 to 3.2), weight loss (OR 2.1, 95%&#x2009;CI 1.5 to 2.8) and fatigue (OR 1.6, 95%&#x2009;CI 1.3 to 2.1).</AbstractText><AbstractText Label="CONCLUSIONS">Patients diagnosed with lung cancer appear to have symptoms and signs recorded in the EHR that distinguish them from similar matched patients in ambulatory care, often 6&#x2009;months or more before diagnosis. These findings suggest opportunities to improve the diagnostic process for lung cancer.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Larry G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Health Services, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Au</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkhardt</LastName><ForeName>Hannah A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zigman Suchsland</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7007-6973</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalski</LastName><ForeName>Lesleigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>Kari A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yetisgen</LastName><ForeName>Meliha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Fiona M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Primary Care Unit Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neal</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lybarger</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Information Sciences and Technology, George Mason University, Fairfax, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Caroline A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, The University of North Carolina, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Epidemiology and Biostatistics, San Diego State University, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Achkar</LastName><ForeName>Morhaf</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4160-0550</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarma</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>National Cancer Institute, NIH, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farjah</LastName><ForeName>Farhood</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-0256-8444</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, USA mjt@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007442</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN261201000040I</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health informatics</Keyword><Keyword MajorTopicYN="N">PRIMARY CARE</Keyword><Keyword MajorTopicYN="N">Respiratory tract tumours</Keyword><Keyword MajorTopicYN="N">Thoracic medicine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37080616</ArticleId><ArticleId IdType="pmc">PMC10124310</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-068832</ArticleId><ArticleId IdType="pii">bmjopen-2022-068832</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Diseases Control and Prevention . Leading cancer cases and deaths, all races/ethnicities, male and female. 2018. Available: https://gis.cdc.gov/grasp/USCS/DataViz.html [Accessed 16 Jan 2022].</Citation></Reference><Reference><Citation>American Lung Association . State of lung cancer 2020 report; 2020.</Citation></Reference><Reference><Citation>Fedewa SA, Bandi P, Smith RA, et al. . Lung cancer screening rates during the covid-19 pandemic. Chest 2022;161:586&#x2013;9. 10.1016/j.chest.2021.07.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.030</ArticleId><ArticleId IdType="pmc">PMC8294072</ArticleId><ArticleId IdType="pubmed">34298006</ArticleId></ArticleIdList></Reference><Reference><Citation>National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395&#x2013;409. 10.1056/NEJMoa1102873</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1102873</ArticleId><ArticleId IdType="pmc">PMC4356534</ArticleId><ArticleId IdType="pubmed">21714641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton W, Peters TJ, Round A, et al. . What are the clinical features of lung cancer before the diagnosis is made? a population based case-control study. Thorax 2005;60:1059&#x2013;65. 10.1136/thx.2005.045880</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.045880</ArticleId><ArticleId IdType="pmc">PMC1747254</ArticleId><ArticleId IdType="pubmed">16227326</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter FM, Rubin G, Bankhead C, et al. . Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer 2015;112 Suppl 1(Suppl 1):S6&#x2013;13. 10.1038/bjc.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2015.30</ArticleId><ArticleId IdType="pmc">PMC4385970</ArticleId><ArticleId IdType="pubmed">25734397</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo MM, Hamilton W, Walter FM, et al. . Symptom signatures and diagnostic timeliness in cancer patients: a review of current evidence. Neoplasia 2018;20:165&#x2013;74. 10.1016/j.neo.2017.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2017.11.005</ArticleId><ArticleId IdType="pmc">PMC5735300</ArticleId><ArticleId IdType="pubmed">29253839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadpara PA, Madhavan SS, Tworek C, et al. . Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States. J Geriatr Oncol 2015;6:101&#x2013;10. 10.1016/j.jgo.2015.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2015.01.001</ArticleId><ArticleId IdType="pmc">PMC4450093</ArticleId><ArticleId IdType="pubmed">25604094</ArticleId></ArticleIdList></Reference><Reference><Citation>SEER statistics . Cancer statistics review, 1975-2018. Available: https://seer.cancer.gov/csr/1975_2018/ [Accessed 16 Jan 2022].</Citation></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, et al. . Comorbidity measures for use with administrative data. Medical Care 1998;36:8&#x2013;27. 10.1097/00005650-199801000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199801000-00004</ArticleId><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>van Walraven C, Austin PC, Jennings A, et al. . A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009;47:626&#x2013;33. 10.1097/MLR.0b013e31819432e5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31819432e5</ArticleId><ArticleId IdType="pubmed">19433995</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson NR, Fan Y, Dalton JE, et al. . A new elixhauser-based comorbidity summary measure to predict in-hospital mortality. Med Care 2015;53:374&#x2013;9. 10.1097/MLR.0000000000000326</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000326</ArticleId><ArticleId IdType="pmc">PMC4812819</ArticleId><ArticleId IdType="pubmed">25769057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2013;63:e1&#x2013;10. 10.3399/bjgp13X660724</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp13X660724</ArticleId><ArticleId IdType="pmc">PMC3529287</ArticleId><ArticleId IdType="pubmed">23336443</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Ghaus SJ, Olsson JK, et al. . Timeliness of care in veterans with non-small cell lung cancer. Chest 2008;133:1167&#x2013;73. 10.1378/chest.07-2654</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-2654</ArticleId><ArticleId IdType="pubmed">18263676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ades AE, Biswas M, Welton NJ, et al. . Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis. Int J Epidemiol 2014;43:1865&#x2013;73. 10.1093/ije/dyu174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu174</ArticleId><ArticleId IdType="pubmed">25172138</ArticleId></ArticleIdList></Reference><Reference><Citation>Redaniel MT, Martin RM, Ridd MJ, et al. . Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the clinical practice research Datalink. PLOS ONE 2015;10:e0126608. 10.1371/journal.pone.0126608</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126608</ArticleId><ArticleId IdType="pmc">PMC4416709</ArticleId><ArticleId IdType="pubmed">25933397</ArticleId></ArticleIdList></Reference><Reference><Citation>Corner J, Hopkinson J, Fitzsimmons D, et al. . Is late diagnosis of lung cancer inevitable? interview study of patients&#x2019; recollections of symptoms before diagnosis. Thorax 2005;60:314&#x2013;9. 10.1136/thx.2004.029264</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.029264</ArticleId><ArticleId IdType="pmc">PMC1747353</ArticleId><ArticleId IdType="pubmed">15790987</ArticleId></ArticleIdList></Reference><Reference><Citation>Tod AM, Craven J, Allmark P. Diagnostic delay in lung cancer: a qualitative study: diagnostic delay in lung cancer. J Adv Nurs 2008;61:336&#x2013;43. 10.1111/j.1365-2648.2007.04542.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04542.x</ArticleId><ArticleId IdType="pubmed">18197868</ArticleId></ArticleIdList></Reference><Reference><Citation>Lybarger K, Ostendorf M, Thompson M, et al. . Extracting covid-19 diagnoses and symptoms from clinical text: a new annotated corpus and neural event extraction framework. J Biomed Inform 2021;117:103761. 10.1016/j.jbi.2021.103761</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103761</ArticleId><ArticleId IdType="pmc">PMC7997694</ArticleId><ArticleId IdType="pubmed">33781918</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner G, Chang J, Dorvall N, et al. . Domain adaptation of a deep learning symptom extractor for different patient populations and clinical settings. AMIA, 2022.</Citation></Reference><Reference><Citation>Paszke A, Gross S, Massa F, et al. . PyTorch: an imperative style, high-performance deep learning library. ArXiv
2019. 10.48550/arXiv.1912.01703
Available: http://arxiv.org/abs/1912.01703</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1912.01703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf T, Debut L, Sanh V, et al. . Transformers: state-of-the-art natural language processing. Proceedings of the 2020 Conference on Empirical Methods in Natural Language Processing; Stroudsburg, PA, USA, :38&#x2013;45Online. 10.18653/v1/2020.emnlp-demos.6</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/2020.emnlp-demos.6</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495&#x2013;9. 10.1016/j.ijsu.2014.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis PM, Vandermeer R. Delays in the diagnosis of lung cancer. J Thorac Dis 2011;3:183&#x2013;8. 10.3978/j.issn.2072-1439.2011.01.01</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2072-1439.2011.01.01</ArticleId><ArticleId IdType="pmc">PMC3256519</ArticleId><ArticleId IdType="pubmed">22263086</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyi H, Hillerdal G, Brand&#xe9;n E. Patient&#x2019;s and doctors&#x2019; delays in the diagnosis of chest tumors. Lung Cancer 2002;35:53&#x2013;7. 10.1016/s0169-5002(01)00293-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0169-5002(01)00293-8</ArticleId><ArticleId IdType="pubmed">11750713</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Achkar M, Zigman Suchsland M, Walter FM, et al. . Experiences along the diagnostic pathway for patients with advanced lung cancer in the USA: a qualitative study. BMJ Open 2021;11:e045056. 10.1136/bmjopen-2020-045056</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045056</ArticleId><ArticleId IdType="pmc">PMC8070881</ArticleId><ArticleId IdType="pubmed">33888529</ArticleId></ArticleIdList></Reference><Reference><Citation>Corner J, Hopkinson J, Roffe L. Experience of health changes and reasons for delay in seeking care: a UK study of the months prior to the diagnosis of lung cancer. Social Science &amp; Medicine 2006;62:1381&#x2013;91. 10.1016/j.socscimed.2005.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2005.08.012</ArticleId><ArticleId IdType="pubmed">16168544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson BD, Aveyard P, Koshiaris C, et al. . Combining simple blood tests to identify primary care patients with unexpected weight loss for cancer investigation: clinical risk score development, internal validation, and net benefit analysis. PLoS Med 2021;18:e1003728. 10.1371/journal.pmed.1003728</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003728</ArticleId><ArticleId IdType="pmc">PMC8407560</ArticleId><ArticleId IdType="pubmed">34464384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma EA, Kobrin SC, Thompson MJ. A proposal to improve the early diagnosis of symptomatic cancers in the united states. Cancer Prev Res (Phila) 2020;13:715&#x2013;20. 10.1158/1940-6207.CAPR-20-0115</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-20-0115</ArticleId><ArticleId IdType="pubmed">32493702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40155450</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Risk factors for extubation-related complications in morbidly obese patients undergoing bariatric surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>426</StartPage><EndPage>434</EndPage><MedlinePgn>426-434</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-025-03484-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">One-third of major anesthesia-related airway complications occur during or shortly after tracheal extubation. Obesity significantly impacts respiratory function and is a key contributor to morbidity and mortality. Patients with morbid obesity often require bariatric surgery. However, extubation-related complications in this specific surgical population have not been previously studied. This study aimed to determine the rate and frequency of complications during tracheal extubation in patients undergoing bariatric surgery and the associated risk factors for these complications.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This was a retrospective cohort study of adult patients above 18 years of age with a body mass index&#x2009;&#x2265;&#x2009;40 kg/m<sup>2</sup> who underwent bariatric surgery between June 2016 and June 2024. Extubation-related complications were defined as the occurrence of any of the following: vomiting, aspiration, laryngospasm, bronchospasm, cardiovascular instability, airway edema, desaturation (SpO<sub>2</sub>&#x2009;&lt;&#x2009;90%), or the need for a rescue device or reintubation during or after tracheal extubation. Logistic regression analysis, adjusted for age and sex, was performed to evaluate the associations. The significance level was adjusted by applying the Bonferroni correction (0.05/16&#x2009;=&#x2009;0.0031), and a p-value&#x2009;&lt;&#x2009;0.0031 was interpreted as statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data from 1193 patients were analyzed. The overall complication rate was 4.4%, with the most frequent complication being desaturation, which occurred in 3.2% of patients. Logistic regression analysis showed that the odds of extubation-related complications increased twofold for obese patients with body mass index 50-59 kg/m<sup>2</sup> (odds ratio [OR] 1.97, 95% confidence interval [95%CI] 0.99-3.94, p&#x2009;=&#x2009;0.055) and threefold for patients with body mass index&#x2009;&gt;&#x2009;60 kg/m<sup>2</sup> (OR 2.95, 95%CI 0.99-8.81, p&#x2009;=&#x2009;0.05). The most commonly associated comorbidities were hypertension and obstructive sleep apnea, with an odds ratio of 2.98 for hypertension and 2.15 for obstructive sleep apnea (95%CI 1.40-6.33, p&#x2009;=&#x2009;0.005; and 95%CI 1.08-4.29, p&#x2009;=&#x2009;0.03; respectively). Despite these clinically important results, after applying the Bonferroni correction, none of these associations remain statistically significant, as the corrected p-values are above the threshold of p&#x2009;=&#x2009;0.0031.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study identified desaturation as the most common complication post-extubation of morbidly obese patients who underwent bariatric surgery. Moreover, we found that the odds of extubation-related complications increased with increasing obesity classes, particularly in patients with body mass index 50-59 kg/m<sup>2</sup> and&#x2009;&gt;&#x2009;60 kg/m<sup>2</sup>, as well as in patients with hypertension and obstructive sleep apnea. These findings suggest the importance of tailored extubation strategies and close perioperative monitoring in morbidly obese patients to mitigate extubation-related risks.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Ayten</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, P O BOX 2713, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vegesna</LastName><ForeName>Atchyuta R R</ForeName><Initials>ARR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Bushra M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0003-4172-5916</Identifier><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, P O BOX 2713, Doha, Qatar. ba1902766@qu.edu.qa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idrous</LastName><ForeName>Al Muiz Osama Ahmed</ForeName><Initials>AMOA</Initials><AffiliationInfo><Affiliation>Department of Medical Education, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elshoeibi</LastName><ForeName>Amgad M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, P O BOX 2713, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Cecil Ninan</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhassan</LastName><ForeName>Osman Osama</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakeel</LastName><ForeName>Afrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karam</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Bariatric and Metabolic Surgery, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizwan</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Bariatric and Metabolic Surgery, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashah</LastName><ForeName>Moataz M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Bariatric and Metabolic Surgery, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, P O BOX 2713, Doha, Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="Y">Airway Extubation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="Y">Obesity, Morbid</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Bariatric surgery</Keyword><Keyword MajorTopicYN="N">Extubation&#xa0;complications</Keyword><Keyword MajorTopicYN="N">Morbid obesity</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors report no conflicts of interest in this work. Ethical approval: This study received IRB approval from the Medical Research Centre at Hamad Medical Corporation (MRC-01&#x2013;24-244).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>25</Day><Hour>20</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>29</Day><Hour>16</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>29</Day><Hour>0</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40155450</ArticleId><ArticleId IdType="pmc">PMC12103353</ArticleId><ArticleId IdType="doi">10.1007/s00540-025-03484-z</ArticleId><ArticleId IdType="pii">10.1007/s00540-025-03484-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ruetzler K, Rivas E, Cohen B, Mosteller L, Martin A, Keebler A, et al. McGrath Video Laryngoscope Versus Macintosh Direct Laryngoscopy for Intubation of Morbidly Obese Patients: A Randomized Trial. Anesth Analg. 2020;131(2):586&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32175948</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5(7):161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5401682</ArticleId><ArticleId IdType="pubmed">28480197</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry RA, Zarmer L, West K, Chung F. Obstructive Sleep Apnea and Risk of Postoperative Complications after Non-Cardiac Surgery. J Clin Med. 2024;13(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11084150</ArticleId><ArticleId IdType="pubmed">38731067</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015;115(6):827&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4650961</ArticleId><ArticleId IdType="pubmed">26556848</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperatore F, Gritti F, Esposito R, Giudice CD, Cafora C, Pennacchio F, et al. Non-Invasive Ventilation Reduces Postoperative Respiratory Failure in Patients Undergoing Bariatric Surgery: A Retrospective Analysis. Medicina (Kaunas). 2023;59(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10456476</ArticleId><ArticleId IdType="pubmed">37629747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucco L, Santer P, Levy N, Hammer M, Grabitz SD, Nabel S, et al. A comparison of postoperative respiratory complications associated with the use of desflurane and sevoflurane: a single-centre cohort study. Anaesthesia. 2021;76(1):36&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">32743803</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaszynski T. A randomized controlled study on the visual grading of the glottis and the hemodynamics response to laryngoscopy when using I-View and MacGrath Mac videolaryngoscopes in super obese patients. J Clin Monit Comput. 2021;35(2):279&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">32240469</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerly BD, Dabbagh O. Morbidity and mortality characteristics of morbidly obese patients admitted to hospital and intensive care units. J Crit Care. 2011;26(2):180&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21036522</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L. Postoperative complications after thoracic surgery in the morbidly obese patient. Anesthesiol Res Pract. 2011;2011: 865634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3254004</ArticleId><ArticleId IdType="pubmed">22242020</ArticleId></ArticleIdList></Reference><Reference><Citation>Domi R, Laho H. Anesthetic challenges in the obese patient. J Anesth. 2012;26(5):758&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22562644</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenberger A, Proietti S, Wicky S, Frascarolo P, Suter M, Spahn DR, et al. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg. 2002;95(6):1788&#x2013;92, table of contents.</Citation><ArticleIdList><ArticleId IdType="pubmed">12456460</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai T, Koga K, Vaughan RS. Respiratory complications associated with tracheal intubation and extubation. Br J Anaesth. 1998;80(6):767&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771306</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;s J, Mill&#xe1;n S, D&#xed;az E, Castanyer E, Gallardo X, Mart&#xed;n-Loeches I, et al. Incidence of airway complications in patients using endotracheal tubes with continuous aspiration of subglottic secretions. Ann Intensive Care. 2017;7(1):109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668230</ArticleId><ArticleId IdType="pubmed">29098448</ArticleId></ArticleIdList></Reference><Reference><Citation>Juang J, Cordoba M, Ciaramella A, Xiao M, Goldfarb J, Bayter JE, et al. Incidence of airway complications associated with deep extubation in adults. BMC Anesthesiol. 2020;20(1):274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597053</ArticleId><ArticleId IdType="pubmed">33121440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas A, Kharadi N, Shafique M, Mehreen T, Habib M, Khan J, et al. Incidence of Weaning Failure in Obese Patients in Intensive Care Unit. Cureus. 2024;16(3): e55881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11002967</ArticleId><ArticleId IdType="pubmed">38595891</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jong A, Capdevila M, Aarab Y, Cros M, Pensier J, Lakbar I, et al. Incidence, Risk Factors, and Long-Term Outcomes for Extubation Failure in ICU in Patients With Obesity: A Retrospective Analysis of a Multicenter Prospective Observational Study. Chest. 2025;167(1):139&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">39182573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017&#x2013;2018. NCHS Data Brief. 2020;360:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487284</ArticleId></ArticleIdList></Reference><Reference><Citation>de Raaff CAL, Gorter-Stam MAW, de Vries N, Sinha AC, Jaap Bonjer H, Chung F, et al. Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. Surg Obes Relat Dis. 2017;13(7):1095&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">28666588</ArticleId></ArticleIdList></Reference><Reference><Citation>de Raaff CAL, de Vries N, van Wagensveld BA. Obstructive sleep apnea and bariatric surgical guidelines: summary and update. Curr Opin Anaesthesiol. 2018;31(1):104&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29176373</ArticleId></ArticleIdList></Reference><Reference><Citation>Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25(10):1822&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">25835983</ArticleId></ArticleIdList></Reference><Reference><Citation>Galinski M, Chouteau M, Lunghi G, Vinurel M, Blazy B, Cher M, et al. Multivariate Analysis of the Failure Risk of First Tracheal Intubation Attempt in a Population of Patients Scheduled for Bariatric Surgery. Obes Surg. 2021;31(10):4392&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34297257</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten TN, Flores AS, McKenzie JA, Nguyen LT, Robinson WB, Kinney TM, et al. Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth. 2011;106(1):131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20959329</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2009;120(1):86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">19528335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadde KM, Martin CK, Berthoud HR, Heymsfield SB. Obesity: Pathophysiology and Management. J Am Coll Cardiol. 2018;71(1):69&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958889</ArticleId><ArticleId IdType="pubmed">29301630</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora L, Sharma S, Carillo JF. Obesity and anesthesia. Curr Opin Anaesthesiol. 2024;37(3):299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">38573180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Wang HT, Gu W. Efficacy of High-Flow Nasal Cannula versus Conventional Oxygen Therapy in Obese Patients during the Perioperative Period: A Systematic Review and Meta-Analysis. Can Respir J. 2022;2022:4415313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9553645</ArticleId><ArticleId IdType="pubmed">36247078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6311385</ArticleId><ArticleId IdType="pubmed">30056777</ArticleId></ArticleIdList></Reference><Reference><Citation>DiCaro MV, Lei K, Yee B, Tak T. The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review. J Clin Med. 2024;13(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11172971</ArticleId><ArticleId IdType="pubmed">38892933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Si LY. Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches. Ups J Med Sci. 2012;117(4):370&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3497224</ArticleId><ArticleId IdType="pubmed">23009224</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasu TS, Grewal R, Doghramji K. Obstructive sleep apnea syndrome and perioperative complications: a systematic review of the literature. J Clin Sleep Med. 2012;8(2):199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3311420</ArticleId><ArticleId IdType="pubmed">22505868</ArticleId></ArticleIdList></Reference><Reference><Citation>Thille AW, Boissier F, Coudroy R, Le Pape S, Arriv&#xe9; F, Marchasson L, et al. Sex difference in the risk of extubation failure in ICUs. Ann Intensive Care. 2023;13(1):130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10730492</ArticleId><ArticleId IdType="pubmed">38112851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Wei K, Zheng X, Zeng J, Chen Q. Effect of noninvasive respiratory support after extubation on postoperative pulmonary complications in obese patients: A systematic review and network meta-analysis. J Clin Anesth. 2023;91: 111280.</Citation><ArticleIdList><ArticleId IdType="pubmed">37801822</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurt E, Saracoglu A, Y&#x131;lmaz M, Yak&#x131;n D&#xfc;zyol &#x130;, Ergen&#xe7; M, Saracoglu KT. Comparison of Cook Re-intubation Catheter and Guidewire in Staged Extubation in Obese Patients Undergoing Bariatric Surgery: A Randomized Controlled Clinical Trial. Kocaeli Medical Journal. 2024;13(2):115&#x2013;21.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38724412</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3374</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of obstetric anesthesia</Title><ISOAbbreviation>Int J Obstet Anesth</ISOAbbreviation></Journal><ArticleTitle>Non-inferiority randomized controlled trial comparing CricOid pressure and para-laryngeal pressure in parturients undergoing cesarean delivery: NiCOP trial.</ArticleTitle><Pagination><StartPage>103997</StartPage><MedlinePgn>103997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijoa.2024.103997</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0959-289X(24)00032-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cricoid pressure has been surrounded with controversies regarding its effectiveness. Application of ultrasound-guided para-laryngeal (PL) force has been shown to occlude the esophagus effectively compared with cricoid pressure (CP) in awake patients. We hypothesized that there would be no meaningful difference in the change in antero-posterior esophageal diameter from with application of cricoid or para-laryngeal pressure in parturients undergoing cesarean delivery under general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective, randomized, non-inferiority trial, 40 parturients scheduled for elective cesarean delivery under general anesthesia were randomized to receive rapid sequence induction with either cricoid pressure (n&#x202f;=&#x202f;20) or para-laryngeal pressure (n&#x202f;=&#x202f;20). The antero-posterior diameter of the esophagus, measured by sonography, was the primary outcome. Visualization of the esophagus, its position in relation to the glottic aperture, esophageal occlusion, percentage of glottic opening (POGO), time to intubation, first pass success rate, overall success rate and adverse events like desaturation or bronchospasm were secondary outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean change in anterior-posterior diameter in the CP group was 0.17 &#xb1;0.1&#x202f;cm vs. 0.28 &#xb1;0.1&#x202f;cm in the PL group. The mean difference (CP-para-laryngeal pressure) between the groups was -0.11 (95% CI -0.17 to -0.1) cm. As the upper limit of the 95% CI was lower than the prespecified non-inferiority margin (&#x3b4;&#x202f;=&#x202f;-0.2), non-inferiority was established (P &lt;0.001]. There was no significant difference in the POGO score (P&#x202f;=&#x202f;0.818), time to intubation (P =0.55), or intubation attempts (P&#x202f;=&#x202f;0.99).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Para-laryngeal pressure was non-inferior to CP in occluding the esophagus in parturients undergoing cesarean delivery under general anesthesia and furthermore, no significant deterioration in intubation parameters was seen.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: jaindivya77@rediffmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandhi</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Obstet Anesth</MedlineTA><NlmUniqueID>9200430</NlmUniqueID><ISSNLinking>0959-289X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000773" MajorTopicYN="N">Anesthesia, Obstetrical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003413" MajorTopicYN="Y">Cricoid Cartilage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007830" MajorTopicYN="N">Larynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="Y">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Anesthesia, general</Keyword><Keyword MajorTopicYN="N">Anesthesia, obstetric</Keyword><Keyword MajorTopicYN="N">Cricoid pressure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>6</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38724412</ArticleId><ArticleId IdType="doi">10.1016/j.ijoa.2024.103997</ArticleId><ArticleId IdType="pii">S0959-289X(24)00032-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37576161</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2413-7170</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Ethiopian journal of health sciences</Title><ISOAbbreviation>Ethiop J Health Sci</ISOAbbreviation></Journal><ArticleTitle>The Effect of Albuterol Spray on Hypoxia and Bronchospasm in Patients with Chronic Obstructive Pulmonary Disease (COPD) under General Anesthesia: A bouble-Blind Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>491</StartPage><EndPage>498</EndPage><MedlinePgn>491-498</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4314/ejhs.v33i3.12</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patients with chronic obstructive pulmonary disease (COPD) experience an increased risk of perioperative pulmonary complications. The aim of this study was to evaluate the effect of albuterol spray on hypoxia and bronchospasm in patients with COPD under general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This single-center, double-blind, parallel-group, randomized clinical trial was performed on 120 smoking patients with COPD who were referred to 5 Azar Educational Hospital in Gorgan, Northern Iran, in 2021. Twenty minutes before general anesthesia and also after completion of surgery and before extubation, 60 patients in the intervention group were inhaled with 2 puffs of albuterol spray. In the control group, patients were inhaled with 2 puffs of placebo spray. In perioperative period, the occurrence of wheezing, bronchospasm, coughing, hemodynamic changes, postoperative shivering, dyspnea, and nausea and vomiting were evaluated in all patients. The Consolidated Standards of Reporting Trials (CONSORT) checklist was used to report important aspects of this study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mean age of the patients was 52.34 &#xb1;8.95 years, and 115 (95.8%) of them were males while the rest were females. The difference between systolic blood pressure before induction of anesthesia (after administration of albuterol spray) between the group receiving albuterol spray and the group not receiving it was statistically significant (p=0.04). Also, the difference between the mean arterial oxygen saturation before tracheal extubation (after re-administration of albuterol spray) between the albuterol spray group and the non-albuterol group was statistically significant (p = 0.03). Wheezing and recurrent cough after induction of anesthesia and after extubation (after albuterol spray administration) was lower in the albuterol group than in the control group (p&lt;0.05). No significant side effects were detected in the albuterol-treated group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">According to the results of this study, it seems that the prophylactic use of albuterol spray is useful in reducing the incidence of wheezing and recurrent cough before induction of anesthesia in COPD patients with smoking.</AbstractText><CopyrightInformation>&#xa9; 2023 Maddah S.M, et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maddah</LastName><ForeName>Seyedmahrokh A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barzegari</LastName><ForeName>Akbar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ethiopia</Country><MedlineTA>Ethiop J Health Sci</MedlineTA><NlmUniqueID>101224773</NlmUniqueID><ISSNLinking>1029-1857</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="Y">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Albuterol</Keyword><Keyword MajorTopicYN="N">Bronchial Spasm</Keyword><Keyword MajorTopicYN="N">Chronic Obstructive</Keyword><Keyword MajorTopicYN="N">Hypoxia</Keyword><Keyword MajorTopicYN="N">Pulmonary Disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37576161</ArticleId><ArticleId IdType="pmc">PMC10416337</ArticleId><ArticleId IdType="doi">10.4314/ejhs.v33i3.12</ArticleId><ArticleId IdType="pii">jEJHS.v33.i3.pg491</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jahanian F, Khatir IG, Ahidashti HA, Amirifard S. The Effect of Intravenous Magnesium Sulphate as an Adjuvant in the Treatment of Acute Exacerbations of COPD in the Emergency Department: A Double-Blind Randomized Clinical Trial. Ethiop J Health Sci. 2021;31(2):267&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188071</ArticleId><ArticleId IdType="pubmed">34158778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrera MC, Labaki WW, Han MK. Advances in Chronic Obstructive Pulmonary Disease. Annu Rev Med. 2021;72:119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011854</ArticleId><ArticleId IdType="pubmed">33502902</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley CM, Sciurba FC. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review. JAMA. 2019;321(8):786&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">30806700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevacqua BK. Pre-operative pulmonary evaluation in the patient with suspected respiratory disease. Indian J Anaesth. 2015;59(9):542&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613400</ArticleId><ArticleId IdType="pubmed">26556912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou R, Miao F, Jin D, Duan Q, Yin C, Feng Q, et al. General Anesthesia for Patients With Chronic Obstructive Pulmonary Disease and Postoperative Respiratory Failure: A Retrospective Analysis of 120 Patients. Front Physiol. 2022;13:842784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189278</ArticleId><ArticleId IdType="pubmed">35707010</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggappa DR, Rao GV, Kannan S. Anaesthesia for patient with chronic obstructive pulmonary disease. Indian J Anaesth. 2015;59(9):574&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613404</ArticleId><ArticleId IdType="pubmed">26556916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausman MS, Jr, Jewell ES, Engoren M. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: does avoiding general anesthesia reduce the risk of postoperative complications? Anesth Analg. 2015;120(6):1405&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">25526396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathioudakis AG, Vestbo J, Singh D. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease: Which One(S), How, and When? Clin Chest Med. 2020;41(3):463&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32800199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopsaftis ZA, Sulaiman NS, Mountain OD, Carson-Chahhoud KV, Phillips PA, Smith BJ. Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review. Syst Rev. 2018;7(1):213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6264607</ArticleId><ArticleId IdType="pubmed">30497532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon J, Panos RJ. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Expert Opin Drug Metab Toxicol. 2010;6(3):381&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">20163324</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadi H, Sotoodeh Khesal S. The effect of salbutamol spray on bronchospasm and hypoxia during general anesthesia in heavy smokers. Razi Journal of Medical Sciences. 2003;10(36):509&#x2013;515.</Citation></Reference><Reference><Citation>Jiang H, Wu X, Lian S, Zhang C, Liu S, Jiang Z. Effects of salbutamol on the kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications in patients with mild-to-moderate chronic obstructive pulmonary disease: A randomized controlled study. PLoS One. 2021;16(5):e0251795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136676</ArticleId><ArticleId IdType="pubmed">34015036</ArticleId></ArticleIdList></Reference><Reference><Citation>Imantalab V, Sedighinejad A, Haghighi M, Mirmansouri A, Sadeghi Meybodi AM, Zareii T. Comparing the three method of preparing heavy smokers with normal spirometry on respiratory complications after CABG. J Anesth Pain. 2015;5(4):14&#x2013;23.</Citation></Reference><Reference><Citation>Duffy SP, Criner GJ. Chronic Obstructive Pulmonary Disease: Evaluation and Management. Med Clin North Am. 2019;103(3):453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">30955513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheaton AG, Liu Y, Croft JB, VanFrank B, Croxton TL, Punturieri A, et al. Chronic Obstructive Pulmonary Disease and Smoking Status - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(24):533&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6586372</ArticleId><ArticleId IdType="pubmed">31220055</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeganathan V, Knight S, Bricknell M, Ridgers A, Wong R, Brazzale DJ, et al. Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery. PLoS One. 2022;17(3):e0266052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963579</ArticleId><ArticleId IdType="pubmed">35349598</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf8;nnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9487432</ArticleId><ArticleId IdType="pubmed">23457163</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrick MA, Robson JM, Thomas C. Smoking and anaesthesia. BJA Educ. 2019;19(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7807986</ArticleId><ArticleId IdType="pubmed">33456847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaballos M, Canal MI, Mart&#xed;nez R, Membrillo MJ, Gonzalez FJ, Orozco HD, et al. Preoperative smoking cessation counseling activities of anesthesiologists: a cross-sectional study. BMC Anesthesiol. 2015;15:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426771</ArticleId><ArticleId IdType="pubmed">25927569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashkin DP. A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2585&#x2013;2596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076803</ArticleId><ArticleId IdType="pubmed">27799757</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning HL. Bronchodilator therapy in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000;6(2):99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">10741767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ES, Bishop MJ. Cough during emergence from isoflurane anesthesia. Anesth Analg. 1998;87(5):1170&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">9806703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurwitz BE, Mendes ES, Schmid A, Parker M, Arana J, Gonzalez A, et al. Airway and Pulmonary &#x3b2;(2)-Adrenergic Vasodilatory Function in Current Smokers and Never Smokers. Chest. 2017;151(3):650&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">28012803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, et al. Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. Br J Anaesth. 2017;119(1):150&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">28974069</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, Hall GL. Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial. JAMA Pediatr. 2019;173(6):527&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547220</ArticleId><ArticleId IdType="pubmed">31009034</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37013278</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-9982</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>JPMA. The Journal of the Pakistan Medical Association</Title><ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Effect of tramadol on extubation response and quality of emergence following Supratentorial surgery: A randomised controlled trial.</ArticleTitle><Pagination><StartPage>2160</StartPage><EndPage>2165</EndPage><MedlinePgn>2160-2165</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.47391/JPMA.4082</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To observe the effect of a single dose of tramadol 1mg/kg on haemodynamic changes related to extubation, and to assess the quality of emergence as judged by incidence of cough, laryngospasm and bronchospasm.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The double-blind randomised controlled trial was conducted at the Department of Anaesthesiology, Aga Khan University Hospital, Karachi, from 2016 to 2017, and comprised patients of either gender aged 18-65 years scheduled for elective supratentorial craniotomy under general anaesthesia. The patients were randomised to two Tramadol and Saline groups. The drug was given 45 minutes before extubation at the time of dura closure. The patients were extubated after resumption of adequate spontaneous breathing. Invasive blood pressure and heart rate were recorded one minute before reversal, at 1 minute interval for five minutes and then every 10 minute for 30 minutes after extubation. Cough, laryngospasm and bronchospasm were noted. Pain, post-operative nausea, vomiting, convulsions and conscious levels were also noted till 6 hours post-operatively. Data was analysed using SPSS 19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 80 patients enrolled, 79(98.75%) completed the study. Of them, 38(48%) were in the Tramadol group; 27(71.1%) males and 11(28.9%) females with a mean age of 43.42&#xb1;13.2 years. The remaining 41(52%) patients were in the Saline group; 28(68.3%) males and 13(31.7%) females with a mean age of 45.9&#xb1;15.9 years. Intergroup comparison showed no significant difference in the extubation response (p&gt;0.05), but the changes in blood pressure and heart rate were shorter in magnitude and duration in the Tramadol group compared to the baseline. Significant rise in blood pressure and heart rate were observed in the Saline group at 5 minutes after extubation (p=0.046). There was no difference in the quality of emergence as judged by cough or secondary complications (p&gt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Tramadol 1mg/kg was considered superior in attenuating the duration and magnitude of haemodynamic response in the shape of hypertension and tachycardia during extubation, but did not affect other parameters in patients undergoing craniotomy.</AbstractText><AbstractText Label="CLINICAL TRIAL NUMBER" NlmCategory="UNASSIGNED">Clinical Trials.gov PRS: NCT02964416, https://clinicaltrials.gov/ct2/show/NCT02964416.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salam</LastName><ForeName>Asma Abdus</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Dr Ziauddin Hospital, Clifton Campus, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehman</LastName><ForeName>Azhar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamim</LastName><ForeName>Muhammad Shahzad</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Section of Neurosurgery Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fauzia Anis</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02964416</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Pak Med Assoc</MedlineTA><NlmUniqueID>7501162</NlmUniqueID><ISSNLinking>0030-9982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>39J1LGJ30J</RegistryNumber><NameOfSubstance UI="D014147">Tramadol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014147" MajorTopicYN="Y">Tramadol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="Y">Bronchial Spasm</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="Y">Laryngismus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Craniotomy, Endotracheal extubation, Haemodynamics, Opioid, Cough.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37013278</ArticleId><ArticleId IdType="doi">10.47391/JPMA.4082</ArticleId><ArticleId IdType="pii">11606</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37081515</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Association between one-session bilateral whole-lung lavage and periprocedural complications in patients with pulmonary alveolar proteinosis: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>91</StartPage><MedlinePgn>91</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">91</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-023-02691-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Whole lung lavage (WLL) has been recognized as the most effective therapy of severe pulmonary alveolar proteinosis (PAP). Most centers perform the lavage of each lung in two sessions under general anesthesia at an interval of several days to weeks. Compared with two-session WLL, one-session bilateral sequential WLL only requires general anesthesia once. However, the safety of one-session WLL in PAP patients has not been assessed by large cohort studies. In this study, we aimed to investigate the association between the mode of WLL procedure (one-session or two-session) and the risk of periprocedural complications in PAP patients.</AbstractText><AbstractText Label="METHODS">In this single-center retrospective cohort study, we included adult patients who were diagnosed as PAP and had undergone WLL procedures under general anesthesia from 2000 to 2022. Patients requiring extra-corporeal oxygenation during WLL were excluded. Since some patients received multiple WLL procedures, we considered each procedure in one-session or two-session group as a unique unit in our analysis. The primary outcome was the occurrence of any complications during hospitalization, including termination of WLL procedure due to fluid leakage or refractory hypoxemia, bronchospasm, delayed endotracheal extubation, cardiovascular event, pneumothorax, and fever.</AbstractText><AbstractText Label="RESULTS">We included a total of 175 WLL procedures (118 patients), with 48 in the two-session group and 127 in the one-session group. Periprocedural complications occurred in 17 (35.4%) and 39 (30.7%) procedures in the two-session and the one-session groups, respectively. The risk of periprocedural complications did not differ significantly between groups, after adjusting the unbalanced confounders in a multivariable model (odds ratio 0.95, 95% confidence interval 0.34 to 2.69, P 0.929) or by inverse probability of treatment weighting (odds ratio 0.70, 95% confidence interval 0.30 to 1.54, P 0.379). Compared with the two-session WLL group, the one-session WLL group had a shorter postprocedural length of hospitalization and comparable decrease in alveolar-arterial oxygen tension gradient from baseline.</AbstractText><AbstractText Label="CONCLUSIONS">One-session bilateral WLL was not associated with an increased risk of periprocedural complications compared with two-session WLL in PAP patients. Experienced physicians may consider performing one-session WLL in view of the comparable safety and efficacy and potential advantages of saving time.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Huanrong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuelun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xinlun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yongjian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9060-6860</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. zhubo@pumch.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, PR China. zhubo@pumch.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011649" MajorTopicYN="Y">Pulmonary Alveolar Proteinosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018893" MajorTopicYN="N">Bronchoalveolar Lavage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011030" MajorTopicYN="Y">Pneumothorax</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bilateral</Keyword><Keyword MajorTopicYN="N">Complication</Keyword><Keyword MajorTopicYN="N">One-session</Keyword><Keyword MajorTopicYN="N">Pulmonary alveolar proteinosis</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Whole-lung lavage</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37081515</ArticleId><ArticleId IdType="pmc">PMC10116806</ArticleId><ArticleId IdType="doi">10.1186/s13023-023-02691-9</ArticleId><ArticleId IdType="pii">10.1186/s13023-023-02691-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752&#x2013;62. doi: 10.1164/rccm.200708-1271OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200708-1271OC</ArticleId><ArticleId IdType="pmc">PMC2720118</ArticleId><ArticleId IdType="pubmed">18202348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respir Med. 2018;6(7):554&#x2013;65. doi: 10.1016/S2213-2600(18)30043-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30043-2</ArticleId><ArticleId IdType="pubmed">29397349</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16. doi: 10.1038/s41572-019-0066-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0066-3</ArticleId><ArticleId IdType="pubmed">30846703</ArticleId></ArticleIdList></Reference><Reference><Citation>Vymazal T, Krecmerova M. Respiratory strategies and airway management in patients with pulmonary alveolar proteinosis: a review. Biomed Res Int. 2015;2015:639543. doi: 10.1155/2015/639543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/639543</ArticleId><ArticleId IdType="pmc">PMC4606191</ArticleId><ArticleId IdType="pubmed">26495308</ArticleId></ArticleIdList></Reference><Reference><Citation>Campo I, Luisetti M, Griese M, et al. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet J Rare Dis. 2016;11(1):115. doi: 10.1186/s13023-016-0497-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-016-0497-9</ArticleId><ArticleId IdType="pmc">PMC5006612</ArticleId><ArticleId IdType="pubmed">27577926</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A, Moreto A, Pinho C, Magalhaes A, Morais A, Fiuza C. Bilateral whole lung lavage in pulmonary alveolar proteinosis&#x2013;a retrospective study. Rev Port Pneumol. 2014;20(5):254&#x2013;9. doi: 10.1016/j.rppneu.2014.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rppneu.2014.04.004</ArticleId><ArticleId IdType="pubmed">25042291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Mendoza J, Celis Valdiviezo E, Patel NM, Simoff MJ. One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis. BMC Pulm Med. 2021;21(1):358. doi: 10.1186/s12890-021-01734-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01734-w</ArticleId><ArticleId IdType="pmc">PMC8575669</ArticleId><ArticleId IdType="pubmed">34749694</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie SG, Cai BQ, Zhang H, Liu YJ, Liu T. [Bilateral sequential whole lung lavage in the same treatment session for pulmonary alveolar proteinosis] Zhonghua nei ke za zhi. 2007;46(2):118&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17445437</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BB, Torres NE, Hyder JA, et al. Whole-lung lavage and pulmonary alveolar proteinosis: review of clinical and patient-centered outcomes. J Cardiothorac Vasc Anesth. 2019;33(9):2453&#x2013;61. doi: 10.1053/j.jvca.2019.03.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.03.047</ArticleId><ArticleId IdType="pubmed">31307910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JM. Reversal of neuromuscular block. BJA Educ. 2020;20(8):259&#x2013;65. doi: 10.1016/j.bjae.2020.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjae.2020.03.008</ArticleId><ArticleId IdType="pmc">PMC7807829</ArticleId><ArticleId IdType="pubmed">33456959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mata-Suarez SM, Castro-Lalin A, Mc Loughlin S, De Domini J, Bianco JC. Whole-lung Lavage-a narrative review of Anesthetic Management. J Cardiothorac Vasc Anesth. 2022;36(2):587&#x2013;93. doi: 10.1053/j.jvca.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.12.002</ArticleId><ArticleId IdType="pubmed">33386193</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmalak BB, Khanna AK, Culver DA, Popovich MJ. Therapeutic whole-lung lavage for pulmonary alveolar proteinosis: a procedural update. J Bronchol Interv Pulmonol. 2015;22(3):251&#x2013;8. doi: 10.1097/LBR.0000000000000180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/LBR.0000000000000180</ArticleId><ArticleId IdType="pubmed">26165897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. The Lancet Respiratory Medicine. 2018;6(7):554&#x2013;65. doi: 10.1016/S2213-2600(18)30043-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30043-2</ArticleId><ArticleId IdType="pubmed">29397349</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaud G, Reddy C, Ernst A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest. 2009;136(6):1678&#x2013;81. doi: 10.1378/chest.09-2295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-2295</ArticleId><ArticleId IdType="pubmed">19995769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Introduction. to tableone. https://cran.r-project.org/web/packages/tableone/vignettes/introduction.html. Accessed 1 Sept 2022.</Citation></Reference><Reference><Citation>Stevenson M, Sergeant E, epiR. Tools for the Analysis of Epidemiological Data. https://cran.r-project.org/web/packages/epiR/index.html. Accessed 1 Sept 2022.</Citation></Reference><Reference><Citation>H&#xf8;jsgaard S, Halekoh U, Yan J, Ekstr&#xf8;m C. geepack: Generalized Estimating Equation Package. https://cran.r-project.org/web/packages/geepack. Accessed 1 Feb 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40023371</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2201</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>The journal of allergy and clinical immunology. In practice</Title><ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation></Journal><ArticleTitle>Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).</ArticleTitle><Pagination><StartPage>1190</StartPage><EndPage>1200.e3</EndPage><MedlinePgn>1190-1200.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2025.02.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2198(25)00196-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Owing to limited treatment options for peanut allergy, patients remain at risk for allergic reactions due to accidental exposure. Epicutaneous immunotherapy (EPIT) is a novel treatment being investigated for peanut allergy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study assessed long-term safety of EPIT with VIASKIN peanut patch 250 &#x3bc;g (VP250) via an open-label extension of the REAL Life Use and Safety of EPIT (REALISE) trial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">REALISE was a phase 3 trial in peanut-allergic children aged 4 through 11 years that included a 6-month, randomized, double-blind, placebo-controlled treatment phase, followed by an open-label, single-arm, active treatment period for up to 36 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 392 participants (male 54.8%; median age 7.2 y) who received at least 1 dose of treatment, 77.8% completed the 36-month active treatment. Mean adherence to treatment was high at 96.4%. Most participants (98.7%) experienced at least 1 treatment-emergent adverse event (TEAE); the majority were mild or moderate and decreased in frequency and severity over time. Most participants (94.6%) experienced at least 1 treatment-related TEAE. Local skin reactions were the most common treatment-related TEAE with the incidence decreasing from year 1 (87.8%) to year 3 (19.2%). Serious treatment-related TEAEs were reported in 2 participants. No specific safety signals were identified in the 14 participants enrolled with a history of severe anaphylaxis (Anaphylaxis Staging System grade 3).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Consistent with previous phase 3 studies, long-term EPIT with VIASKIN peanut patch 250 &#x3bc;g was well tolerated with high adherence in peanut-allergic children aged 4 through 11 years (clinicaltrials.gov; NCT: NCT02916446).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pongracic</LastName><ForeName>Jacqueline A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: jpongracic@luriechildrens.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinique Sp&#xe9;cialis&#xe9;e en Allergie de la Capitale, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sussman</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gordon Sussman Clinical Research, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siri</LastName><ForeName>Dareen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Midwest Allergy Sinus Asthma, Sneeze, Wheeze &amp; Itch Associates (SWIA), Clinical Research Center, Normal, Ill; Department of Otolaryngology, Head &amp; Neck Surgery, Southern Illinois University School of Medicine, Springfield, Ill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriel</LastName><ForeName>Roxanne C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital, Department of Pediatrics, Division of Allergy and Immunology, Elliot and Roslyn Jaffe Food Allergy Institute, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown-Whitehorn</LastName><ForeName>Terri F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anvari</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Immunology, Allergy and Retrovirology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Allergy and Asthma Solutions, Trabuco Canyon, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bird</LastName><ForeName>J Andrew</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Edmond S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinthrajah</LastName><ForeName>R Sharon</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Hey J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineman</LastName><ForeName>Stanley M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta Allergy and Asthma, Atlanta, Ga.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischer</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital Colorado, University of Colorado Denver School of Medicine, Aurora, Colo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Reyes</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>South Texas Allergy and Asthma Medical Professionals, San Antonio, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Edwin H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Allergy and Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanser</LastName><ForeName>Bruce J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver and Aurora, Colo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacGinnitie</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Immunology, Medical College of Wisconsin, Milwaukee, Wis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Hemalini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Allergy and Asthma Specialists, PA, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petroni</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Seattle Allergy and Asthma Research Institute, Seattle, Wash; Clinical Development, BioCryst Pharmaceuticals, Inc., Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupp</LastName><ForeName>Ned</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Allergy and Asthma Research, North Charleston, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lynda C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scurlock</LastName><ForeName>Amy M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, and Arkansas Children's Hospital, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sher</LastName><ForeName>Lawrence D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Peninsula Research Associates, Rolling Hills Estates, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shreffler</LastName><ForeName>Wayne G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Food Allergy Center and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sindher</LastName><ForeName>Sayantani B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergy, Westmead Children's Hospital, Westmead, NSW, Australia; Ottawa Allergy Research Corporation, Ottawa, Ont, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Hugh A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital, Department of Pediatrics, Division of Allergy and Immunology, Elliot and Roslyn Jaffe Food Allergy Institute, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bois</LastName><ForeName>Timoth&#xe9;e</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Todd D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pa; DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Dianne E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France; Department of Clinical Immunology and Allergy, Westmead Children's Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bee</LastName><ForeName>Katharine J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe9;gin</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Section of Allergy, Immunology and Rheumatology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02916446</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol Pract</MedlineTA><NlmUniqueID>101597220</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000485">Allergens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021183" MajorTopicYN="Y">Peanut Hypersensitivity</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003888" MajorTopicYN="Y">Desensitization, Immunologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000485" MajorTopicYN="Y">Allergens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010367" MajorTopicYN="N">Arachis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Desensitization</Keyword><Keyword MajorTopicYN="N">Epicutaneous immunotherapy</Keyword><Keyword MajorTopicYN="N">Food allergy</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Long-term safety</Keyword><Keyword MajorTopicYN="N">Peanut allergy</Keyword><Keyword MajorTopicYN="N">Real-world setting, Children</Keyword><Keyword MajorTopicYN="N">VIASKIN</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>9</Day><Hour>12</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>1</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40023371</ArticleId><ArticleId IdType="doi">10.1016/j.jaip.2025.02.024</ArticleId><ArticleId IdType="pii">S2213-2198(25)00196-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37148836</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative oxygenation assessed by SpO<sub>2</sub>/FiO<sub>2</sub> ratio and respiratory complications after reversal of neuromuscular block with Sugammadex or neostigmine: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>111138</StartPage><MedlinePgn>111138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2023.111138</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(23)00088-0</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">Residual neuromuscular block may lead to postoperative muscle weakness, inadequate oxygenation, and other pulmonary complications. Sugammadex may provide more rapid and effective restoration of neuromuscular function than neostigmine. We therefore tested the primary hypothesis that noncardiac surgical patients given sugammadex oxygenate better during initial recovery than those given neostigmine. Secondarily, we tested the hypothesis that patients given sugammadex have fewer pulmonary complications during hospitalization.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort analysis.</AbstractText><AbstractText Label="SETTING">Postoperative recovery area of a tertiary care hospital.</AbstractText><AbstractText Label="PATIENTS">Adults who had non-cardiothoracic surgery and were given either neostigmine or sugammadex.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS">The primary outcome was the lowest SpO<sub>2</sub>/FiO<sub>2</sub> ratio in the post-anesthesia care unit. The secondary outcome was a composite of pulmonary complications.</AbstractText><AbstractText Label="MAIN RESULTS">Among 71,457 cases, 10,708 (15%) were given sugammadex and 60,749 (85%) received neostigmine. After propensity weighting, the mean minimum SpO<sub>2</sub>/FiO<sub>2</sub> ratio was 301&#xa0;&#xb1;&#xa0;77 (SD) in patients given sugammadex and 303&#xa0;&#xb1;&#xa0;71 in those given neostigmine, yielding an estimated difference in means of -3.5 (95% confidence interval: -5.3, -1.7; P&#xa0;=&#xa0;0.0002). 4.4% of patients given sugammadex and 3.6% of patients given neostigmine had postoperative pulmonary complications (P&#xa0;=&#xa0;0.0005, number-needed-to-be-exposed =136; 95% CI: 83, 330), with the main contributing components being new bronchospasm or exacerbation of obstructive pulmonary disease.</AbstractText><AbstractText Label="CONCLUSIONS">Postoperative minimum SpO<sub>2</sub>/FiO<sub>2</sub> ratio during PACU admission was similar after reversal of neuromuscular block by sugammadex and neostigmine. Reversal with sugammadex was associated with more pulmonary complications, but most were minor and of little consequence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;ssler</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooker</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara-Erazo</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekrami</LastName><ForeName>Elyad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America. Electronic address: ruetzlk@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3982TWQ96G</RegistryNumber><NameOfSubstance UI="D009388">Neostigmine</NameOfSubstance></Chemical><Chemical><RegistryNumber>361LPM2T56</RegistryNumber><NameOfSubstance UI="D000077122">Sugammadex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009388" MajorTopicYN="N">Neostigmine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077122" MajorTopicYN="N">Sugammadex</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019148" MajorTopicYN="Y">Neuromuscular Blockade</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="Y">Neuromuscular Nondepolarizing Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Neostigmine</Keyword><Keyword MajorTopicYN="N">Neuromuscular block</Keyword><Keyword MajorTopicYN="N">Postoperative oxygenation</Keyword><Keyword MajorTopicYN="N">Pulmonary complications</Keyword><Keyword MajorTopicYN="N">Sugammadex</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>6</Day><Hour>18</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37148836</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2023.111138</ArticleId><ArticleId IdType="pii">S0952-8180(23)00088-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16095449</PMID><DateCompleted><Year>2005</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0001-5172</ISSN><JournalIssue CitedMedium="Print"><Volume>49</Volume><Issue>8</Issue><PubDate><Year>2005</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation.</ArticleTitle><Pagination><StartPage>1088</StartPage><EndPage>1091</EndPage><MedlinePgn>1088-91</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The alpha agonist dexmedetomidine, a sedative and analgesic, reduces heart rate and blood pressure dose-dependently. We investigated whether it also has the ability to attenuate airway and circulatory reflexes during emergence from anaesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty ASA I-III patients received a standard anaesthetic. Five minutes before the end of surgery, they were randomly allocated to receive either dexmedetomidine 0.5 microg/kg (Group D) (n=30) or saline placebo (Group P) (n=30) intravenously (i.v.) over 60 s in a double-blind design. The blinded anaesthetist awoke all the patients, and the number of coughs per patient was continuously monitored for 15 min after extubation; coughing was evaluated on a 4-point scale. Any laryngospasm, bronchospasm or desaturation was recorded. Heart rate (HR) and systolic and diastolic blood pressure (SAP, DAP) were measured before, during and after tracheal extubation. The time from tracheal extubation and emergence from anaesthesia were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median coughing scores were 1 (1-3) in Group D and 2 (1-4) in Group P (P&lt;0.05), but there were no differences between the groups in the incidence of breath holding or desaturation. HR, SAP and DAP increased at extubation in both groups (P&lt;0.05), but the increase was less significant with dexmedetomidine. The time from tracheal extubation and emergence from anaesthesia were similar in both groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings suggest that a single-dose bolus injection of dexmedetomidine before tracheal extubation attenuates airway-circulatory reflexes during extubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guler</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Erciyes University, Medical Faculty, Kayseri, Turkey. gulen@erciyes.edu.tr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akin</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tosun</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Eskitascoglu</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mizrak</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Boyaci</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance></Chemical><Chemical><RegistryNumber>451W47IQ8X</RegistryNumber><NameOfSubstance UI="D012965">Sodium Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018712" MajorTopicYN="N">Analgesics, Non-Narcotic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012018" MajorTopicYN="N">Reflex</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012965" MajorTopicYN="N">Sodium Chloride</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>8</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>11</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>8</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16095449</ArticleId><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00780.x</ArticleId><ArticleId IdType="pii">AAS780</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38011027</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Mechanical Power and Postoperative Pulmonary Complications in Noncardiothoracic Elective Surgery Patients: A 10-Year Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>399</StartPage><EndPage>408</EndPage><MedlinePgn>399-408</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004848</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative pulmonary complications is a major issue that affects outcomes of surgical patients. The hypothesis was that the intraoperative ventilation parameters are associated with occurrence of postoperative pulmonary complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-center retrospective cohort study was conducted at the Lille University Hospital, France. The study included 33,701 adults undergoing noncardiac, nonthoracic elective surgery requiring general anesthesia with tracheal intubation between January 2010 and December 2019. Intraoperative ventilation parameters were compared between patients with and without one or more postoperative pulmonary complications (respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, and aspiration pneumonitis) within 7 days of surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 33,701 patients, 2,033 (6.0%) had one or more postoperative pulmonary complications. The lower tidal volume to predicted body weight ratio (odds ratio per -1 ml&#xb7;kgPBW-1, 1.08; 95% CI, 1.02 to 1.14; P &lt; 0.001), higher mechanical power (odds ratio per 4 J&#xb7;min-1, 1.37; 95% CI, 1.26 to 1.49; P &lt; 0.001), dynamic respiratory system compliance less than 30 ml&#xb7;cm H2O (1.30; 95% CI, 1.15 to 1.46; P &lt; 0.001), oxygen saturation measured by pulse oximetry less than 96% (odds ratio, 2.42; 95% CI, 1.97 to 2.96; P &lt; 0.001), and lower end-tidal carbon dioxide (odds ratio per -3 mmHg, 1.06; 95% CI, 1.00 to 1.13; P = 0.023) were independently associated with postoperative pulmonary complications. Patients with postoperative pulmonary complications were more likely to be admitted to the intensive care unit (odds ratio, 12.5; 95% CI, 6.6 to 10.1; P &lt; 0.001), had longer hospital length of stay (subhazard ratio, 0.43; 95% CI, 0.40 to 0.45), and higher in-hospital (subhazard ratio, 6.0; 95% CI, 4.1 to 9.0; P &lt; 0.001) and 1-yr mortality (subhazard ratio, 2.65; 95% CI, 2.33 to 3.02; P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the study's population, decreased rather than increased tidal volume, decreased compliance, increased mechanical power, and decreased end-tidal carbon dioxide were independently associated with postoperative pulmonary complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc., on behalf of the American Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elefterion</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Surgical Critical Care, Department of Anesthesiology and Critical Care, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirenei</LastName><ForeName>Cedric</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8498-8823</Identifier><AffiliationInfo><Affiliation>Lille University Hospital, Surgical Critical Care, Department of Anesthesiology and Critical Care, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kipnis</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Surgical Critical Care, Department of Anesthesiology and Critical Care, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cailliau</LastName><ForeName>Emeline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Biostatistics Department, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruandet</LastName><ForeName>Am&#xe9;lie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Medical Information Department, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavernier</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Surgical Critical Care, Department of Anesthesiology and Critical Care, Lille, France; and Lille University F-59000, ULR 2694-METRICS: Health Technology Assessment and Medical Practices Evaluation, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamer</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lille University, Lille University Hospital, ULR 2694-METRICS: Health Technology Assessment and Medical Practices Evaluation, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebuffe</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Surgical Critical Care, Department of Anesthesiology and Critical Care, Lille, France: Lille University F-59000, ULR 7365-Research Group on Injectable Forms and Associated Technologies, Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="Y">Carbon Dioxide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="Y">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>13</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38011027</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004848</ArticleId><ArticleId IdType="pii">139427</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37645006</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2228-7531</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesiology and pain medicine</Title><ISOAbbreviation>Anesth Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of Laryngeal Mask Airway on Image Quality in Pediatric Patients Undergoing Brain Magnetic Resonance Imaging: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e129532</StartPage><MedlinePgn>e129532</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e129532</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5812/aapm-129532</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Magnetic resonance imaging (MRI) is highly sensitive to motion, resulting in artifacts and lowering image quality. Laryngeal mask airway (LMA) provides numerous advantages over endotracheal tubes as it reduces laryngospasm, coughing, and the risk of postoperative desaturation.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">We aimed to compare LMA with oral airway for airway management during brain MRI in terms of reducing motion artifacts, which can improve image quality.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This randomized, controlled, double-blind trial was carried out on 40 pediatrics aged 1 - 18 years, American Society of Anesthesiologists (ASA) physical status &#x406; and &#x41f; undergoing brain MRI. Patients were randomized into two equal groups according to the airway method, the control (Guedel oral airway) group and the LMA group. A compatible anesthesia machine was used to provide O<sub>2</sub> and sevoflurane 2% - 4%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mean MRI image quality score was significantly higher in the LMA group than in the control group (26.10 &#xb1; 3.97 versus 18.60 &#xb1; 5.30, P &lt; 0.001). Mean arterial blood pressure and heart rate were significantly lower in the LMA group than in the control group at all study times except at baseline and immediate post-extubation (P &lt; 0.05). Cough was significantly lower in LMA than in the control group (15% vs. 50%, P = 0.040). Airway complications (sore throat, laryngeal spasm, and bronchospasm), nausea, and vomiting did not have a significantly different between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Compared to Guedel oral airway, using LMA for airway management in pediatrics undergoing MRI scans improved the image quality with less cough and better hemodynamics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wadod</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1952-5849</Identifier><AffiliationInfo><Affiliation>ICU and Pain Relief, National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboelazm</LastName><ForeName>Omnia Mohammed</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Rawas</LastName><ForeName>Mai Mohammed</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>ICU and Pain Relief, National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Anesth Pain Med</MedlineTA><NlmUniqueID>101585412</NlmUniqueID><ISSNLinking>2228-7523</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway Management</Keyword><Keyword MajorTopicYN="N">Guedel Oral Airway</Keyword><Keyword MajorTopicYN="N">Image Quality</Keyword><Keyword MajorTopicYN="N">Laryngeal Mask Airway</Keyword><Keyword MajorTopicYN="N">Magnetic Resonance Imaging</Keyword></KeywordList><CoiStatement>Conflict of Interests: There is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>3</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37645006</ArticleId><ArticleId IdType="pmc">PMC10461386</ArticleId><ArticleId IdType="doi">10.5812/aapm-129532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Artunduaga M, Liu CA, Morin CE, Serai SD, Udayasankar U, Greer MC, et al. Safety challenges related to the use of sedation and general anesthesia in pediatric patients undergoing magnetic resonance imaging examinations. Pediatr Radiol. 2021;51(5):724&#x2013;35. doi: 10.1007/s00247-021-05044-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-021-05044-5</ArticleId><ArticleId IdType="pmc">PMC8049862</ArticleId><ArticleId IdType="pubmed">33860861</ArticleId></ArticleIdList></Reference><Reference><Citation>McJury MJ. Acoustic Noise and Magnetic Resonance Imaging: A Narrative/Descriptive Review. J Magn Reson Imaging. 2022;55(2):337&#x2013;46. doi: 10.1002/jmri.27525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27525</ArticleId><ArticleId IdType="pubmed">33629790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ucisik-Keser FE, Chi TL, Hamid Y, Dinh A, Chang E, Ferson DZ. Impact of airway management strategies on magnetic resonance image quality. Br J Anaesth. 2016;117 Suppl 1:i97&#x2013;i102. doi: 10.1093/bja/aew210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew210</ArticleId><ArticleId IdType="pubmed">27566792</ArticleId></ArticleIdList></Reference><Reference><Citation>Havsteen I, Ohlhues A, Madsen KH, Nybing JD, Christensen H, Christensen A. Are Movement Artifacts in Magnetic Resonance Imaging a Real Problem?-A Narrative Review. Front Neurol. 2017;8:232. doi: 10.3389/fneur.2017.00232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00232</ArticleId><ArticleId IdType="pmc">PMC5447676</ArticleId><ArticleId IdType="pubmed">28611728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad R, Hu HH, Krishnamurthy R, Krishnamurthy R. Reducing sedation for pediatric body MRI using accelerated and abbreviated imaging protocols. Pediatr Radiol. 2018;48(1):37&#x2013;49. doi: 10.1007/s00247-017-3987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-017-3987-6</ArticleId><ArticleId IdType="pubmed">29292482</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlachov Y, Ganatra RH. Sedation/anaesthesia in paediatric radiology. Br J Radiol. 2012;85(1019):e1018&#x2013;31. doi: 10.1259/bjr/28871143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr/28871143</ArticleId><ArticleId IdType="pmc">PMC3500799</ArticleId><ArticleId IdType="pubmed">22898157</ArticleId></ArticleIdList></Reference><Reference><Citation>Strametz R, Pachler C, Kramer JF, Byhahn C, Siebenhofer A, Weberschock T. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients. Cochrane Database Syst Rev. 2014;2014(6):CD009901. doi: 10.1002/14651858.CD009901.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009901.pub2</ArticleId><ArticleId IdType="pmc">PMC6464046</ArticleId><ArticleId IdType="pubmed">24979320</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho ALR, Vital RB, de Lira CCS, Magro IB, Sato PTS, Lima LHN, et al. Laryngeal Mask Airway Versus Other Airway Devices for Anesthesia in Children With an Upper Respiratory Tract Infection: A Systematic Review and Meta-analysis of Respiratory Complications. Anesth Analg. 2018;127(4):941&#x2013;50. doi: 10.1213/ANE.0000000000003674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003674</ArticleId><ArticleId IdType="pubmed">30059398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevescanin A, Vickov J, Elezovic Baloevic S, Pogorelic Z. Laryngeal Mask Airway Versus Tracheal Intubation for Laparoscopic Hernia Repair in Children: Analysis of Respiratory Complications. J Laparoendosc Adv Surg Tech A. 2020;30(1):76&#x2013;80. doi: 10.1089/lap.2019.0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2019.0382</ArticleId><ArticleId IdType="pubmed">31613680</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Cao H, Tan X, Qiao L, Zhang Q, Shi L. Comparison of the Effect of Laryngeal Mask Airway Versus Endotracheal Tube on Airway Management in Pediatric Patients with Tonsillar Hypertrophy. J Perianesth Nurs. 2021;36(2):142&#x2013;6. doi: 10.1016/j.jopan.2020.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2020.06.020</ArticleId><ArticleId IdType="pubmed">33168406</ArticleId></ArticleIdList></Reference><Reference><Citation>Klucka J, Senkyrik J, Skotakova J, Stoudek R, Toukalkova M, Krikava I, et al. Laryngeal mask airway Unique position in paediatric patients undergoing magnetic resonance imaging (MRI): prospective observational study. BMC Anesthesiol. 2018;18(1):153. doi: 10.1186/s12871-018-0617-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-018-0617-2</ArticleId><ArticleId IdType="pmc">PMC6201529</ArticleId><ArticleId IdType="pubmed">30355285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JJ, Chuang YH, Wu CY. Feasibility and Safety of Using Supraglottic Airway Devices for Pediatric Patients Undergoing Magnetic Resonance Imaging: A Case Series of High-Risk Patients. Asian J Anesthesiol. 2021;59(3):96&#x2013;101. doi: 10.6859/aja.202109_59(3).0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.6859/aja.202109_59(3).0003</ArticleId><ArticleId IdType="pubmed">34266229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tith S, Lalwani K, Fu R. Complications of three deep sedation methods for magnetic resonance imaging. J Anaesthesiol Clin Pharmacol. 2012;28(2):178&#x2013;84. doi: 10.4103/0970-9185.94837.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-9185.94837</ArticleId><ArticleId IdType="pmc">PMC3339721</ArticleId><ArticleId IdType="pubmed">22557739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaballos M, Bastida E, Del Castillo T, De Villoria JG, Jimenez C. In vitro study of magnetic resonance imaging artefacts of six supraglottic airway devices. Anaesthesia. 2010;65(6):569&#x2013;72. doi: 10.1111/j.1365-2044.2010.06299.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2010.06299.x</ArticleId><ArticleId IdType="pubmed">20337623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Nazir N, Khan RM, Ahmed SM. A prospective randomized control study comparing classic laryngeal mask airway with Guedel's airway for tracheal tube exchange and smooth extubation. Anesth Essays Res. 2016;10(3):552&#x2013;6. doi: 10.4103/0259-1162.186611.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.186611</ArticleId><ArticleId IdType="pmc">PMC5062217</ArticleId><ArticleId IdType="pubmed">27746550</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri A, Hajimohamadi F, Soltanghoraee H, Moin A. Complications of using laryngeal mask airway during anaesthesia in patients undergoing major ear surgery. Acta Otorhinolaryngol Ital. 2009;29(3):151&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815362</ArticleId><ArticleId IdType="pubmed">20140161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31124887</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-4801</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of pediatric gastroenterology and nutrition</Title><ISOAbbreviation>J Pediatr Gastroenterol Nutr</ISOAbbreviation></Journal><ArticleTitle>Dexamethasone Reduces Postoperative Nausea in Pediatric Upper Endoscopy With Deep Sedation: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>281</StartPage><EndPage>286</EndPage><MedlinePgn>281-286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MPG.0000000000002398</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We aimed to evaluate the effect of a single dose of preoperative dexamethasone on postoperative nausea and vomiting (PONV), a frequent complication and a major cause of delayed recovery in pediatric upper gastrointestinal endoscopy (UGIE) under sedation.</AbstractText><AbstractText Label="METHODS">In this double-blind randomized controlled study, 98 children aged 2 to 14, with American Society of Anesthesiologists status I to II, and undergoing elective UGIE with deep sedation were included and randomly assigned to 2 groups. Preoperatively, after anesthesia induction with sodium thiopental and maintenance with sevoflurane, patients in the intervention (n&#x200a;=&#x200a;49) and control (n&#x200a;=&#x200a;49) groups, respectively received 0.1&#x200a;mg/kg i.v. dexamethasone and 2&#x200a;cm i.v. 0.9% saline. Postoperatively, PONV incidence was measured as the primary outcome.</AbstractText><AbstractText Label="RESULTS">PONV incidence was significantly less in dexamethasone group (8.2%) compared to the control group (26.5%) (difference&#x200a;=&#x200a;18.3%, 95% confidence interval: 3.4%-33%, P&#x200a;=&#x200a;0.016). For secondary outcomes, between-group differences were not statistically significant: incidence of bronchospasm or laryngospasm (both 4.1%, P&#x200a;=&#x200a;1); emergence delirium assessed with Pediatric Anesthesia Emergence Delirium scale (5.9&#x200a;&#xb1;&#x200a;3.4 vs 5.7&#x200a;&#xb1;&#x200a;3.2, P&#x200a;=&#x200a;0.751); Modified Aldrete score at 0 minutes (9.4&#x200a;&#xb1;&#x200a;0.8 vs 9.3&#x200a;&#xb1;&#x200a;0.9, P&#x200a;=&#x200a;0.909) and at 5 minutes (9.5&#x200a;&#xb1;&#x200a;0.7 vs 9.4&#x200a;&#xb1;&#x200a;0.9, P&#x200a;=&#x200a;0.527); and recovery time (21.1&#x200a;&#xb1;&#x200a;6.6 vs 23.4&#x200a;&#xb1;&#x200a;8.6&#x200a;minutes, P&#x200a;=&#x200a;0.130).</AbstractText><AbstractText Label="CONCLUSIONS">A single preoperative dose of i.v. dexamethasone reduces PONV in children undergoing elective UGIE with deep sedation, but has no significant effect on the patient recovery time or the incidence of postoperative bronchospasm or laryngospasm and emergence delirium.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moheimani</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaseri</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>IRCT</DataBankName><AccessionNumberList><AccessionNumber>IRCT20180929041173N1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Gastroenterol Nutr</MedlineTA><NlmUniqueID>8211545</NlmUniqueID><ISSNLinking>0277-2116</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):271-272. doi: 10.1097/MPG.0000000000002419.</RefSource><PMID Version="1">31211766</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):e52. doi: 10.1097/MPG.0000000000002561.</RefSource><PMID Version="1">31978037</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):e52-e53. doi: 10.1097/MPG.0000000000002560.</RefSource><PMID Version="1">31978038</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="N">Antiemetics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054810" MajorTopicYN="Y">Deep Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005773" MajorTopicYN="Y">Gastroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="N">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31124887</ArticleId><ArticleId IdType="doi">10.1097/MPG.0000000000002398</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27382816</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2016</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0544-0440</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Middle East journal of anaesthesiology</Title><ISOAbbreviation>Middle East J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>EFFECT OF DEXMEDETOMIDINE ON HEMODYNAMIC PARAMETERS DURING EXTUBATION. A PROSPECTIVE RANDOMIZED DOUBLE BLIND STUDY.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>463</EndPage><MedlinePgn>457-63</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Extubation is known to produce significant hemodynamic disturbances. There is a need to avoid increase in heart rate and blood pressure in hypertensive and cardiac patients and in vascular, neuro and intraocular surgeries.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To study the ability of dexmedetomidine to attenuate the hemodynamic responses during extubation.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">80 patients of ASA Grade I-II aged 18-50 years received standard anesthesia. At the closure of skin incision, patients were randomly allocated to receive either dexmedetomidine 0.5 &#xb5;g/kg (Group D) or saline placebo (Group C) intravenously over 10 minutes in a double-blind design. Heart rate (HR), systolic, diastolic and mean arterial pressures (SBP, DBP, MAP) were assessed before, during- and after extubation. Time to eye opening and extubation, sedation, complications such as coughing, laryngospasm, bronchospasm and desaturation were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">HR, SBP, DBP and MAP were comparable to basal values in group D at extubation and lower than baseline values post-extubation but significant increase was noted in group C (P &lt;0.001). Time to extubation and eye opening were prolonged in Group D (P &lt;0.001). Incidence of hypotension was more in group D (22%) but was transient. Incidence of coughing was lower in Group D than in group C (P &lt;0.001). Patients in group D were more sedated for 30 minutes post extubation.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine 0.5 &#xb5;g/kg given before extubation attenuates hemodynamic reflexes during emergence from anesthesia without causing undue sedation, but prolongs time to extubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shruthi</LastName><ForeName>A H</ForeName><Initials>AH</Initials></Author><Author ValidYN="Y"><LastName>Nethra</LastName><ForeName>S S</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Sudheesh</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Devika Rani</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Raghavendra Rao</LastName><ForeName>R S</ForeName><Initials>RS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Lebanon</Country><MedlineTA>Middle East J Anaesthesiol</MedlineTA><NlmUniqueID>8604187</NlmUniqueID><ISSNLinking>0544-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="Y">Airway Extubation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012018" MajorTopicYN="N">Reflex</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27382816</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37469048</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-9982</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JPMA. The Journal of the Pakistan Medical Association</Title><ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Impact Of Incentive-Based Game Therapy And Transporting Children On Toy Vehicle To Operation Theatre On Reducing Anxiety Prior To Induction Of Anesthesia.</ArticleTitle><Pagination><StartPage>1388</StartPage><EndPage>1392</EndPage><MedlinePgn>1388-1392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.47391/JPMA.6630</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To see if transporting paediatric patents to operation theatres using a battery operated vehicle decreases preoperative anxiety and reduce incidents of postoperative adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was conducted from May to August 2019 at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised paediatric patients aged 3-5 years assessed as American Society of Anaesthesiologists grade I and II who were scheduled to undergo elective intrathecal chemotherapy under general anaesthesia. The subjects were randomised into intervention group A and control group B. Patients in group A were part of an incentive-based game in the holding bay area and were transported to the operation theatre using a battery-operated toy vehicle. Those in group B watched a pre-decided cartoon on television screen in the holding bay and were transported further using wheel chair. Induction of anaesthesia was done in the presence of guardians in both the groups. Patient anxiety was assessed using the modified Yale Preoperative Anxiety Scale in holding bay area T0, prior to induction of anaesthesia T1, and postoperative anaesthesia-related recovery T2. Data was analysed using SPSS 22.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 36 patients, 18(50%) were in group A; 12(66.6%) boys and 6(33.3%) girls with mean age 4.01&#xb1;0.48 years. The remaining 18(50%) subjects were in group B; 13(72.2%) boys and 5(27.8%) girls with mean age 3.96 years. The difference in anxiety between the groups at T0 was non-significant (p=0.73). At T1 and T2, the scores were significantly lower group A compared to group B (p&lt;0.05). Group A patients had better bag mask ventilation compliance at induction and remarkably less incidence of hypoxia, bronchospasm, postoperative agitation and early discharge from PACU.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Incentive-based game therapy decreased anxiety among paediatric patients preoperatively, made them more compliant and improved postoperative recovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Ahmed Bilal</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najeeb</LastName><ForeName>Hammad Nabeel</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehman Ghafoor</LastName><ForeName>Ateeq Ur</ForeName><Initials>AU</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Pak Med Assoc</MedlineTA><NlmUniqueID>7501162</NlmUniqueID><ISSNLinking>0030-9982</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="Y">Anxiety</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia, Anxiety, Children, Game therapy, Induction.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37469048</ArticleId><ArticleId IdType="doi">10.47391/JPMA.6630</ArticleId><ArticleId IdType="pii">6630</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22608583</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Use of sugammadex in patients with a history of pulmonary disease.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>297</EndPage><MedlinePgn>289-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2011.09.006</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To evaluate the safety and efficacy of sugammadex for reversal of rocuronium-induced neuromuscular blockade in patients with pulmonary disease.</AbstractText><AbstractText Label="DESIGN">Phase III, randomized, multicenter, parallel-group, comparative, safety-assessor blinded study.</AbstractText><AbstractText Label="SETTING">Nine hospital sites.</AbstractText><AbstractText Label="PATIENTS">77 ASA physical status 2 and 3 patients, aged &#x2265; 18 years, with a history of pulmonary disease, and scheduled for surgery with general anesthesia requiring neuromuscular blockade.</AbstractText><AbstractText Label="INTERVENTIONS">Following anesthesia induction, patients received rocuronium 0.6 mg/kg with 0.15 mg/kg maintenance doses as needed. Patients were randomized to receive sugammadex 2 mg/kg or 4 mg/kg after the last rocuronium dose at reappearance of the second twitch.</AbstractText><AbstractText Label="MEASUREMENTS">Safety evaluations included adverse events, laboratory parameters, vital signs, and evidence of recurrent or residual neuromuscular blockade. Efficacy was evaluated as the time from sugammadex administration to recovery of the train-of-four (TOF) ratio to &#x2265; 0.9.</AbstractText><AbstractText Label="MAIN RESULTS">Safety was comparable between doses, with no evidence of residual or recurrent neuromuscular blockade. Two bronchospasm cases were reported (4 mg/kg group), both in patients with asthma who received desflurane for anesthesia maintenance. Geometric mean (95% confidence interval) times to a TOF ratio of &#x2265; 0.9 were 2.1 (1.7 - 3.1) min (2 mg/kg) and 1.8 (1.5 - 2.7) min (4 mg/kg).</AbstractText><AbstractText Label="CONCLUSION">Sugammadex 2 mg/kg and 4 mg/kg were well tolerated and effective in patients with a history of pulmonary disease. Bronchospasm is a possibility when administering sugammadex to patients with underlying pulmonary disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amao</LastName><ForeName>Rasheed</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Creighton University Medical Center, Omaha, NE 68131, USA. Rashamao@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zornow</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Cowan</LastName><ForeName>Robert McTaggart</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Morte</LastName><ForeName>Jovino B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Allard</LastName><ForeName>Martin W</ForeName><Initials>MW</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00475215</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000732">Androstanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047408">gamma-Cyclodextrins</NameOfSubstance></Chemical><Chemical><RegistryNumber>361LPM2T56</RegistryNumber><NameOfSubstance UI="D000077122">Sugammadex</NameOfSubstance></Chemical><Chemical><RegistryNumber>WRE554RFEZ</RegistryNumber><NameOfSubstance UI="D000077123">Rocuronium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000732" MajorTopicYN="N">Androstanols</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019148" MajorTopicYN="N">Neuromuscular Blockade</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077123" MajorTopicYN="N">Rocuronium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077122" MajorTopicYN="N">Sugammadex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047408" MajorTopicYN="N">gamma-Cyclodextrins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22608583</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2011.09.006</ArticleId><ArticleId IdType="pii">S0952-8180(12)00115-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32997968</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0953</ISSN><JournalIssue CitedMedium="Internet"><Volume>192</Volume><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Environmental research</Title><ISOAbbreviation>Environ Res</ISOAbbreviation></Journal><ArticleTitle>A prospective study on the role of smoking, environmental tobacco smoke, indoor painting and living in old or new buildings on asthma, rhinitis and respiratory symptoms.</ArticleTitle><Pagination><StartPage>110269</StartPage><MedlinePgn>110269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.envres.2020.110269</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0013-9351(20)31166-X</ELocationID><Abstract><AbstractText>We studied associations between tobacco smoke, home environment and respiratory health in a 10 year follow up of a cohort of 11,506 adults in Northern Europe. Multilevel logistic regression models were applied to estimate onset and remission of symptoms. Current smokers at baseline developed more respiratory symptoms (OR&#xa0;=&#xa0;1.39-4.43) and rhinitis symptoms (OR&#xa0;=&#xa0;1.35). Starting smoking during follow up increased the risk of new respiratory symptoms (OR&#xa0;=&#xa0;1.54-1.97) and quitting smoking decreased the risk (OR&#xa0;=&#xa0;0.34-0.60). ETS at baseline increased the risk of wheeze (OR&#xa0;=&#xa0;1.26). Combined ETS at baseline or follow up increased the risk of wheeze (OR&#xa0;=&#xa0;1.27) and nocturnal cough (OR&#xa0;=&#xa0;1.22). Wood painting at baseline reduced remission of asthma (OR 95%CI: 0.61, 0.38-0.99). Floor painting at home increased productive cough (OR 95%CI: 1.64, 1.15-2.34) and decreased remission of wheeze (OR 95%CI: 0.63, 0.40-0.996). Indoor painting (OR 95%CI: 1.43, 1.16-1.75) and floor painting (OR 95%CI: 1.77, 1.11-2.82) increased remission of allergic rhinitis. Living in the oldest buildings (constructed before 1960) was associated with higher onset of nocturnal cough and doctor diagnosed asthma. Living in the newest buildings (constructed 1986-2001) was associated with higher onset of nocturnal breathlessness (OR&#xa0;=&#xa0;1.39) and rhinitis (OR&#xa0;=&#xa0;1.34). In conclusion, smoking, ETS and painting indoor can be risk factors for respiratory symptoms. Wood painting and floor painting can reduce remission of respiratory symptoms. Smoking can increase rhinitis. Living in older buildings can be a risk factor for nocturnal cough and doctor diagnosed asthma. Living in new buildings can increase nocturnal dyspnoea and rhinitis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden. Electronic address: juan.wang@medsci.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janson</LastName><ForeName>Christer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Respiratory-, Allergy- and Sleep Research, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jogi</LastName><ForeName>Rain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Lung Clinic, Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsberg</LastName><ForeName>Bertil</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gislason</LastName><ForeName>Thorarinn</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Sleep, Landspitali University Hospital, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Occupational and Environmental Medicine, Gothenburg University, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tor&#xe9;n</LastName><ForeName>Kjell</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malinovschi</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigsgaard</LastName><ForeName>Torben</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Public Health, Environment, Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schl&#xfc;nssen</LastName><ForeName>Vivi</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health, Environment, Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svanes</LastName><ForeName>Cecilie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johannessen</LastName><ForeName>Ane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertelsen</LastName><ForeName>Randi Jacobsen</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway; Oral Health Centre of Expertise, Western Norway, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Karl A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Surgical and Preoperative Sciences, Surgery, Ume&#xe5; University, SE-901 85, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norb&#xe4;ck</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Environ Res</MedlineTA><NlmUniqueID>0147621</NlmUniqueID><ISSNLinking>0013-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016902" MajorTopicYN="Y">Air Pollution, Indoor</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012220" MajorTopicYN="Y">Rhinitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014028" MajorTopicYN="Y">Tobacco Smoke Pollution</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Environmental tobacco smoke</Keyword><Keyword MajorTopicYN="N">Onset and remission</Keyword><Keyword MajorTopicYN="N">Painting</Keyword><Keyword MajorTopicYN="N">Rhinitis</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>20</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32997968</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2020.110269</ArticleId><ArticleId IdType="pii">S0013-9351(20)31166-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34015036</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Effects of salbutamol on the kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications in patients with mild-to-moderate chronic obstructive pulmonary disease: A randomized controlled study.</ArticleTitle><Pagination><StartPage>e0251795</StartPage><MedlinePgn>e0251795</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0251795</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0251795</ELocationID><Abstract><AbstractText>Bronchodilators dilate the bronchi and increase lung volumes, thereby improving respiratory physiology in patients with chronic obstructive pulmonary disease (COPD). However, their effects on sevoflurane kinetics remain unknown. We aimed to determine whether inhaled salbutamol affected the wash-in and wash-out kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications (PPCs) in patients with COPD undergoing elective surgery. This randomized, placebo-controlled study included 63 consecutive patients with COPD allocated to the salbutamol (n = 30) and control groups (n = 33). The salbutamol group received salbutamol aerosol (2 puffs of ~200 &#x3bc;g) 30 min before anesthesia induction and 30 min before surgery completion. The control group received a placebo. Sevoflurane kinetics were determined by collecting end-tidal samples from the first breaths at 1, 2, 3, 4, 5, 7, 10, and 15 min before the surgery (wash-in) and after closing the vaporizer (wash-out). PPCs were recorded for 7 days. The salbutamol group had higher end-tidal to inhaled sevoflurane ratios (p&lt;0.05, p&lt;0.01) than the control group, from 3 to 10 min during the wash-in period, but no significant differences were observed during the wash-out period. The arterial partial pressure of oxygen to the fraction of inhaled oxygen was significantly higher in the salbutamol group at 30 (320.3&#xb1;17.6 vs. 291.5&#xb1;29.6 mmHg; p = 0.033) and 60 min (327.8&#xb1;32.3 vs. 309.2&#xb1;30.5 mmHg; p = 0.003). The dead space to tidal volume ratios at 30 (20.5&#xb1;6.4% vs. 26.3&#xb1;6.0%, p = 0.042) and 60 min (19.6&#xb1;5.1% vs. 24.8&#xb1;5.5%, p = 0.007) and the incidence of bronchospasm (odds ratio [OR] 0.45, 95% confidence interval [CI] 0.23-0.67, p = 0.023) and respiratory infiltration (OR 0.52, 95% CI, 0.40-0.65, p = 0.017) were lower in the salbutamol group. In patients with COPD, salbutamol accelerates the wash-in rate of sevoflurane and decreases the occurrence of postoperative bronchospasm and pulmonary infiltration within the first 7 days.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Huayong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiujuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Shumei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Changfeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zongming</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7187-0842</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University of School of Medicine), Shaoxing, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="Y">Albuterol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="Y">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="Y">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no potential interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>18</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34015036</ArticleId><ArticleId IdType="pmc">PMC8136676</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0251795</ArticleId><ArticleId IdType="pii">PONE-D-20-33323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agust&#xed; A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019; 381:1248&#x2013;1256. 10.1056/NEJMra1900475</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1900475</ArticleId><ArticleId IdType="pubmed">31553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggappa DR, Rao GV, Kannan S. Anaesthesia for patient with chronic obstructive pulmonary disease. Indian J Anaesth.2015;59:574&#x2013;583. 10.4103/0019-5049.165859</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.165859</ArticleId><ArticleId IdType="pmc">PMC4613404</ArticleId><ArticleId IdType="pubmed">26556916</ArticleId></ArticleIdList></Reference><Reference><Citation>Edrich T, Sadovnikoff N. Anesthesia for patients with severe chronic obstructive pulmonary disease. Curr Opin Anaesthesiol. 2010;23:18&#x2013;24. 10.1097/ACO.0b013e328331ea5b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e328331ea5b</ArticleId><ArticleId IdType="pubmed">19770646</ArticleId></ArticleIdList></Reference><Reference><Citation>Brister NW, Barnette RE, Kim V, Keresztury M. Anesthetic considerations in candidates for lung volume reduction surgery. Proc Am Thorac Soc. 2008;5:432&#x2013;437. 10.1513/pats.200709-149ET</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200709-149ET</ArticleId><ArticleId IdType="pmc">PMC2645315</ArticleId><ArticleId IdType="pubmed">18453351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills GH. Respiratory complications of anaesthesia. Anaesthesia. 2018;73:25&#x2013;33. 10.1111/anae.14137</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14137</ArticleId><ArticleId IdType="pubmed">29313906</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller V, G&#xe1;lffy G, Orosz M, Kov&#xe1;ts Z, Odler B, Selroos O, et al.. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Int J Chron Obstruct Pulmon Dis. 2016;11:93&#x2013;101. 10.2147/COPD.S92331</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S92331</ArticleId><ArticleId IdType="pmc">PMC4716721</ArticleId><ArticleId IdType="pubmed">26834466</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser R, Kelderman S, de Jongh FH, van der Palen J, Thio BJ. Reversibility of pulmonary function after inhaling salbutamol in different doses and body postures in asthmatic children. Respir Med.2015;109:1274&#x2013;1279. 10.1016/j.rmed.2015.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2015.07.015</ArticleId><ArticleId IdType="pubmed">26341548</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S, Karacabeyli D, Galts C, MacInnis MJ, Sporer BC, Koehle MS. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction. J Sci Med Sport.2015;18:607&#x2013;612. 10.1016/j.jsams.2014.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsams.2014.07.021</ArticleId><ArticleId IdType="pubmed">25156879</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockcroft DW, Davis BE, Tollefson G, Yurach Pikaluk M. Acute salbutamol bronchoprotection against methacholine: Asthma compared with chronic obstructive pulmonary disease. Ann Allergy Asthma Immunol. 2020;124:633&#x2013;634. 10.1016/j.anai.2020.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.03.025</ArticleId><ArticleId IdType="pubmed">32244033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellamy D, Hutchison DC. The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema. Br J Dis Chest. 1981;75:190&#x2013;196. 10.1016/0007-0971(81)90052-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0007-0971(81)90052-8</ArticleId><ArticleId IdType="pubmed">7023528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashoor TM, Hasseb AM, Esmat IM. Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial. Korean J Anesthesiol. 2020;73:509&#x2013;517. 10.4097/kja.19418</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.19418</ArticleId><ArticleId IdType="pmc">PMC7714627</ArticleId><ArticleId IdType="pubmed">32106642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J. 1998;12:799&#x2013;804. 10.1183/09031936.98.12040799</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.98.12040799</ArticleId><ArticleId IdType="pubmed">9817148</ArticleId></ArticleIdList></Reference><Reference><Citation>Korman B, Dash RK, Peyton PJ. Effect of net gas volume changes on alveolar and arterial gas partial pressures in the presence of ventilation-perfusion mismatch. J Appl Physiol (1985). 2019;126:558&#x2013;568. 10.1152/japplphysiol.00689.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00689.2018</ArticleId><ArticleId IdType="pmc">PMC6734074</ArticleId><ArticleId IdType="pubmed">30521424</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesney MA, Perouansky M, Pearce RA. Differential uptake of volatile agents into brain tissue in vitro. Measurement and application of a diffusion model to determine concentration profiles in brain slices. Anesthesiology. 2003;99:122&#x2013;130. 10.1097/00000542-200307000-00021</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200307000-00021</ArticleId><ArticleId IdType="pubmed">12826851</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Oh EJ, Han S, Shin B, Shin SH, Im Y, et al.. Intraoperative anesthetic management of patients with chronic obstructive pulmonary disease to decrease the risk of postoperative pulmonary complications after abdominal surgery. J Clin Med. 2020;9:150. 10.3390/jcm9010150</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010150</ArticleId><ArticleId IdType="pmc">PMC7019772</ArticleId><ArticleId IdType="pubmed">31935888</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xe7;&#xf4;a R, Rodrigues DM, Dias M, Ladeira I, Vaz AP, Lima R, et al.. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011. COPD. 2018;15:21&#x2013;26. 10.1080/15412555.2017.1394285</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15412555.2017.1394285</ArticleId><ArticleId IdType="pubmed">29161163</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al.. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018; 378: 2263&#x2013;2274. 10.1056/NEJMoa1801601</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Gala F, Pi&#xf1;eiro P, Reyes A, Vara E, Olmedilla L, Cruz P, et al.. Postoperative pulmonary complications, pulmonary and systemic inflammatory responses after lung resection surgery with prolonged one-lung ventilation. Randomized controlled trial comparing intravenous and inhalational anaesthesia. Br J Anaesth. 2017; 119:655&#x2013;663. 10.1093/bja/aex230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex230</ArticleId><ArticleId IdType="pubmed">29121283</ArticleId></ArticleIdList></Reference><Reference><Citation>Fok TF, Lam K, Ng PC, So HK, Cheung KL, Wong W, et al.. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 1998; 79:F100&#x2013;4. 10.1136/fn.79.2.f100</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.79.2.f100</ArticleId><ArticleId IdType="pmc">PMC1720846</ArticleId><ArticleId IdType="pubmed">9828734</ArticleId></ArticleIdList></Reference><Reference><Citation>Szmidt M, Kosi&#x144;ski SW, R&#xf3;zniecki J. Bronchodilator capacity of salbutamol aerosol after its long-term use. Pol Arch Med Wewn.1983;70:251&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">6677889</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa GM, Faria AC, Di Mango AM, Lopes AJ, Lopes de Melo P. Respiratory impedance and response to salbutamol in healthy individuals and patients with COPD. Respiration.2014;88:101&#x2013;111. 10.1159/000362691</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000362691</ArticleId><ArticleId IdType="pubmed">24992904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducros L, Moutafis M, Castelain MH, Liu N, Fischler M. Pulmonary air trapping during two-lung and one-lung ventilation. J Cardiothorac Vasc Anesth. 1999;13:35&#x2013;39. 10.1016/s1053-0770(99)90170-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1053-0770(99)90170-2</ArticleId><ArticleId IdType="pubmed">10069281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Kim N, Lee CY, Ban MG, Oh YJ. Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial. Eur J Anaesthesiol. 2016;33(4):275&#x2013;282. 10.1097/EJA.0000000000000405</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000405</ArticleId><ArticleId IdType="pmc">PMC4780481</ArticleId><ArticleId IdType="pubmed">26716866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q, Liu L, Pan C, Zhao Z, Xu J, Liu A, et al.. Effects of neurally adjusted ventilatory assist on air distribution and dead space in patients with acute exacerbation of chronic obstructive pulmonary disease. Crit Care. 2017; 21:126. 10.1186/s13054-017-1714-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1714-1</ArticleId><ArticleId IdType="pmc">PMC5455203</ArticleId><ArticleId IdType="pubmed">28578708</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YN, Zhao WG, Xie LX, Cao DS, Chen LA, Zhang JP, et al.. Aspiration of dead space in the management of chronic obstructive pulmonary disease patients with respiratory failure. Respir Care. 2004;49:257&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">14982645</ArticleId></ArticleIdList></Reference><Reference><Citation>Vichitvejpaisal P, Svastdi-Xuto O, Udompunturux S. The use of nebulized salbutamol in patients with bronchospasm during anaesthesia: a clinical trial. J Med Assoc Thai. 1991;74:397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">1791394</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Castro A, Su&#xe1;rez-Lopez V, G&#xf3;mez-Marcos V, Gonz&#xe1;lez-Fernandez C, Iglesias-Posadilla D, Bur&#xf3;n-Mediavilla J, et al.. Utility of the dead space fraction (Vd/Vt) as a predictor of extubation success. Med Intensiva. 2011;35:529&#x2013;538. 10.1016/j.medin.2011.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2011.05.016</ArticleId><ArticleId IdType="pubmed">21782289</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten TN, Hawkins NM, Beam WB, Brandt HA, Koepp DJ, et al.. Factors associated with prolonged anesthesia recovery following laparoscopic bariatric surgery: a retrospective analysis. Obes Surg. 2015;25:1024&#x2013;1030. 10.1007/s11695-014-1468-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-014-1468-7</ArticleId><ArticleId IdType="pmc">PMC4539140</ArticleId><ArticleId IdType="pubmed">25392076</ArticleId></ArticleIdList></Reference><Reference><Citation>Spieth PM, G&#xfc;ldner A, de Abreu MG. Chronic obstructive pulmonary disease. Curr Opin Anaesthesiol. 2012; 25:24&#x2013;29. 10.1097/ACO.0b013e32834dd269</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32834dd269</ArticleId><ArticleId IdType="pubmed">22222756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al.. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32:88&#x2013;105. 10.1097/EJA.0000000000000118</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000118</ArticleId><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118:317&#x2013;334. 10.1093/bja/aex002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex002</ArticleId><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo MJ, Davies RR, Hong KN, Iribarne A, Kawut S, Bacchetta M, et al.. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009;138:1234&#x2013;1238. 10.1016/j.jtcvs.2009.07.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.07.036</ArticleId><ArticleId IdType="pmc">PMC3073984</ArticleId><ArticleId IdType="pubmed">19837222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth. 2012;59:268&#x2013;279. 10.1007/s12630-011-9652-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-011-9652-x</ArticleId><ArticleId IdType="pubmed">22187226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27124034</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>17</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Removal of Laryngeal Mask Airway in Adults Under Target-Controlled, Propofol-Fentanyl Infusion Anesthesia: Awake or Deep Anesthesia?</ArticleTitle><Pagination><StartPage>e3441</StartPage><MedlinePgn>e3441</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3441</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000003441</ELocationID><Abstract><AbstractText>After emergence from anesthesia, the incidence and severity of adverse airway effects caused by the laryngeal mask airway (LMA) can vary, depending on when the device was removed; nonetheless, reports differ regarding the exact optimal timing of LMA removal. The purpose of this study was to compare the rate of adverse events between 2 groups: those whose LMA was removed under general anesthesia ("deep" group) or under target-controlled infusion (TCI) of propofol ("awake" group).Institutional Review Board approval and written informed consent were obtained; 124 patients were then randomly allocated into either the "awake" group or the "deep" group. Anesthesia was induced and maintained using TCI of propofol, as well as intravenous fentanyl. In the "deep" group, the LMA was removed after surgery while the patients were deeply anesthetized using a target effect-site propofol concentration of 2&#x200a;&#x3bc;g/mL, whereas in the "awake" group, the device was removed while the patients followed verbal instructions. The incidence of the following adverse events was recorded: coughing, straining, bronchospasm, laryngospasm, clenching, breath holding, gross purposeful movement, airway obstruction, retching, vomiting, and oxygen desaturation. If any such event occurred, the LMA removal was considered a failure. Airway hyperreactivity was recorded and graded - based on the severity of cough, breath holding, and oxygen desaturation.The failure rate was higher in the "awake" group (15/61; 24.6%) than in the "deep" group (5/60; 8.3%). Airway hyperreactivity was mild (score, &lt;3) in both groups.Removal of the LMA under deep anesthesia using a target-controlled, effect-site propofol concentration of 2&#x200a;&#x3bc;g/mL may be safer and more successful than removal when patients are fully awake after surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ren-Chih</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, National Defense Medical Center and Tri-Service General Hospital, Taipei, Taiwan, Republic of China (R-CH, N-KH, C-HL); and Keelung Branch and Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan, Republic of China (Z-FW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Nan-Kai</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Chueng-He</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhi-Fu</ForeName><Initials>ZF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000771" MajorTopicYN="Y">Anesthesia, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="Y">Fentanyl</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012130" MajorTopicYN="N">Respiratory Hypersensitivity</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="Y">Wakefulness</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27124034</ArticleId><ArticleId IdType="pmc">PMC4998697</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000003441</ArticleId><ArticleId IdType="pii">00005792-201604260-00022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brimacombe J. The advantages of the LMA over the tracheal tube or facemask: a meta-analysis. Can J Anaesth 1995; 42:1017&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pubmed">8590490</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimacombe J, Brain AIJ, Berry A. The Laryngeal Mask Airway Instruction Manual. 3rd ed.Henley-on-Thames, UK: Intravent Research Limited; 1996.</Citation></Reference><Reference><Citation>Gataure PS, Latto IP, Rust S. Complications associated with removal of the laryngeal mask airway: a comparison of removal in deeply anaesthetised versus awake patients. Can J Anaesth 1995; 42:1113&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">8595687</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Abbasi S, Rahimi M. Removal of laryngeal mask airway: awake or deep anesthesia? J Res Med Sci 2005; 10:59&#x2013;62.</Citation></Reference><Reference><Citation>Kitching AJ, Walpole AR, Blogg CE. Removal of the laryngeal mask airway in children: anaesthetized compared with awake. Br J Anaesth 1996; 76:874&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">8679367</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffon M, Plaud B, Dubousset AM, et al. Removal of laryngeal mask airway: airway complications in children, anesthetized versus awake. Paediatr Anaesth 1994; 4:35&#x2013;37.</Citation></Reference><Reference><Citation>Varughese A, McCullock D, Lewis M, et al. Removal of the LMA in children &#x2013; awake or asleep? Anesthesiology 1994; 81:A1321.</Citation></Reference><Reference><Citation>Mathew PJ, Mathew JL. Early versus late removal of the laryngeal mask airway (LMA) for general anaesthesia. Cochrane Database Syst Rev 2015; 8:CD007082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214833</ArticleId><ArticleId IdType="pubmed">26258959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhri S, White M, Kenny GN. Induction of anaesthesia with propofol using a target-controlled infusion system. Anaesthesia 1992; 47:551&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">1626663</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer RA, Llewellyn RL, James MF. Total i.v. anaesthesia with propofol and the laryngeal mask for orthopaedic surgery. Br J Anaesth 1995; 74:123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">7696057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey S, Cameron AE, Asbury AJ. Cardiovascular response to insertion of Brain's laryngeal mask. Anaesthesia 1990; 45:629&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">2400071</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor IN, Kenny GN. Requirements for target-controlled infusion of propofol to insert the laryngeal mask airway. Anaesthesia 1998; 53:222&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">9613265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganatra SB, D&#x2019;Mello J, Butani M, et al. Conditions for insertion of the laryngeal mask airway: comparisons between sevoflurane and propofol using fentanyl as a co-induction agent. A pilot study. Eur J Anaesthesiol 2002; 19:371&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">12095019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kati I, Demirel CB, Huseyinoglu UA, et al. Comparison of propofol and sevoflurane for laryngeal mask airway insertion. Tohoku J Exp Med 2003; 200:111&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">14521253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Gil ML, Brimacombe J, Clar B. Sevoflurane versus propofol for induction and maintenance of anaesthesia with the laryngeal mask airway in children. Paediatr Anaesth 1999; 9:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">10597550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ti LK, Chow MY, Lee TL. Comparison of sevoflurane with propofol for laryngeal mask airway insertion in adults. Anesth Analg 1999; 88:908&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195546</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain AI. The Intravent Laryngeal Mask Instruction Manual. 2nd ed.Henley-on-Thames, UK: Intravent International; 1992.</Citation></Reference><Reference><Citation>Levy L, Pandit UA, Randel GI, et al. Upper respiratory tract infections and general anaesthesia in children. Peri-operative complications and oxygen saturation. Anaesthesia 1992; 47:678&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">1519717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JR, Lee YS, Kim CS, et al. A comparison of the end-tidal sevoflurane concentration for removal of the laryngeal mask airway and laryngeal tube in anesthetized children. Anesth Analg 2008; 106:1122&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">18349182</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim YH, Shin CS, Chang CH, et al. Optimal end-tidal sevoflurane concentration for the removal of the laryngeal mask airway in anesthetized adults. Anesth Analg 2005; 101:1034&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">16192515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahiner Y, Ozkan D, Akkaya T, et al. The end-tidal desflurane concentration for smooth removal of the laryngeal mask airway in anaesthetised adults. Eur J Anaesthesiol 2011; 28:187&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">21206275</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeating K, Bali IM, Dundee JW. The effects of thiopentone and propofol on upper airway integrity. Anaesthesia 1988; 43:638&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">3262318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundman E, Witt H, Sandin R, et al. Pharyngeal function and airway protection during subhypnotic concentrations of propofol, isoflurane, and sevoflurane: volunteers examined by pharyngeal videoradiography and simultaneous manometry. Anesthesiology 2001; 95:1125&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">11684981</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra YK, Ivanova M, Ali SS, et al. The efficacy of a subhypnotic dose of propofol in preventing laryngospasm following tonsillectomy and adenoidectomy in children. Paediatr Anaesth 2005; 15:1094&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16324030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohlrieder M, Tiefenthaler W, Klaus H, et al. Effect of total intravenous anaesthesia and balanced anaesthesia on the frequency of coughing during emergence from the anaesthesia. Br J Anaesth 2007; 99:587&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">17660457</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo JY, Kwak HJ, Lee KC, et al. Predicted EC50 and EC95 of remifentanil for smooth removal of a laryngeal mask airway under propofol anesthesia. Yonsei Med J 2015; 56:1128&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479844</ArticleId><ArticleId IdType="pubmed">26069139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SI, Chambers NA, Somerville NS. Can Bispectral Index aid laryngeal mask placement in children? Paediatr Anaesth 2006; 16:1244&#x2013;1250.</Citation><ArticleIdList><ArticleId IdType="pubmed">17121554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans P, Marechal H, Bonhomme V. Effect of propofol and sevoflurane on coughing in smokers and non-smokers awakening from general anaesthesia at the end of a cervical spine surgery. Br J Anaesth 2008; 101:731&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">18818191</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau SW, Wang FY, Wu CW, et al. Premolar loss following insertion of a classic laryngeal mask airway in a patient in the prone position. J Clin Anesth 2011; 23:588&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">22050808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33121440</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Incidence of airway complications associated with deep extubation in adults.</ArticleTitle><Pagination><StartPage>274</StartPage><MedlinePgn>274</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">274</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-020-01191-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Endotracheal extubation is the most crucial step during emergence from general anesthesia and is usually carried out when patients are awake with return of airway reflexes. Alternatively, extubations can also be accomplished while patients are deeply anesthetized, a technique known as "deep extubation", in order to provide a "smooth" emergence from anesthesia. Deep extubation is seldomly performed in adults, even in appropriate circumstances, likely due to concerns for potential respiratory complications and limited research supporting its safety. It is in this context that we designed our prospective study to understand the factors that contribute to the success or failure of deep extubation in adults.</AbstractText><AbstractText Label="METHODS">In this prospective observational study, 300 patients, age&#x2009;&#x2265;&#x2009;18, American Society of Anesthesiologists Physical Status (ASA PS) Classification I - III, who underwent head-and-neck and ocular surgeries. Patients' demographic, comorbidity, airway assessment, O<sub>2</sub> saturation, end tidal CO<sub>2</sub> levels, time to exit OR, time to eye opening, and respiratory complications after deep extubation in the OR were analyzed.</AbstractText><AbstractText Label="RESULTS">Forty (13%) out of 300 patients had at least one complication in the OR, as defined by persistent coughing, desaturation SpO<sub>2</sub>&#x2009;&lt;&#x2009;90% for longer than 10s, laryngospasm, stridor, bronchospasm and reintubation. When comparing the complication group to the no complication group, the patients in the complication group had significantly higher BMI (30 vs 26), lower O<sub>2</sub> saturation pre and post extubation, and longer time from end of surgery to out of OR (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS">The complication rate during deep extubation in adults was relatively low compared to published reports in the literature and all easily reversible. BMI is possibly an important determinant in the success of deep extubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juang</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7113-7042</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA. jeremy_juang@meei.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA. jeremy_juang@meei.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordoba</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciaramella</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldfarb</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayter</LastName><ForeName>Jorge Enrique</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Clinica El Pinar, Km 2 Anillo vial Floridablanca - Gir&#xf3;n, Ecoparque Empresarial Natura Torre 2 piso 1 y 2, Piedecuesta, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macias</LastName><ForeName>Alvaro Andres</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts Eye and Ear, 243 Charles St, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, 20114, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="N">Wakefulness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult</Keyword><Keyword MajorTopicYN="N">Airway</Keyword><Keyword MajorTopicYN="N">Ambulatory surgery</Keyword><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Deep extubation</Keyword><Keyword MajorTopicYN="N">Emergence</Keyword><Keyword MajorTopicYN="N">Tracheal extubation</Keyword><Keyword MajorTopicYN="N">Volatile anesthetics</Keyword></KeywordList><CoiStatement>The authors do not have any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33121440</ArticleId><ArticleId IdType="pmc">PMC7597053</ArticleId><ArticleId IdType="doi">10.1186/s12871-020-01191-8</ArticleId><ArticleId IdType="pii">10.1186/s12871-020-01191-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Valley RD, Ramza JT, Calhoun P, Freid EB, Bailey AG, Kopp VJ, Georges LS. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of isoflurane and sevoflurane. Anesth Analg. 1999;88(4):742&#x2013;745. doi: 10.1213/00000539-199904000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199904000-00010</ArticleId><ArticleId IdType="pubmed">10195515</ArticleId></ArticleIdList></Reference><Reference><Citation>Valley RD, Freid EB, Bailey AG, Kopp VJ, Georges LS, Fletcher J, Keifer A. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of desflurane and sevoflurane. Anesth Analg. 2003;96(5):1320&#x2013;1324. doi: 10.1213/01.ANE.0000058844.77403.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000058844.77403.16</ArticleId><ArticleId IdType="pubmed">12707126</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin RS. Complications of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):54S&#x2013;58S. doi: 10.1378/chest.129.1_suppl.54S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.129.1_suppl.54S</ArticleId><ArticleId IdType="pubmed">16428692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan C, Frizelle HP, Laffey J, Hannon V, Carey M. The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesia. Anesth Analg. 2000;91(1):201&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">10866913</ArticleId></ArticleIdList></Reference><Reference><Citation>Daley MD, Norman PH, Coveler LA. Tracheal extubation of adult surgical patients while deeply anesthetized: a survey of United States anesthesiologists. J Clin Anesth. 1999;11(6):445&#x2013;452. doi: 10.1016/S0952-8180(99)00043-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(99)00043-4</ArticleId><ArticleId IdType="pubmed">10526821</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RI, Hannallah RS, Norden J, Casey WF, Verghese ST. Emergence airway complications in children: a comparison of tracheal extubation in awake and deeply anesthetized patients. Anesth Analg. 1991;73(3):266&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">1867418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pounder DR, Blackstock D, Steward DJ. Tracheal extubation in children: halothane versus isoflurane, anesthetized versus awake. Anesthesiology. 1991;74(4):653&#x2013;655. doi: 10.1097/00000542-199104000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199104000-00005</ArticleId><ArticleId IdType="pubmed">2008945</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga K, Asai T, Vaughan RS, Latto IP. Respiratory complications associated with tracheal extubation. Timing of tracheal extubation and use of the laryngeal mask during emergence from anaesthesia. Anaesthesia. 1998;53(6):540&#x2013;544. doi: 10.1046/j.1365-2044.1998.00397.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.1998.00397.x</ArticleId><ArticleId IdType="pubmed">9709138</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Davies K, Hegarty M, Erb TO. Habre W. The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial. Eur J Anaesthesiol. 2013;30(9):529&#x2013;536. doi: 10.1097/EJA.0b013e32835df608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835df608</ArticleId><ArticleId IdType="pubmed">23344124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MK, Baek CW, Kang H, Choi GJ, Park YH, Yang SY, Shin HY, Jung YH, Woo YC. Comparison of emergence after deep extubation using desflurane or desflurane with remifentanil in patients undergoing general anesthesia: a randomized trial. J Clin Anesth. 2016;28:19&#x2013;25. doi: 10.1016/j.jclinane.2015.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2015.08.013</ArticleId><ArticleId IdType="pubmed">26796609</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Q, Hu C, Ye M, Shen X. Dexmedetomidine for tracheal extubation in deeply anesthetized adult patients after otologic surgery: a comparison with remifentanil. BMC Anesthesiol. 2015;15:106. doi: 10.1186/s12871-015-0088-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0088-7</ArticleId><ArticleId IdType="pmc">PMC4511974</ArticleId><ArticleId IdType="pubmed">26202786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffe RA, Schmiesing CA, Golianu B. Anesthesiologist's manual of surgical procedures. 5. Philadelphia: Lippincott Williams &amp; Wilkins; 2014.</Citation></Reference><Reference><Citation>Koo CH, Lee SY, Chung SH, Ryu JH. Deep vs. Awake Extubation and LMA Removal in Terms of Airway Complications in Pediatric Patients Undergoing Anesthesia: A Systemic Review and Meta-Analysis. J Clin Med. 2018;7:353. 10.3390/jcm7100353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6210687</ArticleId><ArticleId IdType="pubmed">30322192</ArticleId></ArticleIdList></Reference><Reference><Citation>Peat JK, Gray EJ, Mellis CM, Leeder SR, Woolcock AJ. Differences in airway responsiveness between children and adults living in the same environment: an epidemiological study in two regions of New South Wales. Eur Respir J. 1994;7(10):1805&#x2013;1813. doi: 10.1183/09031936.94.07101805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.94.07101805</ArticleId><ArticleId IdType="pubmed">7828689</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenberger A, Proietti S, Wicky S, Frascarolo P, Suter M, Spahn DR, Magnusson L. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg. 2002;95(6):1788&#x2013;1792. doi: 10.1097/00000539-200212000-00060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200212000-00060</ArticleId><ArticleId IdType="pubmed">12456460</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol. 2010;24(2):211&#x2013;225. doi: 10.1016/j.bpa.2010.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.02.001</ArticleId><ArticleId IdType="pubmed">20608558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang LH, Parekh K, Tsui BYK, Maze M. Perioperative management of the obese surgical patient. Br Med Bull. 2017;124(1):135&#x2013;155. doi: 10.1093/bmb/ldx041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldx041</ArticleId><ArticleId IdType="pmc">PMC5862330</ArticleId><ArticleId IdType="pubmed">29140418</ArticleId></ArticleIdList></Reference><Reference><Citation>Inomata S, Yaguchi Y, Taguchi M, Toyooka H. End-tidal sevoflurane concentration for tracheal extubation (MACEX) in adults: comparison with isoflurane. Br J Anaesth. 1999;82(6):852&#x2013;856. doi: 10.1093/bja/82.6.852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/82.6.852</ArticleId><ArticleId IdType="pubmed">10562778</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, Hu C, Li W. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of sevoflurane and sevoflurane in combination with low-dose remifentanil. Paediatr Anaesth. 2012;22(12):1179&#x2013;1184. doi: 10.1111/j.1460-9592.2012.03906.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2012.03906.x</ArticleId><ArticleId IdType="pubmed">22755543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Yu H, Ye M, Shen X. Sevoflurane in combination with remifentanil for tracheal extubation after otologic surgery. Am J Health Syst Pharm. 2014;71(13):1108&#x2013;1011. doi: 10.2146/ajhp130473.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp130473</ArticleId><ArticleId IdType="pubmed">24939489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignat C, Wille U, Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 1995;56(10):793&#x2013;799. doi: 10.1016/0024-3205(95)00010-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(95)00010-4</ArticleId><ArticleId IdType="pubmed">7885194</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarmush J, D'Angelo R, Kirkhart B, O'Leary C, Pitts MC, 2nd, Graf G, Sebel P, Watkins WD, Miguel R, Streisand J, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology. 1997;87(2):235&#x2013;243. doi: 10.1097/00000542-199708000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199708000-00009</ArticleId><ArticleId IdType="pubmed">9286886</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34109588</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2284-0729</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>European review for medical and pharmacological sciences</Title><ISOAbbreviation>Eur Rev Med Pharmacol Sci</ISOAbbreviation></Journal><ArticleTitle>Predictive power of modified frailty index score for pulmonary complications after major abdominal surgery in the elderly: a single centre prospective cohort study.</ArticleTitle><Pagination><StartPage>3798</StartPage><EndPage>3802</EndPage><MedlinePgn>3798-3802</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.26355/eurrev_202105_25947</ELocationID><ELocationID EIdType="pii" ValidYN="Y">25947</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The primary aim of this prospective cohort study was to evaluate the usefulness of the modified Frailty Index (mFI) score to predict postoperative pulmonary complications (PPCs) in elderly patients undergoing major open abdominal surgery. The secondary purpose was to compare the prediction power of mFI, Ariscat (Assess Respiratory Risk in Surgical Patients in Catalonia), and American Society physical status classification (ASA) scores.</AbstractText><AbstractText Label="PATIENTS AND METHODS">After local Ethical Committee approval, 105 patients aged &#x2265;65 years undergoing open major abdominal surgery were enrolled. Clinical data were compared between patients with or without PPCs (including respiratory failure, aspiration pneumonia, pulmonary infection, pleural effusion, pneumothorax, atelectasis, bronchospasm or un-planned re-intubation). t-test or &#x3c7;2-test were performed for univariate analyses. Logistic regression analysis was used to identify independent predictors of PPCs. Non parametric ROC (Receiver Operating Characteristic) was used for cut-off calculation. AUCs (areas under ROC curve) of preoperative scores were compared using &#x3c7;2-test.</AbstractText><AbstractText Label="RESULTS">PPCs prevalence (11.3%) was associated with increased mFI, ASA, and Ariscat scores, greater age, hemoglobin levels &lt;10 g/dl, peripheral oxygen saturation &lt;95% (p=0.0001) and longer surgery duration. Logistic regression showed that mFI (p=0.0001) and Ariscat (p=0.04) were independent predictors of PPCs. The predictive power of mFI (AUC=0.90) was similar to that of Ariscat (AUC=0.81) (&#x3c7;2=2.53; p=0.11) but greater than that of ASA (AUC=0.69) (&#x3c7;2=9.85; p=0.002). An mFI&#x2265;0.18 was predictive of PPCs (sensitivity=90.91%; specificity=79.07%). An Ariscat score of 27 was the cut-off identified as determining factor for PPCs occurrence (sensitivity=90.91%; specificity=51.16%).</AbstractText><AbstractText Label="CONCLUSIONS">Elderly patients with an mFI &#x2265;0.18 and/or an Ariscat score &#x2265;27 were at higher risk of PPCs after open major abdominal surgery. More attention should be paid to these patients by implementing both strict monitoring and strategies for PPCs prevention in the perioperative period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aceto</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. pa.aceto@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perilli</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Luca</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Schipa</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Fortunato</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Marusco</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sollazzi</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur Rev Med Pharmacol Sci</MedlineTA><NlmUniqueID>9717360</NlmUniqueID><ISSNLinking>1128-3602</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="N">Frailty</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34109588</ArticleId><ArticleId IdType="doi">10.26355/eurrev_202105_25947</ArticleId><ArticleId IdType="pii">25947</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34409194</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Lidocaine versus propofol administration on the attenuation of hemodynamic responses during extubation in the adult elective surgical patient: A prospective cohort.</ArticleTitle><Pagination><StartPage>e07737</StartPage><MedlinePgn>e07737</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e07737</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2021.e07737</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tracheal extubation is the process of removing a tube from the trachea. It is associated with an increase in heart rate, blood pressure, intracranial pressure, intraocular pressure, coughing, bronchospasm, laryngospasm, and bleeding. Many techniques, as well as drugs, have been attempted for attenuation of the airway and cardiovascular responses. Propofol and lidocaine are widely available drugs in resource-limited settings even though their relative effectiveness for smooth extubation is not well established.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the effectiveness of intravenous lidocaine and propofol on the attenuation of extubation-induced hemodynamic responses in the adult elective surgical patient from November 01, 2019, to February 30, 2020, at Asella teaching and referral hospital, Ethiopia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Institutional-based prospective observational cohort study design was conducted on 72 ASA I patients who underwent elective surgery. The study participants were allocated into three groups equally based on anesthetists' extubation plan; Group P, 0.5 mg/kg propofol, group L, 1.5 mg/kg lidocaine administered 2 min before extubation and group C was a control group. Data were analyzed by SPSS version 20 after the normality of the data was checked by the Shapiro Wilk test. One-way ANOVA followed by a Tukey posthoc test has been employed to find the pair-wise significance and a p-value of &lt;0.05 was considered as statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A demographic status and clinical characteristics of the patient were comparable between groups with p-values of &gt;0.05. After extubation; heart rate, systolic, diastolic, and mean arterial blood pressure were decreased significantly in groups of propofol and lidocaine within 10 min. Propofol shows better results in maintaining stable systolic blood pressure up to 3 min, while heart rate, diastolic, and mean arterial pressure were maintained stable up to 5 min after extubation (p = 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">0.5 mg/kg propofol or 1.5 mg/kg lidocaine might help to attenuate extubation induced hemodynamic responses.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nigussie</LastName><ForeName>Ephrem</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science and Medicine, Arsi University, Asella, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aregawi</LastName><ForeName>Adugna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science and Medicine, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrar</LastName><ForeName>Meron</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science and Medicine, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hika</LastName><ForeName>Assefa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science, Aksum University, Aksum, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aberra</LastName><ForeName>Bacha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science, Aksum University, Aksum, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tefera</LastName><ForeName>Belay</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Science and Medicine, Arsi University, Asella, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teshome</LastName><ForeName>Diriba</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, College of Health Sciences, Debre Tabor University, Debre Tabor Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Extubation</Keyword><Keyword MajorTopicYN="N">Hemodynamic responses</Keyword><Keyword MajorTopicYN="N">Lidocaine</Keyword><Keyword MajorTopicYN="N">Propofol</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34409194</ArticleId><ArticleId IdType="pmc">PMC8361261</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2021.e07737</ArticleId><ArticleId IdType="pii">S2405-8440(21)01840-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arouad MT.A-aA., Nasr V.G. The effect of low dose of remifentanyl on responses to the endotracheal tube during emmergence fron general anesthesia. Anesth. Analog. 2009:1320&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pubmed">19299779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishina K.M.K., Maekawa N., Obara H. Attenuation of cardiovascular responses to tracheal extubation with diltiazem vs verapamil. Anesth. Analg. 1996:1205&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pubmed">8638792</ArticleId></ArticleIdList></Reference><Reference><Citation>Minogue S.C.R.J., Lampa M.J. Laryngotracheal topicalization with Lidocaine before intubation. Anesth. Analg. 2004;99:1253&#x2013;1257.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385385</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishina K.M.K., Maekawa N., Obara H. Attenuation of cardiovascular responses to tracheal extubation with diltiazem. Anesth. Analg. 1995;80(6):1217&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">7762855</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeating K.B.I., Dundee J.W. The effects of thiopentone and propofol on upper airway integrity. Anaesthesia. 1988;43:638&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">3262318</ArticleId></ArticleIdList></Reference><Reference><Citation>Propofol P.E.M. Therapeutic indications and side-effects. Curr. Pharmaceut. Des. 2004;10:3639&#x2013;3649.</Citation><ArticleIdList><ArticleId IdType="pubmed">15579060</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrita Rath A.J., Yadav Ghanshyam. July 2018. To Evaluate and Compare the Effectiveness of Iv Dexmedetomidine and Iv Lidocaine on Attenuationof Haemodynamic Responses and Airway Reflexes during Extubation; pp. 2210&#x2013;2211. 5(30)</Citation></Reference><Reference><Citation>Karmarkar S., Varshney S. Tracheal extubation. Cont. Educ. Anaesth. Crit. Care Pain. 2008;8(6):214&#x2013;220.</Citation></Reference><Reference><Citation>Yang S.S., Wang N.-N., Postonogova T., Yang G.J., McGillion M., Beique F. Intravenous Lidocaine to prevent postoperative airway complications in adults: a systematic review and meta-analysis. Br. J. Anaesth. 2020;124(3):314&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">32000978</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez R.M.B.R. Prevention of endotracheal tube-induced coughing during emergence from general anesthesia. Anesth. Analg. 1994;79:792&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">7943794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K.A., Harkin C.P., Bailey P.L. Postoperative tracheal extubation. Anesth. Analg. 1995;80(1):149&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">7802273</ArticleId></ArticleIdList></Reference><Reference><Citation>Cranfield K.A.B.L. Minimum alveolar concentration of desflurane for tracheal extubation in deeply anaesthetized unpremedicated children. BJA (Br. J. Anaesth.) 1997;78:370&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">9135353</ArticleId></ArticleIdList></Reference><Reference><Citation>Soon Y.J.H.B.P., Ju D.K. The effect of a subhypnotic dose of propofol for the prevention of coughing in adults during emergence from anesthesia with sevoflurane and remifentani. Kor. J. Anesthesiol. February 2014;66(2):120&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948438</ArticleId><ArticleId IdType="pubmed">24624269</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong Cheng Yl Yong, Tai Xu Chang. Effects of propofol vs urapidil on perioperative hemodynamics and intraocularpressure duringand extubation in ophthalmic patients. Int. J. Ophthalmol. 2011;4(2):171&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340691</ArticleId><ArticleId IdType="pubmed">22553635</ArticleId></ArticleIdList></Reference><Reference><Citation>Cs Sanikop S.B. Efficacy of intravenous Lidocaine in prevention of post extubation larygospasm in children under going cleft palate surgery. Ind. J. Anesthes. March-April 2010;54(2):132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2900736</ArticleId><ArticleId IdType="pubmed">20661351</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitha K.S., Jsdank Attenuation of hemodynamic response to extubation with I.V. Lignocaine. J.&#xa0;Evol. Med. Dent. Sci. January 2014;3(4):838&#x2013;846.</Citation></Reference><Reference><Citation>KSKaea Laxminarsaiah. Attenuation of cardiovascular responses to tracheal extubation. J.&#xa0;Med. Sci. Clin. Res. January 2018;6(1):32292&#x2013;32298.</Citation></Reference><Reference><Citation>Mohammad T.M.V.R.J., Nader M.V. Attenuation of cardiovascular responses and upper airway events to tracheal extubation by low dose propofol Iranian red. Crescent Med. J. 2013;15(4):298&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785902</ArticleId><ArticleId IdType="pubmed">24083001</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay T. 2018. Comparision of Two Different Pre Extubation Dose of Intravenous Lidocaine on Hemodynamic and Cough Reflex; pp. 1&#x2013;22.</Citation></Reference><Reference><Citation>Nagrale M.H., Psi, Chendra S.P. Comparative study on haemodynamic response to extubation: attenuation with lignocaine, esmolol. Propofol In. J. Res. Med. Sci. January 2016;4(1):144&#x2013;151.</Citation></Reference><Reference><Citation>Shrestha S.C.M., Vaidya P.R., Thapa P. Vol. 13. Jan-Jun 2013. Attenuation of hemodynamic response to tracheal extubation: comparison of esmolol and lidocaine; pp. 26&#x2013;29. (Post Graduate Medical Journal of North American Menopause Society). 1.</Citation></Reference><Reference><Citation>Vaziri M.T.M., Jouybar R., Vaziri N.M., Vaziri N.M., Panah A. Attenuation of cardiovascular responses and upper airway events to tracheal extubation by low dose propofol. Iran. Red Crescent Med. J. 2013;15(4):298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785902</ArticleId><ArticleId IdType="pubmed">24083001</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagrale M., Indurkar P.S., Pardhi C.S. Comparative study on haemodynamic response to extubation: attenuation with lignocaine, esmolol, propofol. Int J Res Med Sci. 2016;4(1):144&#x2013;151.</Citation></Reference><Reference><Citation>Khattak R., Haq I.U., Abbasi T., Ahmad A., Khan S.A., Raja M.H. Efficacy of intravenous Lignocain vs sevoflurane in prevention of coughing and desaturation at extubation in children. J.&#xa0;Ayub Med. Coll. Abbottabad: JAMC (J. Assoc. Med. Can.) 2018;30(2):167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">29938412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassam S., Sandbythomas M., Vaughan R., Hall J.E. Airway management before, during and after extubation: a survey of practice in the United Kingdom and Ireland. Anaesthesia. 2005;60(10):995&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">16179045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25280869</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2014</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.</ArticleTitle><Pagination><StartPage>157</StartPage><MedlinePgn>157</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">157</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2466-14-157</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many people with clinically significant chronic obstructive pulmonary disease (COPD) remain undiagnosed worldwide. There are a number of small studies which have examined possible methods of case finding through primary care, but no large RCTs that have adequately assessed the most cost-effective approach.</AbstractText><AbstractText Label="METHODS/DESIGN" NlmCategory="METHODS">In this study, using a cluster randomised controlled trial (RCT) in 56 general practices in the West Midlands, we plan to investigate the effectiveness and cost-effectiveness of a Targeted approach to case finding for COPD compared with routine practice. Using an individual patient RCT nested in the Targeted arm, we plan also to compare the effectiveness and cost-effectiveness of Active case finding using a postal questionnaire (with supplementary opportunistic questionnaires), and Opportunistic-only case finding during routine surgery consultations.All ever-smoking patients aged 40-79 years, without a current diagnosis of COPD and registered with participating practices will be eligible. Patients in the Targeted arm who report positive respiratory symptoms (chronic cough or phlegm, wheeze or dyspnoea) using a brief questionnaire will be invited for further spirometric assessment to ascertain whether they have COPD or not. Post-bronchodilator spirometry will be conducted to ATS standards using an Easy One spirometer by trained research assistants.The primary outcomes will be new cases of COPD and cost per new case identified, comparing targeted case finding with routine care, and two types of targeted case finding (active versus opportunistic). A multilevel logistic regression model will be used to model the probability of detecting a new case of COPD for each treatment arm, with clustering of patients (by practice and household) accounted for using a multi-level structure.A trial-based analysis will be undertaken using costs and outcomes collected during the trial. Secondary outcomes include the feasibility, efficiency, long-term cost-effectiveness, patient and primary care staff views of each approach.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This will be the largest RCT of its kind, and should inform how best to identify undiagnosed patients with COPD in the UK and other similar healthcare systems. Sensitivity analyses will help local policy-makers decide which sub-groups of the population to target first.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Current controlled trials ISRCTN14930255.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Adab</LastName><ForeName>Peyman&#xe9;</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Health and Populations Sciences, University of Birmingham, Birmingham, UK. p.adab@bham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jowett</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Jen L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Enocson</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Brendan G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Alice M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Ayres</LastName><ForeName>Jon G</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Kar Keung</ForeName><Initials>KK</Initials></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Stockley</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>Sheila</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Siebert</LastName><ForeName>Stanley</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Daley</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fitzmaurice</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN14930255</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>MR/K00414X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PDF/01/023</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0109-10061</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058006" MajorTopicYN="N">General Practice</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25280869</ArticleId><ArticleId IdType="pmc">PMC4271517</ArticleId><ArticleId IdType="doi">10.1186/1471-2466-14-157</ArticleId><ArticleId IdType="pii">1471-2466-14-157</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523&#x2013;532. doi: 10.1183/09031936.06.00124605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.06.00124605</ArticleId><ArticleId IdType="pubmed">16611654</ArticleId></ArticleIdList></Reference><Reference><Citation>Buist AS, McBurnie M, Vollmer WM, Gillespie S, Burney P, Mannino D, Menezes AMB, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, on behalf of the BOLD Collaborative Research Group International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741&#x2013;750. doi: 10.1016/S0140-6736(07)61377-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61377-4</ArticleId><ArticleId IdType="pubmed">17765523</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498&#x2013;1504. doi: 10.1016/S0140-6736(96)07492-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)07492-2</ArticleId><ArticleId IdType="pubmed">9167458</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton M. The burden of COPD in the U.K.: results from the confronting COPD survey. Respir Med. 2003;97(3):S71&#x2013;S79. doi: 10.1016/S0954-6111(03)80027-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0954-6111(03)80027-6</ArticleId><ArticleId IdType="pubmed">12647945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402&#x2013;407. doi: 10.1136/thx.2007.085456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2007.085456</ArticleId><ArticleId IdType="pubmed">18234906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive Lung Disease and Low Lung Function in Adults in the United States: Data From the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160(11):1683&#x2013;1689. doi: 10.1001/archinte.160.11.1683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.11.1683</ArticleId><ArticleId IdType="pubmed">10847262</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043&#x2013;1047. doi: 10.1136/thx.2006.064410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.064410</ArticleId><ArticleId IdType="pmc">PMC2117062</ArticleId><ArticleId IdType="pubmed">17040932</ArticleId></ArticleIdList></Reference><Reference><Citation>US Preventive Services Task Force Screening for Chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008;148:529&#x2013;534. doi: 10.7326/0003-4819-148-7-200804010-00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-7-200804010-00212</ArticleId><ArticleId IdType="pubmed">18316747</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721&#x2013;732. doi: 10.1016/S0140-6736(09)61290-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61290-3</ArticleId><ArticleId IdType="pubmed">19716965</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DMG, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED, on behalf of The Respiratory Eff ectiveness Group Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. The Lancet Respiratory Medicine. 2014;2(4):267&#x2013;276. doi: 10.1016/S2213-2600(14)70008-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70008-6</ArticleId><ArticleId IdType="pubmed">24717623</ArticleId></ArticleIdList></Reference><Reference><Citation>On the state of the Public Health: Annual report of the Chief Medical Officer 2004. Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4115781.pdf 2009</Citation></Reference><Reference><Citation>Healthcare Commission . Clearing the Air. A National Study of Chronic Obstructive Pulmonary Disease. 2006.</Citation></Reference><Reference><Citation>An outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in Englandhttp://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_127974</Citation></Reference><Reference><Citation>British Lung Foundation: Invisible lives. Chronic obstructive pulmonary disease (COPD) - finding the missing millions. Available from: http://www.blf.org.uk/Page/Special-Reports 2008</Citation></Reference><Reference><Citation>Mapel DW, Frost F, Hurly J, Petersen H, Roberts M, Marton J, Shah H. An algorithm for the identification of undiagnsoed COPD cases using administrative claims data. J Manag Care Pharm. 2006;12(6):458&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">16925453</ArticleId></ArticleIdList></Reference><Reference><Citation>Soljak M, Flowers J. Closing the gap. Using prevalence models for long-term conditions in the United Kingdom. J Ambulatory Care Manage. 2008;31(3):211&#x2013;215. doi: 10.1097/01.JAC.0000324665.98777.b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.JAC.0000324665.98777.b6</ArticleId><ArticleId IdType="pubmed">18574378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nottinghamshire County Teaching PCT . Search to find COPD 'Missing Millions'. 2007.</Citation></Reference><Reference><Citation>Sandwell NHS Primary Care Trust . Sandwell Health Report. 2008. Finding the Missing Millions; pp. 1&#x2013;2.</Citation></Reference><Reference><Citation>Frank T, Hazell M, Linehan M, Frank P. The diagnostic accuracies of chronic obstructive pulmonary disease (COPD) in general practice: the results of the MAGIC (Manchester Airways Group Identifying COPD) study. Prim Care Resp J. 2006;15:286&#x2013;293. doi: 10.1016/j.pcrj.2006.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcrj.2006.07.007</ArticleId><ArticleId IdType="pmc">PMC6730827</ArticleId><ArticleId IdType="pubmed">16978921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinkelman D, Price D, Nordyke R, Halbert R. COPD screening efforts in primary care: what is the yield? Prim Care Resp J. 2007;16(1):41&#x2013;48. doi: 10.3132/pcrj.2007.00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3132/pcrj.2007.00009</ArticleId><ArticleId IdType="pmc">PMC6634176</ArticleId><ArticleId IdType="pubmed">17297526</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffels J, Degryse J, Heyrman J, Decramer M. Office Spirometry Significantly Improves Early Detection of COPD in General Practice. Chest. 2004;125(4):1394&#x2013;1399. doi: 10.1378/chest.125.4.1394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.125.4.1394</ArticleId><ArticleId IdType="pubmed">15078751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gingter C, Wilm S, Abholz HH. Is COPD a rare disease? Prevalence and identification rates in smokers aged 40&#xa0;years and over within general practice in Germany. Fam Pract. 2009;26(1):3&#x2013;9. doi: 10.1093/fampra/cmn084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmn084</ArticleId><ArticleId IdType="pubmed">19033180</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002;324(7350):1370. doi: 10.1136/bmj.324.7350.1370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7350.1370</ArticleId><ArticleId IdType="pmc">PMC115215</ArticleId><ArticleId IdType="pubmed">12052807</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandevoorde J, Verbanck S, Gijssels L, Schuermans D, Devroey D, De Backer J, Kartounian J, Vincken W. Early detection of COPD: A case finding study in general practice. Respir Med. 2007;101(3):525&#x2013;530. doi: 10.1016/j.rmed.2006.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2006.06.027</ArticleId><ArticleId IdType="pubmed">16908127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly JL, Elkin SL, Fluxman J, Polkey MI, Soljak MA, Hopkinson NS. Breathlessness and Skeletal Muscle Weakness in Patients Undergoing Lung Health Screening in Primary Care. COPD. 2013;10:40&#x2013;54. doi: 10.3109/15412555.2012.727923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2012.727923</ArticleId><ArticleId IdType="pubmed">23272667</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven JAM, Tange HJ, Muris JWM, van Haaren KMA, Vink G, van Schayck OCP. Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim Care Respir J. 2013;22(3):331&#x2013;337. doi: 10.4104/pcrj.2013.00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.4104/pcrj.2013.00070</ArticleId><ArticleId IdType="pmc">PMC6442827</ArticleId><ArticleId IdType="pubmed">23966214</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon S, Adab P, Griffin C, Jordan R. Case finding for chronic obstructive pulmonary disease in primary care: a pilot randomised controlled trial. Brit J Gen Pract. 2013;63(606):26&#x2013;27. doi: 10.3399/bjgp13X660788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp13X660788</ArticleId><ArticleId IdType="pmc">PMC3529293</ArticleId><ArticleId IdType="pubmed">23336474</ArticleId></ArticleIdList></Reference><Reference><Citation>The UK NSC policy on Chronic Obstructive Pulmonary Diseasehttp://www.screening.nhs.uk/copd</Citation></Reference><Reference><Citation>Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline. Ann Intern Med. 2007;147(9):639&#x2013;653. doi: 10.7326/0003-4819-147-9-200711060-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-9-200711060-00009</ArticleId><ArticleId IdType="pubmed">17975187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilt T, Kim C-B, Kane R, Linabery A, Tacklind J, MacDonald R, Rutks I. Use of spirometry for case finding, diagnosis and management of chronic obstructive pulmonary disease (COPD). Evidence Report/Technology assessment No 121 (prepared by the Minnesota Evidence-based practice Center under Contract No 290-02-0009) 2005;AHRQ Publication No. 05-E017-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781180</ArticleId><ArticleId IdType="pubmed">16238364</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Clinical Excellence . Chronic obstructive pulmonary disease : management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Institute for Health and Clinical Excellence; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">22319804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan RE, Lam K-BH, Cheng KK, Miller MR, Marsh JL, Ayres JG, Fitzmaurice D, Adab P. Case finding for chronic obstructive pulmonary disease: a model for optimizing a targeted approach. Thorax. 2010;65:492&#x2013;498. doi: 10.1136/thx.2009.129395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.129395</ArticleId><ArticleId IdType="pmc">PMC2892752</ArticleId><ArticleId IdType="pubmed">20522845</ArticleId></ArticleIdList></Reference><Reference><Citation>Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, for the UPLIFT investigators Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171&#x2013;1178. doi: 10.1016/S0140-6736(09)61298-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61298-8</ArticleId><ArticleId IdType="pubmed">19716598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazell ML, Morris JA, Linehan MF, Frank PI, Frank TL. Factors influencing the response to postal questionnaire surveys about respiratory symptoms. Prim Care Respir J. 2009;18(3):165&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6619256</ArticleId><ArticleId IdType="pubmed">19104738</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005;26(2):319&#x2013;338. doi: 10.1183/09031936.05.00034805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>EQ-5Dhttp://www.euroqol.org/home.html</Citation></Reference><Reference><Citation>Jones PW. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648&#x2013;654. doi: 10.1183/09031936.00102509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00102509</ArticleId><ArticleId IdType="pubmed">19720809</ArticleId></ArticleIdList></Reference><Reference><Citation>Raab GM, Butcher I. Balance in cluster randomized trials. Stat Med. 2001;20:351&#x2013;365. doi: 10.1002/1097-0258(20010215)20:3&lt;351::AID-SIM797&gt;3.0.CO;2-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0258(20010215)20:3&lt;351::AID-SIM797&gt;3.0.CO;2-C</ArticleId><ArticleId IdType="pubmed">11180306</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter B, Hood K. Balance algorithm for cluster randomised trials. BMC Med Res Methodol. 2008;8:65. doi: 10.1186/1471-2288-8-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-8-65</ArticleId><ArticleId IdType="pmc">PMC2588445</ArticleId><ArticleId IdType="pubmed">18844993</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality and Outcomes Frameworkhttp://www.hscic.gov.uk/qof</Citation></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, Stocks J, and the ERS Global Lung Function Initiative Multi-ethnic reference values for spirometry for the 3&#x2013;95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324&#x2013;1343. doi: 10.1183/09031936.00080312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CR, Hippisley-Cox J, Sheikh A. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients. Br J Gen Pract. 2010;60(576):277&#x2013;284. doi: 10.3399/bjgp10X514729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp10X514729</ArticleId><ArticleId IdType="pmc">PMC2894402</ArticleId><ArticleId IdType="pubmed">20594429</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57(8):785&#x2013;794. doi: 10.1016/j.jclinepi.2003.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2003.12.013</ArticleId><ArticleId IdType="pubmed">15485730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Adams G, Ukoumunne OC, Latinovic R, Chinn S, Campbell MJ. Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data. J Clin Epidemiol. 2005;58:246&#x2013;251. doi: 10.1016/j.jclinepi.2004.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2004.08.012</ArticleId><ArticleId IdType="pubmed">15718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model. J Clin Epidemiol. 2010;63(1):2&#x2013;6. doi: 10.1016/j.jclinepi.2008.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2008.11.004</ArticleId><ArticleId IdType="pubmed">19230611</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacalio AR, Margolis DJ, Berlin JA. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol. 2007;60(9):874&#x2013;882. doi: 10.1016/j.jclinepi.2006.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.12.001</ArticleId><ArticleId IdType="pubmed">17689803</ArticleId></ArticleIdList></Reference><ReferenceList><Title>Pre-publication history</Title><Reference><Citation>The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2466/14/157/prepub</Citation></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31771436</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1819-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Libyan journal of medicine</Title><ISOAbbreviation>Libyan J Med</ISOAbbreviation></Journal><ArticleTitle>Ketofol performance to reduce postoperative emergence agitation in children undergoing adenotonsillectomy.</ArticleTitle><Pagination><StartPage>1688450</StartPage><MedlinePgn>1688450</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1688450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19932820.2019.1688450</ELocationID><Abstract><AbstractText><b>Background</b>: Emergence agitation is a reformed state of mindfulness, which starts with a sudden form of anesthesia and progresses through the early repossession age. Thus, the purpose of this study is to evaluate 1:3 ketofol performance on children 3-15 years old undergoing adenotonsillectomy.<b>Methods</b>: A total of 60 children aged 3-15 years undergoing adenotonsillectomy were randomly allocated to receive low-dose ketamine 0.15 mg/kg followed by propofol 0.45 mg/kg i.v. ketofol (1:3) about 10 min before the end of surgery in comparison to 60 children aged 3-15 years who received only normal saline and dextrose. Anesthesia was induced and maintained with sevoflurane. Postoperative pain and EA were assessed with objective pain score (OPS) and the Pediatric Anesthesia Emergence Delirium (PAED) scale, respectively. EA was defined as a PAED 10 points. Recovery profile and postoperative complications were also recorded.<b>Results</b>: The incidence and severity of EA were found significantly lower in the ketofol group in comparison to the control group with a percentage of (13.33% vs 48.33%) (8% vs 15%) respectively (P &lt; 0.05). Also, the time for interaction from anesthetic tainted to extubating in the ketofol set was significantly less than in the control group (P &lt; 0.05). Interestingly, there are no opposing events such as nausea, laryngospasm, bronchospasm, hypotension, bradycardia, bleeding, or postoperative respiratory depression (respiratory rate: &lt;16) were noticed in the ketofol supervision (P &gt; 0.05). Moreover, the heart rate was meaningfully higher in the control group starting at the time of tracheal extubating in comparison to the children undergone ketofol (P &lt; 0.05). Alert score and time from painkilling tainted till liberation from PACU showed substantial significant changes at ketofol set (P &lt; 0.05).<b>Conclusion</b>: Ketofol (1:3) shows significant performance to reduce postoperative agitation in the children undergone adenotonsillectomy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Idress</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Alwehda Teaching Hospital, Dhamar University, Dhamar city, Yemen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alahdal</LastName><ForeName>Murad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Tissue Engineering, Shenzhen Laboratory of Digital Orthopedic Engineering, Shenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University, Health Science Center), Shenzhen, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratories, school of medicine, Hodeidah University, Al-Hudaydah city, Yemen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Haifa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S El Moughrabi</LastName><ForeName>Arafa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiqian</LastName><ForeName>Huang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Shanglong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Libyan J Med</MedlineTA><NlmUniqueID>101299403</NlmUniqueID><ISSNLinking>1819-6357</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">adenotonsillectomy</Keyword><Keyword MajorTopicYN="N">emergency agitation</Keyword><Keyword MajorTopicYN="N">ketamine</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31771436</ArticleId><ArticleId IdType="pmc">PMC6882471</ArticleId><ArticleId IdType="doi">10.1080/19932820.2019.1688450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marzullo LR, Laurie R. Pharmacologic management of the agitated child. Pediatr Emerg Care. 2014;30(4):269&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddy N. Emergence agitation in children. Br J Anaesth. 2010;105(1):95&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">20551033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak KH. Emergence agitation/delirium: we still don&#x2019;t know. Korean J Anesthesiol. 2010;59(2):73&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2926432</ArticleId><ArticleId IdType="pubmed">20740209</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S. Combining ketamine and propofol (&#x201c;Ketofol&#x201d;) for emergency department procedural sedation and analgesia: a review. West J Emerg Med. 2008;9(1):20&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672224</ArticleId><ArticleId IdType="pubmed">19561698</ArticleId></ArticleIdList></Reference><Reference><Citation>Willman EV, Andolfatto G. A prospective evaluation of &#x201c;ketofol&#x201d; (Ketamine/Propofol Combination) for procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2007;49(1):23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17059854</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia N, Tramer MR. Ketamine and postoperative pain&#x2013;a quantitative systematic review of randomised trials. Pain. 2005;113(1):61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">15621365</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698859</ArticleId><ArticleId IdType="pubmed">22020140</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonenberg M, Reichwald U, Domes G, et al. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. J Psychopharmacol. 2008;22(5):493&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">18208917</ArticleId></ArticleIdList></Reference><Reference><Citation>Paslakis G, Gilles M, Meyer-Lindenberg A, et al. Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series. Pharmacopsychiatry. 2010;43(01):33&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">20013614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinis-Oliveira RJ. Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci Res. 2017;2(1):2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197107</ArticleId><ArticleId IdType="pubmed">30483613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalanne L, Nicot C, Lang J-P, et al. Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report. BMC Psychiatry. 2016;16(1):395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5105239</ArticleId><ArticleId IdType="pubmed">27832755</ArticleId></ArticleIdList></Reference><Reference><Citation>Miner JR, Burton JH. Clinical practice advisory: emergency department procedural sedation with propofol. Ann Emerg Med. 2007;50(2):182&#x2013;187.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">17321006</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc. 2008;67(6):910&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">18440381</ArticleId></ArticleIdList></Reference><Reference><Citation>Machata AM, Willschke H, Kabon B, et al. Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging. Br J Anaesth. 2008;101(2):239&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">18534971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan JW, McLeod SL, Iansavitchene A. Ketamine-propofol versus propofol alone for procedural sedation in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2015;22(9):1003&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">26292077</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G, Altomare C, Sanna E, et al. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem. 2000;7(2):249&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">10637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Shimazawa M, Yoshimura S, et al. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14(2):95&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494023</ArticleId><ArticleId IdType="pubmed">18482023</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips W, Anderson A, Rosengreen M, et al. Propofol versus propofol/ketamine for brief painful procedures in the emergency department: clinical and bispectral index scale comparison. J Pain Palliat Care Pharmacother. 2010;24(4):349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">21133742</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes AG, Africano CJ, Hoskote SS, et al. Ketamine and propofol combination (&#x201c;Ketofol&#x201d;) for endotracheal intubations in critically Ill patients: a case series. Am J Case Rep. 2015;16:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4332295</ArticleId><ArticleId IdType="pubmed">25676819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn T, Mossop D, Newton A, et al. Propofol for procedural sedation in the emergency department. Emer Med J. 2007;24(7):459&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658387</ArticleId><ArticleId IdType="pubmed">17582032</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay SP, Tripathy A, Mallick PN. A practical guide to sedation and analgesia in Paediatric Intensive Care Unit (ICU). J Anim Sci. 2017;4(1).</Citation></Reference><Reference><Citation>Alletag MJ, Auerbach M, Baum CR. Ketamine, propofol, and ketofol use for pediatric sedation. Pediatr Emerg Care. 2012;28(12):1391&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">23222112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokcinar D, Ergin V, Cumaoglu A, et al. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury. Acta Biochim Pol. 2013;60(3):451&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">24020061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tar&#x131;k&#x131; K&#x131;l&#x131; Ebru KR. Comparison of ketamine-propofol mixture (ketofol) and midazolam-meperidine in endoscopic retrograde cholangiopancreatography (ERCP) for oldest old patients. Ther Clin Risk Manag. 2019;15:755&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592063</ArticleId><ArticleId IdType="pubmed">31417263</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh C, Kim Y, Eom H, et al. Procedural sedation using a propofol&#x2013;ketamine combination (Ketofol) vs. propofol alone in the Loop Electrosurgical Excision Procedure (LEEP): a randomized controlled trial. J Clin Med. 2019;8(7):943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6678246</ArticleId><ArticleId IdType="pubmed">31261820</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuya A, Matsukawa T, Ozaki M, et al. Intravenous ketamine attenuates arterial pressure changes during the induction of anaesthesia with propofol. Eur J Anaesthesiol. 2001;18(2):88&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11270030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Park H-P, Jeong M-H, et al. Efficacy of ketamine for postoperative pain following robotic thyroidectomy: A prospective randomised study. J Int Med Res. 2018;46(3):1109&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972244</ArticleId><ArticleId IdType="pubmed">29124992</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Esmaoglu A, Guler G, et al. Propofol and propofol&#x2013;ketamine in pediatric patients undergoing cardiac catheterization. Pediatr Cardiol. 2005;26(5):553&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">16132313</ArticleId></ArticleIdList></Reference><Reference><Citation>Daabiss M, Elsherbiny M, Alotibi R. Assessment of different concentration of ketofol in procedural operation. Br J Med Pract. 2009;2(1):27&#x2013;31.</Citation></Reference><Reference><Citation>Ghojazadeh M, Sanaie S, Paknezhad SP, et al. Using ketamine and propofol for procedural sedation of adults in the emergency department: a systematic review and meta-analysis. Adv Pharm Bull. 2019;9(1):5&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6468222</ArticleId><ArticleId IdType="pubmed">31011553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortero RF, Clark LD, Tolan MM, et al. The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain. Anesthesia Analg. 2001;92(6):1465&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375826</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Guler G, Esmaoglu A, et al. A comparison of fentanyl-propofol with a ketamine-propofol combination for sedation during endometrial biopsy. J Clin Anesth. 2005;17(3):187&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15896585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed AA. Prevention of sevoflurane agitation in children undergoing congenital hernia repair, impact of adding dexmedetomidine to caudal analgesia. Egypt J Anaesth. 2015;31(3):227&#x2013;231.</Citation></Reference><Reference><Citation>Vlajkovic G, Sindjelic R. Emergence delirium in children: many questions, few answers. Anesthesia Analg. 2007;104(1):84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179249</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">23878434</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0970-9185</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of anaesthesiology, clinical pharmacology</Title><ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubation.</ArticleTitle><Pagination><StartPage>162</StartPage><EndPage>167</EndPage><MedlinePgn>162-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-9185.111665</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The &#x3b1;2-adrenoreceptor agonist, dexmedetomidine, provides excellent sedation with minimal cardiovascular instability or respiratory depression and may be a useful adjunct to facilitate smooth tracheal extubation.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Fifty American Society of Anesthesiologists grade I-II patients, aged 20-45 years, scheduled for elective general surgical, urological and gynecological surgeries were studied after randomization into two groups. Group A and B, received an intravenous infusion of dexmedetomidine 0.75 mcg/kg or placebo respectively, over 15 minutes before anticipated time of end of surgery, in a double blind manner. Anesthesia techniques were standardized. Heart rate, systolic, diastolic, mean arterial pressures were recorded while starting injection, at 1, 3, 5, 10, 15 minutes after starting injection, during extubation, at 1, 3, 5 minutes after extubation, and thereafter every 5 minutes for 30 minutes. Quality of extubation was evaluated on a 5 point scale and postoperative sedation on a 6 point scale. Any event of laryngospasm, bronchospasm, desaturation, respiratory depression, vomiting, hypotension, undue sedation was noted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Heart rate, systolic, diastolic, mean arterial pressures were significantly higher in group B (P &lt; 0.05). Extubation quality score of majority of patients was 2 in group A and 3 in group B. Sedation score of most patients was 3 in group A and 2 in group B. Bradycardia and hypotension incidences were higher in group A. One patient in group A, two patients in group B had vomiting. No patient had any other side effects.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine 0.75 mcg/kg administered 15 minutes before extubation, stabilizes hemodynamics and facilitates smooth extubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bindu</LastName><ForeName>Barkha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Gandhi Hospital, Musheerabad, Secunderabad, Andhra Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasupuleti</LastName><ForeName>Surender</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gowd</LastName><ForeName>Upender P</ForeName><Initials>UP</Initials></Author><Author ValidYN="Y"><LastName>Gorre</LastName><ForeName>Venkateshwarlu</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Murthy</LastName><ForeName>Radha R</ForeName><Initials>RR</Initials></Author><Author ValidYN="Y"><LastName>Laxmi</LastName><ForeName>M Bhanu</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA><NlmUniqueID>9516972</NlmUniqueID><ISSNLinking>0970-9185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">extubation</Keyword><Keyword MajorTopicYN="N">hemodynamics</Keyword><Keyword MajorTopicYN="N">&#x3b1;2-adrenoreceptor agonist</Keyword></KeywordList><CoiStatement><b>Conflict of Interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23878434</ArticleId><ArticleId IdType="pmc">PMC3713660</ArticleId><ArticleId IdType="doi">10.4103/0970-9185.111665</ArticleId><ArticleId IdType="pii">JOACP-29-162</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Minogue SC, Ralph J, Lampa MJ. Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia. Anesth Analg. 2004;99:1253&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385385</ArticleId></ArticleIdList></Reference><Reference><Citation>Aouad MT, Al-Alami AA, Nasr VG, Souki FG. The effect of low dose remifentanil on responses to the endotracheal tube during emergence from general anesthesia. Anesth Analg. 2009;96:1320&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19299779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10730549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulaiman S, Karthekeyan RB, Vakamudi M, Sundar AS, Ravullapalli H, Gandham R. The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting. Ann Card Anaesth. 2012;15:39&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22234020</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011;27:297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3161450</ArticleId><ArticleId IdType="pubmed">21897496</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Eur J Anaesthesiol. 2008;25:816&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA, Huddleston P, Hamman B, Tai S, Matter G. The patient state index correlates well with the Ramsay sedation score in ICU patients. Anesthesiology. 2004;101:A338.</Citation></Reference><Reference><Citation>Dosing Guidelines for Precedex&#xae;.  [Last retrieved on 2010 Nov 21].  Available from: http://www.precedex.com/wp-content/uploads/2010/02/Dosing_Guide.pdf .</Citation></Reference><Reference><Citation>McGee JP, Maroof M, Passannante AN, Isenberg AV, Maroof BM. Use of dexmedetomidine for smooth recovery from general anesthesia after ECT, a case series. Anesthesiology. 2007;107:A844.</Citation></Reference><Reference><Citation>Aksu R, Ak&#xfd;n A, Bicer C, Esmaoglu A, Tosun Z, Boyac&#xfd; A. Comparison of the effects of dexmedetomidine versus fentanyl on airway reflexes and hemodynamic responses to tracheal extubation during rhinoplasty: A double-blind, randomized, controlled study. Curr Ther Res Clin Exp. 2009;70:209&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3967279</ArticleId><ArticleId IdType="pubmed">24683231</ArticleId></ArticleIdList></Reference><Reference><Citation>Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10735784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanskanen PE, Kytta JV, Randell TT, Aantaa RE. Dexmedetomidine as an anesthetic adjuvant in patients undergoing intracranial tumor surgery: A double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006;97:658&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">16914460</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anesthesiol Scand. 2005;49:1088&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: Dexmedetomidine versus midazolam. South Med J. 2004;97:451&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15180019</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results. Br J Anaesth. 2005;94:821&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15764627</ArticleId></ArticleIdList></Reference><Reference><Citation>Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth. 2001;87:684&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">11878517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadhasivam S, Boat A, Mahmoud M. Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children. J Clin Anesth. 2009;21:493&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">20006257</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaaslan K, Yilmaz F, Gulcu N, Colak C, Sereflican M, Kocoglu H. Comparison of dexmedetomidine and midazolam for monitored anesthesia care combined with tramadol via patient-controlled analgesia in endoscopic nasal surgery: A prospective, randomized, double-blind, clinical study. Curr Ther Res Clin Exp. 2007;68:69&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965987</ArticleId><ArticleId IdType="pubmed">24678121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA. Bariatric surgery: The role of dexmedetomidine. Semin Anesth Perioper Med Pain. 2006;25:51&#x2013;6.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34781421</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2468-824X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Asian journal of anesthesiology</Title><ISOAbbreviation>Asian J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Effect of Intramuscular Dexmedetomidine Administration Before Extubation on Post-Extubation Haemodynamics, Postoperative Sedation, and Analgesic Requirements: A Double Blind Placebo Controlled Study.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>110</EndPage><MedlinePgn>102-110</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.6859/aja.202109_59(3).0004</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dexmedetomidine, an &#x3b1;2-adrenoreceptor agonist has been successfully used for attenuating stress response to laryngoscopy. The present study was designed to evaluate the effects of intramuscular dexmedetomidine 30 minutes before extubation on hemodynamic response in patients undergoing laminectomy for prolapsed intervertebral disc (PIVD) under endotracheal intubation and general anesthesia.</AbstractText><AbstractText Label="METHODS">Present double-blinded randomized placebo-controlled study, included 100 patients from either sex with American Society of Anesthesiologists grades I and II and age from 18 to 60 years undergoing laminectomy for PIVD under general anesthesia. Patients were randomly divided into two groups of 50 each based on computer generated random numbers. The study group received dexmedetomidine (2.0 &#x3bc;g/ kg, i.m.) in 2.5 mL saline, and the control group received normal saline (placebo, i.m.) 2.5 mL. Drugs had been administered 30 minutes before anticipated time of extubation intramuscularly at the deltoid region. Comparison of continuous variables between two groups was done by using student's unpaired t-test. Categorical data were analyzed by using chi-square test and Fischer Exact test as applicable.</AbstractText><AbstractText Label="RESULTS">Heart rate was found to be significantly lower in the study group, 15 minutes before extubation (P = 0.003), during and after extubation (P &#xff1c; 0.0001). The systolic and diastolic blood pressure was significantly lower in the study group during and after extubation (P &#xff1c; 0.05). Cough was significantly lower in the study group during extubation. No significant difference was observed in other complications (respiratory stridor, incidence of laryngospasm or bronchospasm and reintubation) between the two groups. Pain score at 5 minutes, 2 hours, and 4 hours post-extubation was significantly lower in the study group (P &#xff1c; 0.01). P-value &#xff1c; 0.05 was considered statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS">Dexmedetomidine provides haemodynamic stability during extubation and post-extubation. It also provides post-operative calmness and reduces analgesic requirement and post-extubation complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ambesh</LastName><ForeName>S P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Madhulika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care Unit, Department of Anesthesiology, Era's Lucknow Medical College and Hospital, Lucknow, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China (Republic : 1949- )</Country><MedlineTA>Asian J Anesthesiol</MedlineTA><NlmUniqueID>101710889</NlmUniqueID><ISSNLinking>2468-824X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>15</Day><Hour>21</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34781421</ArticleId><ArticleId IdType="doi">10.6859/aja.202109_59(3).0004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28727896</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>ProSeal versus Classic laryngeal mask airway (LMA) for positive pressure ventilation in adults undergoing elective surgery.</ArticleTitle><Pagination><StartPage>CD009026</StartPage><MedlinePgn>CD009026</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD009026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD009026.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The development of supraglottic airway devices has revolutionized airway management during general anaesthesia. Two devices are widely used in clinical practice to facilitate positive pressure ventilation: the ProSeal laryngeal mask airway (pLMA) and the Classic laryngeal mask airway (cLMA). It is not clear whether these devices have important clinical differences in terms of efficacy or complications.</AbstractText><AbstractText Label="OBJECTIVES">To compare the effectiveness of the ProSeal laryngeal mask airway (pLMA) and the Classic LMA (cLMA) for positive pressure ventilation in adults undergoing elective surgery.</AbstractText><AbstractText Label="SEARCH METHODS">We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 3) in the Cochrane Library; MEDLINE (Ovid SP, 1997 to April 2017); Embase (Ovid SP, 1997 to April 2017); the Institute for Scientific Information (ISI) Web of Science (1946 to April 2017); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO host, 1982 to April 2017).We searched trial registries for ongoing studies to April 2017.We did not impose language restrictions. We restricted our search to the time from 1997 to April 2017 because pLMA was introduced into clinical practice in the year 2000.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included randomized controlled trials (RCTs) that compared the effectiveness of pLMA and cLMA for positive pressure ventilation in adults undergoing elective surgery. We planned to include only data related to the first phase of cross-over RCTs.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard methodological procedures expected by the Cochrane Collaboration.</AbstractText><AbstractText Label="MAIN RESULTS">We included eight RCTs that involved a total of 829 participants (416 and 413 participants in the pLMA and cLMA groups, respectively). We identified six cross-over studies that are awaiting classification; one is completed but has not been published, and data related to the first treatment period for the other five studies were not yet available. Seven included studies provided data related to the primary outcome, and eight studies provided data related to more than one secondary outcome.Our analysis was hampered by the fact that a large proportion of the included studies reported no events in either study arm. No studies reported significant differences between devices in relation to the primary review outcome: failure to adequately mechanically ventilate. We evaluated this outcome by assessing two variables: inadequate oxygenation (risk ratio (RR) 0.75, 95% confidence interval (CI) 0.17 to 3.31; four studies, N = 617) and inadequate ventilation (not estimable; one study, N = 80).More time was required to establish an effective airway using pLMA (mean difference (MD) 10.12 seconds, 95% CI 5.04 to 15.21; P &lt; 0.0001; I&#xb2; = 73%; two studies, N = 434). Peak airway pressure during positive pressure ventilation was lower in cLMA participants (MD 0.84, 95% CI 0.02 to 1.67; P = 0.04; I&#xb2; = 0%; four studies, N = 259). Mean oropharyngeal leak (OPL) pressure was higher in pLMA participants (MD 6.93, 95% CI 4.23 to 9.62; P &lt; 0.00001; I&#xb2; = 87%; six studies, N = 709).The quality of evidence for all outcomes, as assessed by GRADE score, is low mainly owing to issues related to blinding and imprecision.Data show no important differences between devices with regard to failure to insert the device, use of an alternate device, mucosal injury, sore throat, bronchospasm, gastric insufflation, regurgitation, coughing, and excessive leak. Data were insufficient to allow estimation of differences for obstruction related to the device. None of the studies reported postoperative nausea and vomiting as an outcome.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">We are uncertain about the effects of either of the airway devices in terms of failure of oxygenation or ventilation because there were very few events. Results were uncertain in terms of differences for several complications. Low-quality evidence suggests that the ProSeal laryngeal mask airway makes a better seal and therefore may be more suitable than the Classic laryngeal mask airway for positive pressure ventilation. The Classic laryngeal mask airway may be quicker to insert, but this is unlikely to be clinically meaningful.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qamarul Hoda</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi, Pakistan, 74800.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samad</LastName><ForeName>Khalid</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ullah</LastName><ForeName>Hameed</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD009026</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>1.  Muhammad Qamarul Hoda: none known. 2.  Khalid Samad: none known. 3.  Hameed Ullah: none known. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28727896</ArticleId><ArticleId IdType="pmc">PMC6483343</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD009026.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Ambi 2011 {published data only}</Title><Reference><Citation>Ambi U, Koppal R, Joshi C, Prakashappa DS, Iyer H. LMA Classic and LMA proseal: a comparative study in paralyzed anaesthetized patients. Journal of Clinical and Diagnostic Research 2011;5:940&#x2010;3.</Citation></Reference></ReferenceList><ReferenceList><Title>Brimacombe 2002 {published data only}</Title><Reference><Citation>Brimacombe J, Keller C, Fullekrug B, Agr&#xf2; F, Rosenblatt W, Dierdorf SF, et al. A multicenter study comparing the ProSeal and Classic laryngeal mask airway in anesthetized, nonparalyzed patients. Anesthesiology 2002;96(2):289&#x2010;95. [PUBMED: 11818758]</Citation><ArticleIdList><ArticleId IdType="pubmed">11818758</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Keller 2000 {published data only}</Title><Reference><Citation>Keller C, Brimacombe J. Mucosal pressure and oropharyngeal leak pressure with the ProSeal versus laryngeal mask airway in anaesthetized paralysed patients. British Journal of Anaesthesia 2000;85(2):262&#x2010;6. [PUBMED: 10992836]</Citation><ArticleIdList><ArticleId IdType="pubmed">10992836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khazin 2008 {published data only}</Title><Reference><Citation>Khazin V, Ezri T, Yishai R, Sessler DI, Serour F, Szmuk P, et al. Gastroesophageal regurgitation during anesthesia and controlled ventilation with six airway devices. Journal of Clinical Anesthesia 2008;20(7):508&#x2010;13. [PUBMED: 19019665]</Citation><ArticleIdList><ArticleId IdType="pubmed">19019665</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lu 2002 {published data only}</Title><Reference><Citation>Lu PP, Brimacombe J, Yang C, Shyr M. ProSeal versus the Classic laryngeal mask airway for positive pressure ventilation during laparoscopic cholecystectomy. British Journal of Anaesthesia 2002;88(6):824&#x2010;7. [PUBMED: 12173201]</Citation><ArticleIdList><ArticleId IdType="pubmed">12173201</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Natalini 2003a {published data only}</Title><Reference><Citation>Natalini G, Franceschetti ME, Pantelidi MT, Rosano A, Lanza G, Bernardini A. Comparison of the standard laryngeal mask airway and the ProSeal laryngeal mask airway in obese patients. British Journal of Anaesthesa 2003;90(3):323&#x2010;6. [PUBMED: 12594145]</Citation><ArticleIdList><ArticleId IdType="pubmed">12594145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Natalini 2003b {published data only}</Title><Reference><Citation>Natalini G, Lanza G, Rosano A, Dell'Agnolo P, Bernardini A. Standard laryngeal mask airway and LMA&#x2010;ProSeal during laparoscopic surgery. Journal of Clinical Anesthesia 2003;15(6):428&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">14652119</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shin 2010 {published data only}</Title><Reference><Citation>Shin WJ, Cheong YS, Yang HS, Nishiyama T. The supraglottic airway I&#x2010;gel in comparison with ProSeal laryngeal mask airway and classic laryngeal mask airway in anaesthetized patients. European Journal of Anaesthesiology 2010;27(7):598&#x2010;601. [PUBMED: 19915475]</Citation><ArticleIdList><ArticleId IdType="pubmed">19915475</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Brain 2000 {published data only}</Title><Reference><Citation>Brain AI, Verghese C, Strube PJ. The LMA 'ProSeal' &#x2010; a laryngeal mask with an oesophageal vent. British Journal of Anaesthesia 2000;84(5):650&#x2010;4. [PUBMED: 10844848]</Citation><ArticleIdList><ArticleId IdType="pubmed">10844848</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Francksen 2007 {published data only}</Title><Reference><Citation>Francksen H, Bein B, Cavus E, Renner J, Scholz J, Steinfath M, et al. Comparison of LMA Unique, Ambu laryngeal mask and Soft Seal laryngeal mask during routine surgical procedures. European Journal of Anaesthesiology 2007;24(2):134&#x2010;40. [PUBMED: 16895620]</Citation><ArticleIdList><ArticleId IdType="pubmed">16895620</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goldmann 2011 {published data only}</Title><Reference><Citation>Goldmann K, Gerlach M, Borntr&#xe4;ger C. ProSeal&#x2122; laryngeal mask in normal weight and obese patients: oxygenation under pressure&#x2010;controlled ventilation and different end&#x2010;expiratory pressures [ProSeal&#xae; &#x2010; Kehlkopfmaske in normalgewichtigen und adip&#xf6;sen Patienten]. Anaesthesist 2011;60(10):908&#x2010;15. [PUBMED: 21796447]</Citation><ArticleIdList><ArticleId IdType="pubmed">21796447</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hosten 2009 {published data only}</Title><Reference><Citation>Hosten T, Gurkan Y, Ozdamar D, Tekin M, Toker K, Solak M. A new supraglottic airway device: LMA&#x2010;supreme, comparison with LMA&#x2010;Proseal. Acta Anaesthesiologica Scandinavica 2009;53(7):852&#x2010;7. [PUBMED: 19426239]</Citation><ArticleIdList><ArticleId IdType="pubmed">19426239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lopez 2011 {published data only}</Title><Reference><Citation>L&#xf3;pez AM, Valero R, Hurtado P, Gamb&#xfa;s P, Pons M, Anglada T. Comparison of the LMA Supreme&#x2122; with the LMA Proseal&#x2122; for airway management in patients anaesthetized in prone position. British Journal of Anaesthesia 2011;107(2):265&#x2010;71. [PUBMED: 21576096]</Citation><ArticleIdList><ArticleId IdType="pubmed">21576096</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Maltby 2003 {published data only}</Title><Reference><Citation>Maltby JR, Beriault MT, Watson NC, Liepert DJ, Fick GH. LMA&#x2010;Classic (TM) and LMA&#x2010;ProSeal (TM) are effective alternatives to endotracheal intubation for gynecologic laparoscopy. Canadian Journal of Anesthesia 2003;50(1):71&#x2010;7. [PUBMED: 12514155]</Citation><ArticleIdList><ArticleId IdType="pubmed">12514155</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Seet 2010 {published data only}</Title><Reference><Citation>Seet E, Rajeev S, Firoz T, Yousaf F, Wong J, Wong DT, et al. Safety and efficacy of laryngeal mask airway Supreme versus laryngeal mask airway ProSeal: a randomized controlled trial. European Journal of Anaesthesiology 2010;27(7):602&#x2010;7. [PUBMED: 20540172]</Citation><ArticleIdList><ArticleId IdType="pubmed">20540172</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shariffuddin 2008 {published data only}</Title><Reference><Citation>Shariffuddin II, Wang CY. Randomised crossover comparison of the Ambu AuraOnce Laryngeal Mask with the LMA Classic laryngeal mask airway in paralysed anaesthetised patients. Anaesthesia 2008;63(1):82&#x2010;5. [PUBMED: 18086075]</Citation><ArticleIdList><ArticleId IdType="pubmed">18086075</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tham 2010 {published data only}</Title><Reference><Citation>Tham HM, Tan SM, Woon KL, Zhao YD. A comparison of the Supreme laryngeal mask airway with the ProSeal laryngeal mask airway in anesthetized paralyzed adult patients: a randomized crossover study. Canadian Journal of Anesthesia 2010;57(7):672&#x2010;8. [PUBMED: 20411444]</Citation><ArticleIdList><ArticleId IdType="pubmed">20411444</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Verghese 2008 {published data only}</Title><Reference><Citation>Verghese C, Ramaswamy B. LMA &#x2010; Supreme &#x2010; a new single&#x2010;use LMA with gastric access: a report on its clinical efficacy. British Journal of Anaesthesia 2008;101:405&#x2010;10. [PUBMED: 18559351]</Citation><ArticleIdList><ArticleId IdType="pubmed">18559351</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>Brimacombe 2000 {published data only}</Title><Reference><Citation>Brimacombe J, Keller C. The ProSeal laryngeal mask airway: a randomized, crossover study with the standard laryngeal mask airway in paralyzed, anesthetized patients. Anesthesiology 2000;93(1):104&#x2010;9. [PUBMED: 10861152]</Citation><ArticleIdList><ArticleId IdType="pubmed">10861152</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 2001 {published data only}</Title><Reference><Citation>Brimacombe J, Keller C, Boehler M, P&#xfc;hringer F. Positive pressure ventilation with the ProSeal versus classic laryngeal mask airway: a randomized, crossover study of healthy female patients. Anesthesia and Analgesia 2001;93(5):1351&#x2013;3. [PUBMED: 11682428 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11682428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 2002 {published data only}</Title><Reference><Citation>Cook TM, Nolan JP, Verghese C, Strube PJ, Lees M, Millar JM, et al. Randomized crossover comparison of the ProSeal with the Classic laryngeal mask airway in unparalysed anaesthetized patients. British Journal of Anaesthesia 2002;88(4):527&#x2010;33. [PUBMED: 12066729]</Citation><ArticleIdList><ArticleId IdType="pubmed">12066729</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2007 {published data only}</Title><Reference><Citation>Li CW, Xue FS, Mao P, Xu YC, Liu Y, Zhang GH, et al. An auto control comparison of the use of ProSeal laryngeal mask airway and standard laryngeal mask airway for positive pressure ventilation. Chinese Critical Care Medicine 2007;19(2):81&#x2010;5. [00706531]</Citation><ArticleIdList><ArticleId IdType="pubmed">17326908</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Natalini 2003c {published data only}</Title><Reference><Citation>Natalini G, Rosano A, Lanza G, Martinelli E, Pletti C, Bernardini A. Resistive load of laryngeal mask airway and ProSeal laryngeal mask airway in mechanically ventilated patients. Acta Anaesthesiologica Scandinavica 2003;6(47):761&#x2010;4. [PUBMED: 12803596]</Citation><ArticleIdList><ArticleId IdType="pubmed">12803596</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT02979171 {unpublished data only}</Title><Reference><Citation>Comparison in difficult airway scenario induced in patients with Laryngeal Mask Airway (LMA) &#x2010; Classic&#x2122;, LMA&#x2122; &#x2010; Flexible and LMA &#x2010; Proseal&#x2122;. https://clinicaltrials.gov/ct2/show/record/NCT02979171?term=classic+laryngeal+mask+airway&amp;rank=10 (first received 5 April 2016).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Benumof 1992</Title><Reference><Citation>Benumof JL. Laryngeal mask airway. Indications and contraindications. Anesthesiology 1992;77(5):843&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1443734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Benumof 1996</Title><Reference><Citation>Benumof JL. Laryngeal mask airway and the ASA difficult airway algorithm. Anesthesiology 1996;84(3):686&#x2010;99. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8659797</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bernardini 2009</Title><Reference><Citation>Bernardini A, Natalini G. Risk of pulmonary aspiration with laryngeal mask airway and tracheal tube: analysis on 65 712 procedures with positive pressure ventilation. Anaesthesia 2009;64(12):1289&#x2010;94. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19860753</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Blanc 1974</Title><Reference><Citation>Blanc VF, Tremblay NA. The complications of tracheal intubation: a new classification with a review of the literature. Anesthesia and Analgesia 1974;53(2):202&#x2010;13. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4593090</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bogetz 1994</Title><Reference><Citation>Bogetz MS. The laryngeal mask airway &#x2010; role in managing the difficult airway. International Anesthesiology Clinics 1994;32(4):109&#x2010;17. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7875906</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brain 1983</Title><Reference><Citation>Brain AI. The laryngeal mask &#x2010; a new concept in airway management. British Journal of Anaesthesia 1983;55(8):801&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6349667</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brain 1985</Title><Reference><Citation>Brain AI, McGhee TD, McAteer EJ, Thomas A, Abu&#x2010;Saad MA, Bushman JA. The laryngeal mask airway. Development and preliminary trials of a new type of airway. Anaesthesia 1985;40(4):356&#x2010;61. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">4003736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 1995</Title><Reference><Citation>Brimacombe J. The advantages of the LMA over the tracheal tube or facemask: a meta&#x2010;analysis. Canadian Journal of Anaesthesia 1995;42(11):1017&#x2010;23. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8590490</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 1995a</Title><Reference><Citation>Brimacombe JR, Berry A. The incidence of aspiration associated with the laryngeal mask airway: a meta&#x2010;analysis of published literature. Journal of Clinical Anesthesia 1995;7(4):297&#x2010;305. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7546756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 1996</Title><Reference><Citation>Brimacombe J. Analysis of 1500 laryngeal mask uses by one anaesthetist in adults undergoing routine anaesthesia. Anaesthesia 1996;51(1):76&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8669573</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 2002a</Title><Reference><Citation>Brimacombe J, Keller C. The ProSeal laryngeal mask airway. Anesthesiology Clinics of North America 2002;20(4):871&#x2010;91. [PUBMED: 12512267]</Citation><ArticleIdList><ArticleId IdType="pubmed">12512267</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 2005</Title><Reference><Citation>Cook TM, Lee G, Nolan JP. The ProSeal laryngeal mask airway: a review of the literature. Canadian Journal of Anesthesia 2005;52(7):739&#x2010;60. [PUBMED: 16103390]</Citation><ArticleIdList><ArticleId IdType="pubmed">16103390</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>DerSimonian 1986</Title><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177&#x2010;88. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Devitt 1994</Title><Reference><Citation>Devitt JH, Wenstone R, Noel AG, O'Donnell MP. The laryngeal mask airway and positive&#x2010;pressure ventilation. Anesthesiology 1994;80(3):550&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8141451</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Evans 2002</Title><Reference><Citation>Evans NR, Gardner SV, James MF. ProSeal laryngeal mask protects against aspiration of fluid in the pharynx. British Journal of Anaesthesia 2002;88(4):584&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12066738</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT 2014 [Computer program]</Title><Reference><Citation>GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014 (accessed before 20 February 2017).</Citation></Reference></ReferenceList><ReferenceList><Title>Griffin 1990</Title><Reference><Citation>Griffin RM, Hatcher IS. Aspiration pneumonia and the laryngeal mask airway. Anaesthesia 1990;45(12):1039&#x2010;40. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">2132310</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck&#x2010;Ytter Y, Sch&#xfc;nemann HJ. What is "quality of evidence" and why is it important to clinicians?. British Medical Journal 2008;336(7651):995&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2011a</Title><Reference><Citation>Higgins JP, Deeks J. Obtaining standard deviations from standard errors and confidence intervals for group means. Cochrane Handbook for Systematic Reviews of Interventions, 2011, issue 5.</Citation></Reference></ReferenceList><ReferenceList><Title>Jones 1995</Title><Reference><Citation>Jones JR. Laryngeal mask airway: an alternative for the difficult airway. AANA Journal 1995;63(5):444&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7502644</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>J&#xfc;ni 2001</Title><Reference><Citation>J&#xfc;ni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. British Medical Journal 2001;323(7303):42&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1120670</ArticleId><ArticleId IdType="pubmed">11440947</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Keller 2004</Title><Reference><Citation>Keller C, Brimacombe J, Bittersohl J, Lirk P, Goedecke A. Aspiration and the laryngeal mask airway: three cases and a review of the literature. British Journal of Anaesthesia 2004;93(4):579&#x2010;82. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15247112</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lopez&#x2010;Gil 2005</Title><Reference><Citation>Lopez&#x2010;Gil M, Brimacombe J. The ProSeal laryngeal mask airway in children. Paediatric Anaesthesia 2005;15(3):229&#x2010;34. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15725321</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luckhaupt 1986</Title><Reference><Citation>Luckhaupt H, Brusis T. History of intubation. Laryngologie, Rhinologie, Otologie 1986;65(9):506&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3537595</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Maltby 2000</Title><Reference><Citation>Maltby JR, Beriault MT, Watson NC, Fick GH. Gastric distension and ventilation during laparoscopic cholecystectomy: LMA&#x2010;Classic vs. tracheal intubation. Canadian Journal of Anaesthesia 2000;47(7):622&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10930200</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mark 2003</Title><Reference><Citation>Mark DA. Protection from aspiration with the LMA&#x2010;ProSeal after vomiting: a case report. Canadian Journal of Anaesthesia 2003;50(1):78&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12514156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McHardy 1999</Title><Reference><Citation>McHardy FE, Chung F. Postoperative sore throat: cause, prevention and treatment. Anaesthesia 1999;54(5):444&#x2010;53. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10995141</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RevMan 5.3 [Computer program]</Title><Reference><Citation>The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Szmuk 2008</Title><Reference><Citation>Szmuk P, Ezri T, Evron S, Roth Y, Katz J. A brief history of tracheostomy and tracheal intubation, from the bronze age to the space age. Intensive Care Medicine 2008;34(2):222&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17999050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Todesco 1993</Title><Reference><Citation>Todesco J, Dodd C, Williams RT. Laryngeal mask airway: defining the limits. Canadian Journal of Anesthesia 1993;40(9):900&#x2010;1. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8403188</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Van Damme 1994</Title><Reference><Citation>Damme E. The laryngeal mask in ambulatory anesthesia. An evaluation of 5,000 ambulatory anesthesia incidents [Die Kehlkopfmaske in der ambulanten An&#xe4;sthesie. Eine Auswertung von 5000 ambulanten Narkosen]. An&#xe4;sthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 1994;29(5):284&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7948496</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Verghese 1996</Title><Reference><Citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and non conventional usage. Anesthesia and Analgesia 1996;82(1):129&#x2010;33. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8712387</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Villars 2005</Title><Reference><Citation>Villars P, Koczka E, Haynie C. The use of the laryngeal mask airway with mechanical positive pressure ventilation. AANA Journal 2005;73(1):18. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15727277</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wan 2014</Title><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC medical research methodology 2014;14(1):135. [PUBMED: 25524443]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wat 2003</Title><Reference><Citation>Wat LI. The laryngeal mask airway for oral and maxillofacial surgery. International Anesthesiology Clinics 2003;41(3):29&#x2010;56. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12872024</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2012</Title><Reference><Citation>Zhang X, Chen M, Li Q. The ProSeal laryngeal mask airway is more effective than the LMA&#x2010;Classic in pediatric anesthesia: a meta&#x2010;analysis. Journal of Clinical Anesthesia 2012;24(8):639&#x2010;46. [PUBMED: 23122975]</Citation><ArticleIdList><ArticleId IdType="pubmed">23122975</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Qamarul Hoda 2011</Title><Reference><Citation>Qamarul Hoda M, Samad K, Ullah H. Proseal versus Classic laryngeal mask airway (LMA) for positive pressure ventilation in adult patients undergoing elective surgery. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD009026]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009026</ArticleId><ArticleId IdType="pmc">PMC6483343</ArticleId><ArticleId IdType="pubmed">28727896</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32836188</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Comparison of low and high inspiratory oxygen fraction added to lung-protective ventilation on postoperative pulmonary complications after abdominal surgery: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>110009</StartPage><MedlinePgn>110009</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2020.110009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(20)30924-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">Intraoperative lung-protective ventilation strategy has been recommended to reduce postoperative pulmonary complications (PPCs). However, the role of inspiratory oxygen fraction (FiO<sub>2</sub>) in this protection remains highly uncertain. We aimed to evaluate the effect of intraoperative low (30%) versus high (80%) FiO<sub>2</sub> in the context of lung-protective ventilation strategy on PPCs in patients undergoing abdominal surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, two-arm, randomized controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary university hospital in China.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">A total of ASA I-III 252 patients aged &#x2265;18, who were scheduled for elective abdominal surgery under general anesthesia were included in the study.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Patients were randomly assigned to receive either 30% or 80% FiO<sub>2</sub> during the intraoperative period. All patients received volume-controlled mechanical ventilation with lung-protective ventilation approach, which included a tidal volume of 8&#xa0;ml&#xa0;kg<sup>-1</sup> of predicted body weight, a positive end-expiratory pressure level of 6-8 cmH<sub>2</sub>O, and repeated recruitment maneuvers.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome was a composite of postoperative pulmonary complications within the first 7 postoperative days, consisting of respiratory infection, respiratory failure, bronchospasm, atelectasis, pleural effusion, pneumothorax, and aspiration pneumonitis. The severity grade of PPCs was measured as a key secondary outcome.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Two hundred and fifty-one patients completed the trial. PPCs occurred in 43 of 125 (34.4%) patients assigned to receive 30% FiO<sub>2</sub> compared with 59 of 126 (46.8%) patients receiving 80% FiO<sub>2</sub> (relative risk 0.74, 97.5% confidence interval, 0.51-1.02, p&#xa0;= 0.045, &gt; 0.025). The severity of PPCs within the first 7&#xa0;days following surgery was attenuated significantly in the low (30%) FiO<sub>2</sub> group (p&#xa0;= 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients undergoing abdominal surgery under general anesthesia, an intraoperative lung-protective ventilation strategy with 30% FiO<sub>2</sub> compared with 80% FiO<sub>2</sub> did not reduce the incidence of PPCs. And the use of 30% FiO<sub>2</sub> resulted in less severe pulmonary complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue-Fei</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yu-Lian</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Meng-Qiu</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jia-Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Lei-Lei</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University &amp; The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu 610041, China. Electronic address: yuhaishan117@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="Y">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal surgery</Keyword><Keyword MajorTopicYN="N">Inspiratory oxygen fraction</Keyword><Keyword MajorTopicYN="N">Lung-protective ventilation strategy</Keyword><Keyword MajorTopicYN="N">Postoperative pulmonary complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32836188</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2020.110009</ArticleId><ArticleId IdType="pii">S0952-8180(20)30924-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20463565</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-7385</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>7</Issue><PubDate><Year>2010</Year><Month>Jul</Month></PubDate></JournalIssue><Title>American journal of physical medicine &amp; rehabilitation</Title><ISOAbbreviation>Am J Phys Med Rehabil</ISOAbbreviation></Journal><ArticleTitle>Risk factors for chest illness in chronic spinal cord injury: a prospective study.</ArticleTitle><Pagination><StartPage>576</StartPage><EndPage>583</EndPage><MedlinePgn>576-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PHM.0b013e3181ddca8e</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Chest illnesses commonly cause morbidity in persons with chronic spinal cord injury. Risk factors remain poorly characterized because previous studies have not accounted for factors other than spinal cord injury.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Between 1994 and 2005, 403 participants completed a respiratory questionnaire and underwent spirometry. Participants were contacted at a median of 1.7 yrs [interquartile range: 1.3-2.5 yrs] apart over a mean (SD) of 5.1 +/- 3.0 yrs and asked to report chest illnesses that had resulted in time off work, spent indoors, or in bed since prior contact.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 97 participants, there were 247 chest illnesses (0.12/person-year) with 54 hospitalizations (22%). Spinal cord injury level, completeness of injury, and duration of injury were not associated with illness risk. Adjusting for age and smoking history, any wheeze (relative risk = 1.92; 95% confidence interval: 1.19, 3.08), pneumonia or bronchitis since spinal cord injury (relative risk = 2.29; 95% confidence interval: 1.40, 3.75), and physician-diagnosed chronic obstructive pulmonary disease (relative risk = 2.17; 95% confidence interval: 1.08, 4.37) were associated with a greater risk of chest illness. Each percent-predicted decrease in forced expiratory volume in 1 sec was associated with a 1.2% increase in risk of chest illness (P = 0.030).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In chronic spinal cord injury, chest illness resulting in time spent away from usual activities was not related to the level or completeness of spinal cord injury but was related to reduced pulmonary function, wheeze, chronic obstructive pulmonary disease, a history of pneumonia and bronchitis, and smoking.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stolzmann</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, VA Boston Healthcare System, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>David R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tun</LastName><ForeName>Carlos G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Garshick</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HD042141</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Phys Med Rehabil</MedlineTA><NlmUniqueID>8803677</NlmUniqueID><ISSNLinking>0894-9115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001991" MajorTopicYN="N">Bronchitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011782" MajorTopicYN="N">Quadriplegia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20463565</ArticleId><ArticleId IdType="mid">NIHMS261302</ArticleId><ArticleId IdType="pmc">PMC3021458</ArticleId><ArticleId IdType="doi">10.1097/PHM.0b013e3181ddca8e</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith BM, Evans CT, Kurichi JE, et al. Acute respiratory tract infection visits of veterans with spinal cord injuries and disorders: Rates, trends, and risk factors. J Spinal Cord Med. 2007;30:355&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2031934</ArticleId><ArticleId IdType="pubmed">17853657</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver FM, Smith B, Evans CT, et al. Outcomes of outpatient visits for acute respiratory illness in veterans with spinal cord injuries and disorders. Am J Phys Med Rehabil. 2006;85:718&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">16924184</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVivo MJ, Stover SL. Long term survival and causes of death. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord Injury: Clinical Outcomes From the Model Systems. Gaithersburg, MD: Aspen Publishers, Inc; 1995. pp. 234&#x2013;71.</Citation></Reference><Reference><Citation>Dryden DM, Saunders LD, Rowe BH, et al. Utilization of health services following spinal cord injury: A 6-year follow-up study. Spinal Cord. 2004;42:513&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15249928</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas DD, Hoffman JM, Kirshblum S, et al. Etiology and incidence of rehospitalization after traumatic spinal cord injury: A multicenter analysis. Arch Phys Med Rehabil. 2004;85:1757&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">15520970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain NB, Brown R, Tun CG, et al. Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury. Arch Phys Med Rehabil. 2006;87:1327&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1896316</ArticleId><ArticleId IdType="pubmed">17023241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledsome JR, Sharp JM. Pulmonary function in acute cervical cord injury. Am Rev Respir Dis. 1981;124:41&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7258818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris BG. Epidemiology Standardization Project (American Thoracic Society) Am Rev Respir Dis. 1978;118(6 Part 2):1&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">742764</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino RJ, Barros T, Biering-Sorenson F, et al. International standards for neurological classification of spinal cord injury. J Spinal Cord Injury Med. 2003;26:550&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16296564</ArticleId></ArticleIdList></Reference><Reference><Citation>Garshick E, Ashba J, Tun CG, et al. Assessment of stature in spinal cord injury. J Spinal Cord Med. 1997;20:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9097254</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley A, Garshick E, Gross ER, et al. Spirometry testing standards in spinal cord injury. Chest. 2003;123:725&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1896104</ArticleId><ArticleId IdType="pubmed">12628869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashba J, Garshick E, Tun CG, et al. Spirometry&#x2014;Acceptability and reproducibility in spinal cord injured subjects. J Am Paraplegia Soc. 1993;16:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">8270915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tully K, Koke K, Garshick E, et al. Maximal expiratory pressures in spinal cord injury using two mouthpieces. Chest. 1997;112:113&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228365</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10569435</ArticleId></ArticleIdList></Reference><Reference><Citation>Soden RJ, Walsh J, Middleton JW, et al. Causes of death after spinal cord injury. Spinal Cord. 2000;38:604&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11093321</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel HL, Coll JR, Charlifue SW, et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord. 1998;36:266&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">9589527</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss ST, Tager IB, Speizer FE, et al. Persistent wheeze. Its relation to respiratory illness, cigarette smoking, and level of pulmonary function in a population sample of children. Am Rev Respir Dis. 1980;122:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">7447154</ArticleId></ArticleIdList></Reference><Reference><Citation>Speizer FE. Asthma and persistent wheeze in the Harvard Six Cities Study. Chest. 1990;98(5 Suppl):191S&#x2013;195S.</Citation><ArticleIdList><ArticleId IdType="pubmed">2226008</ArticleId></ArticleIdList></Reference><Reference><Citation>Frostad A, Soyseth V, Haldorsen T, et al. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax. 2006;61:951&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2121183</ArticleId><ArticleId IdType="pubmed">16809414</ArticleId></ArticleIdList></Reference><Reference><Citation>Samsa GP, Landsman PB, Hamilton B. Inpatient hospital utilization among veterans with traumatic spinal cord injury. Arch Phys Med Rehabil. 1996;77:1037&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">8857883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mckinley WO, Jackson AB, Cardenas DD, et al. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil. 1999;80:1402&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10569434</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30857395</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1816-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Asian cardiovascular &amp; thoracic annals</Title><ISOAbbreviation>Asian Cardiovasc Thorac Ann</ISOAbbreviation></Journal><ArticleTitle>A risk score for predicting respiratory complications after thoracic surgery.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>287</EndPage><MedlinePgn>278-287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0218492319835994</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory complications are some of the most common complications following thoracic surgery and can lead to higher perioperative morbidity and mortality. The purpose of this study was to develop a simple clinical score for prediction of respiratory complications after thoracic surgery, and determine the internal validity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective cohort study, all consecutive patients were aged 18 years and over and undergoing non-cardiac thoracic surgery at a tertiary-care university hospital. Respiratory complications included bronchospasm, atelectasis, pneumonia, respiratory failure, and adult respiratory distress syndrome within 30 days of surgery or before discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1488 patients were included over a 7-year period, and 15.8% (235 of 1488 patients) developed respiratory complications. The significant predictors of respiratory complications were chronic obstructive pulmonary disease, American Society of Anesthesiologist physical status &#x2265; 3, right-sided surgery, duration of surgery longer than 180 min, preoperative arterial oxygen saturation on room air&#x2009;&lt;&#x2009;96%, and open thoracotomy. The area under receiving operating characteristic curve was 0.78 (95% confidence interval: 0.75-0.82) and 0.76 (95% confidence interval: 0.70-0.83) for the derivation and validation cohorts, respectively. The model was well calibrated with a Hosmer-Lemeshow goodness-of-fit of 7.32 ( p&#x2009;=&#x2009;0.293).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study developed and internally validated a simple clinical risk score for prediction of respiratory complications following thoracic surgery. This score can be used to stratify high-risk patients, address modifiable risk factors for respiratory complications, and provide preventive strategies for improving postoperative outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pipanmekaporn</LastName><ForeName>Tanyong</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7154-5671</Identifier><AffiliationInfo><Affiliation>1 Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Clinical Epidemiology and Clinical Statistic Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunchungmongkol</LastName><ForeName>Nutchanart</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>1 Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Punjasawadwong</LastName><ForeName>Yodying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1 Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapisatepun</LastName><ForeName>Worawut</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>1 Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantraworasin</LastName><ForeName>Apichat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2 Clinical Epidemiology and Clinical Statistic Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saokaew</LastName><ForeName>Surasak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>4 Center of Health Outcomes Research and Therapeutic Safety, School of Pharmaceutical Sciences, University of Phayao, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Center of Pharmaceutical Outcome Research (CPOR), Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>6 Unit of Excellence on Herbal Medicine, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>7 School of Phamacy, Monash University Malaysia, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Asian Cardiovasc Thorac Ann</MedlineTA><NlmUniqueID>9503417</NlmUniqueID><ISSNLinking>0218-4923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="Y">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung diseases</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">risk assessment</Keyword><Keyword MajorTopicYN="N">thoracic surgical procedures</Keyword><Keyword MajorTopicYN="N">validation studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30857395</ArticleId><ArticleId IdType="doi">10.1177/0218492319835994</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30384855</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Risk prediction tool for use and predictors of duration of postoperative oxygen therapy in children undergoing non-cardiac surgery: a case-control study.</ArticleTitle><Pagination><StartPage>137</StartPage><MedlinePgn>137</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">137</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-018-0595-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">We aimed to construct a prediction tool for postoperative oxygen therapy and determine predictors of duration of use among children undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS">Data from this case-control study was obtained from a database of 9820 children aged &lt;&#x2009;15&#xa0;years who underwent general anesthesia between January 2010 and December 2013 at a tertiary care hospital in southern Thailand. The primary outcomes were the use and duration (hours) of postoperative oxygen therapy (cases). Cases were matched with controls on age group and year of surgery in a ratio of 1:4. A negative binomial hurdle model was used to obtain significant predictors of any use and number of hours of oxygen therapy. A risk score was derived from the coefficients of the significant predictors. The risk score, adjusted odds ratio (OR) for any use and count ratio (CR) for duration of postoperative oxygen therapy and 95% confidence interval (CI) were determined.</AbstractText><AbstractText Label="RESULTS">A total of 288 cases and 1152 controls were included. The median (inter-quartile range) duration of oxygen therapy delivered was 17 (9-22) hours. An optimal risk score for predictors of oxygen use was 12 (0-32) giving an area under the receiver operating characteristic curve of 0.93. Predictors of high risk need for oxygen therapy (score&#x2009;&#x2265;&#x2009;12) were thoracic surgery (OR&#x2009;=&#x2009;278, 95% CI&#x2009;=&#x2009;44.6-1733) and having desaturation perioperatively (OR&#x2009;=&#x2009;459.8, 95% CI&#x2009;=&#x2009;169.7-1246). Intermediate risk factors (score 8-11) were having bronchospasm (OR&#x2009;=&#x2009;92.4, 95% CI&#x2009;=&#x2009;29.7-287.5) and upper airway obstruction/laryngospasm (OR&#x2009;=&#x2009;61.5, 95% CI&#x2009;=&#x2009;14.4-262.4) perioperatively. Significant predictors of duration of oxygen therapy were probably difficult airway (CR&#x2009;=&#x2009;2.2, 95% CI&#x2009;=&#x2009;1.4-3.5), history of delayed development (CR&#x2009;=&#x2009;2.3, 95% CI&#x2009;=&#x2009;1.5-3.6), airway (CR&#x2009;=&#x2009;3.0, 95% CI&#x2009;=&#x2009;1.6-5.8), orthopedic (CR&#x2009;=&#x2009;2.1, 95% CI&#x2009;=&#x2009;1.1-4.3), thoracic (CR&#x2009;=&#x2009;4.9, 95% CI&#x2009;=&#x2009;2.3-10.1) and abdominal surgery (CR&#x2009;=&#x2009;4.2, 95% CI&#x2009;=&#x2009;2.1-8.1), compared to eye surgery.</AbstractText><AbstractText Label="CONCLUSIONS">Our risk prediction tool for the use of postoperative oxygen therapy provided a high predictive ability. Children who have thoracic surgery, desaturation, bronchospasm, upper airway obstruction or laryngospasm will most likely need postoperative oxygen therapy, regardless of other factors, while those with a probably difficult airway, history of delayed development, or thoracic/abdominal surgery will most likely need longer duration of oxygen therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oofuvong</LastName><ForeName>Maliwan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5840-5965</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand. oomaliwa@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratprasert</LastName><ForeName>Siriwimol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chanchayanon</LastName><ForeName>Thavat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Duration of use</Keyword><Keyword MajorTopicYN="N">Pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">Postoperative oxygen therapy</Keyword><Keyword MajorTopicYN="N">Predictors</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the Institutional Ethics Committee of the Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand, Chairperson Assoc. Prof. Boonsin Tangtrakulwanich, EC number 57294081 on October 8, 2014 and amendment approval EC number 57294081 on February 6, 2017. The consent to participate was not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30384855</ArticleId><ArticleId IdType="pmc">PMC6214164</ArticleId><ArticleId IdType="doi">10.1186/s12871-018-0595-4</ArticleId><ArticleId IdType="pii">10.1186/s12871-018-0595-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singh V, Gupta P, Khatana S, Bhagol A. Supplemental oxygen therapy: important considerations in oral and maxillofacial surgery. Natl J of Maxillofac Surg. 2011;2:10&#x2013;14. doi: 10.4103/0975-5950.85846.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-5950.85846</ArticleId><ArticleId IdType="pmc">PMC3304228</ArticleId><ArticleId IdType="pubmed">22442602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman J. Perioperative respiratory complications in children. Lancet. 2010;376:745&#x2013;746. doi: 10.1016/S0140-6736(10)61199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61199-3</ArticleId><ArticleId IdType="pubmed">20816527</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS. Respiratory complications in the pediatric postanesthesia care unit. Anesthesiol Clin. 2014;32:45&#x2013;61. doi: 10.1016/j.anclin.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2013.10.004</ArticleId><ArticleId IdType="pubmed">24491649</ArticleId></ArticleIdList></Reference><Reference><Citation>Baijal RG, Bidani SA, Minard CG, Watcha MF. Perioperative respiratory complications following awake and deep extubation in children undergoing adenotonsillectomy. Paediatr Anaesth. 2015;25:392&#x2013;399. doi: 10.1111/pan.12561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12561</ArticleId><ArticleId IdType="pubmed">25370474</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue FS, Tong SY, Liao X, Liu JH, Zhang RJ, An G, Luo LK. Observation of the correlation of postanesthesia recovery scores with early postoperative hypoxaemia in children. Paediatr Anaesth. 1999;9:145&#x2013;151. doi: 10.1046/j.1460-9592.1999.9220256.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.1999.9220256.x</ArticleId><ArticleId IdType="pubmed">10189656</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui N, Arzola C, Teresi J, Fox G, Guerina L, Friedman Z. Predictors of desaturation in the postoperative anesthesia care unit: an observational study. J Clin Anesth. 2013;25:612&#x2013;617. doi: 10.1016/j.jclinane.2013.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2013.04.018</ArticleId><ArticleId IdType="pubmed">24095886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintong T, Klanarong S, Suksompong S, Chua-in W, Chatmongkolchat S, Werawatganon T. The Thai Anesthesia Incident Monitoring Study (Thai AIMS) of oxygen desaturation in the post-anesthetic care unit. J Med Assoc Thail. 2008;91:1531&#x2013;1538.</Citation><ArticleIdList><ArticleId IdType="pubmed">18972896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallstrom TJ. American Association for Respiratory Care (AARC).AARC clinical practice guideline: oxygen therapy for adults in the acute care facility--2002 revision &amp; update. Respir Care. 2002;47:717&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">12078655</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Pattaravit N, Nuanjun K. Risk over time and risk factors of intraoperative respiratory events: a historical cohort study of 14,153 children. BMC Anesthesiol. 2014;14:13. doi: 10.1186/1471-2253-14-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-13</ArticleId><ArticleId IdType="pmc">PMC4016417</ArticleId><ArticleId IdType="pubmed">24597484</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue FS, Luo LK, Tong SY, Liao X, Deng XM, An G. Study of the safe threshold of apneic period in children during anesthesia induction. J Clin Anesth. 1996;8:568&#x2013;574. doi: 10.1016/S0952-8180(96)00138-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(96)00138-9</ArticleId><ArticleId IdType="pubmed">8910179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu MC, Pavlicova M, Nunes EV. Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. Am J Drug Alcohol Abuse. 2011;37:367&#x2013;375. doi: 10.3109/00952990.2011.597280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00952990.2011.597280</ArticleId><ArticleId IdType="pmc">PMC3238139</ArticleId><ArticleId IdType="pubmed">21854279</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelon B, Chang HH, Ling Q, Hastings NS. Spatiotemporal hurdle models for zeroinflated count data: exploring trends in emergency department visits. Stat Methods Med Res. 2016;25:2558&#x2013;2576. doi: 10.1177/0962280214527079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280214527079</ArticleId><ArticleId IdType="pubmed">24682266</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R, Yeramaneni S, Hossain MM, Anneken AM, Varughese AM. Perioperative respiratory adverse events in pediatric ambulatory anesthesia: development and validation of a risk prediction tool. Anesth Analg. 2016;122:1578&#x2013;1585. doi: 10.1213/ANE.0000000000001216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001216</ArticleId><ArticleId IdType="pubmed">27101501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomori H, Kobayashi R. Postoperative pulmonary complications in patients undergoing thoracic surgery with special reference to preoperative respiratory muscle strength and nutrition. Nihon KyobuGeka Gakkai Zasshi. 1994;42:1272&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">7989783</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz LE. Postoperative complications of thoracic surgery: their recognition and treatment. AANA J. 1980;48:222&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">7415773</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito H, Minamiya Y, Kawai H, Motoyama S, Katayose Y, Kimura K, Saito R, Ogawa JI. Estimation of pulmonary oxygen consumption in the early postoperative period after thoracic surgery. Anesthesia. 2007;62:648&#x2013;653. doi: 10.1111/j.1365-2044.2007.05058.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2007.05058.x</ArticleId><ArticleId IdType="pubmed">17567338</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Christensen R, O&#x2019;Brien LM. The STBUR questionnaire for predicting perioperative respiratory adverse events in children at risk for sleep-disordered breathing. Paediatr Anaesth. 2013;23:510&#x2013;516. doi: 10.1111/pan.12155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12155</ArticleId><ArticleId IdType="pmc">PMC3648590</ArticleId><ArticleId IdType="pubmed">23551934</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, Habre W. Risk assessment for respiratory complications in pediatric anesthesia: a prospective cohort study. Lancet. 2010;376:773&#x2013;783. doi: 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Pattaravit N, Nuanjun K. Association between intraoperative and post-anesthetic care unit respiratory events among 12,641 children in southern Thailand. BJMMR. 2015;6:1101&#x2013;1112. doi: 10.9734/BJMMR/2015/15789.</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/BJMMR/2015/15789</ArticleId></ArticleIdList></Reference><Reference><Citation>Uakritdathikarn T, Chongsuvivatwong V, Geater AF, Vasinanukorn M, Thinchana S, Klayna S. Perioperative desaturation and risk factors in general anesthesia. J Med Assoc Thail. 2008;91:1020&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Burke C, Kostrzewa A, Lewis I. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108:375&#x2013;380. doi: 10.1097/ALN.0b013e318164ca9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318164ca9b</ArticleId><ArticleId IdType="pubmed">18292674</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Valois T, Withington DE. Laryngeal mask airway and difficult airway management in adolescent: a case report. Paediatr Anaesth. 2008;18:1228&#x2013;1229. doi: 10.1111/j.1460-9592.2008.02724.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2008.02724.x</ArticleId><ArticleId IdType="pubmed">18717805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanchayanon T, Suraseranivongse S, Chau-in W. The Thai Anesthesia Incidents Study (THAI Study) of difficult intubation: a qualitative analysis. J Med Assoc Thail. 2005;88(Suppl 7):S62&#x2013;S68.</Citation><ArticleIdList><ArticleId IdType="pubmed">16858984</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Chanchayanon T, Sriyanaluk B, Saefung B, Nuanjun K. Excess costs and length of hospital stay attributable to perioperative respiratory events in children. Anesth Analg. 2015;120:411&#x2013;419. doi: 10.1213/ANE.0000000000000557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000557</ArticleId><ArticleId IdType="pubmed">25517194</ArticleId></ArticleIdList></Reference><Reference><Citation>Proesmans M, Vreys M, Huenaerts E, Haest E, Coremans S, Vermeulen F, Feys H. Respiratory morbidity in children with profound intellectual and multiple disability. Pediatr Pulmonol. 2015;50:1033&#x2013;1038. doi: 10.1002/ppul.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.23114</ArticleId><ArticleId IdType="pubmed">25327770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe9;si C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, Cambonie G. Highflow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care. 2014;4:29. doi: 10.1186/s13613-014-0029-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-014-0029-5</ArticleId><ArticleId IdType="pmc">PMC4273693</ArticleId><ArticleId IdType="pubmed">25593745</ArticleId></ArticleIdList></Reference><Reference><Citation>AARC AARC clinical practice guideline. Oxygen therapy in the home or alternate site health care facility--2007 revision &amp; update. Respir Care. 2007;52:1063&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">17715561</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh J, McGrath-Morrow SA, Collaco JM. Oxygen weaning after hospital discharge in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2016;51:1206&#x2013;1211. doi: 10.1002/ppul.23442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.23442</ArticleId><ArticleId IdType="pmc">PMC5556369</ArticleId><ArticleId IdType="pubmed">27093064</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindal SK. Oxygen therapy: important considerations. Indian J Chest Dis Allied Sci. 2008;50:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">18610694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler L, James J, Byrne S, Forton J. Audit of oxygen prescribing in a children&#x2019;s hospital. Arch Dis Child. 2016;101:e2. doi: 10.1136/archdischild-2016-311535.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2016-311535.36</ArticleId><ArticleId IdType="pubmed">27540216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31791239</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial.</ArticleTitle><Pagination><StartPage>219</StartPage><MedlinePgn>219</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">219</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-019-0892-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Tracheobronchial foreign body aspiration in children is a life-threatening, emergent situation. Currently, the use of fiberoptic bronchoscopy for removing foreign bodies is attracting increasing attention. Oxygen desaturation, body movement, laryngospasm, bronchospasm, and breath-holding are common adverse events during foreign body removal. Dexmedetomidine, as a highly selective &#x3b1;<sub>2</sub>-adrenergic agonist, produces sedative and analgesic effects, and does not induce respiratory depression. We hypothesized that intranasal dexmedetomidine at 1&#xa0;&#x3bc;g&#xa0;kg&#x2009;-&#x2009;1 administered 25&#x2009;min before anesthesia induction can reduce the incidence of adverse events during fiberoptic bronchoscopy under inhalation general anesthesia with sevoflurane.</AbstractText><AbstractText Label="METHODS">In all, 40 preschool-aged children (6-48&#x2009;months) with an American Society of Anesthesiologists physical status of I or II were randomly allocated to receive either intranasal dexmedetomidine at 1&#xa0;&#x3bc;g&#xb7;kg&#x2009;-&#x2009;1 or normal saline at 0.01&#xa0;ml&#xa0;kg<sup>-&#x2009;1</sup> 25&#x2009;min before anesthesia induction. The primary outcome was the incidence of perioperative adverse events. Heart rate, respiratory rate, parent-child separation score, tolerance of the anesthetic mask, agitation score, consumption of sevoflurane, and recovery time were also recorded.</AbstractText><AbstractText Label="RESULTS">Following pre-anesthesia treatment with either intranasal dexmedetomidine or saline, the incidences of laryngospasm (15% vs. 50%), breath-holding (10% vs. 40%), and coughing (5% vs. 30%) were significantly lower in patients given dexmedetomidine than those given saline. Patients who received intranasal dexmedetomidine had a lower parent-child separation score (P&#xa0;=&#x2009;0.017), more satisfactory tolerance of the anesthetic mask (P&#xa0;=&#x2009;0.027), and less consumption of sevoflurane (38.18&#x2009;&#xb1;&#x2009;14.95 vs. 48.03&#x2009;&#xb1;&#x2009;14.45&#x2009;ml, P&#xa0;=&#x2009;0.041). The frequency of postoperative agitation was significantly lower in patients given intranasal dexmedetomidine (P&#xa0;=&#x2009;0.004), and the recovery time was similar in the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Intranasal dexmedetomidine 1&#xa0;&#x3bc;g&#xb7;kg<sup>-&#x2009;1</sup>, with its sedative and analgesic effects, reduced the incidences of laryngospasm, breath-holding, and coughing during fiberoptic bronchoscopy for FB removal. Moreover, it reduced postoperative agitation without a prolonged recovery time.</AbstractText><AbstractText Label="TRAIL REGISTRATION">The study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR1800017273) on July 20, 2018.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Yanmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yushan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4246-7648</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China. lwu2019@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China. lwu2019@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR1800017273</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005336" MajorTopicYN="N">Fiber Optic Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="N">Premedication</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053120" MajorTopicYN="N">Respiratory Aspiration</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">Fiberoptic bronchoscopy</Keyword><Keyword MajorTopicYN="N">Foreign body</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31791239</ArticleId><ArticleId IdType="pmc">PMC6886218</ArticleId><ArticleId IdType="doi">10.1186/s12871-019-0892-6</ArticleId><ArticleId IdType="pii">10.1186/s12871-019-0892-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahajan JK, Rathod KK, Bawa M, Rao KL. Tracheobronchial foreign body aspirations: lessons learned from a 10-year audit. J Bronchol Interv Pulmonol. 2011;18:223&#x2013;228. doi: 10.1097/LBR.0b013e31822386a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/LBR.0b013e31822386a4</ArticleId><ArticleId IdType="pubmed">23208564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai J, Wu XY, Han N, Wang LY, Chen WM. A retrospective study of anesthesia during rigid bronchoscopy for airway foreign body removal in children: propofol and sevoflurane with spontaneous ventilation. Paediatr Anaesth. 2014;24:1031&#x2013;1036. doi: 10.1111/pan.12509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12509</ArticleId><ArticleId IdType="pubmed">25145573</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglis AF, Wagner DV. Lower complication rates associated with bronchial foreign bodies over the last 20 years. Ann Otol Rhinol Larygnol. 1992;101:61&#x2013;66. doi: 10.1177/000348949210100115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348949210100115</ArticleId><ArticleId IdType="pubmed">1728887</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell PT. Rigid bronchoscopy for foreign body removal: anaesthesia and ventilation. Paediatr Anaesth. 2004;14:84&#x2013;89. doi: 10.1046/j.1460-9592.2003.01194.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2003.01194.x</ArticleId><ArticleId IdType="pubmed">14717878</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson KL. Airway foreign bodies: what&#x2019;s new? Semin Respir Crit Care Med. 2004;25:405&#x2013;411. doi: 10.1055/s-2004-832713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2004-832713</ArticleId><ArticleId IdType="pubmed">16088484</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissberg D, Schwartz I. Foreign bodies in the tracheobronchial tree. Chest. 1987;91:730&#x2013;733. doi: 10.1378/chest.91.5.730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.91.5.730</ArticleId><ArticleId IdType="pubmed">3568776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Chhawchharia R. Flexible Fiberoptic bronchoscopy in pediatric practice. Indian Pediatr. 2019;56:578&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">31333214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal IS, Dhooria S, Ram B, Singh N, Aggarwal AN, Gupta D, Agarwal R, et al. Foreign body inhalation in the adult population: experience of 25,998 bronchoscopies and systematic review of literature. Respir Care. 2015;60:1438&#x2013;1448. doi: 10.4187/respcare.03976.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03976</ArticleId><ArticleId IdType="pubmed">25969517</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang W, Zhengxia P, Hongbo L, Yonggang L, Jiangtao D, Shengde W, et al. Diagnosis and treatment of tracheobronchial foreign bodies in 1024 children. J Pediatr Surg. 2012;47:2004&#x2013;2010. doi: 10.1016/j.jpedsurg.2012.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2012.07.036</ArticleId><ArticleId IdType="pubmed">23163990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheta SA, AI-Sarheed MA, Abdelhalim AA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth. 2014;24:181&#x2013;189. doi: 10.1111/pan.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12287</ArticleId><ArticleId IdType="pubmed">24237879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg. 2008;106:1715&#x2013;1721. doi: 10.1213/ane.0b013e31816c8929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31816c8929</ArticleId><ArticleId IdType="pubmed">18499600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao YS, Qian B, Chen YQ, Zhou LJ, Liu J. Intranasal dexmedetomidine premedication reduces the minimum alveolar concentration of sevoflurane for tracheal intubation in children: a randomized trial. J Clin Anesth. 2014;26:309&#x2013;314. doi: 10.1016/j.jclinane.2013.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2013.12.012</ArticleId><ArticleId IdType="pubmed">24875890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngwenyama NE, Anderson J, Hoernschemeyer DG, Tobias JD. Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr Anaesth. 2008;18:1190&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pubmed">19076573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2012;108:503&#x2013;511. doi: 10.1093/bja/aer400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer400</ArticleId><ArticleId IdType="pubmed">22174346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KZ, Ye M, Hu CB, Shen X. Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. Br J Anaesth. 2014;112:892&#x2013;897. doi: 10.1093/bja/aet490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet490</ArticleId><ArticleId IdType="pubmed">24554548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W, Ma G, Su QG, Fang Y, Gu BC, Zou XM. Dexmedetomidine versus midazolam for conscious sedation in postoperative patients undergoing flexible bronchoscopy: a randomized study. J Int Med Res. 2012;40:1371&#x2013;1380. doi: 10.1177/147323001204000415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147323001204000415</ArticleId><ArticleId IdType="pubmed">22971488</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JW, Balyan R, Dong M, Mahmoud M, Lam JE, Pratap JN, et al. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Br J Anaesth. 2018;120:1056&#x2013;1065. doi: 10.1016/j.bja.2018.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.01.035</ArticleId><ArticleId IdType="pubmed">29661383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen VM, Hui TW, Irwin MG, Yao T-J, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia. 2010;65:922&#x2013;929. doi: 10.1111/j.1365-2044.2010.06453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2010.06453.x</ArticleId><ArticleId IdType="pubmed">20645951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk T, Erbuyun K, Keles GT, Ozer M, Yuksel H. Tok Demet. The effect of remifentanil on the emergence characteristics of children undergoing FBO for bronchoalveolar lavage with sevoflurane anaesthesia. Eur J Anaesthesiol. 2009;26:338&#x2013;342. doi: 10.1097/EJA.0b013e32831de50d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32831de50d</ArticleId><ArticleId IdType="pubmed">19401665</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao R, Li JY, Liu GY. Comparison of sevoflurane volatile induction/maintenance anaesthesia and propofol-remifentanil total intravenous anaesthesia for rigid bronchoscopy under spontaneous breathing for tracheal/bronchial foreign body removal in children. Eur J Anaesthesiol. 2010;27:930&#x2013;934. doi: 10.1097/EJA.0b013e32833d69ad.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32833d69ad</ArticleId><ArticleId IdType="pubmed">20683333</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin. 2009;25:451&#x2013;469. doi: 10.1016/j.ccc.2009.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2009.04.004</ArticleId><ArticleId IdType="pubmed">19576524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787&#x2013;790. doi: 10.1097/00000542-200409000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200409000-00028</ArticleId><ArticleId IdType="pubmed">15329604</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand. 2005;49:1088&#x2013;1091. doi: 10.1111/j.1399-6576.2005.00780.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00780.x</ArticleId><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Eur J Anaesthesiol. 2008;25:816&#x2013;820. doi: 10.1017/S0265021508004201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0265021508004201</ArticleId><ArticleId IdType="pubmed">18400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Piastra M, Pizza A, Gaddi S, Luca E, Genovese O, Picconi E, et al. Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure. BMC Pediatr. 2018;18:282. doi: 10.1186/s12887-018-1256-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-018-1256-y</ArticleId><ArticleId IdType="pmc">PMC6109351</ArticleId><ArticleId IdType="pubmed">30144795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Kang K, Liu H, Jia L, Tang R, Yu K, et al. Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: a retrospective study. Medicine (Baltimore) 2017;96:e7090. doi: 10.1097/MD.0000000000007090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007090</ArticleId><ArticleId IdType="pmc">PMC5484192</ArticleId><ArticleId IdType="pubmed">28640084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Kanamaru A, Tsubone H, Nishimura R, Sasaki N. Respiratory reflexes in response to upper-airway administration of sevoflurane and isoflurane in anesthetized, spontaneously breathing dogs. Vet Surg. 2001;30:87&#x2013;96. doi: 10.1053/jvet.2001.20329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jvet.2001.20329</ArticleId><ArticleId IdType="pubmed">11172464</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurg J, Lechamy JB, Laudenbach V, Henzel D, Peytavin G, Desmonts JM. Anesthetics affect the uptake but not the depolarization-evoked release of GABA in rats striatal synaptosomes. Anesthesiology. 1995;82:502&#x2013;511. doi: 10.1097/00000542-199502000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199502000-00020</ArticleId><ArticleId IdType="pubmed">7856908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M, Kai Y, Ikemoto Y. Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology. 1994;81:988&#x2013;994. doi: 10.1097/00000542-199410000-00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199410000-00026</ArticleId><ArticleId IdType="pubmed">7943850</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth. 2005;94:821&#x2013;824. doi: 10.1093/bja/aei119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei119</ArticleId><ArticleId IdType="pubmed">15764627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud M, Radhakrishman R, Gunter J, Sadhasivam S, Schapiro A, McAuliffe J. Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children. Pediatr Anaesth. 2010;20:506&#x2013;515. doi: 10.1111/j.1460-9592.2010.03311.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03311.x</ArticleId><ArticleId IdType="pubmed">20412456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud M, Gunter J, Donnelly LF, Wang Y, Nick TD, Sadhasivam S. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg. 2009;109:745&#x2013;753. doi: 10.1213/ane.0b013e3181adc506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181adc506</ArticleId><ArticleId IdType="pubmed">19690241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95:461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">12145072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim NY, Kim SY, Yoon HJ, Kil HK. Effect of dexmedetomidine on sevoflurane requirements and emergence agitation in children undergoing ambulatory surgery. Yonsei Med J. 2014;55:209&#x2013;215. doi: 10.3349/ymj.2014.55.1.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2014.55.1.209</ArticleId><ArticleId IdType="pmc">PMC3874907</ArticleId><ArticleId IdType="pubmed">24339309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Act Anaesthesiol Scand. 2010;54:710&#x2013;716. doi: 10.1111/j.1399-6576.2009.02177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2009.02177.x</ArticleId><ArticleId IdType="pubmed">20003127</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Zoghbi JF, Zhu W, Grafe MR, Brambrink AM. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats. Br J Anaesth. 2017;119:506&#x2013;516. doi: 10.1093/bja/aex222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex222</ArticleId><ArticleId IdType="pubmed">28969317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009;110:1077&#x2013;1085. doi: 10.1097/ALN.0b013e31819daedd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31819daedd</ArticleId><ArticleId IdType="pubmed">19352168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xiong M, Nadavaluru PR, Zuo W, Ye JH, Eloy JD, et al. Dexmedetomidine attenuates neurotoxicity induced by prenatal propofol exposure. J Neurosurg Anesthesiol. 2016;28:51&#x2013;64. doi: 10.1097/ANA.0000000000000181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000181</ArticleId><ArticleId IdType="pubmed">25844953</ArticleId></ArticleIdList></Reference><Reference><Citation>Andropoulos DB. Effect of anesthesia on the developing brain: infant and fetus. Fetal Diagn Ther. 2018;43:1&#x2013;11. doi: 10.1159/000475928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000475928</ArticleId><ArticleId IdType="pubmed">28586779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26817181</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0125-2208</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</Title><ISOAbbreviation>J Med Assoc Thai</ISOAbbreviation></Journal><ArticleTitle>An Equivalence Trial Comparing Labetalol and Diltiazem in Controlling Emergence Hypertension after Supratentorial Tumor Surgery.</ArticleTitle><Pagination><StartPage>1104</StartPage><EndPage>1111</EndPage><MedlinePgn>1104-11</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypertension and tachycardia during emergence from anesthesia for craniotomy could increase risks of cerebral complications. Several anesthetic, sedative, and antihypertensive drugs have been suggested that may be successful at suppressing these unwanted hemodynamic consequences.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the equivalent efficacy and side effects of two antihypertensive drugs, diltiazem and labetalol.</AbstractText><AbstractText Label="MATERIAL AND METHOD" NlmCategory="METHODS">A block randomized control trial was performed in 184 patients who developed emergence hypertensive response after craniotomyfor supratentorial tumor removal. Systolic blood pressure (SBP) of each patient was suppressed by 2.5 mg of study drugs and repeated with fix dosage of 2.5 mg every two to three minutes to maintain SBP lower than 140 mmHg with a cumulative dose within 20 mg. Data regarding demographic, successful rate in controlling hypertension, drug dosage, and incidence of side effects were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The success rate of treatment of labetalol was equivalent to diltiazem (87.1% and 80.2% respectively) [p = 0.003, 95% CI = 6.88 (-2.06 to 15.8)]. There was no statistical significant difference on dosage of drugs used or incidence ofside effect (hypotension, bradycardia, heart block, and bronchospasm). Median (minimum-maximum) dosage of labetalol and diltiazem were 10 mg (2.5-20 mg) and 10 mg (2.5-20 mg) respectively. The expense for labetalol was 1/6 of diltiazem.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Labetalol has equivalent efficacy to diltiazem. Both drugs used low median dosage giving low incidence of side-effects. Labetalol is a good alternative drug to control hypertensive response during emergence from anesthesia for post-craniotomy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sirivanasandha</LastName><ForeName>Busara</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sakaew</LastName><ForeName>Arerat</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sutthivaiyakit</LastName><ForeName>Kulwadee</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Raksamani</LastName><ForeName>Kasana</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Waitayawinyu</LastName><ForeName>Pichaya</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Rushatamukayanunt</LastName><ForeName>Pranee</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Punkla</LastName><ForeName>Walaiporn</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Med Assoc Thai</MedlineTA><NlmUniqueID>7507216</NlmUniqueID><ISSNLinking>0125-2208</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EE92BBP03H</RegistryNumber><NameOfSubstance UI="D004110">Diltiazem</NameOfSubstance></Chemical><Chemical><RegistryNumber>R5H8897N95</RegistryNumber><NameOfSubstance UI="D007741">Labetalol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004110" MajorTopicYN="N">Diltiazem</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007741" MajorTopicYN="N">Labetalol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015173" MajorTopicYN="N">Supratentorial Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N">Thailand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26817181</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19854614</PMID><DateCompleted><Year>2010</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-0020</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of oral and maxillofacial surgery</Title><ISOAbbreviation>Int J Oral Maxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia in pediatric cleft lip and palate surgery: a randomized comparison study.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>9</EndPage><MedlinePgn>5-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijom.2009.09.007</ELocationID><Abstract><AbstractText>Careful choice of anesthetic agents in pediatric patients reduces the frequency of anesthesia-related complications. The frequency and type of intraoperative and postoperative complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia were compared in 140 consecutive children (aged 3 months to 10 years) undergoing cleft lip and palate repair. Midazolam-fentanyl anesthesia was induced with midazolam (0.05 mg/kg), fentanyl (0.005 mg/kg) and vecuronium (0.1mg/kg), and maintained with the same agents according to the defined parametars. Sevoflurane-fentanyl anesthesia was induced and maintained with sevoflurane (5-8 vol% and 0.8-1 vol%, respectively) in an oxygen/air mixture and supplemented with fentanyl (0.005 mg/kg). Both groups were comparable in basic demographic data, hemodynamic and respiratory parameters. Difficult intubation occurred in 6 of 76 children (midazolam-fentanyl group) and 4 of 64 children (sevoflurane-fentanyl group) (P=0.754). Ventricular extrasystole and bronchospasm occurred in one patient each in the sevoflurane-fentanyl group. Postoperatively, emergence agitation was observed in the sevoflurane-fentanyl group (17 cases; P&lt;0.001); postoperative nausea and vomiting occurred in 2 children (midazolam-fentanyl group) and 3 children (sevoflurane-fentanyl group) (P=0.660). Midazolam-based anesthesia in children is safer than sevoflurane-based anesthesia regarding occurrence of emergence agitation.</AbstractText><CopyrightInformation>Copyright 2009 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mili&#x107;</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Dubrava University Hospital, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goranovi&#x107;</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Knezevi&#x107;</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Int J Oral Maxillofac Surg</MedlineTA><NlmUniqueID>8605826</NlmUniqueID><ISSNLinking>0901-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019162">Anesthetics, Combined</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>7E4PHP5N1D</RegistryNumber><NameOfSubstance UI="D014673">Vecuronium Bromide</NameOfSubstance></Chemical><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber><NameOfSubstance UI="D008874">Midazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019162" MajorTopicYN="N">Anesthetics, Combined</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002971" MajorTopicYN="N">Cleft Lip</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002972" MajorTopicYN="N">Cleft Palate</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="N">Methyl Ethers</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="N">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011229" MajorTopicYN="N">Preanesthetic Medication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011595" MajorTopicYN="N">Psychomotor Agitation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014673" MajorTopicYN="N">Vecuronium Bromide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018879" MajorTopicYN="N">Ventricular Premature Complexes</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19854614</ArticleId><ArticleId IdType="doi">10.1016/j.ijom.2009.09.007</ArticleId><ArticleId IdType="pii">S0901-5027(09)01103-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34188527</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>Pressure-Controlled Volume-Guaranteed Ventilation Improves Respiratory Dynamics in Pediatric Patients During Laparoscopic Surgery: A Prospective Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2721</StartPage><EndPage>2728</EndPage><MedlinePgn>2721-2728</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S318008</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Pressure-controlled volume-guaranteed (PCV-VG) combines the characteristics of pressure-controlled ventilation (PCV) and volume-controlled ventilation (VCV). It has been reported that PCV-VG decreases airway pressure and improves oxygenation among the adult group. In this study, the respiratory dynamics of PCV-VG and VCV are compared in pediatric patients ventilated with laryngeal mask airway and underwent laparoscopic hernia of the sac ligation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Sixty-four pediatric patients were included in this prospective, randomized clinical trial. Pediatric patients were randomly allocated to receive VCV and PCV-VG ventilation during the general anesthesia. The hemodynamic and respiratory variables were recorded at the time when laryngeal mask airway was placed, pneumoperitoneum began, 5 mins after pneumoperitoneum began, pneumoperitoneum ended, and the operation ended respectively. The respiratory adverse events were recorded after the operation and on the first day after the operation. In this study, respiratory adverse events are defined as cough, hoarseness, hypoxemia, laryngospasm, bronchospasm, and sore throat.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistical difference in hemodynamic variables at all time points between the two groups. Compared to the VCV group, peak airway pressure (Ppeak) and plateau airway pressure in the PCV-VG group decreased significantly. Pulmonary dynamic compliance (Cydn) in the PCV-VG group was significantly higher than that in the VCV group. The respiratory adverse events appeared to have no statistical difference between VCV and PCV groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PCV-VG provides a lower Ppeak and better Cydn in pediatric patients compared with the VCV group during laparoscopic surgery. The results suggested that PCV-VG may be a superior way of mechanical ventilation for pediatric patients who ventilated with laryngeal mask airway and experienced laparoscopic surgery.</AbstractText><CopyrightInformation>&#xa9; 2021 Liu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuesheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Erwei</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3855-7627</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events</Keyword><Keyword MajorTopicYN="N">mechanical ventilation</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">pediatric intensive care</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34188527</ArticleId><ArticleId IdType="pmc">PMC8235931</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S318008</ArticleId><ArticleId IdType="pii">318008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Keidan I, Berkenstadt H, Segal E, et al. Pressure versus volume-controlled ventilation with a laryngeal mask airway in paediatric patients. Paediatr Anaesth. 2001;11:691&#x2013;694. doi:10.1046/j.1460-9592.2001.00746.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2001.00746.x</ArticleId><ArticleId IdType="pubmed">11696145</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Zhu H, Shi H, et al. Volume-targeted ventilation is more suitable than pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2014;99:F158&#x2013;165. doi:10.1136/archdischild-2013-304613</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2013-304613</ArticleId><ArticleId IdType="pubmed">24277660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Lee SK, Kim KM, et al. Comparison of volume-controlled ventilation mode and pressure-controlled ventilation with volume-guaranteed mode in the prone position during lumbar spine surgery. BMC Anesthesiol. 2019;19:133. doi:10.1186/s12871-019-0806-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0806-7</ArticleId><ArticleId IdType="pmc">PMC6661081</ArticleId><ArticleId IdType="pubmed">31351445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghabach MB, El Hajj EM, El Dib RD, et al. Ventilation of nonparalyzed patients under anesthesia with laryngeal mask airway, comparison of three modes of ventilation: volume controlled ventilation, pressure controlled ventilation, and pressure controlled ventilation-volume guarantee. Anesth Essays Res. 2017;11:197&#x2013;200. doi:10.4103/0259-1162.200238</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.200238</ArticleId><ArticleId IdType="pmc">PMC5341651</ArticleId><ArticleId IdType="pubmed">28298784</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalini G, Facchetti P, Dicembrini MA, et al. Pressure controlled versus volume controlled ventilation with laryngeal mask airway. J Clin Anesth. 2001;13:436&#x2013;439. doi:10.1016/S0952-8180(01)00297-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(01)00297-5</ArticleId><ArticleId IdType="pubmed">11578888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadi P, Guenoun T, Journois D, et al. Pressure-controlled ventilation improves oxygenation during laparoscopic obesity surgery compared with volume-controlled ventilation. Br J Anaesth. 2008;100:709&#x2013;716. doi:10.1093/bja/aen067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen067</ArticleId><ArticleId IdType="pubmed">18407943</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Casas JB, Montoya R. Difference in inspiratory flow between volume and pressure control ventilation in patients with flow dyssynchrony. J Crit Care. 2017;42:264&#x2013;267. doi:10.1016/j.jcrc.2017.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.08.007</ArticleId><ArticleId IdType="pubmed">28802791</ArticleId></ArticleIdList></Reference><Reference><Citation>Toker MK, Altiparmak B, Uysal AI, et al. [Comparison of pressure-controlled volume-guaranteed ventilation and volume-controlled ventilation in obese patients during gynecologic laparoscopic surgery in the Trendelenburg position]. Rev Bras Anestesiol. 2019;69:553&#x2013;560. (Portuguese). doi:10.1016/j.bjan.2019.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC9391862</ArticleId><ArticleId IdType="pubmed">31836201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari A, Baskaran D. Pressure-controlled volume guaranteed mode improves respiratory dynamics during laparoscopic cholecystectomy: a comparison with conventional modes. Anesth Essays Res. 2018;12:206&#x2013;212. doi:10.4103/aer.AER_96_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aer.AER_96_17</ArticleId><ArticleId IdType="pmc">PMC5872865</ArticleId><ArticleId IdType="pubmed">29628583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YS, Won YJ, Lee DK, et al. Lung ultrasound score-based perioperative assessment of pressure-controlled ventilation-volume guaranteed or volume-controlled ventilation in geriatrics: a prospective randomized controlled trial. Clin Interv Aging. 2019;14:1319&#x2013;1329. doi:10.2147/CIA.S212334</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S212334</ArticleId><ArticleId IdType="pmc">PMC6646045</ArticleId><ArticleId IdType="pubmed">31409981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Lee SK, Rhim CC, et al. Comparison of volume-controlled, pressure-controlled, and pressure-controlled volume-guaranteed ventilation during robot-assisted laparoscopic gynecologic surgery in the Trendelenburg position. Int J Med Sci. 2020;17:2728&#x2013;2734. doi:10.7150/ijms.49253</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.49253</ArticleId><ArticleId IdType="pmc">PMC7645327</ArticleId><ArticleId IdType="pubmed">33162800</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao W, Yang M, Cheng Q, et al. Effect of pressure-controlled ventilation-volume guaranteed on one-lung ventilation in elderly patients undergoing thoracotomy. Med Sci Monit. 2020;26:e921417. doi:10.12659/MSM.921417</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.921417</ArticleId><ArticleId IdType="pmc">PMC7058148</ArticleId><ArticleId IdType="pubmed">32092047</ArticleId></ArticleIdList></Reference><Reference><Citation>Song SY, Jung JY, Cho MS, et al. Volume-controlled versus pressure-controlled ventilation-volume guaranteed mode during one-lung ventilation. Korean J Anesthesiol. 2014;67:258&#x2013;263. doi:10.4097/kjae.2014.67.4.258</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2014.67.4.258</ArticleId><ArticleId IdType="pmc">PMC4216788</ArticleId><ArticleId IdType="pubmed">25368784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35413787</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1731-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Anaesthesiology intensive therapy</Title><ISOAbbreviation>Anaesthesiol Intensive Ther</ISOAbbreviation></Journal><ArticleTitle>Efficiency of laryngeal mask airway ProtectorTM and i-gel&#xae; as a conduit in Aintree catheter-guided fibreoptic tracheal intubation: a randomised clinical trial.</ArticleTitle><Pagination><StartPage>120</StartPage><EndPage>126</EndPage><MedlinePgn>120-126</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5114/ait.2022.115366</ELocationID><ELocationID EIdType="pii" ValidYN="Y">46842</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fibreoptic intubation through a supraglottic airway device (SAD) is recom-mended in difficult airway management algorithms. The Difficult Airway Society published a guideline describing the details of this technique in 2011. This study was designed to compare the efficiency of two different 2nd generation SADs as a conduit for Aintree catheter-guided fibreoptic tracheal intubation.</AbstractText><AbstractText Label="METHODS">80 adult patients with an ASA score of 1-3 undergoing elective surgical procedures were included in the study. The patients were intubated after randomization to two groups: the i-gel group and the laryngeal mask airway (LMA) Protector group. SAD insertion time and tracheal intubation time were recorded separately. Demographic data, changes in haemodynamic parameters during the procedure, and complications were noted.</AbstractText><AbstractText Label="RESULTS">In the LMA Protector and i-gel groups, the number of attempts (1.14 &#xb1; 0.35 vs. 1.24 &#xb1; 0.49 times, P = 0.394), device insertion time (14.89 &#xb1; 8.11 vs. 17.84 &#xb1; 16.59 seconds, P = 0.896), and the need for an optimization manoeuvre (43.2% vs. 37.8%, P = 0.813) were similar (P &gt; 0.05). The fibreoptic laryngeal appearance scale and haemodynamic parameters were similar (P &gt; 0.05). However, the airway complication rate was significantly higher in the LMA Protector group than in the i-gel group (21.6% vs. 2.7%, P = 0.013). The most common complications were bronchospasm and bloody secretion on SAD.</AbstractText><AbstractText Label="CONCLUSIONS">With the stable haemodynamic parameters, acceptable insertion time and lower complication rate, we concluded that the i-gel may be preferable in fibre-optic tracheal intubation. The rigid structure of the LMA Protector compared to the i-gel might contribute to this result.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Kartal Dr. L&#xfc;tfi K&#x131;rdar Research and Education Hospital, Health Sciences University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Ayse</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Derince Research and Education Hospital, Health Sciences University, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydas</LastName><ForeName>Asli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Derince Research and Education Hospital, Health Sciences University, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Derince Research and Education Hospital, Health Sciences University, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Anaesthesiol Intensive Ther</MedlineTA><NlmUniqueID>101472620</NlmUniqueID><ISSNLinking>1642-5758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005336" MajorTopicYN="N">Fiber Optic Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Protector LMA.</Keyword><Keyword MajorTopicYN="N">airway management</Keyword><Keyword MajorTopicYN="N">i-gel LMA</Keyword><Keyword MajorTopicYN="N">laryngeal masks</Keyword><Keyword MajorTopicYN="N">intubation</Keyword></KeywordList><CoiStatement>none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35413787</ArticleId><ArticleId IdType="pmc">PMC10156480</ArticleId><ArticleId IdType="doi">10.5114/ait.2022.115366</ArticleId><ArticleId IdType="pii">46842</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong P, Sng BL, Lim WY. Rescue supraglottic airway devices at caesa-rean delivery: what are the options to consider? Int J Obstet Anesth 2020; 42: 65-75. doi: 10.1016/j.ijoa.2019.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2019.11.004</ArticleId><ArticleId IdType="pubmed">31843342</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerk C, Mitchell VS, McNarry AF, et al. . Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 2015; 115: 827-848. doi: 10.1093/bja/aev371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev371</ArticleId><ArticleId IdType="pmc">PMC4650961</ArticleId><ArticleId IdType="pubmed">26556848</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs A, McGrath BA, Goddard C, et al. . Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth 2018; 120: 323-352. doi: 10.1016/j.bja.2017.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.10.021</ArticleId><ArticleId IdType="pubmed">29406182</ArticleId></ArticleIdList></Reference><Reference><Citation>https://das.uk.com/files/AIC_abbreviated_Guide_Final_for_DAS.pdf</Citation></Reference><Reference><Citation>Yildiz E, Saracoglu K, Saracoglu A, Sorbello M, Kizilay D, Kafali H. Performance of first and second generation supraglottic airway devices in patients with simulated difficult airway: a randomised controlled trial. Anaesthesiol Intensive Ther 2019; 51: 373-379. doi: 10.5114/ait.2019.91193.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2019.91193</ArticleId><ArticleId IdType="pubmed">31893603</ArticleId></ArticleIdList></Reference><Reference><Citation>Metterlein T, Dintenfelder A, Plank C, Graf B, Roth G. A comparison of various supraglottic airway devices for fiberoptical guided tracheal intubation. Braz J Anesthesiol 2017; 67: 166-171. doi: 10.1016/j.bjane.2015.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjane.2015.09.007</ArticleId><ArticleId IdType="pubmed">28236864</ArticleId></ArticleIdList></Reference><Reference><Citation>Saracoglu KT, Demir A, Pehlivan G, Saracoglu A, Eti Z. Analysing the efficacy of the I-gel supraglottic airway device in the supine and lateral decubitus positions. Anaesthesiol Intensive Ther 2018; 50: 259-262. doi: 10.5603/AIT.a2018.0028.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.a2018.0028</ArticleId><ArticleId IdType="pubmed">30221337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mich&#xe1;lek P, Donaldson W, McAleavey F, Abraham A, Mathers RJ, Telford C. The i-gel supraglottic airway as a conduit for fibreoptic tracheal intubation&#x2013;a randomized comparison with the single-use intubating laryngeal mask airway and CTrach laryngeal mask in patients with predicted difficult laryngoscopy. Prague Med Rep 2016; 117: 164-175. doi: 10.14712/23362936.2016.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.14712/23362936.2016.17</ArticleId><ArticleId IdType="pubmed">27930894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca C, Tourville CC, Jefferson H, Nowicka A, Patteril M, Athanassoglou V. Fibreoptic-guided tracheal intubation through i-gel&#xae; and LMA&#xae; ProtectorTM supraglottic airway devices&#x2013;a randomised comparison. Anaesthesia 2019; 74: 203-210. doi: 10.1111/anae.14475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14475</ArticleId><ArticleId IdType="pubmed">30467827</ArticleId></ArticleIdList></Reference><Reference><Citation>Theiler L, Gutzmann M, Kleine-Brueggeney M, Urwyler N, Kaempfen B, Greif R. i-gel&#x2122; supraglottic airway in clinical practice: a prospective observational multicentre study. Br J Anaesth 2012; 109: 990-995. doi: 10.1093/bja/aes309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes309</ArticleId><ArticleId IdType="pubmed">22956643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tham LY, Beh ZY, Shariffuddin II, Wang CY. Unilateral hypoglossal nerve palsy after the use of laryngeal mask airway (LMA) Protector. Korean J Anesthesiol 2019; 72: 606-609. doi: 10.4097/kja.d.18.00354.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.d.18.00354</ArticleId><ArticleId IdType="pmc">PMC6900420</ArticleId><ArticleId IdType="pubmed">31304693</ArticleId></ArticleIdList></Reference><Reference><Citation>Monem A, Khan FA. Laryngeal mask airway insertion anaesthesia and insertion techniques. J Pak Med Assoc 2007; 57: 607-611.</Citation><ArticleIdList><ArticleId IdType="pubmed">18173045</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C, Brimacombe JR, Keller K, Morris R. Comparison of four methods for assessing airway sealing pressure with the laryngeal mask airway in adult patients. Br J Anaesth 1999; 82: 286-287. doi: 10.1093/bja/82.2.286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/82.2.286</ArticleId><ArticleId IdType="pubmed">10365012</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimacombe J, Berry A. A proposed fiber-optic scoring system to standardize the assessment of laryngeal mask airway position. Anesth Analg 1993; 76: 457.</Citation><ArticleIdList><ArticleId IdType="pubmed">8424538</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A, Gregoire-Bertrand F, Massicotte N, et al. . I-gel versus LMA-Fastrach supraglottic airway for flexible bronchoscope-guided tracheal intubation using a Parker (GlideRite) endotracheal tube: a randomized controlled trial. Anesth Analg 2015; 121: 430-436. doi: 10.1213/ANE.0000000000000807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000807</ArticleId><ArticleId IdType="pubmed">26076387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleine-Brueggeney M, Theiler L, Urwyler N, Vogt A, Greif R. Randomized trial comparing the i-gel&#x2122; and Magill tracheal tube with the single-use ILMA&#x2122; and ILMA&#x2122; tracheal tube for fibreoptic-guided intubation in anaesthetized patients with a predicted difficult airway. Br J Anaesth 2011; 107: 251-257. doi: 10.1093/bja/aer103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer103</ArticleId><ArticleId IdType="pubmed">21652616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamgbade OA, Macnab WR, Khalaf WM. Evaluation of the i-gel airway in 300 patients. Eur J Anaesthesiol 2008; 25: 865-866. doi: 10.1017/S0265021508004511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0265021508004511</ArticleId><ArticleId IdType="pubmed">18534042</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert AAJ, Wyssusek KH, Pelecanos A, Roets M, Kumar CM. A prospective randomized comparison of airway seal using the novel vision-guided insertion of LMA-Supreme&#xae; and LMA-Protector&#xae;. J Clin Monit Comput 2020; 34: 285-294. doi: 10.1007/s10877-019-00301-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00301-3</ArticleId><ArticleId IdType="pubmed">30953222</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary N, Kumar A, Kohli A, Wadhawan S, Bhadoria P. I-Gel as an intubation conduit: Comparison of three different types of endotracheal tubes. Indian J Anaesth 2019; 63: 218-224. doi: 10.4103/ija.IJA_615_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_615_18</ArticleId><ArticleId IdType="pmc">PMC6423952</ArticleId><ArticleId IdType="pubmed">30988537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sng BL, Ithnin FB, Mathur D, Lew E, Han NR, Sia AT. A preliminary assessment of the LMA protector&#x2122; in non-paralysed patients. BMC Anesthesiol 2017; 17: 26. doi: 10.1186/s12871-017-0323-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0323-5</ArticleId><ArticleId IdType="pmc">PMC5319052</ArticleId><ArticleId IdType="pubmed">28219323</ArticleId></ArticleIdList></Reference><Reference><Citation>Landsdalen HE, Berge M, Kristensen F, Guttormsen AB, S&#xf8;fteland E. Continuous ventilation during intubation through a supraglottic airway device guided by fiberoptic bronchoscopy: a observational assessment. Acta Anaesthesiol Scand 2017; 61: 23-30. doi: 10.1111/aas.12824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12824</ArticleId><ArticleId IdType="pubmed">27808401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28108038</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>389</Volume><Issue>10070</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>701</StartPage><EndPage>708</EndPage><MedlinePgn>701-708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(16)31719-6</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(16)31719-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative respiratory adverse events (PRAE) are the most common critical incidents in paediatric anaesthesia and occur more often in infants. Use of laryngeal mask airways (LMAs) is associated with reduced PRAE compared with endotracheal tubes in older children (&gt;1 year). We aimed to evaluate the effect of these devices on the incidence of PRAE in infants.</AbstractText><AbstractText Label="METHODS">We did a randomised controlled trial at the Princess Margaret Hospital for Children in Perth (WA, Australia) by recruiting infants (aged 0-12 months) undergoing general (with or without regional or local) anaesthesia with anticipated fentanyl dose 1 &#x3bc;g/kg or lower for minor elective surgery. We excluded patients contraindicated for LMA or endotracheal tube; who had known cardiac disease or airway or thoracic malformations; who were receiving midazolam premedication; who were undergoing airway, thoracic, or abdomen surgery at the time of participation; and if the parents did not speak English. Written parental or guardian consent was obtained before enrolment. Participants were randomly assigned (1:1), by computer-generated variable block randomisation, to receive an LMA (PRO-Breathe, Well Lead Medical Co Ltd, Panyu, China) or an endotracheal tube (Microcuff, Halyard Health Inc, Atlanta, GA, USA). Sealed randomisation envelopes were used to conceal device assignment. An interim analysis was planned once half the number of infants needed (145) had been recruited. The primary outcome was incidence of PRAE, assessed in the intention-to-treat population. The institutional ethics committee at the Princess Margaret Hospital for Children granted ethical approval (1786/EP). The trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12610000250033).</AbstractText><AbstractText Label="FINDINGS">The trial began on July 8, 2010, and was ended early on May 7, 2015, after the interim analysis results met the study stopping rules. During this time, 239 infants were assessed and 181 eligible infants were randomly assigned to receive an LMA (n=85) or an endotracheal tube (n=95). Four infants were not included in the analysis (two due to cancelled procedures, one did not meet inclusion criteria, and one with missing dataset). In the intention-to-treat analysis, PRAE occurred in 50 (53%) infants in the endotracheal tube group and in 15 (18%) infants in the LMA group (risk ratio [RR] 2&#xb7;94, 95% CI 1&#xb7;79-4&#xb7;83, p&lt;0&#xb7;0001). Laryngospasm and bronchospasm (major PRAE) were recorded in 18 (19%) infants in the endotracheal tube group and in three (4%) infants in the LMA group (RR 5&#xb7;30, 95% CI 1&#xb7;62-17&#xb7;35, p=0&#xb7;002). No deaths were reported.</AbstractText><AbstractText Label="INTERPRETATION">In infants undergoing minor elective procedures, LMAs were associated with clinically significantly fewer PRAE and lower occurrence of major PRAE (laryngospasm and bronchospasm) than endotracheal tubes. This difference should be a consideration in airway device selection.</AbstractText><AbstractText Label="FUNDING">Princess Margaret Hospital Foundation, National Health and Australian Medical Research Council, Stan Perron Charitable Trust, and Callahan Estate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>Thomas F E</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramgolam</LastName><ForeName>Anoop</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guicheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, WA, Australia; School of Public Health, Curtin University, Perth, WA, Australia; Centre for Genetic Origins of Health and Disease, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Graham L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Centre of Child Health Research, University of Western Australia, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia; School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia. Electronic address: britta.regli-vonungern@health.wa.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2017 Feb 18;389(10070):673-674. doi: 10.1016/S0140-6736(17)30120-4.</RefSource><PMID Version="1">28108039</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28108038</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pii">S0140-6736(16)31719-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29108938</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>39</EndPage><MedlinePgn>29-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(17)30424-1</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(17)30424-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.</AbstractText><AbstractText Label="METHODS">In this double-blind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with cough, wheeze, or dyspnoea and less than 20% bronchodilator reversibility across 26 primary care centres and hospitals in the UK and Singapore. Patients were assessed for 2 weeks before being randomly assigned (1:1) to 4 weeks of treatment with extrafine inhaled corticosteroids (QVAR 80 &#x3bc;g, two puffs twice per day, equivalent to 800 &#x3bc;g per day beclomethasone dipropionate) or placebo. Randomisation was stratified by baseline FeNO measurement: normal (&#x2264;25 parts per billion [ppb]), intermediate (&gt;25 tp &lt;40 ppb), and high (&#x2265;40 ppb). The primary endpoint was change in Asthma Control Questionnaire (ACQ7) mean score. We used generalised linear modelling to assess FeNO as a predictor of response, estimating an interaction effect between FeNO and treatment on change in ACQ7. We did our primary and secondary analyses in the per-protocol set, which excluded patients with non-completion of the primary endpoint, non-compliance to treatment (ascertained by patient report), and study visits made outside the predefined visit windows. This study is registered on ClinicalTrials.gov, number NCT02294279.</AbstractText><AbstractText Label="FINDINGS">Between Feb 4, 2015, and July 12, 2016, we randomly assigned 294 patients to extrafine inhaled corticosteroid treatment (n=148) or placebo (n=146). Following exclusions due to protocol violations, we analysed 214 patients (114 extrafine inhaled corticosteroids and 100 placebo). We observed a significant interaction between baseline FeNO and treatment group for every 10 ppb increase in baseline FeNO, with the change in ACQ7 greater in the extrafine inhaled corticosteroids group than in the placebo group (difference between groups 0&#xb7;071, 95% CI 0&#xb7;002 to 0&#xb7;139; p=0&#xb7;044). The most common adverse events were nasopharyngitis (18 [12%] patients in the treatment group vs 13 [9%] in the placebo group), infections and infestations (25 [17%] vs 21 [14%]), and respiratory, thoracic, and mediastinal disorders (13 [9%] vs 17 [12%]).</AbstractText><AbstractText Label="INTERPRETATION">FeNO measurement is an easy and non-invasive tool to use in clinical practice in patients with non-specific respiratory symptoms to predict response to inhaled corticosteroids. Further research is needed to examine its role in patients with evidence of other airway diseases, such as chronic obstructive pulmonary disease.</AbstractText><AbstractText Label="FUNDING">Sponsored by OPRI with partial funding by Circassia and study drugs provided by TEVA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Price</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>University of Aberdeen, Aberdeen, UK; Observational &amp; Pragmatic Research Institute, Singapore. Electronic address: dprice@opri.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhl</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mainz University Hospital, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Daryl</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mundesley Medical Centre, Norfolk, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardener</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godley</LastName><ForeName>Clifford</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Avondale Medical Practice, Strathaven, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruffydd-Jones</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Box Surgery, Box, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGarvey</LastName><ForeName>Lorcan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Hospital Organization Tokyo National Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Dermot</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syk</LastName><ForeName>J&#xf6;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden; Uppsala University, Uppsala, Sweden; Academic Primary Health Care Centre, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ngiap Chuan</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>SingHealth Polyclinics, Singapore; Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>TzeLee</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konduru</LastName><ForeName>Priyanka Raju</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Optimum Patient Care, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngantcha</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Alcontres</LastName><ForeName>Martina Stagno</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapperre</LastName><ForeName>Therese S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>National University of Singapore, Singapore; Pulmonary Department, Bispebjerg Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02294279</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>KGZ1SLC28Z</RegistryNumber><NameOfSubstance UI="D001507">Beclomethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2018 Jan;6(1):3-5. doi: 10.1016/S2213-2600(17)30429-0.</RefSource><PMID Version="1">29108939</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="N">Anti-Asthmatic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001507" MajorTopicYN="N">Beclomethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045853" MajorTopicYN="N">Exhalation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29108938</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(17)30424-1</ArticleId><ArticleId IdType="pii">S2213-2600(17)30424-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24014230</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2013</Volume><Issue>9</Issue><PubDate><Year>2013</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Supraglottic airway devices versus tracheal intubation for airway management during general anaesthesia in obese patients.</ArticleTitle><Pagination><StartPage>CD010105</StartPage><MedlinePgn>CD010105</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD010105</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD010105.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The number of obese patients requiring general anaesthesia is likely to increase in coming years, and obese patients pose considerable challenges to the anaesthetic team. Tracheal intubation may be more difficult and risk of aspiration of gastric contents into the lungs is increased in obese patients. Supraglottic airway devices (SADs) offer an alternative airway to traditional tracheal intubation with potential benefits, including ease of fit and less airway disturbance. Although SADs are now widely used, clinical concerns remain that their use for airway management in obese patients may increase the risk of serious complications.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We wished to examine whether supraglottic airway devices can be used as a safe and effective alternative to tracheal intubation in securing the airway during general anaesthesia in obese patients (with a body mass index (BMI) &gt; 30 kg/m(2)).</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched for eligible trials in the following databases: Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 8, 2012), MEDLINE via Ovid (from 1985 to 9 September 2012) and EMBASE via Ovid (from 1985 to 9 September 2012). The Cochrane highly sensitive filter for randomized controlled trials was applied in MEDLINE and EMBASE. We also searched trial registers such as www.clinicaltrials.gov&#xa0;and the Current Controlled Clinical Trials Website (http://www.controlled-trials.com/) for ongoing trials. The start date of these searches was limited to 1985, shortly before the first SAD was introduced, in 1988. We undertook forward and backward citation tracing for key review articles and eligible articles identified through the electronic resources.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We considered all randomized controlled trials of participants aged 16 years and older with a BMI &gt; 30 kg/m(2) undergoing general anaesthesia. We compared the use of any model of SAD with the use of tracheal tubes (TTs) of any design.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">We used standard methodological procedures expected by The Cochrane Collaboration. Two review authors independently assessed trial quality and extracted data, including information on adverse events. We contacted study authors for additional information. If sufficient data were available, results were presented as pooled risk ratios (RRs) with 95% confidence intervals (CIs) based on random-effects models (inverse variance method). We employed the Chi(2) test and calculated the I(2) statistic to investigate study heterogeneity.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We identified two eligible studies, both comparing the use of one model of SAD, the ProSeal laryngeal mask airway (PLMA) with a TT, with a total study population of 232. One study population underwent laparoscopic surgery. The included studies were generally of high quality, but there was an unavoidable high risk of bias in the main airway variables, such as change of device or laryngospasm, as the intubator could not be blinded. Many outcomes included data from one study only.A total of 5/118 (4.2%) participants randomly assigned to PLMA across both studies were changed to TT insertion because of failed or unsatisfactory placement of the device. Postoperative episodes of hypoxaemia (oxygen saturation &lt; 92% whilst breathing air) were less common in the PLMA groups (RR 0.27, 95% CI 0.10 to 0.72). We found a significant postoperative difference in mean oxygen saturation, with saturation 2.54% higher in the PLMA group (95% CI 1.09% to 4.00%). This analysis showed high levels of heterogeneity between results (I(2) = 71%). The leak fraction was significantly higher in the PLMA group, with the largest difference seen during abdominal insufflation&#xff0d;a 6.4% increase in the PLMA group (95% CI 3.07% to 9.73%).No cases of pulmonary aspiration of gastric contents, mortality or serious respiratory complications were reported in either study. We are therefore unable to present effect estimates for these outcomes.In all, 2/118 participants with a PLMA suffered laryngospam or bronchospasm compared with 4/114 participants with a TT. The pooled estimate shows a non-significant reduction in laryngospasm in the PLMA group (RR 0.48, 95% CI 0.09 to 2.59).Postoperative coughing was less common in the PLMA group (RR 0.10, 95% CI 0.03 to 0.31), and there was no significant difference in the risk of sore throat or dysphonia (RR 0.25, 95% CI 0.03 to 2.13). On average, PLMA placement took 5.9 seconds longer than TT placement (95% CI 3 seconds to 8.8 seconds). There was no significant difference in the proportion of successful first placements of a device, with 33/35 (94.2%) first-time successes in the PLMA group and 32/35 (91.4%) in the TT group.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">We have inadequate information to draw conclusions about safety, and we can only comment on one design of SAD (the PLMA) in obese patients. We conclude that during routine and laparoscopic surgery, PLMAs may take a few seconds longer to insert, but this is unlikely to be a matter of clinical importance. A failure rate of 3% to 5% can be anticipated in obese patients. However, once fitted, PLMAs provide at least as good oxygenation, with the caveat that the leak fraction may increase, although in the included studies, this did not affect ventilation. We found significant improvement in oxygenation during and after surgery, indicating better pulmonary performance of the PLMA, and reduced postoperative coughing, suggesting better recovery for patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Health and Medicine, Furness Building, Lancaster University, Lancaster, UK, LA1 4YG.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Andrew F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Sharon R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10/4001/04</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD010105</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>From March to August 2011, AN worked for the Cardiff Research Consortium, which provides research and consultancy services to the pharmaceutical industry. The Cardiff Research Consortium has no connection with AN's work with The Cochrane Collaboration. AN&#x2019;s husband has small direct holdings in several drug and biotech companies as part of a wider balanced share portfolio. TMC was previously paid by Intavent Orthofix and the LMA company, several years ago, for lecturing. This company manufactures and distributes several supraglottic airway devices. His department has been given free or at cost airway equipment for evaluation or research from numerous airway companies. TMC has never had any financial involvement in any such company. All other authors: none known.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24014230</ArticleId><ArticleId IdType="pmc">PMC11180383</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD010105.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Carron 2012 {published and unpublished data}</Title><Reference><Citation>Carron M, Veronese S, Gomiero W, Foletto M, Nitti D, Ori C, et al. Hemodynamic and hormonal stress responses to endotracheal tube and ProSeal Laryngeal Mask Airway for laparoscopic gastric banding. Anesthesiology. 2012/05/23 2012; Vol. 117, issue 2:309&#x2010;20. [ISRCTN18342801]</Citation><ArticleIdList><ArticleId IdType="pubmed">22614132</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zoremba 2009 {published and unpublished data}</Title><Reference><Citation>Zoremba M, Aust H, Eberhart L, Braunecker S, Wulf H. Comparison between intubation and the laryngeal mask airway in moderately obese adults. Acta Anaesthesiologica Scandinavica 2009; Vol. 53, issue 4:436&#x2010;42. [19226293]</Citation><ArticleIdList><ArticleId IdType="pubmed">19226293</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Abdi 2010 {published data only}</Title><Reference><Citation>Abdi W, Amathieu R, Adhoum A, Poncelet C, Slavov V, Kamoun W, et al. Sparing the larynx during gynecological laparoscopy: a randomized trial comparing the LMA Supreme (TM) and the ETT. Acta Anaesthesiologica Scandinavica 2010; Vol. 54, issue 2:141&#x2010;6. [WOS:000273448700004]</Citation><ArticleIdList><ArticleId IdType="pubmed">19681772</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Arslan 2012 {published data only}</Title><Reference><Citation>Arslan ZI, Ozdamar D, Yildiz TS, Solak ZM, Toker K. Tracheal intubation in morbidly obese patients: a comparison of the Intubating Laryngeal Mask Airway and Laryngeal Mask Airway CTrach. Anaesthesia 2012;67(3):261&#x2010;5. [PUBMED: 22321082]</Citation><ArticleIdList><ArticleId IdType="pubmed">22321082</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Borkowski 2005 {published data only}</Title><Reference><Citation>Borkowski A, Perl T, Heuer J, Timmermann A, Braun U. The applicability of the ProSeal laryngeal mask airway for laparotomies. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 2005; Vol. 40, issue 8:477&#x2010;86. [WOS:000231183300005]</Citation><ArticleIdList><ArticleId IdType="pubmed">16078158</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dhonneur 2006 {published data only}</Title><Reference><Citation>Dhonneur G, Ndoko SK, Yavchitz A, Foucrier A, Fessenmeyer C, Pollian C, et al. Tracheal intubation of morbidly obese patients: LMA CTrach vs direct laryngoscopy. British Journal of Anaesthesia 2006;97(5):742&#x2010;5. [PUBMED: 16997840]</Citation><ArticleIdList><ArticleId IdType="pubmed">16997840</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hohlrieder 2007 {published data only}</Title><Reference><Citation>Hohlrieder M, Brimacombe J, Eschertzhuber S, Ulmer H, Keller C. A study of airway management using the ProSeal LMA laryngeal mask airway compared with the tracheal tube on postoperative analgesia requirements following gynaecological laparoscopic surgery. Anaesthesia. 2007/08/19 2007; Vol. 62, issue 9:913&#x2010;8. [ NCT00402870]</Citation><ArticleIdList><ArticleId IdType="pubmed">17697218</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khazin 2008 {published data only}</Title><Reference><Citation>Khazin V, Ezri T, Yishai R, Sessler DI, Serour F, Szmuk P, et al. Gastroesophageal regurgitation during anesthesia and controlled ventilation with six airway devices. Journal of Clinical Anesthesia 2008; Vol. 20, issue 7:508&#x2010;13. [WOS:000261708800005]</Citation><ArticleIdList><ArticleId IdType="pubmed">19019665</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Larsson 2009 {published data only}</Title><Reference><Citation>Larsson A. LMA: a big choice. Acta Anaesthesiol Scand. 2009/03/26 2009; Vol. 53, issue 4:421&#x2010;2. [19317859]</Citation><ArticleIdList><ArticleId IdType="pubmed">19317859</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2013 {published data only}</Title><Reference><Citation>Li RP, Xue FS, Cheng Y, Liao X. Comparative performance of GlideScope((R)) videolaryngoscope and Fastrach intubation laryngeal mask airway in the morbidly obese patients. Acta Anaesthesiologica Scandinavica 2013; Vol. 57, issue 2:262&#x2010;3. [PUBMED: 22998074]</Citation><ArticleIdList><ArticleId IdType="pubmed">22998074</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lim 2007 {published data only}</Title><Reference><Citation>Lim Y, Goel S, Brimacombe JR. The ProSeal (TM) laryngeal mask airway is an effective alternative to laryngoscope&#x2010;guided tracheal intubation for gynaecological laparoscopy. Anaesthesia and Intensive Care 2007; Vol. 35, issue 1:52&#x2010;6. [WOS:000245610100009]</Citation><ArticleIdList><ArticleId IdType="pubmed">17323666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Maltby 2002 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Maltby JR, Beriault MT, Watson NC, Liepert D, Fick GH. The LMA&#x2010;ProSeal is an effective alternative to tracheal intubation for laparoscopic cholecystectomy. Canadian Journal of Anaesthesia 2002; Vol. 49, issue 8:857&#x2010;62. [12374716]</Citation><ArticleIdList><ArticleId IdType="pubmed">12374716</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Maltby 2003 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Maltby JR, Beriault MT, Watson NC, Liepert DJ, Fick GH. LMA&#x2010;Classic and LMA&#x2010;ProSeal are effective alternatives to endotracheal intubation for gynecologic laparoscopy. Canadian Journal of Anaesthesia 2003; Vol. 50, issue 1:71&#x2010;7. [12514155]</Citation><ArticleIdList><ArticleId IdType="pubmed">12514155</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mann 2012 {published data only}</Title><Reference><Citation>Mann V, Mann STW, Rupp D, Rohrig R, Weigand MA, Muller M. Influence of head position and neuromuscular block on the clinical efficacy of supraglottic airway devices. A prospective randomized study to compare the laryngeal tube suction (LT(TM)) with the ProSeal((TM)) laryngeal mask. Notfall and Rettungsmedizin 2012; Vol. 15, issue 2:136&#x2010;41. [WOS:000304153300007]</Citation></Reference></ReferenceList><ReferenceList><Title>Miller 2006 {published data only}</Title><Reference><Citation>Miller DM, Camporota L. Advantages of ProSeal (TM) and SLIPA (TM) airways over tracheal tubes for gynecological laparoscopies. Canadian Journal of Anaesthesia&#x2010;Journal Canadien D Anesthesie 2006; Vol. 53, issue 2:188&#x2010;93. [WOS:000234952200014]</Citation><ArticleIdList><ArticleId IdType="pubmed">16434761</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Olsen 2012 {unpublished data only}</Title><Reference><Citation>Olsen KS. Laryngeal mask or endotracheal tube for back surgery in the prone position. http://clinicaltrials.gov/show/NCT01041352. 2012.</Citation></Reference></ReferenceList><ReferenceList><Title>Uppal 2009 {published data only}</Title><Reference><Citation>Uppal V, Fletcher G, Kinsella J. Comparison of the i&#x2010;gel with the cuffed tracheal tube during pressure&#x2010;controlled ventilation. British Journal of Anaesthesia 2009; Vol. 102, issue 2:264&#x2010;8. [WOS:000262518400018]</Citation><ArticleIdList><ArticleId IdType="pubmed">19151051</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weber 2011 {published data only}</Title><Reference><Citation>Weber U, Oguz R, Potura LA, Kimberger O, Kober A, Tschernko E. Comparison of the i&#x2010;gel and the LMA&#x2010;Unique laryngeal mask airway in patients with mild to moderate obesity during elective short&#x2010;term surgery. Anaesthesia 2011; Vol. 66, issue 6:481&#x2010;7. [21568982]</Citation><ArticleIdList><ArticleId IdType="pubmed">21568982</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ydemann 2012 {published data only}</Title><Reference><Citation>Ydemann M, Rovsing L, Lindekaer AL, Olsen KS. Intubation of the morbidly obese patient: GlideScope((R)) vs. Fastrach. Acta anaesthesiologica Scandinavica 2012;56(6):755&#x2010;61. [PUBMED: 22524487]</Citation><ArticleIdList><ArticleId IdType="pubmed">22524487</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Adams 2000</Title><Reference><Citation>Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. British Journal of Anaesthesia 2000;85(1):91&#x2010;108. [PUBMED: 10927998]</Citation><ArticleIdList><ArticleId IdType="pubmed">10927998</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bernardini 2009</Title><Reference><Citation>Bernardini A, Natalini G. Risk of pulmonary aspiration with laryngeal mask airway and tracheal tube: analysis on 65 712 procedures with positive pressure ventilation. Anaesthesia 2009;64(12):1289&#x2010;94. [PUBMED: 19860753]</Citation><ArticleIdList><ArticleId IdType="pubmed">19860753</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brain 1985</Title><Reference><Citation>Brain AI, McGhee TD, McAteer EJ, Thomas A, Abu&#x2010;Saad MA, Bushman JA. The laryngeal mask airway. Development and preliminary trials of a new type of airway. Anaesthesia. 1985/04/01 1985; Vol. 40, issue 4:356&#x2010;61. [PUBMED: 4003736]</Citation><ArticleIdList><ArticleId IdType="pubmed">4003736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brain 2000</Title><Reference><Citation>Brain AI, Verghese C, Strube PJ. The LMA 'ProSeal'&#xff0d;a laryngeal mask with an oesophageal vent. British Journal of Anaesthesia. 2000/06/09 2000; Vol. 84, issue 5:650&#x2010;4. [PUBMED: 10844848]</Citation><ArticleIdList><ArticleId IdType="pubmed">10844848</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 1995</Title><Reference><Citation>Brimacombe J. The advantages of the LMA over the tracheal tube or facemask: a meta&#x2010;analysis (Structured abstract). Canadian Journal of Anesthesia 1995; Vol. 42, issue 11:1017&#x2010;23. [CENTRAL: DARE&#x2010;11995003157]</Citation><ArticleIdList><ArticleId IdType="pubmed">8590490</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brimacombe 1995a</Title><Reference><Citation>Brimacombe JR, Berry A. The incidence of aspiration associated with the laryngeal mask airway: a meta&#x2010;analysis of published literature. Journal of Clinical Anesthesia 1995; Vol. 7, issue 4:297&#x2010;305. [PUBMED: 7546756]</Citation><ArticleIdList><ArticleId IdType="pubmed">7546756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 2005</Title><Reference><Citation>Cook TM, Lee G, Nolan JP. The ProSeal laryngeal mask airway: a review of the literature. Canadian Journal of Anaesthesia. 2005/08/17 2005; Vol. 52, issue 7:739&#x2010;60. [PUBMED: 16103390]</Citation><ArticleIdList><ArticleId IdType="pubmed">16103390</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 2007</Title><Reference><Citation>Cook TM, Gibbison B. Analysis of 1000 consecutive uses of the ProSeal laryngeal mask airway by one anaesthetist at a district general hospital. British Journal of Anaesthesia 2007;99(3):436&#x2010;9. [PUBMED: 17604305]</Citation><ArticleIdList><ArticleId IdType="pubmed">17604305</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 2011</Title><Reference><Citation>Cook TM, Howes B. Supraglottic airway devices: recent advances. Continuing Education in Anaesthesia, Critical Care and Pain 2011; Vol. 11, issue 2:56&#x2010;61.</Citation></Reference></ReferenceList><ReferenceList><Title>Cook 2011a</Title><Reference><Citation>Cook TM, Woodall N, Frerk C. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: anaesthesia. British Journal of Anaesthesia. 2011/03/31 2011; Vol. 106, issue 5:617&#x2010;31. [PUBMED: 21447488]</Citation><ArticleIdList><ArticleId IdType="pubmed">21447488</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Frappier 2003</Title><Reference><Citation>Frappier J, Guenoun T, Journois D, Philippe H, Aka E, Cadi P, et al. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesthesia and Analgesia. 2003/04/23 2003; Vol. 96, issue 5:1510&#x2010;5, table of contents. [12707159]</Citation><ArticleIdList><ArticleId IdType="pubmed">12707159</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goldmann 2011</Title><Reference><Citation>Goldmann K, Gerlach M, Borntrager C. [ProSealTM laryngeal mask in normal weight and obese patients: oxygenation under pressure&#x2010;controlled ventilation and different end&#x2010;expiratory pressures]. Anaesthesist 2011; Vol. 60, issue 10:908&#x2010;15. [21796447]</Citation><ArticleIdList><ArticleId IdType="pubmed">21796447</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck&#x2010;Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ. 2008/05/06 2008; Vol. 336, issue 7651:995&#x2010;8. [PUBMED: 18456631]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011] . The Cochrane Collaboration, 2011. www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Hohlrieder 2007a</Title><Reference><Citation>Hohlrieder M, Brimacombe J, Goedecke A, Keller C. Postoperative nausea, vomiting, airway morbidity, and analgesic requirements are lower for the ProSeal laryngeal mask airway than the tracheal tube in females undergoing breast and gynaecological surgery. British Journal of Anaesthesia. 2007/07/10 2007; Vol. 99, issue 4:576&#x2010;80. [17617554]</Citation><ArticleIdList><ArticleId IdType="pubmed">17617554</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Juvin 2003</Title><Reference><Citation>Juvin P, Lavaut E, Dupont H, Lefevre P, Demetriou M, Dumoulin JL, et al. Difficult tracheal intubation is more common in obese than in lean patients. Anesthesia and Analgesia. 2003/07/23 2003; Vol. 97, issue 2:595&#x2010;600, table of contents. [PUBMED: 12873960]</Citation><ArticleIdList><ArticleId IdType="pubmed">12873960</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Karkouti 2000</Title><Reference><Citation>Karkouti K, Rose DK, Wigglesworth D, Cohen MM. Predicting difficult intubation: a multivariable analysis. Canadian Journal of Anaesthesia. 2000/08/25 2000; Vol. 47, issue 8:730&#x2010;9. [PUBMED: 10958088]</Citation><ArticleIdList><ArticleId IdType="pubmed">10958088</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kelly 2008</Title><Reference><Citation>Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity (2005) 2008;32(9):1431&#x2010;7. [PUBMED: 18607383]</Citation><ArticleIdList><ArticleId IdType="pubmed">18607383</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kristensen 2010</Title><Reference><Citation>Kristensen MS. Airway management and morbid obesity. European Journal of Anaesthesiology. 2010/08/07 2010; Vol. 27, issue 11:923&#x2010;7. [20689440]</Citation><ArticleIdList><ArticleId IdType="pubmed">20689440</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lundstrom 2009</Title><Reference><Citation>Lundstrom LH, Moller AM, Rosenstock C, Astrup G, Wetterslev J. High body mass index is a weak predictor for difficult and failed tracheal intubation: a cohort study of 91,332 consecutive patients scheduled for direct laryngoscopy registered in the Danish Anesthesia Database. Anesthesiology. 2009/02/06 2009; Vol. 110, issue 2:266&#x2010;74. [PUBMED: 19194154]</Citation><ArticleIdList><ArticleId IdType="pubmed">19194154</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Malhotra 2008</Title><Reference><Citation>Malhotra A, Hillman D. Obesity and the lung: 3. Obesity, respiration and intensive care. Thorax 2008;63(10):925&#x2010;31. [PUBMED: 18820119]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711075</ArticleId><ArticleId IdType="pubmed">18820119</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marley 2005</Title><Reference><Citation>Marley RA, Hoyle B, Ries C. Perianesthesia respiratory care of the bariatric patient. Journal of Perianesthesia Nursing 2005;20(6):404&#x2010;31; quiz 432&#x2010;4. [PUBMED: 16387272]</Citation><ArticleIdList><ArticleId IdType="pubmed">16387272</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Natalini 2002</Title><Reference><Citation>Natalini G, Franceschetti ME, Pletti C, Recupero D, Lanza G, Bernardini A. Impact of laryngeal mask airway and tracheal tube on pulmonary function during the early postoperative period. Acta Anaesthesiologica Scandinavica 2002;46(5):525&#x2010;8. [PUBMED: 12027846]</Citation><ArticleIdList><ArticleId IdType="pubmed">12027846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Natalini 2003</Title><Reference><Citation>Natalini G, Franceschetti ME, Pantelidi MT, Rosano A, Lanza G, Bernardini A. Comparison of the standard laryngeal mask airway and the ProSeal laryngeal mask airway in obese patients. British Journal of Anaesthesia 2003; Vol. 90, issue 3:323&#x2010;6. [12594145]</Citation><ArticleIdList><ArticleId IdType="pubmed">12594145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>OECD 2010</Title><Reference><Citation>Obesity and the economics of prevention: Fit not fat. http://www.oecd.org/health/healthpoliciesanddata/obesityandtheeconomicsofpreventionfitnotfat.htm (accessed 9 October 2012)..</Citation></Reference></ReferenceList><ReferenceList><Title>OECD 2012</Title><Reference><Citation>OECD. Obesity update. http://www.oecd.org/health/49716427.pdf (accessed 22 May 2013).</Citation></Reference></ReferenceList><ReferenceList><Title>Piper 2004</Title><Reference><Citation>Piper SN, Triem JG, Rohm KD, Maleck WH, Schollhorn TAH, Boldt J. ProSeal (TM) laryngeal mask versus endotracheal intubation in patients undergoing gynaecologic laparoscopy (Retracted article. See vol. 46, pg. 490, 2011). Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 2004; Vol. 39, issue 3:132&#x2010;7. [WOS:000220327200003]</Citation><ArticleIdList><ArticleId IdType="pubmed">15042502</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qamarul 2011</Title><Reference><Citation>Qamarul Hoda M, Samad K, Ullah H. ProSeal versus classic laryngeal mask airway (LMA) for positive pressure ventilation in adult patients undergoing elective surgery. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD009026]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009026</ArticleId><ArticleId IdType="pmc">PMC6483343</ArticleId><ArticleId IdType="pubmed">28727896</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RevMan 5.2 [Computer program]</Title><Reference><Citation>The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.</Citation></Reference></ReferenceList><ReferenceList><Title>Tanaka 2003</Title><Reference><Citation>Tanaka A, Isono S, Ishikawa T, Sato J, Nishino T. Laryngeal resistance before and after minor surgery: endotracheal tube versus laryngeal mask airway. Anesthesiology 2003;99(2):252&#x2010;8. [PUBMED: 12883396]</Citation><ArticleIdList><ArticleId IdType="pubmed">12883396</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Verghese 1996</Title><Reference><Citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesthesia and Analgesia 1996; Vol. 82, issue 1:129&#x2010;33. [PUBMED: 8712387]</Citation><ArticleIdList><ArticleId IdType="pubmed">8712387</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Voyagis 1996</Title><Reference><Citation>Voyagis GS, Photakis D, Kellari A, Kostanti E, Kaklis S, Secha&#x2010;Dousaitou PN, et al. The laryngeal mask airway: a survey of its usage in 1,096 patients. Minerva Anestesiologica 1996;62(9):277&#x2010;80. [PUBMED: 9038036]</Citation><ArticleIdList><ArticleId IdType="pubmed">9038036</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>WHO 2012</Title><Reference><Citation>World Health Organisation. 10 facts on obesity. http://www.who.int/features/factfiles/obesity/facts/en/index1.html. Accessed on 2 September 2013.</Citation></Reference></ReferenceList><ReferenceList><Title>Woodall 2011</Title><Reference><Citation>Woodall NM, Cook TM. National census of airway management techniques used for anaesthesia in the UK: first phase of the Fourth National Audit Project at the Royal College of Anaesthetists. British Journal of Anaesthesia 2011; Vol. 106, issue 2:266&#x2010;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">21131655</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yu 2010</Title><Reference><Citation>Yu SH, Beirne OR. Laryngeal mask airways have a lower risk of airway complications compared with endotracheal intubation: a systematic review (Structured abstract). Journal of Oral and Maxillofacial Surgery 2010; Vol. 68, issue 10:2359&#x2010;76. [CENTRAL: DARE&#x2010;12010007389]</Citation><ArticleIdList><ArticleId IdType="pubmed">20674126</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2009</Title><Reference><Citation>Zhang YJ, Liu XZ, Liu B. Proseal laryngeal mask airway versus endotracheal tubes for intraoperative airway management during laparoscopic biliary tract surgery: a systematic review (Provisional abstract). Chinese Journal of Evidence&#x2010;Based Medicine 2009; Vol. 9, issue 5:552&#x2010;7. [CENTRAL: DARE&#x2010;12009105697]</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Nicholson 2012</Title><Reference><Citation>Nicholson A, Cook TM, Lewis SR, Reed SS, Smith AF. Supraglottic airway devices versus tracheal intubation for airway management during general anaesthesia in obese patients. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010105]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010105</ArticleId><ArticleId IdType="pmc">PMC11180383</ArticleId><ArticleId IdType="pubmed">24014230</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27594440</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study.</ArticleTitle><Pagination><StartPage>902</StartPage><EndPage>910</EndPage><MedlinePgn>902-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(16)30223-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(16)30223-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Antimicrobial resistance is a serious threat to public health, with most antibiotics prescribed in primary care. General practitioners (GPs) report defensive antibiotic prescribing to mitigate perceived risk of future hospital admission in children with respiratory tract infections. We developed a clinical rule aimed to reduce clinical uncertainty by stratifying risk of future hospital admission.</AbstractText><AbstractText Label="METHODS">8394 children aged between 3 months and 16 years presenting with acute cough (for &#x2264;28 days) and respiratory tract infection were recruited to a prognostic cohort study from 247 general practitioner practices in England. Exposure variables included demographic characteristics, parent-reported symptoms, and physical examination signs. The outcome was hospital admission for respiratory tract infection within 30 days, collected using a structured, blinded review of medical records.</AbstractText><AbstractText Label="FINDINGS">8394 (100%) children were included in the analysis, with 78 (0&#xb7;9%, 95% CI 0&#xb7;7%-1&#xb7;2%) admitted to hospital: 15 (19%) were admitted on the day of recruitment (day 1), 33 (42%) on days 2-7; and 30 (39%) on days 8-30. Seven characteristics were independently associated (p&lt;0&#xb7;01) with hospital admission: age &lt;2 years, current asthma, illness duration of 3 days or less, parent-reported moderate or severe vomiting in the previous 24 h, parent-reported severe fever in the previous 24 h or a body temperature of 37&#xb7;8&#xb0;C or more at presentation, clinician-reported intercostal or subcostal recession, and clinician-reported wheeze on auscultation. The area under the receiver operating characteristic (AUROC) curve for the coefficient-based clinical rule was 0&#xb7;82 (95% CI 0&#xb7;77-0&#xb7;87, bootstrap validated 0&#xb7;81). Assigning one point per characteristic, a points-based clinical rule consisting of short illness, temperature, age, recession, wheeze, asthma, and vomiting (mnemonic STARWAVe; AUROC 0&#xb7;81, 0&#xb7;76-0&#xb7;85) distinguished three hospital admission risk strata: very low (0&#xb7;3%, 0&#xb7;2-0&#xb7;4%) with 1 point or less, normal (1&#xb7;5%, 1&#xb7;0-1&#xb7;9%) with 2 or 3 points, and high (11&#xb7;8%, 7&#xb7;3-16&#xb7;2%) with 4 points or more.</AbstractText><AbstractText Label="INTERPRETATION">Clinical characteristics can distinguish children at very low, normal, and high risk of future hospital admission for respiratory tract infection and could be used to reduce antibiotic prescriptions in primary care for children at very low risk.</AbstractText><AbstractText Label="FUNDING">National Institute for Health Research (NIHR).</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK. Electronic address: alastair.hay@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond</LastName><ForeName>Niamh M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, Saint Mary's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovering</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muir</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Specialist Virology Centre, Public Health Laboratory Bristol, Public Health England, Myrtle Road, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeming</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vipond</LastName><ForeName>Barry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Specialist Virology Centre, Public Health Laboratory Bristol, Public Health England, Myrtle Road, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Tim J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CDF-2009-02-10</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR-RP-02-12-012</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0608-10018</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2016 Nov;4(11):850-852. doi: 10.1016/S2213-2600(16)30272-7.</RefSource><PMID Version="1">27594439</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27594440</ArticleId><ArticleId IdType="pmc">PMC5080970</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(16)30223-5</ArticleId><ArticleId IdType="pii">S2213-2600(16)30223-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Department of Health  UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>The White House Washington  National Strategy for Combating Antibiotic Resistant Bacteria. http://www.cdc.gov/drugresistance/pdf/carb_national_strategy.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>WHO  Antimicrobial resistance: Global Report on Surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>NHS England  The NHS Atlas of Variation in Healthcare: reducing unwarranted variation to increase value and improve quality. http://www.rightcare.nhs.uk/atlas/RC_nhsAtlas3_HIGH_150915.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Public Health England  English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/362374/ESPAUR_Report_2014__3_.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483949</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research  About antimicrobial resistance. http://www.themedcalls.nihr.ac.uk/amr/about-antimicrobial-resistance (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Okkes M, Oskam SK, HL The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract. 2002;51:31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Heron J, Ness A, the ALSPAC study team The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study. Fam Pract. 2005;22:367&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">15897210</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ. 1998;317:637&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28658</ArticleId><ArticleId IdType="pubmed">9727992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral C, Lucas PJ, Ingram J, Hay AD, Horwood J. &#x201c;It's safer to &#x2026;&#x201d; parent consulting and clinician antibiotic prescribing decisions for children with respiratory tract infections: an analysis across four qualitative studies. Soc Sci Med. 2015;136&#x2013;137:156&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">26004209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas PJ, Cabral C, Hay AD, Horwood J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015;33:11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377734</ArticleId><ArticleId IdType="pubmed">25716427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003;326:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140007</ArticleId><ArticleId IdType="pubmed">12531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study. Br J Gen Pract. 2016;66:e207&#x2013;e213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758501</ArticleId><ArticleId IdType="pubmed">26852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Davies R, Christensen H. The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Services Rese. 2013;13:322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765099</ArticleId><ArticleId IdType="pubmed">23958109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Birnie K, Busby J. The diagnosis of urinary tract infections in young children (DUTY): a diagnostic and prospective observational study to derive and validate a clinical algorithm for the diagnosis of UTI in children presenting to primary care with an acute illness. Health Technol Assess. 2016;20:1&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4958930</ArticleId><ArticleId IdType="pubmed">27401902</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Fahey T, Peters TJ, Wilson A. Predicting complications from a acute cough in pre-school children in primary care: a prospective cohort study. Br J Gen Pract. 2004;54:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1314771</ArticleId><ArticleId IdType="pubmed">14965400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20:696&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">14701895</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Kengne AP, Woodward M. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pubmed">22397945</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. BMJ. 2000;320:1174&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27359</ArticleId><ArticleId IdType="pubmed">10784539</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackway-Jones K, Molyneux E, Phillips B, Wieteska S. Advanced paediatric life support&#x2014;the practical approach. 4 edn. Blackwell Publishing Ltd; Oxford: 2005.</Citation></Reference><Reference><Citation>NICE  Feverish illness in children. Assessment and initial management in children younger than 5 years. https://www.nice.org.uk/guidance/cg47?unlid=335701897201612317341 (accessed Aug 19, 2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad M. English Indices of Deprivation 2010. Department for Communities and Local Government; London: 2010.</Citation></Reference><Reference><Citation>Steyerberg EW, Harrell FE, Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470385</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Census statistical bulletin: population and household estimates for Wales. March 2011. http://www.ons.gov.uk/ons/rel/census/2011-census/population-and-household-estimates-for-wales/stb-2011-census-wales.html (accessed Oct 6, 2013).</Citation></Reference><Reference><Citation>Office for National Statistics . Integrated Household Survey April 2011 to March 2012: Experimental Statistics. Her Majesty's Stationary Office (HMSO); London: 2012.</Citation></Reference><Reference><Citation>Oostenbrink R, Thompson M, Lakhanpaul M. Children with fever and cough at emergency care: diagnostic accuracy of a clinical model to identify children at low risk of pneumonia. Eur J Emerg Med. 2013;20:273&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">22868746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward G, Thompson M, Hay AD. What factors influence prognosis in children with acute cough and respiratory tract infection in primary care? BMJ. 2012;345:e6212.</Citation><ArticleIdList><ArticleId IdType="pubmed">22996938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182981</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocks N, Fahey T. Labelling of acute respiratory illness: evidence of between-practitioner variation in the UK. Fam Pract. 2002;19:375&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110558</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharek PJ, Horbar JD, Mason W. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006;118:1332&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Fahey T, Peters TJ, Wilson AD. Predicting complications from acute cough in pre-school children in primary care: a prospective cohort study. Br J Gen Pract. 2004;54:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1314771</ArticleId><ArticleId IdType="pubmed">14965400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Gorst C, Montgomery A, Peters TJ, Fahey T. Validation of a clinical rule to predict complications of acute cough in preschool children: a prospective study in primary care. Br J Gen Pract. 2007;57:530&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2099635</ArticleId><ArticleId IdType="pubmed">17727745</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D, European Research Network on Recognising Serious Infection investigators Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375:834&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">20132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Aertgeerts B, Bruyninckx R, Aerts M, Buntinx F. Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract. 2007;57:538&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2099636</ArticleId><ArticleId IdType="pubmed">17727746</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Johnson AM, Islam A, Duckworth G, Livermore DM, Hayward AC. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ. 2007;335:982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2072032</ArticleId><ArticleId IdType="pubmed">17947744</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Care and Health Excellence  Respiratory tract infections: prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. https://www.nice.org.uk/guidance/CG69 (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Finkelstein JA, Davis RL, Dowell SF. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11433046</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Care and Health Excellence  Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. https://www.nice.org.uk/Guidance/NG15 (accessed Aug 19, 2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210248</ArticleId><ArticleId IdType="pubmed">34222900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Van Staa T, Dregan A. Electronic health records for intervention research: a cluster randomized trial to reduce antibiotic prescribing in primary care (eCRT Study) Ann Fam Med. 2014;12:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096472</ArticleId><ArticleId IdType="pubmed">25024243</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Vodicka T, Cohen H. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898587</ArticleId><ArticleId IdType="pubmed">24335668</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001;322:336&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26576</ArticleId><ArticleId IdType="pubmed">11159657</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Moore MV, Turner S. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010;340:c199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2817051</ArticleId><ArticleId IdType="pubmed">20139214</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Stuart B, Hobbs FD. Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. BMJ. 2013;347:f6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898431</ArticleId><ArticleId IdType="pubmed">24277339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18931209</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2008</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>5</Issue><PubDate><Year>2008</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A prospective, randomized comparison of cobra perilaryngeal airway and laryngeal mask airway unique in pediatric patients.</ArticleTitle><Pagination><StartPage>1523</StartPage><EndPage>1530</EndPage><MedlinePgn>1523-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ane.0b013e3181852617</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Cobra Perilaryngeal Airway (PLA) provides better sealing pressure than the Laryngeal Mask Airway Unique (LMAU) during positive-pressure ventilation in adults. We compared the performance of the CobraPLA and LMAU in infants and children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two-hundred pediatric patients were randomly assigned to a CobraPLA or an Laryngeal Mask Airway (LMA). We measured airway sealing at cuff inflation pressures of 40 and 60 cm H2O; ease and time of insertion; device stability; efficacy of ventilation; number of insertion attempts; incidence of postoperative sore throat, dysphonia, laryngospasm, bronchospasm, and gastric gas insufflation. Steady-state end-tidal(CO2) was measured at the head of the CobraPLA and at the "Y-piece" piece of the anesthetic circuit. For the major outcomes, the airway groups were subdivided post hoc into small and large CobraPLA and small and large LMA subgroups. Results are presented as means +/- sds; P &lt; 0.05 was considered statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Airway sealing pressure with the cuff inflated to 60 cm H2O in the large CobraPLA subgroup (22 +/- 7 cm H2O) was significantly more than that of the small CobraPLA subgroup (18 +/- 5 cm H2O) and large LMA subgroup (16 +/- 5 cm H2O; P &lt; 0.001). The CobraPLA was more stable than the LMA (same anatomic fit score before and after surgery) and produced less gastric insufflation. Head CobraPLA end-tidal(CO2) values were 6.4 +/- 6 mm Hg more than those of the Y piece of the circle circuit.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The CobraPLA airway performed as well as the LMAU during anesthesia in pediatric patients for a large range of outcomes and was superior for some.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szmuk</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Texas Southwestern Medical School and Children's Medical Center at Dallas, 1935, B3304, Motor St., Dallas, TX 75235, USA. peter.szmuk@utsouthwestern.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghelber</LastName><ForeName>Oscar</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Matuszczak</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rabb</LastName><ForeName>Marry F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Ezri</LastName><ForeName>Tiberiu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18931209</ArticleId><ArticleId IdType="doi">10.1213/ane.0b013e3181852617</ArticleId><ArticleId IdType="pii">107/5/1523</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26994025</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2715</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>198</Issue><PubDate><Year>2015</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>JNMA; journal of the Nepal Medical Association</Title><ISOAbbreviation>JNMA J Nepal Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Adverse Events in Children Receiving General Anaesthesia with Laryngeal Mask Airway Insertion.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>82</EndPage><MedlinePgn>77-82</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Perioperative adverse events are more common in children compared to adult population. Reporting an adverse event proves effective in identifying problems and helps in prevention and early management. Our objective was to identify the types, incidence, and the time of occurrence of perioperative adverse event. We also aimed to find out whether the occurrence of the types of adverse events differ in children below and above five years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective study in 242, ASA Physical Status I and II children aged day one to 14 years, receiving general anesthesia with laryngeal mask airway for various elective surgeries. Adverse events observed in the perioperative period were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adverse events related to respiratory system (n=26, 55%) were the most common followed by cardiovascular system (n= 14, 30%). Adverse events were observed in 24(10%) children in the operating room and in 20 (8%) children in the post anaesthesia care unit. In the operating room, majority (14 of 27, 52%) of the events occurred immediately after removal of laryngeal mask airway. Respiratory events were more common in children below five years (p=0.007), whereas cardiac events were more common in children above five years (p=0.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The commonest adverse event in children is related to respiratory system. Adverse events occur more frequently in the operating room, mostly immediately after removal of laryngeal mask airway. Respiratory events are more frequent in children below five years whereas cardiac events are more frequent in children above five years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khatiwada</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattarai</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokharel</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subedi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Nepal</Country><MedlineTA>JNMA J Nepal Med Assoc</MedlineTA><NlmUniqueID>0045233</NlmUniqueID><ISSNLinking>0028-2715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009390" MajorTopicYN="N">Nepal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events; children; laryngeal mask airway; laryngospasm; perioperative.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26994025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40269708</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Effect of passive tobacco smoke on the incidence of respiratory adverse events in female patients undergoing general anesthesia- a cohort study.</ArticleTitle><Pagination><StartPage>203</StartPage><MedlinePgn>203</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">203</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-025-03069-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Passive smoking is linked to increased respiratory adverse events (AEs) during general anesthesia (GA). This study aims to assess whether females exposed to passive tobacco smoke undergoing GA, experience a higher incidence of perioperative respiratory AEs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-center prospective cohort study was conducted from July 2021 to July 2022, at a University Hospital. After approval from the ethical review committee, 150 female patients receiving GA for elective surgeries requiring endotracheal intubation were included and classified into Passive Smoking Exposure (PSE) and Non-Passive Smoking Exposure (NPSE) groups. Data on respiratory adverse events (AEs) including laryngospasm, bronchospasm, breath holding, desaturation, hypersecretion, coughing, wheezing, and stridor during the perioperative period was collected using a proforma. Statistical analysis was performed using RStudio with Chi-square, Fisher's exact test, and Mann-Whitney U test to determine significance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 150 female participants, 75 were included in the PSE and 75 in the NPSE groups. The PSE group had an overall statistically significant incidence of respiratory AEs compared to the NPSE group (69.3 vs. 16.0%, p&#x2009;&lt;&#x2009;0.001). Hypersecretion (50.7% vs. 4%) and desaturation (38.7% vs. 6.7%) intraoperatively and desaturation (14.7% vs. 1.3%) and cough (10.7% vs. 0% ) in the post-anesthesia care unit (PACU) were significantly more common in the PSE group (p&#x2009;&lt;&#x2009;0.001). At 12&#xa0;h postoperatively, 56% of the PSE group had respiratory issues versus 32% in the NPSE group (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Passive smokers had a significantly higher incidence of perioperative respiratory AEs with GA, necessitating the need for preoperative strategies to address passive smoke exposure.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanif</LastName><ForeName>Maryyam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, The Aga Khan University, Stadium Road, PO Box 3500, Karachi, Pakistan. maryam.khattak@rocketmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismail</LastName><ForeName>Samina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, The Aga Khan University, Stadium Road, PO Box 3500, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014028" MajorTopicYN="Y">Tobacco Smoke Pollution</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="Y">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Laryngospasm</Keyword><Keyword MajorTopicYN="N">Passive smoking</Keyword><Keyword MajorTopicYN="N">Women</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Ethical approval was obtained from the Ethics Research Committee of The Aga Khan University and Hospital (Approval no 2020-3672-14238). A written informed consent was taken from all the enrolled participants. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40269708</ArticleId><ArticleId IdType="pmc">PMC12016089</ArticleId><ArticleId IdType="doi">10.1186/s12871-025-03069-z</ArticleId><ArticleId IdType="pii">10.1186/s12871-025-03069-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soleimani F, Dobaradaran S, De-la-Torre GE, Schmidt TC, Saeedi R. Content of toxic components of cigarette, cigarette smoke vs cigarette butts: A comprehensive systematic review. Sci Total Environ. 2022;813:152667.</Citation><ArticleIdList><ArticleId IdType="pubmed">34963586</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek E, Karaman Y, Gonullu M, Tekgul Z, Cakmak M. The effect of passive exposure to tobacco smoke on perioperative respiratory complications and the duration of recovery. Rev Bras Anestesiol. 2016;66:492&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27432528</ArticleId></ArticleIdList></Reference><Reference><Citation>Erhan &#xd6;L, &#x130;leri A, Bulut OK, &#xd6;zer AB. Passive smoking also affects recovery from anaesthesia. Turk J Anaesthesiol Reanim. 2017;45:242&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5579222</ArticleId><ArticleId IdType="pubmed">28868176</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nasser B. Influence of tobacco smoking on perioperative risk of venous thromboembolism. Turk J Anaesthesiol Reanim. 2020;48(1):11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001800</ArticleId><ArticleId IdType="pubmed">32076674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Han W, Jiang J, Liu B, Wu Y, Zou X, et al. Passive smoking and stroke in men and women: a National population-based case-control study in China. Sci Rep. 2017;7(1):45542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5374519</ArticleId><ArticleId IdType="pubmed">28361935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Yang S, He Y, Liu M, Wang Y, Wang J, et al. Association between passive smoking and hypertension in Chinese non-smoking elderly women. Hypertens Res. 2017;40(4):399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">27928149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair F, Husnain MI, Zhao T, Ahmad H, Khanam R. A gender-specific assessment of tobacco use risk factors: evidence from the latest Pakistan demographic and health survey. BMC Public Health. 2022;22(1):1133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9172179</ArticleId><ArticleId IdType="pubmed">35668426</ArticleId></ArticleIdList></Reference><Reference><Citation>Saqib MA, Rafique I, Qureshi H, Munir MA, Bashir R, Arif BW, Bhatti K, Ahmed SA, Bhatti L. Burden of tobacco in Pakistan: findings from global adult tobacco survey 2014. Nicotine Tob Res. 2018;20(9):1138&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">29059338</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiswell C, Akram Y. Impact of environmental tobacco smoke exposure on anaesthetic and surgical outcomes in children: a systematic review and meta-analysis. Arch Dis Child. 2017;102(2):123&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5284464</ArticleId><ArticleId IdType="pubmed">27417307</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;t&#xfc;nc&#xfc; A, Dilmen O, Utku T, Erbabacan E, Ekici B, K&#xf6;ksal G, et al. The effects of passive smoking on COHb, PaO2 and PaCO2 levels and postoperative respiratory complications in children undergoing general anesthesia. Turk Arch Ped. 2012;47:204&#x2013;9.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19329013</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation.</ArticleTitle><Pagination><StartPage>103</StartPage><EndPage>107</EndPage><MedlinePgn>103-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2008.06.028</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether oropharyngeal instillation of lidocaine after anesthetic induction modifies the hemodynamic response to intubation.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, randomized, double-blind, placebo-controlled study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Operating room of a university hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">56 ASA physical status I and II adult patients scheduled for elective surgery requiring orotracheal intubation and general anesthesia.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomized to receive oropharyngeal instillation with either 5 mL 2% lidocaine (n = 28, lidocaine group) or 5 mL normal saline (n = 28, control group) 45 seconds after anesthetic induction bolus. Orotracheal intubation was attempted three minutes later.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Systolic (SBP), diastolic (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded at baseline, just before intubation, and for three minutes postintubation at one-minute intervals. Occurrence of adverse events such as arrhythmias, ischemic changes in electrocardiography, and bronchospasm after intubation were also documented.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">All postintubation values of SBP, DBP, MAP, and HR were significantly lower in the lidocaine group than the control group (P &lt; 0.01). In both groups, postintubation HRs were significantly higher than baseline values (P &lt; 0.05). More patients (P &lt; 0.001) became hypertensive postintubation in the control group (14/28, 50%) than the lidocaine group (2/28, 7%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Oropharyngeal instillation of lidocaine for three minutes before intubation attenuates the cardiovascular responses to intubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hsiao-Lun</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Cathay General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tzong-Jeng</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chen-Chuan</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Chih-Cheng</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chi-Cheng</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Chie</LastName><ForeName>Wei-Chu</ForeName><Initials>WC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="Y">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="Y">Lidocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009960" MajorTopicYN="Y">Oropharynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19329013</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2008.06.028</ArticleId><ArticleId IdType="pii">S0952-8180(09)00016-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29258438</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Supreme&#x2122; laryngeal mask airway use in general Anesthesia for category 2 and 3 Cesarean delivery: a prospective cohort study.</ArticleTitle><Pagination><StartPage>169</StartPage><MedlinePgn>169</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-017-0460-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Supreme&#x2122; laryngeal mask airway (SLMA) is a single-use LMA with double lumen design that allows separation of the respiratory and the alimentary tract, hence potentially reducing the gastric volume and risk of aspiration. The purpose of this prospective cohort study is to evaluate the the role of the SLMA as an airway technique for women undergoing category 2 and 3 Cesarean delivery under general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We recruited 584 parturients who underwent category 2 or 3 Cesarean delivery under general anesthesia, in which 193 parturients underwent category 2 and 391 parturients underwent category 3 Cesarean delivery. The primary outcome was insertion success rate at 1st attempt in SLMA insertion. The secondary outcomes included anaesthetic, obstetric outcomes and maternal side effects associated with airway device.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 1st attempt insertion success rate was 98.3%, while the overall insertion success rate was 100%. The mean (Standard deviation) time to effective ventilation was 15.6 (4.4) seconds. Orogastric tube insertion was successful at the 1st attempt in all parturients. There was no clinical evidence of aspiration or regurgitation. No episodes of hypoxemia, laryngospasm or bronchospasm were observed intra-operatively. The incidence of complications was low and with good maternal satisfaction reported.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The SLMA could be an alternative effective airway in category 2 and 3 parturients emergency Cesarean Delivery under general anesthesia in a carefully-selected obstetric population.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinical Trials Registration: Clinicaltrials.gov Registration NCT02026882 . Registered on December 31, 2013.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yang</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Quanzhou Macare Women's Hospital, Department of Anesthesiology and Perioperative Medicine, Quanzhou, 362000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Wei Yu</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Quanzhou Macare Women's Hospital, Department of Anesthesiology and Perioperative Medicine, Quanzhou, 362000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yong Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Qinghai University Affiliated Hospital, Xining, Qinghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>Wen Shu</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Nian-Lin Reena</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Division of Clinical Support Services, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultana</LastName><ForeName>Rehena</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assam</LastName><ForeName>Pryseley N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Singapore Clinical Research Institute, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sia</LastName><ForeName>Alex Tiong-Heng</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sng</LastName><ForeName>Ban Leong</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0001-5374-4271</Identifier><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. sng.ban.leong@singhealth.com.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. sng.ban.leong@singhealth.com.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02026882</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Emergency Cesarean section</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Supreme&#x2122; laryngeal mask</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by Institutional Review Board at the Quanzhou Women&#x2019;s and Children&#x2019;s Hospital in China. The study was registered with the hospital ethics committee (dated 11th Nov 2013). All patients signed a written informed consent before enrolment. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29258438</ArticleId><ArticleId IdType="pmc">PMC5735892</ArticleId><ArticleId IdType="doi">10.1186/s12871-017-0460-x</ArticleId><ArticleId IdType="pii">10.1186/s12871-017-0460-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper GM, JH MC. Maternal deaths from anaesthesia. An extract from why mothers die 2000-2002, the confidential enquiries into maternal deaths in the United Kingdom: chapter 9: anaesthesia. Br J Anaesth. 2005;94(4):417&#x2013;423. doi: 10.1093/bja/aei066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei066</ArticleId><ArticleId IdType="pubmed">15758081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhyre JM, Riesner MN, Polley LS, Naughton NN. A series of anesthesia-related maternal deaths in Michigan, 1985-2003. Anesthesiology. 2007;106(6):1096&#x2013;1104. doi: 10.1097/01.anes.0000267592.34626.6b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000267592.34626.6b</ArticleId><ArticleId IdType="pubmed">17525583</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnardo PD, Jenkins JG. Failed tracheal intubation in obstetrics: a 6-year review in a UK region. Anaesthesia. 2000;55(7):690&#x2013;694. doi: 10.1046/j.1365-2044.2000.01536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2000.01536.x</ArticleId><ArticleId IdType="pubmed">10919428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawthorne L, Wilson R, Lyons G, Dresner M. Failed intubation revisited: 17-yr experience in a teaching maternity unit. Br J Anaesth. 1996;76(5):680&#x2013;684. doi: 10.1093/bja/76.5.680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/76.5.680</ArticleId><ArticleId IdType="pubmed">8688269</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn AC, Milne D, Columb M, Gorton H, Knight M. Failed tracheal intubation in obstetric anaesthesia: 2 yr national case-control study in the UK. Br J Anaesth. 2013;110(1):74&#x2013;80. doi: 10.1093/bja/aes320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes320</ArticleId><ArticleId IdType="pubmed">22986421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman K, Jenkins JG. Failed tracheal intubation in obstetrics: no more frequent but still managed badly. Anaesthesia. 2005;60(2):168&#x2013;171. doi: 10.1111/j.1365-2044.2004.04069.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2004.04069.x</ArticleId><ArticleId IdType="pubmed">15644015</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimacombe J. Analysis of 1500 laryngeal mask uses by one anaesthetist in adults undergoing routine anaesthesia. Anaesthesia. 1996;51(1):76&#x2013;80. doi: 10.1111/j.1365-2044.1996.tb07660.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1996.tb07660.x</ArticleId><ArticleId IdType="pubmed">8669573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, Lee G, Nolan JP. The ProSeal laryngeal mask airway: a review of the literature. Can J Anaesth. 2005;52(7):739&#x2013;760. doi: 10.1007/BF03016565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03016565</ArticleId><ArticleId IdType="pubmed">16103390</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996;82(1):129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">8712387</ArticleId></ArticleIdList></Reference><Reference><Citation>Awan R, Nolan JP, Cook TM. Use of a ProSeal laryngeal mask airway for airway maintenance during emergency caesarean section after failed tracheal intubation. Br J Anaesth. 2004;92(1):144&#x2013;146. doi: 10.1093/bja/aeh019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeh019</ArticleId><ArticleId IdType="pubmed">14665568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, Brooks TS, Van der Westhuizen J, Clarke M. The Proseal LMA is a useful rescue device during failed rapid sequence intubation: two additional cases. Can J Anaesth. 2005;52(6):630&#x2013;633. doi: 10.1007/BF03015775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03015775</ArticleId><ArticleId IdType="pubmed">15983151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasham FM, Andrews PJ, Juneja MM, Ackerman WE., 3rd The laryngeal mask airway facilitates intubation at cesarean section. A case report of difficult intubation. Int J Obstet Anesth. 1993;2(3):181&#x2013;182. doi: 10.1016/0959-289X(93)90014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0959-289X(93)90014-9</ArticleId><ArticleId IdType="pubmed">15636882</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma B, Sahai C, Sood J, Kumra VP. The ProSeal laryngeal mask airway in two failed obstetric tracheal intubation scenarios. Int J Obstet Anesth. 2006;15(4):338&#x2013;339. doi: 10.1016/j.ijoa.2006.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2006.04.010</ArticleId><ArticleId IdType="pubmed">16945516</ArticleId></ArticleIdList></Reference><Reference><Citation>Halaseh BK, Sukkar ZF, Hassan LH, Sia AT, Bushnaq WA, Adarbeh H. The use of ProSeal laryngeal mask airway in caesarean section--experience in 3000 cases. Anaesth Intensive Care. 2010;38(6):1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong DT, Yang JJ, Jagannathan N. Brief review: the LMA supreme supraglottic airway. Can J Anaesth. 2012;59(5):483&#x2013;493. doi: 10.1007/s12630-012-9673-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9673-0</ArticleId><ArticleId IdType="pubmed">22318376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao WY, Li SY, Sng BL, Lim Y, Sia AT. The LMA supreme in 700 parturients undergoing Cesarean delivery: an observational study. Can J Anaesth. 2012;59(7):648&#x2013;654. doi: 10.1007/s12630-012-9718-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9718-4</ArticleId><ArticleId IdType="pubmed">22556005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, et al. Urgency of caesarean section: a new classification. J R Soc Med. 2000;93(7):346&#x2013;350. doi: 10.1177/014107680009300703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107680009300703</ArticleId><ArticleId IdType="pmc">PMC1298057</ArticleId><ArticleId IdType="pubmed">10928020</ArticleId></ArticleIdList></Reference><Reference><Citation>Han TH, Brimacombe J, Lee EJ, Yang HS. The laryngeal mask airway is effective (and probably safe) in selected healthy parturients for elective Cesarean section: a prospective study of 1067 cases. Can J Anaesth. 2001;48(11):1117&#x2013;1121. doi: 10.1007/BF03020379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03020379</ArticleId><ArticleId IdType="pubmed">11744589</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge ET, Nicholas SD, Newton JR, Temple JG. Gastro-oesophageal reflux in pregnancy. Altered function of the barrier to reflux in asymptomatic women during early pregnancy. Scand J Gastroenterol. 1984;19(1):85&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">6538697</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the progression of Gastroesophageal reflux disease study. J Gastroenterol Hepatol. 2007;22(11):1728&#x2013;1731. doi: 10.1111/j.1440-1746.2006.04549.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2006.04549.x</ArticleId><ArticleId IdType="pubmed">17914941</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RB, Shirley MA. Reducing the risk of acid aspiration during cesarean section. Anesth Analg. 1974;53(6):859&#x2013;868. doi: 10.1213/00000539-197453060-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-197453060-00010</ArticleId><ArticleId IdType="pubmed">4473928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercker S, Schmidbauer W, Volk T, Bogusch G, Bubser HP, Hensel M, et al. A comparison of seal in seven supraglottic airway devices using a cadaver model of elevated esophageal pressure. Anesth Analg. 2008;106(2):445&#x2013;448. doi: 10.1213/ane.0b013e3181602ae1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181602ae1</ArticleId><ArticleId IdType="pubmed">18227299</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans NR, Gardner SV, James MF. ProSeal laryngeal mask protects against aspiration of fluid in the pharynx. Br J Anaesth. 2002;88(4):584&#x2013;587. doi: 10.1093/bja/88.4.584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/88.4.584</ArticleId><ArticleId IdType="pubmed">12066738</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C, Brimacombe J, Kleinsasser A, Loeckinger A. Does the ProSeal laryngeal mask airway prevent aspiration of regurgitated fluid? Anesth Analg. 2000;91(4):1017&#x2013;1020. doi: 10.1097/00000539-200010000-00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200010000-00046</ArticleId><ArticleId IdType="pubmed">11004067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y, Goel S, Brimacombe JR. The ProSeal laryngeal mask airway is an effective alternative to laryngoscope-guided tracheal intubation for gynaecological laparoscopy. Anaesth Intensive Care. 2007;35(1):52&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17323666</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer W, Bercker S, Volk T, Bogusch G, Mager G, Kerner T. Oesophageal seal of the novel supralaryngeal airway device I-gel in comparison with the laryngeal mask airways classic and ProSeal using a cadaver model. Br J Anaesth. 2009;102(1):135&#x2013;139. doi: 10.1093/bja/aen319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen319</ArticleId><ArticleId IdType="pubmed">19011262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191&#x2013;205. doi: 10.1016/S0002-9378(16)39829-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9378(16)39829-5</ArticleId><ArticleId IdType="pubmed">20993766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushambi MC, Kinsella SM, Popat M, Swales H, Ramaswamy KK, Winton AL, Quinn AC. Obstetric Anaesthetists' Association and difficult airway society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia. 2015;70(11):1286&#x2013;1306. doi: 10.1111/anae.13260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.13260</ArticleId><ArticleId IdType="pmc">PMC4606761</ArticleId><ArticleId IdType="pubmed">26449292</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini S, Ahuja S, Guleria K. To evaluate the use of ProSeal laryngeal mask airway in patients undergoing elective lower segment Cesarean section under general anesthesia: a prospective randomized controlled study. J Obstet Anaesth Crit Care. 2016;6:11&#x2013;15. doi: 10.4103/2249-4472.181059.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2249-4472.181059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33092957</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7533</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</Title><ISOAbbreviation>Surg Obes Relat Dis</ISOAbbreviation></Journal><ArticleTitle>The use of intraoperative bedside lung ultrasound in optimizing positive end expiratory pressure in obese patients undergoing laparoscopic bariatric surgeries.</ArticleTitle><Pagination><StartPage>372</StartPage><EndPage>378</EndPage><MedlinePgn>372-378</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.soard.2020.09.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1550-7289(20)30553-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anesthetic management of patients with obesity undergoing laparoscopic abdominal surgeries requires careful plan for intraoperative mechanical ventilation aiming to avoid lung atelectasis and/or overdistention. There are conflicting data on the optimum positive end expiratory pressure (PEEP) during these surgeries. We hypothesized that lung ultrasound could be used for PEEP titration during laparoscopic surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study is to evaluate the effectiveness of intraoperative individualized lung ultrasound-guided PEEP in obese patients undergoing laparoscopic bariatric surgery on intraoperative partial arterial oxygen tension (PaO<sub>2</sub>) and early postoperative pulmonary complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A randomized controlled trial included 40 adult patients with body mass index (BMI) &gt; 35 kg/m<sup>2</sup> undergoing laparoscopic bariatric surgery. Patients were randomized into: control group (n&#xa0;= 20) who received PEEP 4 cm.H<sub>2</sub> O and ultrasound-guided group (n = 20) who received individualized lung ultrasound stepwise PEEP. All patients received volume-controlled ventilation with a tidal volume of 6 mL/kg of ideal weight and a fraction of inspired oxygen of .5. The primary outcome was the difference in partial arterial oxygen tension (PaO<sub>2</sub>) between the control group and the ultrasound-guided group. The secondary outcomes included the incidence of early postoperative pulmonary atelectasis, respiratory failure, bronchospasm, hypoxia or pneumothorax.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">General surgery operating theatre at Cairo University hospitals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ultrasound-guided group showed higher PO<sub>2</sub> after PEEP optimization and postoperatively compared with control group (P = .005, and P = .01 respectively). Also, ultrasound-guided group showed no postoperative complications compared with control group that had 5 cases who developed postoperative pulmonary complications in the form of hypoxia and basal collapse in the first 24 hour postoperatively chest x ray (0% versus 25%, P = .047).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with obesity undergoing laparoscopic bariatric surgery, the use of lung&#xa0;ultrasound individualized stepwise PEEP approach improved oxygenation, compliance and reduced the incidence of postoperative pulmonary atelectasis and hypoxia without causing hemodynamic&#xa0;instability.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elshazly</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical ICU, and Pain Management, Cairo University, Cairo, Egypt. Electronic address: dr.mohamed.elshazly8686@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khair</LastName><ForeName>Tamer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical ICU, and Pain Management, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassem</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical ICU, and Pain Management, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansour</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical ICU, and Pain Management, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Obes Relat Dis</MedlineTA><NlmUniqueID>101233161</NlmUniqueID><ISSNLinking>1550-7289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Bariatric surgery</Keyword><Keyword MajorTopicYN="N">Lung ultrasound</Keyword><Keyword MajorTopicYN="N">Obese patients</Keyword><Keyword MajorTopicYN="N">PEEP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33092957</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2020.09.023</ArticleId><ArticleId IdType="pii">S1550-7289(20)30553-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17052415</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2006</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1022-386X</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2006</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of the College of Physicians and Surgeons--Pakistan : JCPSP</Title><ISOAbbreviation>J Coll Physicians Surg Pak</ISOAbbreviation></Journal><ArticleTitle>Comparison of armoured laryngeal mask airway with endotracheal tube for adenotonsillectomy.</ArticleTitle><Pagination><StartPage>685</StartPage><EndPage>688</EndPage><MedlinePgn>685-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the reliability of armoured laryngeal mask airway for adenotonsillectomy and to compare the haemodynamic changes during anaesthesia with those of endotracheal tube.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A prospective comparative study.</AbstractText><AbstractText Label="PLACE AND DURATION OF STUDY" NlmCategory="METHODS">Services Hospital Lahore/ Services Institute of Medical Sciences from April to September 2003.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A total of 100 patients undergoing adenotonsillectomy between ages 10-35 years and ASA I status were enrolled for the study. Two groups with 50 patients in each group were formed. Group I patients underwent surgery with armoured laryngeal mask airway while group II underwent surgery with endotracheal intubation. Baseline heart rate, systolic blood pressure and diastolic blood pressure were noted pre-operatively, one minute after insertion and every five minutes after induction in both the groups. A change in all these haemodynamic parameters from the baseline was noted. The effect of Boyle Davis Gag and adequacy of surgical access were also noted. Occurrence of cough, laryngospasm and stridor were noted at the time of recovery in both the groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline variables in both groups were identical. Surgical access was adequate in 48/50 patients in group I while it was adequate in 49/50 patients in group II. The frequencies of cough, laryngeal spasm and stridor were lower in group I. In group I, there was insignificant change from baseline in heart rate, systolic and diastolic blood pressure at one, five and ten minutes after induction. In group II, significant change from baseline was observed in heart rate (p &lt; 0.01), systolic blood pressure (p &lt; 0.05) and diastolic blood pressure (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Armoured laryngeal mask is reliable for performing adenotonsillectomies. It provides adequate surgical access for adenotonsillectomy. It is also associated with lower occurrence of cough, bronchospasm and stridor at recovery. Use of armoured laryngeal mask is associated with fewer haemodynamic changes compared with those of endotracheal tube.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Services Institute of Medical Sciences/ Services Hospital, Lahore. drayub@wol.net.pk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Khalid</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>J Coll Physicians Surg Pak</MedlineTA><NlmUniqueID>9606447</NlmUniqueID><ISSNLinking>1022-386X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17052415</ArticleId><ArticleId IdType="pii">040579197</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29402235</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2296</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC family practice</Title><ISOAbbreviation>BMC Fam Pract</ISOAbbreviation></Journal><ArticleTitle>What gives rise to clinician gut feeling, its influence on management decisions and its prognostic value for children with RTI in primary care: a prospective cohort study.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12875-018-0716-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The objectives were to identify 1) the clinician and child characteristics associated with; 2) clinical management decisions following from, and; 3) the prognostic value of; a clinician's 'gut feeling something is wrong' for children presenting to primary care with acute cough and respiratory tract infection (RTI).</AbstractText><AbstractText Label="METHODS">Multicentre prospective cohort study where 518 primary care clinicians across 244 general practices in England assessed 8394 children aged &#x2265;3&#xa0;months and &lt;&#x2009;16&#xa0;years for acute cough and RTI. The main outcome measures were: Self-reported clinician 'gut feeling'; clinician management decisions (antibiotic prescribing, referral for acute admission); and child's prognosis (reconsultation with evidence of illness deterioration, hospital admission in the 30&#xa0;days following recruitment).</AbstractText><AbstractText Label="RESULTS">Clinician years since qualification, parent reported symptoms (illness severity score&#x2009;&#x2265;&#x2009;7/10, severe fever &lt;&#x2009;24&#xa0;h, low energy, shortness of breath) and clinical examination findings (crackles/ crepitations on chest auscultation, recession, pallor, bronchial breathing, wheeze, temperature&#x2009;&#x2265;&#x2009;37.8&#xa0;&#xb0;C, tachypnoea and inflamed pharynx) independently contributed towards a clinician 'gut feeling that something was wrong'. 'Gut feeling' was independently associated with increased antibiotic prescribing and referral for secondary care assessment. After adjustment for other associated factors, gut feeling was not associated with reconsultations or hospital admissions.</AbstractText><AbstractText Label="CONCLUSIONS">Clinicians were more likely to report a gut feeling something is wrong, when they were more experienced or when children were more unwell. Gut feeling is independently and strongly associated with antibiotic prescribing and referral to secondary care, but not with two indicators of poor child health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. Sophie.turnbull@bristol.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PS, UK. Sophie.turnbull@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Patricia J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>School for Policy Studies, University of Bristol, 8 Priory Road, Bristol, BS8 1TZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond</LastName><ForeName>Niamh M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care West (NIHR CLAHRC West), University Hospitals Bristol NHS Foundation Trust, 9th Floor, Whitefriars, Lewins Mead, Bristol, BS1 2NT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral</LastName><ForeName>Christie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Level D, St Michael's Hospital, Southwell St, Bristol, BS2 8EG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, W2 1NY, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, WA, 98195-4696, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Aldermoor Close, Southampton, SO16 5ST, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Tim J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, University of Bristol, 69 St Michael's Hill, Bristol, BS2 8DZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CDF-2009-02-10</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0608-10018</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Fam Pract</MedlineTA><NlmUniqueID>100967792</NlmUniqueID><ISSNLinking>1471-2296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009722" MajorTopicYN="N">Nurse Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="Y">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Decision making</Keyword><Keyword MajorTopicYN="N">Emotions</Keyword><Keyword MajorTopicYN="N">Paediatric</Keyword><Keyword MajorTopicYN="N">Primary health care</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Respiratory tract infections</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the South West Central Bristol Research Ethics Committee, UK (reference number: 10/H0102/54) and research governance approvals were obtained for all areas prior to the start of recruitment. The study was sponsored by the University of Bristol, which ensured the study met all regulatory approvals. All participants&#x2019; parent or legal carers gave written, informed consent on behalf of the child. All children aged 11 and over gave informed assent. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402235</ArticleId><ArticleId IdType="pmc">PMC5800050</ArticleId><ArticleId IdType="doi">10.1186/s12875-018-0716-7</ArticleId><ArticleId IdType="pii">10.1186/s12875-018-0716-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hay AD, Heron J, Ness A. The prevalence of symptoms and consultations in pre-school children in the Avon longitudinal study of parents and children (ALSPAC): a prospective cohort study. Fam Pract. 2005;22(4):367&#x2013;374. doi: 10.1093/fampra/cmi035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmi035</ArticleId><ArticleId IdType="pubmed">15897210</ArticleId></ArticleIdList></Reference><Reference><Citation>Okkes IM, Oskam SK, Lamberts H. The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract. 2002;51(1):31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Redmond NM, Turnbull S, Christensen H, Thornton H, Little P, Thompson M, Delaney B, Lovering AM, Muir P, et al. Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study. Lancet Respir Med. 2016;11:902&#x2013;10. doi: 10.1016/S2213-2600(16)30223-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)30223-5</ArticleId><ArticleId IdType="pmc">PMC5080970</ArticleId><ArticleId IdType="pubmed">27594440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas PJ, Cabral C, Hay AD, Horwood J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015:33(1):11-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377734</ArticleId><ArticleId IdType="pubmed">25716427</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study. B J Gen Pract. 2016;66(644):e207&#x2013;13. doi: 10.3399/bjgp16X683821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp16X683821</ArticleId><ArticleId IdType="pmc">PMC4758501</ArticleId><ArticleId IdType="pubmed">26852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral C, Lucas PJ, Ingram J, Hay AD, Horwood J. "It's safer to ..." parent consulting and clinician antibiotic prescribing decisions for children with respiratory tract infections: an analysis across four qualitative studies. Soc Sci Med. 2015;136-137C:156&#x2013;164. doi: 10.1016/j.socscimed.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2015.05.027</ArticleId><ArticleId IdType="pubmed">26004209</ArticleId></ArticleIdList></Reference><Reference><Citation>Washington TWH. National strategy for combating antibioticresistant bacteria. Washington: Centers for Disease Control and Prevention publisher location; 2014.</Citation></Reference><Reference><Citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483949</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley A, Kostopoulou O. Clinical intuition in family medicine: more than first impressions. Ann Fam Med. 2013;11(1):60&#x2013;66. doi: 10.1370/afm.1433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1433</ArticleId><ArticleId IdType="pmc">PMC3596024</ArticleId><ArticleId IdType="pubmed">23319507</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson VA, Prowse Turner JA, Pennycook G. Intuition, reason, and metacognition. Cogn Psychol. 2011;63(3):107&#x2013;140. doi: 10.1016/j.cogpsych.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cogpsych.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798215</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolper E, van Bokhoven M, Houben P, Van Royen P, van de Wiel M, van der Weijden T, Jan Dinant G. The diagnostic role of gut feelings in general practice. A focus group study of the concept and its determinants. BMC Fam Pract. 2009;10:17. doi: 10.1186/1471-2296-10-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2296-10-17</ArticleId><ArticleId IdType="pmc">PMC2649045</ArticleId><ArticleId IdType="pubmed">19226455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman D. A perspective on judgment and choice: mapping bounded rationality. Am Psychol. 2003;58(9):697&#x2013;720. doi: 10.1037/0003-066X.58.9.697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0003-066X.58.9.697</ArticleId><ArticleId IdType="pubmed">14584987</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JS, Stanovich KE. Dual-Process Theories of Higher Cognition: Advancing the Debate. 2013;8(3):223&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">26172965</ArticleId></ArticleIdList></Reference><Reference><Citation>Toplak ME, West RF, Stanovich KE. The cognitive reflection test as a predictor of performance on heuristics-and-biases tasks. Mem Cogn. 2011;39(7):1275&#x2013;1289. doi: 10.3758/s13421-011-0104-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13421-011-0104-1</ArticleId><ArticleId IdType="pubmed">21541821</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Thompson M, Buntinx F, Mant D. Clinicians' gut feeling about serious infections in children: observational study. BMJ. 2012;345:e6144. doi: 10.1136/bmj.e6144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e6144</ArticleId><ArticleId IdType="pmc">PMC3458229</ArticleId><ArticleId IdType="pubmed">23015034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hams SP. A gut feeling? Intuition and critical care nursing. Intensive Crit Care Nurs. 2000;16(5):310&#x2013;318. doi: 10.1054/iccn.2000.1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/iccn.2000.1500</ArticleId><ArticleId IdType="pubmed">11000605</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375(9717):834&#x2013;845. doi: 10.1016/S0140-6736(09)62000-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)62000-6</ArticleId><ArticleId IdType="pubmed">20132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Davies R, Christensen H, Blair PS, Lovering AM, Leeming JP, Muir P, Vipond B, Thornton H, Fletcher M, et al. The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Serv Res. 2013;13:322. doi: 10.1186/1472-6963-13-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-13-322</ArticleId><ArticleId IdType="pmc">PMC3765099</ArticleId><ArticleId IdType="pubmed">23958109</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad M.&#xa0;English Indices of Deprivation 2010.&#xa0;London: Department for Communities and Local Government; 2010.</Citation></Reference><Reference><Citation>Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20(6):696&#x2013;705. doi: 10.1093/fampra/cmg613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmg613</ArticleId><ArticleId IdType="pubmed">14701895</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Vodicka T, Cohen H, Blair P, Biuckley T, Heneghan C, Hay A. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898587</ArticleId><ArticleId IdType="pubmed">24335668</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. BMJ. 2000;320(7243):1174&#x2013;1178. doi: 10.1136/bmj.320.7243.1174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.320.7243.1174</ArticleId><ArticleId IdType="pmc">PMC27359</ArticleId><ArticleId IdType="pubmed">10784539</ArticleId></ArticleIdList></Reference><Reference><Citation>Strozik KS, Pieper CH, Roller J. Capillary refilling time in newborn babies: normal values. Arch Dis Child Fetal Neonatal Ed. 1997;76(3):F193&#x2013;F196. doi: 10.1136/fn.76.3.F193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.76.3.F193</ArticleId><ArticleId IdType="pmc">PMC1720653</ArticleId><ArticleId IdType="pubmed">9175951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibby SM, Hatherill M, Murdoch IA. Capillary refill and core-peripheral temperature gap as indicators of haemodynamic status in paediatric intensive care patients. Arch Dis Child. 1999;80(2):163&#x2013;166. doi: 10.1136/adc.80.2.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.80.2.163</ArticleId><ArticleId IdType="pmc">PMC1717816</ArticleId><ArticleId IdType="pubmed">10325733</ArticleId></ArticleIdList></Reference><Reference><Citation>National Collaborating Centre for Women&#x2019;s and Children&#x2019;s Health.&#xa0;Feverish Illness in Children: Assessment and Initial Management in Children Younger than 5 Years.&#xa0;London: National Collaborating Centre for Women&#x2019;s and Children&#x2019;s Health; 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson J. Advanced paediatric life support. 3. London: BMJ Books; 2001.</Citation></Reference><Reference><Citation>Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. doi: 10.1136/bmj.b2393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2393</ArticleId><ArticleId IdType="pmc">PMC2714692</ArticleId><ArticleId IdType="pubmed">19564179</ArticleId></ArticleIdList></Reference><Reference><Citation>Census statistical bulletin: Population and Household Estimates for Wales, March 2011 [http://www.ons.gov.uk/ons/rel/census/2011-census/population-and-household-estimates-for-wales/stb-2011-census-wales.html].</Citation></Reference><Reference><Citation>Little P, Stuart B, Smith S, Thompson MJ, Knox K, van den Bruel A, Lown M, Moore M, Mant D. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ. 2017;357:j2148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439222</ArticleId><ArticleId IdType="pubmed">28533265</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Turnbull S, Stuart B, Thornton HV, Christensen H, Blair PS, Delaney BC, Thompson M, Peters TJ, Hay AD et al: Do antibiotics prescribed for children presenting to primary care with cough and respiratory tract infections (RTIs) modify adverse outcomes? In submission 2017.</Citation></Reference><Reference><Citation>Stolper E, Van de Wiel M, Van Royen P, Van Bokhoven M, Van der Weijden T, Dinant GJ. Gut feelings as a third track in general practitioners' diagnostic reasoning. J Gen Intern Med. 2011;26(2):197&#x2013;203. doi: 10.1007/s11606-010-1524-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-010-1524-5</ArticleId><ArticleId IdType="pmc">PMC3019314</ArticleId><ArticleId IdType="pubmed">20967509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogarth RM. Educating intuition. Chicago, IL: University of Chicago Press; 2001.</Citation></Reference><Reference><Citation>Betsch T. The nature of intuition and its neglect in research on judgment and decision making. New York, NY: Psychology Press; 2008.</Citation></Reference><Reference><Citation>Hjertholm P, Moth G, Ingeman ML, Vedsted P. Predictive values of GPs&#x2019; suspicion of serious disease: a population-based follow-up study. Br J Gen Pract. 2014;64(623):e346&#x2013;e353. doi: 10.3399/bjgp14X680125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp14X680125</ArticleId><ArticleId IdType="pmc">PMC4032017</ArticleId><ArticleId IdType="pubmed">24868072</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Society for Academic Primary Care Annual Research Meeting. Glasgow: Society for Academic Primary Care; 2012. &#x201c;Recognising the sick child in amongst the just unwell&#x201d;: health practitioner prescribing decisions in consultations for acute RTI in children.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32860696</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1559-0488</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of burn care &amp; research : official publication of the American Burn Association</Title><ISOAbbreviation>J Burn Care Res</ISOAbbreviation></Journal><ArticleTitle>Does High-Frequency Chest Wall Oscillation Have an Impact on Improving Pulmonary Function in Patients With Smoke Inhalation Injury?</ArticleTitle><Pagination><StartPage>300</StartPage><EndPage>304</EndPage><MedlinePgn>300-304</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jbcr/iraa147</ELocationID><Abstract><AbstractText>Smoke inhalation results in bronchospasm of the trachea, increasing secretion of mucus, casts formation, and improvement of blood flow of the airway. High frequency chest wall oscillation is a common modality used for clearing mucus secretion in patients suffering from hypersecretion of thick mucus and used also to help cough clearance. This study aimed to detect the effect of high frequency chest wall oscillation in improving pulmonary function in burn patients suffering from smoke inhalation. Sixty smoke inhalation injury patients were randomly distributed into two groups of equal size. Group A: received high frequency chest wall oscillation and conventional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks. Group B: received traditional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks. Pulmonary function test (forced vital capacity, forced expiratory volume in the first second and peak expiratory flow rate) was measured at enrollment and after 8 weeks by using spirometer. Pulmonary function increased significantly posttreatment when compared with that pretreatment in groups A and B (P &gt; .001). Also, they increased significantly in group A compared with that of group B posttreatment (P &gt; .05). High-frequency chest wall oscillation have an impact on improving pulmonary function and should be handled to be a part of the pulmonary rehabilitation plan for smoke inhalation injury patients.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allam</LastName><ForeName>Nesma M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy for Surgery, Faculty of Physical Therapy, Cairo University, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badawy</LastName><ForeName>Manar M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy for Cardiovascular, Pulmonary Disorders and Geriatrics, Faculty of Physical Therapy, Misr University for Science and Technology, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Burn Care Res</MedlineTA><NlmUniqueID>101262774</NlmUniqueID><ISSNLinking>1559-047X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035641" MajorTopicYN="N">Chest Wall Oscillation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015208" MajorTopicYN="N">Smoke Inhalation Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32860696</ArticleId><ArticleId IdType="doi">10.1093/jbcr/iraa147</ArticleId><ArticleId IdType="pii">5897037</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15358689</PMID><DateCompleted><Year>2004</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0903-1936</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Endobronchial brachytherapy in the treatment of malignant lung tumours.</ArticleTitle><Pagination><StartPage>348</StartPage><EndPage>352</EndPage><MedlinePgn>348-52</MedlinePgn></Pagination><Abstract><AbstractText>A prospective study was made to assess the short-term clinical and endoscopic response to high-dose-rate endobronchial brachytherapy (HDREB) in patients with malignant endobronchial tumours. From July 1995 to May 2000, 288 HDREB sessions were carried out on 81 patients. The mean patient age was 61.57 yrs (range 34-82); males were predominant (87.65%). Tumours were primary in 76 patients (93.82%) and metastatic in five patients (6.18%). The inclusion criteria were malignant endobronchial tumour and either palliative treatment for incurable disease or intent-to-cure treatment for residual malignancy on the bronchial resection surface after surgery or an inoperable tumour. The exclusion criteria were as follows: impediments to catheter placement, expected survival &lt;2 months, Karnofsky index &lt;60, or absence of informed consent. The clinical response of a symptom was categorised as complete (disappearance of the symptom), partial (less than complete) or absent. The endoscopic response was considered to be complete if lesions disappeared and biopsy findings remained negative 1 month after the last radiation session; partial if lesions improved to some extent, but the biopsy findings were positive; and absent if there was no change in relation to baseline. The technique consisted of delivering high-dose irradiation from an Ir192 source to a target volume using one or two endobronchial catheters inserted under optical or video bronchoscopic guidance. Four sessions were scheduled at weekly intervals and 500 cGy was applied per session over a length of 1-9 cm, measured 0.5-1 cm from the centre of the source. In total, 85% of the symptoms analysed (haemoptysis, cough, dyspnoea, expectoration, and stridor) disappeared with HDREB, which was categorised as a complete response. The endoscopic response was complete in 56.79% of patients, partial or less than complete in 40.74% and absent in 2.46%. One major complication occurred (bronchial fistula 1.2%), but no lethal haemoptysis. Minor complications (pneumonitis, bronchospasm and bronchial stenosis) each occurred in one patient (1.2%). High-dose-rate endobronchial brachytherapy is a good palliative treatment for endoluminal lung neoplasms, effectively alleviating symptoms and endoscopic evidence in many cases with an acceptable rate of complications. High-dose-rate endobronchial brachytherapy can be carried out as an intent-to-cure procedure in highly selected cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Escobar-Sacrist&#xe1;n</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Pulmonology Service, Defence Military Service, C/ Glorieta del Ejercito s/n, 28025 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granda-Orive</LastName><ForeName>J I</ForeName><Initials>JI</Initials></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez Jim&#xe9;nez</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Rodero Ba&#xf1;os</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Saez Valls</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007496">Iridium Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001918" MajorTopicYN="N">Brachytherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007496" MajorTopicYN="N">Iridium Radioisotopes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>12</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15358689</ArticleId><ArticleId IdType="doi">10.1183/09031936.04.00114902</ArticleId><ArticleId IdType="pii">24/3/348</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17023241</PMID><DateCompleted><Year>2006</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9993</ISSN><JournalIssue CitedMedium="Print"><Volume>87</Volume><Issue>10</Issue><PubDate><Year>2006</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Archives of physical medicine and rehabilitation</Title><ISOAbbreviation>Arch Phys Med Rehabil</ISOAbbreviation></Journal><ArticleTitle>Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury.</ArticleTitle><Pagination><StartPage>1327</StartPage><EndPage>1333</EndPage><MedlinePgn>1327-33</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess factors that influence pulmonary function, because respiratory system dysfunction is common in chronic spinal cord injury (SCI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Veterans Affairs Boston SCI service and the community.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Between 1994 and 2003, 339 white men with chronic SCI completed a respiratory questionnaire and underwent spirometry.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Not applicable.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), and FEV(1)/FVC.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adjusting for SCI level and completeness, FEV(1) (-21.0 mL/y; 95% confidence interval [CI], -26.3 to -15.7 mL/y) and FVC (-17.2 mL/y; 95% CI, -23.7 to -10.8 mL/y) declined with age. Lifetime cigarette use was also associated with a decrease in FEV(1) (-3.8 mL/pack-year; 95% CI, -6.5 to -1.1 mL/pack-year), and persistent wheeze and elevated body mass index were associated with a lower FEV(1)/FVC. A greater maximal inspiratory pressure (MIP) was associated with a greater FEV(1) and FVC. FEV(1) significantly decreased with injury duration (-6.1 mL/y; 95% CI, -11.7 to -0.6 mL/y), with the greatest decrement in the most neurologically impaired. The most neurologically impaired also had a greater FEV(1)/FVC, and their FEV(1) and FVC were less affected by age and smoking.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Smoking, persistent wheeze, obesity, and MIP, in addition to SCI level and completeness, were significant determinants of pulmonary function. In SCI, FEV(1), FVC, and FEV(1)/FVC may be less sensitive to factors associated with change in airway size and not reliably detect the severity of airflow obstruction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Nitin B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Research Service, VA Boston Healthcare System, West Roxbury, MA 02132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tun</LastName><ForeName>Carlos G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Garshick</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HD042141</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD42141</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Phys Med Rehabil</MedlineTA><NlmUniqueID>2985158R</NlmUniqueID><ISSNLinking>0003-9993</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013898" MajorTopicYN="N">Thoracic Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>11</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2007</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17023241</ArticleId><ArticleId IdType="mid">NIHMS21771</ArticleId><ArticleId IdType="pmc">PMC1896316</ArticleId><ArticleId IdType="doi">10.1016/j.apmr.2006.06.015</ArticleId><ArticleId IdType="pii">S0003-9993(06)00685-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeVivo MJ, Stover SL. Long term survival and causes of death. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord injury: clinical outcomes from the model systems. Gaithersburg: Aspen; 1995. pp. 289&#x2013;316.</Citation></Reference><Reference><Citation>DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehabil. 1993;74:248&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">8439250</ArticleId></ArticleIdList></Reference><Reference><Citation>Garshick E, Kelley A, Cohen SA, et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005;43:408&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1298182</ArticleId><ArticleId IdType="pubmed">15711609</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugl-Meyer AR. Effects of respiratory muscle paralysis in tetraplegic and paraplegic patients. Scand J Rehabil Med. 1971;3:141&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">5161287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugl-Meyer AR, Grimby G. Ventilatory function in tetraplegic patients. Scand J Rehabil Med. 1971;3:151&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">5161288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokkola K, Moller K, Lehtonen T. Pulmonary function in tetraplegic and paraplegic patients. Ann Clin Res. 1975;7:76&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1181978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohry A, Molho M, Rozin R. Alterations of pulmonary function in spinal cord injured patients. Paraplegia. 1975;13:101&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1178209</ArticleId></ArticleIdList></Reference><Reference><Citation>Almenoff PL, Spungen AM, Lesser M, Bauman WA. Pulmonary function survey in spinal cord injury: influences of smoking and level and completeness of injury. Lung. 1995;173:297&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">7564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Linn WS, Adkins RH, Gong H, Jr, Waters RL. Pulmonary function in chronic spinal cord injury: a cross-sectional survey of 222 southern California adult outpatients. Arch Phys Med Rehabil. 2000;81:757&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">10857520</ArticleId></ArticleIdList></Reference><Reference><Citation>Linn WS, Spungen AM, Gong H, Jr, Adkins RH, Bauman WA, Waters RL. Forced vital capacity in two large outpatient populations with chronic spinal cord injury. Spinal Cord. 2001;39:263&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11438842</ArticleId></ArticleIdList></Reference><Reference><Citation>Linn WS, Spungen AM, Gong H, Jr, Bauman WA, Adkins RH, Waters RL. Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury. J Spinal Cord Med. 2003;26:28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">12830966</ArticleId></ArticleIdList></Reference><Reference><Citation>Spungen AM, Grimm DR, Schilero G, et al. Relationship of respiratory symptoms with smoking status and pulmonary function in chronic spinal cord injury. J Spinal Cord Med. 2002;25:23&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11939462</ArticleId></ArticleIdList></Reference><Reference><Citation>Huldtgren AC, Fugl-Meyer AR, Jonasson E, Bake B. Ventilatory dysfunction and respiratory rehabilitation in post-traumatic quadriplegia. Eur J Respir Dis. 1980;61:347&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">7202607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditunno JF, Jr, Young W, Donovan WH, Creasey G. The international standards booklet for neurological and functional classification of spinal cord injury. American Spinal Injury Association Paraplegia. 1994;32:70&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">8015848</ArticleId></ArticleIdList></Reference><Reference><Citation>Garshick E, Ashba J, Tun CG, Lieberman SL, Brown R. Assessment of stature in spinal cord injury. J Spinal Cord Med. 1997;20:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9097254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris BG. Epidemiology Standardization Project (American Thoracic Society) Am Rev Respir Dis. 1978;118(6 Pt 2):1&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">742764</ArticleId></ArticleIdList></Reference><Reference><Citation>Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">7663792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashba J, Garshick E, Tun CG, et al. Spirometry&#x2014;acceptability and reproducibility in spinal cord injured subjects. J Am Paraplegia Soc. 1993;16:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">8270915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley A, Garshick E, Gross ER, Lieberman SL, Tun CG, Brown R. Spirometry testing standards in spinal cord injury. Chest. 2003;123:725&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1896104</ArticleId><ArticleId IdType="pubmed">12628869</ArticleId></ArticleIdList></Reference><Reference><Citation>Tully K, Koke K, Garshick E, Lieberman SL, Tun CG, Brown R. Maximal expiratory pressures in spinal cord injury using two mouthpieces. Chest. 1997;112:113&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872837</ArticleId></ArticleIdList></Reference><Reference><Citation>Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir. 1982;18:419&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">7074238</ArticleId></ArticleIdList></Reference><Reference><Citation>Dockery DW, Ware JH, Ferris BG, Jr, et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis. 1985;131:511&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">3873193</ArticleId></ArticleIdList></Reference><Reference><Citation>Forner JV. Lung volumes and mechanics of breathing in tetraplegics. Paraplegia. 1980;18:258&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">7422342</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas F, Axen K, Pineda H, Gandino D, Haas A. Temporal pulmonary function changes in cervical cord injury. Arch Phys Med Rehabil. 1985;66:139&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">3977564</ArticleId></ArticleIdList></Reference><Reference><Citation>Dicpinigaitis PV, Spungen AM, Bauman WA, Absgarten A, Almenoff PL. Bronchial hyperresponsiveness after cervical spinal cord injury. Chest. 1994;105:1073&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8162727</ArticleId></ArticleIdList></Reference><Reference><Citation>Almenoff PL, Alexander LR, Spungen AM, Lesser MD, Bauman WA. Bronchodilatory effects of ipratropium bromide in patients with tetraplegia. Paraplegia. 1995;33:274&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7630654</ArticleId></ArticleIdList></Reference><Reference><Citation>Affonce D, Brown R, Fredberg JJ, Garshick E, Lutchen KR. Does ability to maximally dilate airways relate to airway tone and inspiratory capacity in subjects with hyperreactivity [abstract] Am J Respir Crit Care Med. 2004;169:A248.</Citation></Reference><Reference><Citation>Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123:659&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">7271065</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">6859656</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study Chest. 1994;106:827&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">8082366</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola MS, Jaakkola JJ, Ernst P, Becklake MR. Respiratory symptoms in young adults should not be overlooked. Am Rev Respir Dis. 1993;147:359&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">8430959</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group Chest. 1999;116:603&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">10492260</ArticleId></ArticleIdList></Reference><Reference><Citation>Litonjua AA, Sparrow D, Celedon JC, DeMolles D, Weiss ST. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax. 2002;57:581&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1746377</ArticleId><ArticleId IdType="pubmed">12096199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111:891&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9106566</ArticleId></ArticleIdList></Reference><Reference><Citation>Sue DY. Obesity and pulmonary function: more or less? Chest. 1997;111:844&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9106556</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistelli F, Bottai M, Viegi G, et al. Smooth reference equations for slow vital capacity and flow-volume curve indexes. Am J Respir Crit Care Med. 2000;161(3 Pt 1):899&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">10712340</ArticleId></ArticleIdList></Reference><Reference><Citation>Estenne M, Heilporn A, Delhez L, Yernault JC, De Troyer A. Chest wall stiffness in patients with chronic respiratory muscle weakness. Am Rev Respir Dis. 1983;128:1002&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">6228174</ArticleId></ArticleIdList></Reference><Reference><Citation>Scanlon PD, Loring SH, Pichurko BM, et al. Respiratory mechanics in acute quadriplegia. Lung and chest wall compliance and dimensional changes during respiratory maneuvers Am Rev Respir Dis. 1989;139:615&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">2923360</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva EV. The validity of self-reported weight in US adults: a population based cross-sectional study. BMC Public Health. 2001;1:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC59896</ArticleId><ArticleId IdType="pubmed">11716792</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw MY, Lin MC, Cheng PT, Wong MK, Tang FT. Resistive inspiratory muscle training: its effectiveness in patients with acute complete cervical cord injury. Arch Phys Med Rehabil. 2000;81:752&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10857519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21147783</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intubating conditions and adverse events during sevoflurane induction in infants.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>229</EndPage><MedlinePgn>225-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aeq346</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to compare intubating conditions and adverse events after sevoflurane induction in infants, with or without the use of rocuronium or alfentanil.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventy-five infants, aged 1-24 months, undergoing elective surgery under general anaesthesia were randomly assigned to receive 8% sevoflurane with either placebo (i.v. saline 0.5 ml kg&#x207b;&#xb9;), rocuronium (0.3 mg kg&#x207b;&#xb9;), or alfentanil (20 &#xb5;g kg&#x207b;&#xb9;). The primary outcome measure was intubating conditions evaluated 90 s after test drug injection by an anaesthetist unaware of the patient's group. The secondary outcome criteria were respiratory (Sp(O&#x2082;) &lt;90%, laryngospasm, closed vocal cords preventing intubation, bronchospasm) and haemodynamic adverse events (heart rate and mean arterial pressure variations &#x2265;30% control value).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Intubating conditions were significantly better in the rocuronium group, with clinically acceptable intubating conditions in 92%, vs 70% in the alfentanil group and 63% in the placebo group (P=0.044). Adverse respiratory events were significantly less frequent in the rocuronium group: 0% vs 33% in the placebo group and 30% in the alfentanil group (P=0.006). Haemodynamic adverse events were more frequent in the alfentanil group: 48% vs 7% in the placebo group and 16% in the rocuronium group (P=0.0019).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In 1- to 24-month-old infants, the addition of 0.3 mg kg&#x207b;&#xb9; rocuronium to 8% sevoflurane improved intubating conditions and decreased the frequency of respiratory adverse events. Alfentanil provided no additional benefit in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devys</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fondation Ophtalmologique Adolphe de Rothschild, 25&#x2013;29 rue Manin, 75019 Paris, France. jmdevys@fo-rothschild.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourissoux</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Donnette</LastName><ForeName>F X</ForeName><Initials>FX</Initials></Author><Author ValidYN="Y"><LastName>Plat</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Schauvli&#xe8;ge</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Le Bigot</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Dureau</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Plaud</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000732">Androstanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>1N74HM2BS7</RegistryNumber><NameOfSubstance UI="D015760">Alfentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>WRE554RFEZ</RegistryNumber><NameOfSubstance UI="D000077123">Rocuronium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015760" MajorTopicYN="N">Alfentanil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000732" MajorTopicYN="N">Androstanols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="N">Methyl Ethers</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077123" MajorTopicYN="N">Rocuronium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21147783</ArticleId><ArticleId IdType="doi">10.1093/bja/aeq346</ArticleId><ArticleId IdType="pii">S0007-0912(17)33328-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16398965</PMID><DateCompleted><Year>2006</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2006</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1022-386X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the College of Physicians and Surgeons--Pakistan : JCPSP</Title><ISOAbbreviation>J Coll Physicians Surg Pak</ISOAbbreviation></Journal><ArticleTitle>Predicting postoperative cardio-pulmonary complications by a test of stair climbing.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>764</EndPage><MedlinePgn>761-4</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess whether a test of stair climbing ability could be used to predict the risk of developing postoperative cardiopulmonary complications in patients undergoing general anesthesia.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cohort study.</AbstractText><AbstractText Label="PLACE AND DURATION OF STUDY" NlmCategory="METHODS">The Aga Khan University Hospital, Karachi. The duration of the study was from December 2003 to December 2004.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">This study was carried out on consecutive, adult patients presenting for elective thoracic or abdominal surgery under general anesthesia. Pre-operatively, patients were asked to climb a standard staircase. Number of steps climbed was recorded. Those unable to climb stairs due to debilitating cardiac, pulmonary or rheumatologic disease were categorized as 0 stairs climbed. Outcome variables were postoperative cardiopulmonary complications or mortality. Period of follow-up was until hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-eight patients were enrolled, 59 (75.6%) climbed 1 flight of stairs, 19 (24.3%) climbed &lt; 1 flight. All-cause cardiopulmonary complications rate was 26 %. The most frequent complication was lobar atelectasis, followed by bronchospasm and acute MI. The complication rate was 22.8% in those able to climb 1 flight and 40% in those patients who climbed &lt; 1 flight. The group that climbed &lt; 1 flight tended to have complications associated with poor reserves of the cardiopulmonary systems, i.e. pulmonary edema, exacerbation of underlying lung disease. The relative risk of developing complications, if unable to climb at least 1 flight of stairs, was calculated to be 1.8 (95% CI 0.7 - 4.6).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Stair climbing can be a useful pre-operative tool to predict the risk of postoperative cardiopulmonary complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>Nawal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Pulmonary and Critical Care Medicine, Department of Medicine, The Aga Khan University, Stadium Road. Karachi-74800, Pakistan. nawal.salahuddin@aku.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatimi</LastName><ForeName>Saulat</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>Nawal</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Huda</LastName><ForeName>Shehzad</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Shafquat</LastName><ForeName>Azam</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>J Coll Physicians Surg Pak</MedlineTA><NlmUniqueID>9606447</NlmUniqueID><ISSNLinking>1022-386X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16398965</ArticleId><ArticleId IdType="pii">040579197</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33067310</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Impact of oral corticosteroids on respiratory outcomes in acute preschool wheeze: a randomised clinical trial.</ArticleTitle><Pagination><StartPage>339</StartPage><EndPage>344</EndPage><MedlinePgn>339-344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2020-318971</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine if administration of oral prednisolone to preschool children with acute wheeze alters respiratory outcomes.</AbstractText><AbstractText Label="DESIGN">Double-blind, randomised, placebo-controlled equivalence trial.</AbstractText><AbstractText Label="SETTING">Three hospitals in New Zealand.</AbstractText><AbstractText Label="PATIENTS">477 children aged 24-59 months with acute wheeze associated with respiratory illness.</AbstractText><AbstractText Label="INTERVENTIONS">2 mg/kg (maximum 40 mg) oral prednisolone or similar placebo, once daily for 3 days.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Primary outcome was change in Preschool Respiratory Assessment Measure (PRAM) score 24 hours after intervention. Secondary outcomes included PRAM score at 4 hours, length of emergency department and inpatient stays, admission and representation rates, time to return to normal activities and use of additional oral prednisolone or intravenous medications. Analysis was by intention-to-treat.</AbstractText><AbstractText Label="RESULTS">There was no difference between groups for change in PRAM score at 24 hours (difference between means -0.39, 95% CI -0.84 to 0.06, p=0.09). Absolute PRAM score was lower in the prednisolone group at 4 hours (median (IQR) 1 (0-2) vs 2 (0-3), p=0.01) and 24 hours (0 (0-1) vs 0 (0-1), p=0.01), when symptoms had resolved for most children regardless of initial treatment. Admission rate, requirement for additional oral prednisolone and use of intravenous medication were lower in the prednisolone group, although there were no differences between groups for time taken to return to normal activities or rates of representation within 7 days.</AbstractText><AbstractText Label="CONCLUSION">Oral prednisolone does not alter respiratory outcomes at 24 hours or beyond in preschool children presenting with acute wheeze.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2192-3245</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Waikato Hospital, Hamilton, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Owen</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Department, Waitakere Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shepherd</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neutze</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidz First, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trenholme</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidz First, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eunicia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Emergency Department, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brabyn</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Department, Waikato Hospital, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonisch</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grey</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Departments of Paediatrics, Emergency Medicine, and Pharmacology and Physiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>John M D</ForeName><Initials>JMD</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asher</LastName><ForeName>Innes</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalziel</LastName><ForeName>Stuart R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand s.dalziel@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Arch Dis Child. 2021 Apr 21;106(5):e27. doi: 10.1136/archdischild-2020-318971corr1.</RefSource><PMID Version="1">33785530</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general paediatrics</Keyword><Keyword MajorTopicYN="N">respiratory</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33067310</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2020-318971</ArticleId><ArticleId IdType="pii">archdischild-2020-318971</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31149004</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1729-0503</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>African health sciences</Title><ISOAbbreviation>Afr Health Sci</ISOAbbreviation></Journal><ArticleTitle>Comparison of effects of propofol and ketofol (Ketamine-Propofol mixture) on emergence agitation in children undergoing tonsillectomy.</ArticleTitle><Pagination><StartPage>1736</StartPage><EndPage>1744</EndPage><MedlinePgn>1736-1744</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4314/ahs.v19i1.50</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to compare the effect of propofol and ketofol (ketamine-propofol mixture) on EA in children undergoing tonsillectomy.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">In this randomized clinical trial, 87 ASA class I and II patients, aged 3-12 years, who underwent tonsillectomy, were divided into two groups to receive either propofol 100 &#xb5;g/kg/min (group p, n=44) or ketofol : ketamine 25 &#xb5;g/kg/min + propofol 75 &#xb5;g/kg/min (group k, n= 43). Incidence and severity of EA was evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scales on arrival at the recovery room, and 10 and 30 min after that time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistically significant difference in demographic data between the two groups. In the ketofol group, the need for agitation treatment and also mean recovery duration were lower than in the propofol group (30 and 41%, and 29.9 and 32.7 min), without statistically significant difference (P value=0.143 and P value=0.187). Laryngospasm or bronchospasm occurred in 2 patients in each group and bleeding was observed in only one individual in the ketofol group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Infusion of ketofol in children undergoing tonsillectomy provides shorter recovery time and lower incidence of EA despite the non significant difference with propofol.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jalili</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Assistant Professor of Anesthesiology, Department of Anesthesiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esmaeeili</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Department of Anesthesiology, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamali</LastName><ForeName>Koorosh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PhD, Associate Professor of Epidemiology, Department of Public Health, School of Public Health, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashtchi</LastName><ForeName>Vahideh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Assistant Professor of Anesthesiology, Department of Anesthesiology, School of Nursing and Midwifery, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Afr Health Sci</MedlineTA><NlmUniqueID>101149451</NlmUniqueID><ISSNLinking>1680-6905</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emergence agitation</Keyword><Keyword MajorTopicYN="N">ketofol</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31149004</ArticleId><ArticleId IdType="pmc">PMC6531964</ArticleId><ArticleId IdType="doi">10.4314/ahs.v19i1.50</ArticleId><ArticleId IdType="pii">jAFHS.v19.i1.pg1736</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Voepel-Lewis T, Burke C, Hadden S.M, Tait AR, Malviya S. Nurses' diagnoses and treatment decisions regarding care of the agitated child. J Perianesth Nurs. 2005;20(4):239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya Akihiro. Emergence agitation in children: risk factors, prevention, and treatment. J Anesth. 2016;30:261&#x2013;267. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">26601849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasar VG, Hannallah RS. Emergence agitation in children: a review. MEJ Anesth. 2011;21(2):175&#x2013;184. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">22435269</ArticleId></ArticleIdList></Reference><Reference><Citation>Beskow A, Westrin P. Sevoflurane causes more postoperative agitation in children than does halothane. Acta-Anaesthesiol Scand. 1999;43(5):536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">10342001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollister GR, Burn JM. Side effects of ketamine in pediatric anesthesia. Anesth Analg. 1974;53(2):264&#x2013;267. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">4856136</ArticleId></ArticleIdList></Reference><Reference><Citation>De grood PM, Coenen LG, Van Egmond J, Booij LH, Crul JF. Propofol emulsion for induction and maintenance of anesthesia. A combined technique of general and regional aneshtsia. Acta Anaesthesiol Scand. 1987;31:219&#x2013;223. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">3495089</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Shahwan I, Chowdary K. Ketamine is effective in decreasing the incidence of emergence agitation in children undergoing dental repair under sevoflurane general anesthesia. Paediatric Anaesthesia. 2007;17(9):846&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">17683402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepous&#xe9; C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delirium in adults in the post-anaesthesia care unit. Brit J Anaesth. 2006;96(6):747&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">16670111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohkamkar M, Farhoudi F, Alam-Sahebpour A, et al. Postanesthetic Emergence Agitation in Pediatric Patients under General Anesthesia. Iran J Pediatr. 2014;24(2):184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4268839</ArticleId><ArticleId IdType="pubmed">25535538</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104(1):84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179249</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmani S, Delivet H, Hilly J. Emergence delirium in children: an update. Current Opinion in Anaesthesiology. 2014;27(3):309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">24784918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Moon BE, Kim H, Lee JR. Comparison of propofol and fentanyl administered at the end of anaesthesia for prevention of emergence agitation after sevofluraneanaesthesia in children. British Journal of Anaesthesia. 2013;110(2):274&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen IT, Finkel JC, Hannallah RS, et al. Rapid emergence does not explain agitation following sevofluraneanaesthesia in infants and children: a comparison with propofol. Paediatr Anaesth. 2003;13:63&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lop&#xe9;z Gil ML, Brimacombe J, Clar B. Sevoflurane versus propofol for induction and maintenance of anaesthesia with the laryngeal mask airway in children. Paediatr Anaesth. 1999;9:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">10597550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama S, Furukawa H, Yanai H. Propofol reduces the incidence of emergence agitation in preschool-aged children as well as in school-aged children: a comparison with sevoflurane. J Anesth. 2007;21:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">17285408</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard V, Dumont L, Pellegrini M. Quality of recovery in children: sevoflurane versus propofol. Acta Anaesthesiol Scand. 2000;44:307&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">10714845</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahn EL, Holt KR. Procedural sedation and analgesia: a review and new concepts. Emergency Med Clin North Am. 2005;23:503&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">15829394</ArticleId></ArticleIdList></Reference><Reference><Citation>De grood PM, Coenen LG, Van Egmond J, Booij LH, Crul JF. Propofol emulsion for induction and maintenance of anesthesia. A combined technique of general and regional aneshtsia. Acta Anaesthesiol Scand. 1987;31:219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">3495089</ArticleId></ArticleIdList></Reference><Reference><Citation>Green SM, Krauss B. The semantics of ketamine. Ann Emergency Med. 2000;39:480&#x2013;482. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">11054203</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu F, Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract Res ClinAnaesthesiol. 2002;16:475&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">12516886</ArticleId></ArticleIdList></Reference><Reference><Citation>Warncke T, Stubhaug A, et al. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997;72:99&#x2013;106. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">9272793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieters BJ, Penn E, Nicklaus P, Bruegger D, Mehta B, Weatherly R. Emergence delirium and postoperative pain in children undergoing adenotonsillectomy: a comparison of propofolvssevoflurane anesthesia. Paediatric Anaesthesia. 2010;20(10):944&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">20735801</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama K, Inomata S, Okubo N, Watanabe I. Pretreatment with small-dose ketamine reduces predicted effect-site concentration of propofol required for loss of consciousness and laryngeal mask airway insertion in women. J ClinAnesth. 2011;23:113&#x2013;118. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">21377074</ArticleId></ArticleIdList></Reference><Reference><Citation>Godambe SA, Elliot V, Matheny D, Pershad J. Comparison of propofol/fentanyl versus ketamine/midazolam for brief orthopedic procedural sedation in a pediatric emergency department. Pediatrics. 2003;112:116&#x2013;123. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">12837876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharieff GQ, Trocinski DR, Kanegaye JT, Fisher B, Harley JR. Ketamine-propofol combination sedation for fracture reduction in the pediatric emergency department. Pediatr Emergency Care. 2007;23(12):881&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">18091596</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A, Mosdossy G, McLeod S, Lehnhardt K, Peddle M, Rieder M. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emergency Med. 2011;57(5):425&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">20947210</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfatto G, Willman E. A prospective case series of pediatric procedural sedation and analgesia in the emergency department using single-syringe ketamine-propofol combination (ketofol) Acad Emergency Med. 2010;17(2):194&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">20370749</ArticleId></ArticleIdList></Reference><Reference><Citation>David H, Shipp J. Randomized controlled trial of ketamine/propofol versus propofol alone for emergency department procedural sedation. Ann Emergency Med. 2011;57(5):435.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256626</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S. Combining ketamine and propofol (&#x201c;ketofol&#x201d;) for emergency department procedural sedation and analgesia: a review. West J Emergency Med. 2008;9(1):20&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672224</ArticleId><ArticleId IdType="pubmed">19561698</ArticleId></ArticleIdList></Reference><Reference><Citation>Daabiss M, Elsherbiny M, AlOtibi R. Assessment of different concentrations of ketofol in procedural operation. BJMP. 2009;2(1):27&#x2013;31.</Citation></Reference><Reference><Citation>Wang Y, Jiang X, Pang L, et al. A randomized double-blind controlled study of the efficacy of ketofol with propofol-fentanyl and propofol alone in termination of pregnancy. Afr J pharm pharmacol. 2012;6(34):2510&#x2013;2514.</Citation></Reference><Reference><Citation>Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004;100(5):1138&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">15114210</ArticleId></ArticleIdList></Reference><Reference><Citation>Somaini M, Engelhardt T, Fumagalli R, Ingelmo PM. Emergence delirium or pain after anaesthesia--how to distinguish between the two in young children: a retrospective analysis of observational studies. Br J Anaesth. 2016;116:377.</Citation><ArticleIdList><ArticleId IdType="pubmed">26865130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa SA, Costi D, Cyna AM. A comparison of emergence delirium scales following general anesthesia in children. Paediatr Anaesth. 2010;20:704&#x2013;711. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">20497353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya A, Kuratani N, Satoh D, Kurosawa S. Lower incidence of emergence agitation in children after propofol anesthesia compared with sevoflurane: a meta-analysis of randomized controlled trials. J Anesth. 2014;28:4&#x2013;11. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">23800983</ArticleId></ArticleIdList></Reference><Reference><Citation>Costi D, Cyna AM, Ahmed S, et al. Effects of sevoflurane versus other general anaesthesia on emergence agitation in children. Cochrane Database Syst Rev. 2014:CD007084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10898224</ArticleId><ArticleId IdType="pubmed">25212274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalens BJ, Pinard AM, L&#xe9;tourneau DR, et al. Prevention of emergence agitation after sevoflurane anesthesia for pediatric cerebral magnetic resonance imaging by small doses of ketamine or nalbuphine administered just before discontinuing anesthesia. Anesth Analg. 2006;102:1056.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmani S, Stany I, Brasher C, et al. Pharmacological Prevention of Sevoflurane- and Desflurane-Related Emergence Agitation in Children: A Meta-Analysis of Published Studies. British Journal of Anaesthesia. 2010;104:216&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047899</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LM, Braz LG, M&#xf3;dolo NS. Emergence agitation in pediatric anesthesia: current features. J Pediatr (Rio J) 2008;84(2):107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372935</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis PG, Greeberg JA, Genldeman M, Fertal K. Recovery characteristics of sevoflurane and halothane in preschool-aged children undergoing bilateral myringotomy and pressure equalization tube insertion. Anesth Analg. 1999;88:34&#x2013;38. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">9895062</ArticleId></ArticleIdList></Reference><Reference><Citation>Isik B, M Arslan, Tunga AD, Kurtipec O. Dexmedetomidine decreases emergence agitation in pediatric pacientes after sevoflurane anesthesia without surgery. Paediatr Anaesth. 2006;16:748&#x2013;753. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879517</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldon BC, Bell M, Craddock T. The effect of caudal analgesia on emergence agitation in children after sevoflurane versus halothane anesthesia. Anesth Analg. 2004;98:321&#x2013;326. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">14742362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui TW, Short TG, Hong W, et al. Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology. 1995;82:641&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">7879932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallimore D, Anderson BJ, Short TG, et al. Ketamine anesthesia in children-exploring infusion regimens. Pediatr Anesth. 2008;18:708&#x2013;714. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">18613930</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulter Finn LS, Hannam Jacqueline A, Anderson Brian J. Ketofol dosingsimulations for procedural sedation. Pediatric Emergency Care. 2014;30(9)</Citation><ArticleIdList><ArticleId IdType="pubmed">25162687</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Esmaoglu A, Guler G, Demircioglu R, Narin N, Boyaci A. Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Pediatr-Cardiol. 2005;26(5):553&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">16132313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosun Z, Esmaoglu A, Coruh A. Propofol -ketamine vspropofol-fentanyl combinations for deep sedation and analgesia in pediatric patients undergoing burn dressing changes. Pediatr Anesth. 2008;18:43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18095965</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulter FLS, Hannam JA, Anderson BJ. Ketofol dosing simulations for procedural sedation. Pediatric Emergency Care. 2014;30(9):621&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162687</ArticleId></ArticleIdList></Reference><Reference><Citation>Amornyotin S. Ketofol: A Combination of Ketamine and Propofol. Journal of Anesthesia &amp; Critical Care. 2014;1(15)</Citation></Reference><Reference><Citation>Sherry N, Riz k, Enas M, Samir Use of ketofol to control emergence agitation in children undergoing adenotonsillectomy. Egyptian Journal of Anaesthesia. 2014;30:13&#x2013;19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37541486</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Metoprolol for prevention of bucking at orotracheal extubation: a double-blind, placebo-controlled randomised trial.</ArticleTitle><Pagination><StartPage>744455</StartPage><MedlinePgn>744455</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">744455</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2023.07.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(23)00080-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory responses to extubation can cause serious postoperative complications. Beta-blockers, such as metoprolol, can interfere with the cough pathway. However, whether metoprolol can effectively control respiratory reflexes during extubation remains unclear. The objective of this study is to evaluate the efficacy of intravenous metoprolol in attenuating respiratory responses to tracheal extubation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized, double-blinded, placebo-controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary referral center located in Bras&#xed;lia, Brazil. Recruitment: June 2021 to December 2021.</AbstractText><AbstractText Label="SAMPLE" NlmCategory="METHODS">222 patients of both sexes with an American Society of Anesthesiologists (ASA) physical status I-III aged 18-80 years. Patients were randomly assigned to receive intravenous metoprolol 5 mg IV or placebo at the end of surgery. The primary outcome was the proportion of patients who developed bucking secondary to endotracheal tube stimulation of the tracheal mucosa during extubation. Secondary outcomes included coughing, bronchospasm, laryngospasm, Mean Blood Pressure (MAP), and Heart Rate (HR) levels.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred and seven participants were included in the final analysis: 102 in the metoprolol group and 105 in the placebo group. Patients who received metoprolol had a significantly lower risk of bucking (43.1% vs. 64.8%, Relative Risk [RR = 0.66], 95% Confidence Interval [95% CI 0.51-0.87], p = 0.003). In the metoprolol group, 6 (5.9%) patients had moderate/severe coughing compared with 33 (31.4%) in the placebo group (RR = 0.19; 95% CI 0.08-0.43, p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metoprolol reduced the risk of bucking at extubation in patients undergoing general anesthesia compared to placebo.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Espa&#xf1;a S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Queiroz</LastName><ForeName>Murilo Neves</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Hospital de Base do Distrito Federal, Bras&#xed;lia, DF, Brazil; Escola Superior de Ci&#xea;ncias da Sa&#xfa;de, Bras&#xed;lia, DF, Brazil; TSA, Sociedade Brasileira de Anestesiologia, Rio de Janeiro, RJ, Brazil. Electronic address: murilo.queiroz@escs.edu.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendon&#xe7;a</LastName><ForeName>Fabr&#xed;cio Tavares</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Hospital de Base do Distrito Federal, Bras&#xed;lia, DF, Brazil; TSA, Sociedade Brasileira de Anestesiologia, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Matos</LastName><ForeName>Maur&#xed;cio Vargas</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Hospital de Base do Distrito Federal, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lino</LastName><ForeName>Rafael Santos</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Hospital de Base do Distrito Federal, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Luiz S&#xe9;rgio Fernandes</ForeName><Initials>LSF</Initials><AffiliationInfo><Affiliation>Hospital de Base do Distrito Federal, Bras&#xed;lia, DF, Brazil; Escola Superior de Ci&#xea;ncias da Sa&#xfa;de, Bras&#xed;lia, DF, Brazil; Clarity Healthcare Intelligence, Jundia&#xed;, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>GEB06NHM23</RegistryNumber><NameOfSubstance UI="D008790">Metoprolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008790" MajorTopicYN="Y">Metoprolol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="Y">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway extubation</Keyword><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Metoprolol</Keyword><Keyword MajorTopicYN="N">Tachycardia and hypertension</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37541486</ArticleId><ArticleId IdType="pmc">PMC10963920</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2023.07.012</ArticleId><ArticleId IdType="pii">S0104-0014(23)00080-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tung A, Fergusson NA, Ng N, Hu V, Dormuth C, Griesdale DEG. Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis. Br J Anaesth. 2020 doi: 10.1016/j.bja.2019.12.041. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.12.041</ArticleId><ArticleId IdType="pubmed">32098647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendon&#xe7;a FT, Barreto Filho JH, Hungria MBCS, Magalh&#xe3;es TC. Efficacy of a single dose of esmolol to prevent extubation-related complications during emergence from anesthesia: a randomized, double-blind, placebo-controlled trial. Braz J Anesthesiol. 2023;73:426&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10362437</ArticleId><ArticleId IdType="pubmed">34560115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Li Y, Wang S, Xu S, Ju X, Ma L. Effects of intravenous infusion of lidocaine and dexmedetomidine on inhibiting cough during the tracheal extubation period after thyroid surgery. BMC Anesthesiol. 2019;19:66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500031</ArticleId><ArticleId IdType="pubmed">31054568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SS, Wang NN, Postonogova T, et al. Intravenous lidocaine to prevent postoperative airway complications in adults: a systematic review and meta-analysis. Br J Anaesth. 2020;124:314&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">32000978</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai T, Koga K, Vaughan RS. Respiratory complications associated with tracheal intubation and extubation. Br J Anaesth. 1998;80:767&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771306</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs A, McGrath BA, Goddard C, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120:323&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">29406182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostan H, Eroglu A. Comparison of the clinical efficacies of fentanyl, esmolol and lidocaine in preventing the hemodynamic responses to endotracheal intubation and extubation. J Curr Surg. 2012;2:24&#x2013;28.</Citation></Reference><Reference><Citation>Prajwal Patel HS, Shashank MR, Shivaramu BT. Attenuation of hemodynamic response to tracheal extubation: a comparative study between esmolol and labetalol. Anesth Essays Res. 2018;12:180&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872860</ArticleId><ArticleId IdType="pubmed">29628578</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xf6;r&#xfc;koglu D, G&#xf6;ktug A, Alanoglu Z, Tulunay M. Comparison of intravenous metoprolol, verapamil and diltiazem on the attenuation of haemodynamic changes associated with tracheal extubation. Eur J Anaesthesiol. 1999;16:462&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">10457878</ArticleId></ArticleIdList></Reference><Reference><Citation>Azhar R, Gauhar A. Haemodynamic response to tracheal extubation: verapamil versus metoprolol. Gen Med Open Access. 2015:1&#x2013;4.</Citation></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Minogue SC, Ralph J, Lampa MJ. Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia. Anesth Analg. 2004;99:1253&#x2013;1257.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnani E, Sanjeev OP, Singh A, Tripathi M, Chourasia HK. A comparative study of intravenous esmolol, labetalol and lignocaine in low doses for attenuation of sympathomimetic responses to laryngoscopy and endotracheal intubation. Anesth Essays Res. 2017;11:745&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5594800</ArticleId><ArticleId IdType="pubmed">28928581</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson A, Isaac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg. 1990;71:675&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">1978612</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektook NH, Ali S, Fadhil H. Comparative study between lidocaine and Metoprolol on hemodynamic attenuation during laryngoscope and endotracheal intubation. Gulf J Scientific Res. 2018;6:330&#x2013;334.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19142544</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1980-5322</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>1</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Clinics (Sao Paulo, Brazil)</Title><ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Non-asthmatic patients show increased exhaled nitric oxide concentrations.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>10</EndPage><MedlinePgn>5-10</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Evaluate whether exhaled nitric oxide may serve as a marker of intraoperative bronchospasm.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Intraoperative bronchospasm remains a challenging event during anesthesia. Previous studies in asthmatic patients suggest that exhaled nitric oxide may represent a noninvasive measure of airway inflammation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 146,358 anesthesia information forms, which were received during the period from 1999 to 2004, were reviewed. Bronchospasm was registered on 863 forms. From those, three groups were identified: 9 non-asthmatic patients (Bronchospasm group), 12 asthmatics (Asthma group) and 10 subjects with no previous airway disease or symptoms (Control group). All subjects were submitted to exhaled nitric oxide measurements (parts/billion), spirometry and the induced sputum test. The data was compared by ANOVA followed by the Tukey test and Kruskal-Wallis followed by Dunn's test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The normal lung function test results for the Bronchospasm group were different from those of the asthma group (p &lt;0.05). The median percentage of eosinophils in induced sputum was higher for the Asthma [2.46 (0.45-6.83)] compared with either the Bronchospasm [0.55 (0-1.26)] or the Control group [0.0 (0)] (p &lt;0.05); exhaled nitric oxide followed a similar pattern for the Asthma [81.55 (57.6-86.85)], Bronchospasm [46.2 (42.0 -62.6] and Control group [18.7 (16.0-24.7)] (p&lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Non-asthmatic patients with intraoperative bronchospasm detected during anesthesia and endotracheal intubation showed increased expired nitric oxide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saraiva-Romanholo</LastName><ForeName>Beatriz M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Fabio S</ForeName><Initials>FS</Initials></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Francine M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Maria do Patroc&#xed;nio T</ForeName><Initials>Mdo P</Initials></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Milton A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Joaquim E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clinics (Sao Paulo)</MedlineTA><NlmUniqueID>101244734</NlmUniqueID><ISSNLinking>1807-5932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045853" MajorTopicYN="N">Exhalation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19142544</ArticleId><ArticleId IdType="pmc">PMC2671975</ArticleId><ArticleId IdType="doi">10.1590/s1807-59322009000100002</ArticleId><ArticleId IdType="pii">S1807-5932(22)02698-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olsson GL. Bronchospasm during anesthesia. A computer-aided incidence study of 136,929 patients. Acta Anaesthesiol Scand. 1987;31:244&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">3577646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizov R, Brown RH, Weiss YS, Baranov D, Hennes H, Baker S, et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology. 1995;82:1111&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner DO, Warner MA, Barnes RD, Offord KP, Schroeder DR, Gray DT, et al. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996;85:460&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8853074</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and
          PreventionIssued January, 1995. Updated 2005. [http://www.ginasthma.org]</Citation></Reference><Reference><Citation>Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N. A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol. 1998;113:33&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9776548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7508323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado CM, Leick-Maldonado EA, Kasahara DI, Capelozzi VL, Martins MA, Tiberio IFLC. Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2005;289:L677&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">15937069</ArticleId></ArticleIdList></Reference><Reference><Citation>Leme AS, Kasahara DI, Nunes MP, Martins MA, Vieira JE. Exhaled nitric oxide collected with two different mouthpieces: a study in asthmatic patients. Braz J Med Biol Res. 2002;35:1133&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12424484</ArticleId></ArticleIdList></Reference><Reference><Citation>Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996;153:1510&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8630594</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl Med. 2005;352:2163&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15914548</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and PreventionIssued January, 1995. Updated 2002. NIH Publication. No 02-3659.2002</Citation></Reference><Reference><Citation>American Thoracic Society Standardization of spirometry. Am J Respir Crit Care Med. 1995;152:1107&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">7663792</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">10588636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 1997;10:1683&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">9230267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzichini E, Pizzichini MMM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">8804934</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rensen EL, Straathof KC, Veseselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma. Thorax. 1999;54:403&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1763792</ArticleId><ArticleId IdType="pubmed">10212103</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva-Romanholo BM, Barnabe V, Carvalho AL, Martins MA, Saldiva PH, Nunes Mdo P. Comparison of three methods for differential cell count in induced sputum. Chest. 2003;124:1060&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12970038</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter WE, Hardt NS, Fuhrman S. Immunoglobulin E: importance in parasitic infections and hypersensitivity responses. Arch Pathol Lab Med. 2000;124:1382&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10975945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy. 1993;48:473&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8238806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima RG, Pastorino AC, Casagrande RR, Sole D, Leone C, Jacob CM. Prevalence of asthma, rhinitis and eczema in 6 - 7 years old students from the western districts of S&#xe3;o Paulo City, using the standardized questionnaire of the &#x201c;International Study of Asthma and Allergies in Childhood&#x201d; (ISAAC)-phase IIIB. Clinics. 2007;62:225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17589661</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, De Jongste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsivenes. Am J Respir Crit Care Med. 2000;162:953&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10988112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonov SA, O&#x2019;Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med. 1995;151:1894&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">7767537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther. 2005;27:1238&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16199248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz MJ, Leung DYM, McCormick DR, Harbeck R, Szefler SJ, White CW. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr Pulmonol. 1997;24:305&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax. 1996;51:233&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090631</ArticleId><ArticleId IdType="pubmed">8779123</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997;131:381&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9329413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Jataknaon A, John M, Gilbey T, O&#x2019;Connor BJ, Chung K, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999;159:22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jilma B, Kastner J, Mensik C, Vondrovec B, Hildebrandt J, Krejcy K, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 1996;58:469&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">8569419</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J. 2000;16:1008&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11153569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758706</ArticleId><ArticleId IdType="pubmed">9624291</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol. 2000;106:638&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">11031333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose M, Takahashi T, Sugiura H, Endoh E, Miura M, Mashito Y, et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J. 2000;15:248&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">10706487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma. 2003;40:653&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14579996</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Giudice MM, Brunese FP, Piacentini GL, Pedulla M, Capristo C, Decimo F, et al. Fractional exhaled nitric oxide (FENO), lung function and airway hyperresponsiveness in na&#xef;ve atopic asthmatic children. J Asthma. 2004;41:759&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">15584636</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley SJ, Goldthorpe S, Custovic A, Woodcock A. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol. 2003;91:398&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">14582820</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallarossa D, Battistini E, Silvestri M, Sabatini F, Fregonese L, Brazzola G, et al. Steroid-na&#xef;ve adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and exhaled nitric oxide levels. J Asthma. 2003;40:301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12807174</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-na&#xef;ve patients with mild asthma. Am J Resp Crit Care Med. 1998;157:894&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9517608</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998;157:4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9445270</ArticleId></ArticleIdList></Reference><Reference><Citation>Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG.Dissociation by steroids of eosinophilic inflammation from
            airway hyperresponsiveness in murine airways Respir
            Res 200343[http://www.respiratory-research/content/4/1/3]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152648</ArticleId><ArticleId IdType="pubmed">12657158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31009034</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6211</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA pediatrics</Title><ISOAbbreviation>JAMA Pediatr</ISOAbbreviation></Journal><ArticleTitle>Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>527</StartPage><EndPage>533</EndPage><MedlinePgn>527-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapediatrics.2019.0788</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Tonsillectomy is a common pediatric procedure for the treatment of sleep-disordered breathing and chronic tonsillitis. Up to half of children having this procedure experience a perioperative respiratory adverse event.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether inhaled albuterol sulfate (salbutamol sulfate) premedication decreases the risk of perioperative respiratory adverse events in children undergoing anesthesia for tonsillectomy.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">A randomized, triple-blind, placebo-controlled trial (the Reducing Anesthetic Complications in Children Undergoing Tonsillectomies [REACT] trial) was conducted at Perth Children's Hospital (formerly Princess Margaret Hospital for Children), the only tertiary pediatric hospital in Western Australia. Participants included 484 children aged 0 to 8 years who were undergoing anesthesia for tonsillectomy. The study was conducted between July 15, 2014, and May 18, 2017.</AbstractText><AbstractText Label="INTERVENTIONS">Participants were randomized to receive either albuterol (2 actuations, 200 &#x3bc;g) or placebo before their surgery.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Occurrence of perioperative respiratory adverse events (bronchospasm, laryngospasm, airway obstruction, desaturation, coughing, and stridor) until discharge from the postanesthesia care unit.</AbstractText><AbstractText Label="RESULTS">Of 484 randomized children (median [range] age, 5.6 [1.6-8.9] years; 285 [58.9%] boys), 479 data sets were available for intention-to-treat analysis. Perioperative respiratory adverse events occurred in 67 of 241 children (27.8%) receiving albuterol and 114 of 238 children (47.9%) receiving placebo. After adjusting for age, type of airway device, and severity of obstructive sleep apnea in a binary logistic regression model, the likelihood of perioperative respiratory adverse events remained significantly higher in the placebo group compared with the albuterol group (odds ratio, 2.8; 95% CI, 1.9-4.2; P&#x2009;&lt;&#x2009;.001). Significant differences were seen in children receiving placebo vs albuterol in laryngospasm (28 [11.8%] vs 12 [5.0%]; P&#x2009;=&#x2009;.009), coughing (79 [33.2%] vs 27 [11.2%]; P&#x2009;&lt;&#x2009;.001), and oxygen desaturation (54 [22.7%] vs 36 [14.9%]; P&#x2009;=&#x2009;.03).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Albuterol premedication administered before tonsillectomy under general anesthesia in young children resulted in a clinically significant reduction in rates of perioperative respiratory adverse events compared with the rates in children who received placebo. Premedication with albuterol should be considered for children undergoing tonsillectomy.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Australian New Zealand Clinical Trials Registry identifier: ACTRN12614000739617.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slevin</LastName><ForeName>Lliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>Thomas F E</ForeName><Initials>TFE</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guicheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Public Health, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genetic Origins of Health and Disease, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Graham L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physiotherapy and Exercise Science, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Child Health Research, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Pediatr</MedlineTA><NlmUniqueID>101589544</NlmUniqueID><ISSNLinking>2168-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arch Dis Child Educ Pract Ed. 2020 Dec;105(6):383-384. doi: 10.1136/archdischild-2019-318590.</RefSource><PMID Version="1">31969376</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr von Ungern-Sternberg reported receiving grants from the Perth Children&#x2019;s Hospital (PCH) Foundation and Australia and New Zealand College of Anaesthetists (ANZCA), and other support from the PCH Foundation during the conduct of the study. Dr Sommerfield reported receiving grants from the PCH Foundation and from Australian and New Zealand College of Anaesthetists during the conduct of the study. Ms Slevin reported receiving grants from the PCH Foundation and ANZCA during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31009034</ArticleId><ArticleId IdType="pmc">PMC6547220</ArticleId><ArticleId IdType="doi">10.1001/jamapediatrics.2019.0788</ArticleId><ArticleId IdType="pii">2731129</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ENTUK Indications for Tonsillectomy: Position Paper. London, UK: Royal College of Surgeons of England; 2009.</Citation></Reference><Reference><Citation>Burton MJ, Glasziou PP, Chong LY, Venekamp RP. Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Cochrane Database Syst Rev. 2014;(11):CD001802. doi:10.1002/14651858.CD001802.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001802.pub3</ArticleId><ArticleId IdType="pmc">PMC7075105</ArticleId><ArticleId IdType="pubmed">25407135</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Intercollegiate Guidelines Network Management of sore throat and indications for tonsillectomy. Edinburgh, UK: Scottish Intercollegiate Guidelines Network; 2010.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Davies K, Hegarty M, Erb TO, Habre W. The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial. Eur J Anaesthesiol. 2013;30(9):529-536. doi:10.1097/EJA.0b013e32835df608</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835df608</ArticleId><ArticleId IdType="pubmed">23344124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JC, King MA, Mitchell RB, Kelly JP. Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg. 2006;103(5):1115-1121. doi:10.1213/01.ane.0000244318.77377.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000244318.77377.67</ArticleId><ArticleId IdType="pubmed">17056942</ArticleId></ArticleIdList></Reference><Reference><Citation>Regli A, von Ungern-Sternberg BS. Diagnosis and management of respiratory adverse events in the operating room. Curr Anesthesiol Rep. 2015;5(2):156-167. doi:10.1007/s40140-015-0103-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40140-015-0103-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus intravenous induction of anesthesia in children with a high risk of perioperative respiratory adverse events: a randomized controlled trial. Anesthesiology. 2018;128(6):1065-1074. doi:10.1097/ALN.0000000000002152</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002152</ArticleId><ArticleId IdType="pubmed">29498948</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TFE, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet. 2017;389(10070):701-708. doi:10.1016/S0140-6736(16)31719-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalfaro P, Sly PD, Sims C, Habre W. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth Analg. 2001;93(4):898-902. doi:10.1097/00000539-200110000-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00019</ArticleId><ArticleId IdType="pubmed">11574353</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwood T, Morris W, Martin LD, et al. . Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. Can J Anaesth. 2003;50(3):277-284. doi:10.1007/BF03017798</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03017798</ArticleId><ArticleId IdType="pubmed">12620952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Sommerfield D, et al. . Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. Br J Anaesth. 2017;119(1):150-157. doi:10.1093/bja/aex139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex139</ArticleId><ArticleId IdType="pubmed">28974069</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Habre W, Erb TO, Heaney M. Salbutamol premedication in children with a recent respiratory tract infection. Paediatr Anaesth. 2009;19(11):1064-1069. doi:10.1111/j.1460-9592.2009.03130.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2009.03130.x</ArticleId><ArticleId IdType="pubmed">19694973</ArticleId></ArticleIdList></Reference><Reference><Citation>Regli A, Becke K, von Ungern-Sternberg BS. An update on the perioperative management of children with upper respiratory tract infections. Curr Opin Anaesthesiol. 2017;30(3):362-367. doi:10.1097/ACO.0000000000000460</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000460</ArticleId><ArticleId IdType="pubmed">28291127</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, et al. . Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010;376(9743):773-783. doi:10.1016/S0140-6736(10)61193-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, et al. ; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network . Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5(5):412-425. doi:10.1016/S2213-2600(17)30116-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30116-9</ArticleId><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavreska V, Verheggen M, Oostryck J, Stick SM, Hall GL. Determining the time to maximal bronchodilator response in asthmatic children. J Asthma. 2009;46(1):25-29. doi:10.1080/02770900802460555</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770900802460555</ArticleId><ArticleId IdType="pubmed">19191133</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Commission on Safety and Quality in Health Care The First Australian Atlas of Healthcare Variation. Canberra, Australia: ACSQHC; 2015.</Citation></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Deep or awake removal of laryngeal mask airway in children at risk of respiratory adverse events undergoing tonsillectomy&#x2014;a randomised controlled trial. Br J Anaesth. 2018;120(3):571-580. doi:10.1016/j.bja.2017.11.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.11.094</ArticleId><ArticleId IdType="pubmed">29452814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaw R, Chung F, Pasupuleti V, Mehta J, Gay PC, Hernandez AV. Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome. Br J Anaesth. 2012;109(6):897-906. doi:10.1093/bja/aes308</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes308</ArticleId><ArticleId IdType="pubmed">22956642</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Morin I, Hickey C, Manoukian JJ, Nixon GM, Brouillette RT. Urgent adenotonsillectomy: an analysis of risk factors associated with postoperative respiratory morbidity. Anesthesiology. 2003;99(3):586-595. doi:10.1097/00000542-200309000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200309000-00013</ArticleId><ArticleId IdType="pubmed">12960542</ArticleId></ArticleIdList></Reference><Reference><Citation>McColley SA, April MM, Carroll JL, Naclerio RM, Loughlin GM. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118(9):940-943. doi:10.1001/archotol.1992.01880090056017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1992.01880090056017</ArticleId><ArticleId IdType="pubmed">1503720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawar D. Common post-operative complications in children. Indian J Anaesth. 2012;56(5):496-501. doi:10.4103/0019-5049.103970</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.103970</ArticleId><ArticleId IdType="pmc">PMC3531006</ArticleId><ArticleId IdType="pubmed">23293390</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi Y, Kuwahara M, Nanji A, et al. . The difference in citric acid-induced cough in congenitally bronchial-hypersensitive (BHS) and bronchial-hyposensitive (BHR) guinea pigs. Exp Anim. 2001;50(5):371-378. doi:10.1538/expanim.50.371</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.50.371</ArticleId><ArticleId IdType="pubmed">11769539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17388233</PMID><DateCompleted><Year>2007</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4894</ISSN><JournalIssue CitedMedium="Print"><Volume>116</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Annals of otology, rhinology, and laryngology</Title><ISOAbbreviation>Ann Otol Rhinol Laryngol</ISOAbbreviation></Journal><ArticleTitle>Administration of esmolol in microlaryngeal surgery for blunting the hemodynamic response during laryngoscopy and tracheal intubation in cigarette smokers.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>111</EndPage><MedlinePgn>107-11</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Cigarette smokers constitute a group of patients with an increased hemodynamic response to tracheal intubation. We studied the dose-response and side effects of bolus administration of esmolol hydrochloride in cigarette smokers undergoing elective microlaryngeal surgery, when esmolol was used for reducing the intense hemodynamic response to laryngoscopy and tracheal intubation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We randomly allocated 165 patients (American Society of Anesthesiologists physical status classes I to III) to receive placebo (Eplac) or esmolol 1 mg/kg (E1) or 2 mg/kg (E2). The esmolol was given 2 minutes before laryngoscopy and tracheal intubation. The same anesthetic technique was used in all patients. Cardiovascular parameters were recorded every minute for the first 5 minutes and thereafter every 3 minutes. Bronchospasm, other side effects, and rescue esmolol treatment were noted during anesthesia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In group Eplac, significant increases (p &lt; .05) in arterial blood pressure and heart rate were observed in the first 3 minutes after tracheal intubation. In group E1, significant increases (p &lt; .05) in diastolic blood pressure were observed in the first 2 minutes after intubation. In group E2, no significant fluctuations were recorded in cardiovascular parameters after intubation. During surgery, 17% of the patients in group Eplac showed an increase in blood pressure and tachycardia.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We conclude that esmolol administration of 2 mg/kg during induction of anesthesia in smokers provides hemodynamic stability after laryngoscopy and tracheal intubation with no severe side effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Louizos</LastName><ForeName>Antonios A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hippocration General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadzilia</LastName><ForeName>Sophie J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Davilis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Samanta</LastName><ForeName>Evangelia G</ForeName><Initials>EG</Initials></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Loucas G</ForeName><Initials>LG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Otol Rhinol Laryngol</MedlineTA><NlmUniqueID>0407300</NlmUniqueID><ISSNLinking>0003-4894</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>MDY902UXSR</RegistryNumber><NameOfSubstance UI="C036604">esmolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007818" MajorTopicYN="N">Laryngeal Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="Y">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008866" MajorTopicYN="N">Microsurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011412" MajorTopicYN="N">Propanolamines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>3</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>4</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>3</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17388233</ArticleId><ArticleId IdType="doi">10.1177/000348940711600205</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28882740</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of sleep deprivation after a night shift duty on simulated crisis management by residents in anaesthesia. A randomised crossover study.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>166</EndPage><MedlinePgn>161-166</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2017.05.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(16)30120-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sleep deprivation has been associated with an increased incidence of medical errors and can jeopardise patients' safety during medical crisis management. The aim of the study was to assess the effect of sleep deprivation on the management of simulated anaesthesia crisis by residents in anaesthesiology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A randomised, comparative, monocentric crossover study involving 48 residents in anaesthesia was performed on a high fidelity patient simulator. Each resident was evaluated in a sleep-deprived state (deprived group, after a night shift duty) and control state (control group, after a night of sleep). Performance was assessed through points obtained during crisis scenario 1 (oesophageal intubation followed by anaphylactic shock) and scenario 2 (anaesthesia-related bronchospasm followed by ventricular tachycardia). Sleep periods were recorded by actigraphy. Two independent observers assessed the performances. The primary endpoint of the study was the score obtained for each scenario.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Resident's crisis management performance is associated with sleep deprivation (scenario 1: control=39 [33-42] points vs. deprived=26 [19-40] points, P=0.02; scenario 2: control=21 [17-24] vs. deprived=14 [12-19], P=0.01). The main errors observed were: error in drug administration and dose, delay in identification of hypotension, and missing communication with the surgical team about situation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present study showed that sleep deprivation is associated with impairment of performance to manage crisis situations by residents in anaesthesia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Soci&#xe9;t&#xe9; fran&#xe7;aise d&#x2019;anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arzalier-Daret</LastName><ForeName>S&#xe9;gol&#xe8;ne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>P&#xf4;le de r&#xe9;animations-anesth&#xe9;sie (niveau&#xa0;6), CHU de Caen, avenue C&#xf4;te-de-Nacre, 14033 Caen cedex 9, France; P&#xf4;le des formations et de recherche en sant&#xe9;, laboratoire de simulation m&#xe9;dicale NorSims, facult&#xe9; de m&#xe9;decine, UNICAEN, universit&#xe9; Caen-Normandie, 2, rue des Rochambelles, 14032 Caen cedex, France. Electronic address: arzalier-s@chu-caen.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bul&#xe9;on</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>P&#xf4;le de r&#xe9;animations-anesth&#xe9;sie (niveau&#xa0;6), CHU de Caen, avenue C&#xf4;te-de-Nacre, 14033 Caen cedex 9, France; P&#xf4;le des formations et de recherche en sant&#xe9;, laboratoire de simulation m&#xe9;dicale NorSims, facult&#xe9; de m&#xe9;decine, UNICAEN, universit&#xe9; Caen-Normandie, 2, rue des Rochambelles, 14032 Caen cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocca</LastName><ForeName>Marie-Laure</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Inserm, U1075 COMETE, p&#xf4;le des formations et de recherche en sant&#xe9;, facult&#xe9; de m&#xe9;decine, UNICAEN, universit&#xe9; Caen-Normandie, 2, rue des Rochambelles, 14032 Caen cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denise</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Inserm, U1075 COMETE, p&#xf4;le des formations et de recherche en sant&#xe9;, facult&#xe9; de m&#xe9;decine, UNICAEN, universit&#xe9; Caen-Normandie, 2, rue des Rochambelles, 14032 Caen cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xe9;rard</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>P&#xf4;le de r&#xe9;animations-anesth&#xe9;sie (niveau&#xa0;6), CHU de Caen, avenue C&#xf4;te-de-Nacre, 14033 Caen cedex 9, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanouz</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>P&#xf4;le de r&#xe9;animations-anesth&#xe9;sie (niveau&#xa0;6), CHU de Caen, avenue C&#xf4;te-de-Nacre, 14033 Caen cedex 9, France; Inserm, EA4650, UNICAEN, universit&#xe9; Caen-Normandie, esplanade de la Paix, CS 14032, 14032 Caen cedex 5, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072080" MajorTopicYN="Y">Anesthesiologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007396" MajorTopicYN="Y">Internship and Residency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019300" MajorTopicYN="N">Medical Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016544" MajorTopicYN="N">Patient Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012892" MajorTopicYN="N">Sleep Deprivation</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020178" MajorTopicYN="N">Sleep Disorders, Circadian Rhythm</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia</Keyword><Keyword MajorTopicYN="N">Patient safety</Keyword><Keyword MajorTopicYN="N">Simulation</Keyword><Keyword MajorTopicYN="N">Sleep deprivation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28882740</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2017.05.010</ArticleId><ArticleId IdType="pii">S2352-5568(16)30120-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31993265</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Effect of Pharmacological Agents Administered for Attenuating the Extubation Response on the Quality of Extubation: A Systematic Review.</ArticleTitle><Pagination><StartPage>e6427</StartPage><MedlinePgn>e6427</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e6427</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.6427</ELocationID><Abstract><AbstractText>Background Several drugs have been tried to obtund the hemodynamic extubation response but all have variable side effects that may affect the quality of short-term recovery. Objective Our primary objective was to evaluate the effect of pharmacological agents, such as dexmedetomidine, local anesthetics, and so on, administered for attenuating the extubation response on the quality of extubation, as judged by the presence or absence of cough, sedation, and laryngospasm/bronchospasm in adult patients who had undergone general anesthesia. A secondary objective was to evaluate the effect of these drugs on other immediate post-extubation complications such as&#xa0;respiratory depression, desaturation, bradycardia, hypotension, and nausea and vomiting (PONV). Methods This is a systematic review of (randomized controlled trials)<i>&#xa0;</i>RCTs with meta-analysis. The Medical Literature Analysis and Retrieval System Online (MEDLINE), Cumulative Index of Nursing and Allied Health Literature (CINAHL), and&#xa0;Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched for RCTs on the effect of pharmacological agents on both the hemodynamic extubation response as well as the quality of extubation. Results Fourteen out of 24 included studies were subjected to a meta-analysis. The risk of cough was less likely in the intervention group as compared to control groups (OR 0.26, 95% CI 0.15 to 0.46, p&lt;0.00001, I<sup>2</sup>=35%).&#xa0;Sedation, hypotension (OR= 10.47; 95% CI: 1.86, 58.80, p=0.008, I<sup>2</sup>=0%), and bradycardia (OR= 6.57; 95% CI: 2.09, 20.64, p=0.001, I<sup>2</sup>=0%) were reported with dexmedetomidine. Only one study reported laryngospasm with dexmedetomidine and two studies with opioids. Conclusion Dexmedetomidine 0.4 to 0.5 ug/kg was associated with smooth extubation, minimal coughing, no laryngospasm/ bronchospasm, and with stable hemodynamics, without causing respiratory depression, PONV, and desaturation. However, in higher doses (more than 0.5 ug/kg), it caused bradycardia, hypotension, and sedation. Other pharmacological agents, such as&#xa0;local anesthetics, calcium channel blockers, and opioids, did not attenuate cough associated with extubation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019, Salim et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salim</LastName><ForeName>Bushra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Aga Khan University, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Saima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Aga Khan University, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>M Asghar</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Aga Khan University, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raza</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Aga Khan University, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fauzia A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Anaesthesiology, Aga Khan University, Karachi, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">cough</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">endotracheal extubation</Keyword><Keyword MajorTopicYN="N">lidocaine</Keyword><Keyword MajorTopicYN="N">opioids</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31993265</ArticleId><ArticleId IdType="pmc">PMC6970457</ArticleId><ArticleId IdType="doi">10.7759/cureus.6427</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Effect on postoperative sore throat of spraying the endotracheal tube cuff with benzydamine hydrochloride, 10% lidocaine, and 2% lidocaine. Hung NK, Wu CT, Chan SM, et al.  https://www.ncbi.nlm.nih.gov/pubmed/20304980. Anesth Analg. 2010;111:882&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">20304980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fentanyl attenuates cardiovascular responses to tracheal extubation. Nishina K, Mikawa K, Maekawa N, Obara H. Acta Anaesthesiol Scand. 1995;39:85&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">7725888</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of the effects of dexmedetomidine versus fentanyl on airway reflexes and hemodynamic responses to tracheal extubation during rhinoplasty: a double-blind, randomized, controlled study. Aksu R, Akin A, Bi&#xe7;er C, Esmao&#x11f;lu A, Tosun Z, Boyaci A. Curr Ther Res. 2009;70:209&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3967279</ArticleId><ArticleId IdType="pubmed">24683231</ArticleId></ArticleIdList></Reference><Reference><Citation>Local airway anesthesia attenuates hemodynamic responses to intubation and extubation in hypertensive surgical patients. Meng Y-F, Cui G-X, Gao W, Li Z-W. Med Sci Monit Int Med J Exp Clin Res. 2014;20:1518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156342</ArticleId><ArticleId IdType="pubmed">25175842</ArticleId></ArticleIdList></Reference><Reference><Citation>Attenuation of extubation responses: comparison of prior treatment with verapamil and dexmedetomidine. Mistry T, Purohit S, Arora G, Gill N, Sharma J. J Neuroanaesth Crit Care. 2016;3:33&#x2013;39.</Citation></Reference><Reference><Citation>Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery. Kim DJ, Kim SH, So KY, Jung KT. BMC Anesthesiol. 2015;15:139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4597422</ArticleId><ArticleId IdType="pubmed">26446479</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of different doses of dexmedetomidine on the recovery quality from general anesthesia undergoing thyroidectomy [Article in Chinese] Zhao X, Tong D, Long B, Wu X. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:239&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">24709495</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of endotracheal lidocaine administration with continuous infusion of remifentanil for attenuating tube-induced coughing during emergence from total intravenous anesthesia. Yamasaki H, Takahashi K, Yamamoto S, Yamamoto Y, Miyata Y, Terai T. J Anesth. 2013;27:822&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">23649919</ArticleId></ArticleIdList></Reference><Reference><Citation>Teaching pain recognition through art: the Ramsay-Caravaggio sedation scale. Poropat F, Cozzi G, Magnolato A, et al. Ital J Pediatr. 2018;44:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793413</ArticleId><ArticleId IdType="pubmed">29386058</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of dexmedetomidine on haemodynamic and recovery responses during tracheal extubation: a randomized comparative study. Devi Vankayalapati S, Ramsali V M, Dumpala S, Pasupuleti S. J Evol Med Dent Sci. 2016;5:2880&#x2013;2883.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC. Cochrane Handbook for Systematic Reviews of Interventions. 2008. Assessing Risk of Bias in Included Studies; pp. 187&#x2013;241.</Citation></Reference><Reference><Citation>Attenuation of cardiovascular responses to tracheal extubation: verapamil versus diltiazem. Mikawa K1, Nishina K, Maekawa N, Obara H. https://www.ncbi.nlm.nih.gov/pubmed/8638792. Anesth Analg. 1996;82:1205&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pubmed">8638792</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandin E 1, lidocaine, and prostaglandin E 1-lidocaine combination for attenuating cardiovascular responses to extubation. Nishina K, Mikawa K, Takao Y, Shiga M, Maekawa N, Obara H. Can J Anaesth. 1997;44:1211&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">9398965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidocaine sprayed down the endotracheal tube attenuates the airway-circulatory reflexes by local anesthesia during emergence and extubation. Jee D, Park SY. Anesth Analg. 2003;96:293&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505969</ArticleId></ArticleIdList></Reference><Reference><Citation>Single&#x2010;dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Acta Anaesthesiol Scand. 2005;49:1088&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>The effect of low-dose remifentanil on the hemodynamic responses of endotracheal extubation. Mahoori A, Noroozinia H, Hasani E, Karami N, Pashaei N, Hatami S. http://acta.tums.ac.ir/index.php/acta/article/view/4536. Acta Med Iran. 2014;52:844&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">25415818</ArticleId></ArticleIdList></Reference><Reference><Citation>The efficacy of lidocaine administered via the LITATM tracheal tube in attenuating the extubation response in beta&#x2010;blocked patients following craniotomy. Andrzejowski J, Francis G. Anaesthesia. 2002;57:387&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">11949645</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of a single dose of dexmedetomidine for cough suppression during anesthetic emergence: a randomized controlled trial. Lee JS, Choi SH, Kang YR, Kim Y, Shim YH. Can J Anesth. 2015;62:392&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">25523837</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of a remifentanil bolus dose on the cardiovascular response to emergence from anaesthesia and tracheal extubation. Shajar MA, Thompson JP, Hall AP, Leslie NAP, Fox AJ. Br J Anaest. 1999;83:654&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">10673886</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of dexmedetomidine, lidocaine, and their combination in attenuation of cardiovascular and catecholamine responses to tracheal extubation and anesthesia emergence in hypertensive patients. Moustafa AM, Atalla H, Koptan HM. http://roaic.eg.net/article.asp?issn=2356-9115;year=2015;volume=2;issue=2;spage=1;epage=6;aulast=Moustafa Res Opin Anesth Intensive Care. 2015;2:1&#x2013;6.</Citation></Reference><Reference><Citation>Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation. Nho JS, Lee SY, Kang JM, et al. Br J Anaesth. 2009;103:817&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">19864308</ArticleId></ArticleIdList></Reference><Reference><Citation>The effect of low-dose remifentanil on responses to the endotracheal tube during emergence from general anesthesia. Aouad MT, Al-Alami AA, Nasr VG, Souki FG, Zbeidy RA, Siddik-Sayyid SM. Anesth Analg. 2009;108:1157&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">19299779</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexmedetomidine for tracheal extubation in deeply anesthetized adult patients after otologic surgery: a comparison with remifentanil. Fan Q, Hu C, Ye M, Shen X. BMC Anesthesiol. 2015;15:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511974</ArticleId><ArticleId IdType="pubmed">26202786</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of the effect of intravenous dexmedetomidine and lignocaine spray instilled into the endotracheal tube on extubation response in patients undergoing spine surgery. Dutta D, Godara M, Purohit S, Kalra P, Sharma S, Gill N. J Neuroanaesth Crit Care. 2016;3:239&#x2013;244.</Citation></Reference><Reference><Citation>Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Eur J Anaesthesiol. 2008Oct;25:816&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">18400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of dexmedetomidine and lignocaine on attenuation of airway and pressor responses during tracheal extubation. Sharma VB, Prabhakar H, Rath GP, Bithal PK. J Neuroanaesthesiol Crit Care. 2014;1:50&#x2013;55.</Citation></Reference><Reference><Citation>Ropivacaine via trans-cricothyroid membrane injection inhibits the extubation response in patients undergoing surgery for maxillary and mandibular fractures. Gao W, Xi JH, Ju NY, Cui GX. https://www.ncbi.nlm.nih.gov/pubmed/24668638. Genet Mol Res. 2014;13:1635&#x2013;1642.</Citation><ArticleIdList><ArticleId IdType="pubmed">24668638</ArticleId></ArticleIdList></Reference><Reference><Citation>Attenuation of circulatory and airway responses to endotracheal extubation in craniotomies for intracerebral space occupying lesions: dexmedetomidine versus lignocaine. Kothari D, Tandon N, Singh M, Kumar A. Anesth Essays Res. 2014;8:78&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4173576</ArticleId><ArticleId IdType="pubmed">25886109</ArticleId></ArticleIdList></Reference><Reference><Citation>A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubation. Bindu B, Pasupuleti S, Gowd UP, Gorre V, Murthy RR, Laxmi MB. J Anaesthesiol Clin Pharmacol. 2013;29:162&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713660</ArticleId><ArticleId IdType="pubmed">23878434</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of dexmedetomidine on hemodynamic parameters during extubation. A prospective randomized double blind study. Shruthi AH, Nethra SS, Sudheesh K, Devika DR, Raghavendra RSR. https://www.ncbi.nlm.nih.gov/pubmed/27382816. Middle East J Anaesthesiol. 2016;23:457&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">27382816</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17660173</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0741-238X</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2007</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Advances in therapy</Title><ISOAbbreviation>Adv Ther</ISOAbbreviation></Journal><ArticleTitle>Remifentanil-propofol in vertebral disk operations: hemodynamics and recovery versus desflurane-n(2)o inhalation anesthesia.</ArticleTitle><Pagination><StartPage>622</StartPage><EndPage>631</EndPage><MedlinePgn>622-31</MedlinePgn></Pagination><Abstract><AbstractText>The purpose of this study was to ascertain whether total intravenous anesthesia (TIVA) with propofol and remifentanil differs from inhalational anesthesia with desflurane and nitrous oxide in terms of hemodynamics, recovery profile, and postoperative analgesic demand in patients undergoing elective microsurgical vertebral disk resection. A total of 60 patients were randomly assigned to receive TIVA with propofol and remifentanil or inhalational anesthesia with desflurane and nitrous oxide. The TIVA group (n=30) then received 50%/50% N(2)O/O(2). A constant infusion of remifentanil was provided at 0.125 microg/kg/min accompanied by propofol at 10 mg/kg/h in the first 10 min, 6 mg/kg/h in the second 10 min, then 4 mg/kg/h. The desflurane group (n=30) received 50%/50% N(2)O/O(2), with 5% desflurane after intubation and 6% before incision; desflurane was administered in a minimum alveolar concentration 1 fashion during the operation. Hemodynamic, O(2) saturation, and end-tidal CO(2) data were recorded before induction, after intubation, after prone positioning, 5, 10, 15, 20, and 30 min into the operation, and at 15-min intervals thereafter until the end of the operation. Details on perioperative bradycardia, hypotension or hypertension, spontaneous breathing, extubation, eye opening, recovery time of ability to give name and date of birth, postoperative nausea and vomiting, shivering, agitation, and hypoxia were recorded. Patients anesthetized with desflurane responded to skin incision with increasing blood pressure and tachycardia; however, no other hemodynamic differences were noted between the 2 groups. In the TIVA group, recovery times were shorter for spontaneous ventilation (2.33-3.53 min), extubation (3.13-3.88 min), eye opening (4.06-6.23 min), and being able to give name and date of birth (5.4-7.9 min) compared with times in the desflurane group (P&lt;.05). In the TIVA group, more postoperative shivering (16.7% of patients) and greater analgesic demand were seen than in the desflurane group. Although nausea and vomiting were more common in the desflurane group, no difference in bronchospasm was reported. In the TIVA group, a shorter recovery period and a greater demand for postoperative analgesia were seen. Because of the lack of residual analgesic effects, postoperative analgesic treatment should be initiated immediately in patients undergoing TIVA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gozdemir</LastName><ForeName>Muhammet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ataturk Research and Training Hospital, Department of Anesthesiology, Ankara, Turkey. doktormuhammet@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sert</LastName><ForeName>Huseyin</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>Nisa</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kanbak</LastName><ForeName>Orhan</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Usta</LastName><ForeName>Burhanettin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Demircioglu</LastName><ForeName>Ruveyda Irem</ForeName><Initials>RI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Ther</MedlineTA><NlmUniqueID>8611864</NlmUniqueID><ISSNLinking>0741-238X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>CRS35BZ94Q</RegistryNumber><NameOfSubstance UI="D000077335">Desflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>CYS9AKD70P</RegistryNumber><NameOfSubstance UI="D007530">Isoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>P10582JYYK</RegistryNumber><NameOfSubstance UI="D000077208">Remifentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077335" MajorTopicYN="N">Desflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017586" MajorTopicYN="Y">Diskectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007530" MajorTopicYN="N">Isoflurane</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077208" MajorTopicYN="N">Remifentanil</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17660173</ArticleId><ArticleId IdType="doi">10.1007/BF02848787</ArticleId><ArticleId IdType="pii">642</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18279487</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>The effects of aminophylline on bispectral index during inhalational and total intravenous anaesthesia.</ArticleTitle><Pagination><StartPage>583</StartPage><EndPage>587</EndPage><MedlinePgn>583-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2044.2008.05445.x</ELocationID><Abstract><AbstractText>Aminophylline is usually used during anaesthesia to treat bronchospasm but recent findings suggest that it can also be used to shorten recovery time after general anaesthesia. However, it is unclear whether aminophylline shows similar properties during a steady-state phase of deep surgical anaesthesia. We therefore wanted to test the hypothesis that the administration of aminophylline leads to an increase in bispectral index as a surrogate parameter suggesting a lighter plane of anaesthesia. The study was designed as a double-blind, randomised, controlled trial with two main groups (aminophylline and placebo) and two subgroups (sevoflurane and propofol). We studied 60 patients. The injection of aminophylline 3 mg x kg(-1) was associated with significant increases in bispectral index up to 10 min after its injection, while heart rate and blood pressure did not change. It appears that aminophylline has the ability to partially antagonise the sedative effects of general anaesthetics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>H&#xfc;pfl</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and General Intensive Care, Medical University Vienna, W&#xe4;hringer G&#xfc;rtel 18-20, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmatzer</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Buzath</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Burger</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>H&#xf6;rauf</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ihra</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Marhofer</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Nagele</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>27Y3KJK423</RegistryNumber><NameOfSubstance UI="D000628">Aminophylline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000628" MajorTopicYN="N">Aminophylline</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="Y">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000771" MajorTopicYN="Y">Anesthesia, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>6</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18279487</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2044.2008.05445.x</ArticleId><ArticleId IdType="pii">ANA5445</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21664082</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6283</ISSN><JournalIssue CitedMedium="Internet"><Volume>212</Volume><Issue>1-3</Issue><PubDate><Year>2011</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Forensic science international</Title><ISOAbbreviation>Forensic Sci Int</ISOAbbreviation></Journal><ArticleTitle>Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>101</EndPage><MedlinePgn>96-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.forsciint.2011.05.020</ELocationID><Abstract><AbstractText>The diagnosis of fatal anaphylaxis can be difficult for clinical features may not always be evident in necropsy. Therefore post mortem determination of tryptase and other blood parameters can be helpful in verifying the diagnosis. We compared post mortem tryptase, histamine and diamine oxidase (DAO) serum levels of two patients who had died after a Hymenoptera sting and one patient who died of bronchospasm during anaesthesia with data obtained from 55 control subjects who had died from other causes than anaphylaxis. In the three anaphylactic cases, serum tryptase level was 880, 68 and 200 &#x3bc;g/l (normal range in living subjects: &lt;11.4 &#x3bc;g/l), histamine was 37.5, 8.5 and 23.2 ng/ml (normal range: &lt;0.3 ng/ml) and DAO was 1, 30 and 4 U/ml (normal range 10-30 U/ml), respectively. Values in the control group were as follows: tryptase 1-340 &#x3bc;g/l (mean 24.2 &#xb1; 58.2), histamine 5.0-22.0 ng/ml (mean 14.7 &#xb1; 3.9) and DAO 0-114 U/ml (mean 21.1 &#xb1; 27.8). 19/55 (34.5%) of the controls had elevated tryptase levels &gt;11.4 &#x3bc;g/l, with four of them showing values &gt;45 &#x3bc;g/ml. Significantly higher histamine levels were seen in blood samples taken more than 24h post mortem (p&lt;0.05), whereas the timing of blood collection had no effect on tryptase and DAO levels. While moderately elevated tryptase levels are common in post mortem sera, values above 45 &#x3bc;g/l may support the diagnosis of fatal anaphylaxis. Strongly elevated histamine levels might give an additional clue on fatal anaphylaxis, whereas DAO does not seem to be helpful.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>D E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>FAZ - Floridsdorf Allergy Center, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krauskopf</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hemmer</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Moritz</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Jarisch</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Forensic Sci Int</MedlineTA><NlmUniqueID>7902034</NlmUniqueID><ISSNLinking>0379-0738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>820484N8I3</RegistryNumber><NameOfSubstance UI="D006632">Histamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.4.3.21</RegistryNumber><NameOfSubstance UI="D006631">Amine Oxidase (Copper-Containing)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.59</RegistryNumber><NameOfSubstance UI="D053802">Tryptases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006631" MajorTopicYN="N">Amine Oxidase (Copper-Containing)</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005554" MajorTopicYN="N">Forensic Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006632" MajorTopicYN="N">Histamine</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007299" MajorTopicYN="N">Insect Bites and Stings</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053802" MajorTopicYN="N">Tryptases</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21664082</ArticleId><ArticleId IdType="doi">10.1016/j.forsciint.2011.05.020</ArticleId><ArticleId IdType="pii">S0379-0738(11)00235-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28974069</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>157</EndPage><MedlinePgn>150-157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aex139</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative respiratory adverse events (PRAE) remain the leading cause of morbidity and mortality in the paediatric population. This double-blinded randomized control trial investigated whether inhaled salbutamol premedication decreased the occurrence of PRAE in children identified as being at high risk of PRAE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Children with at least two parentally reported risk factors for PRAE undergoing elective surgery were eligible for recruitment. They were randomized to receive either salbutamol (200 &#xb5;g) or placebo prior to their surgery and PRAE (bronchospasm, laryngospasm, airway obstruction, desaturation, coughing and stridor) were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 470 children (6-16&#x2009;yr, 277 males, 59%) recruited, 462 were available for an intention-to-treat analysis. Thirty-two (14%) and 27 (12%) children from the placebo and salbutamol groups experienced PRAE. This difference was not significant [odds ratio (OR): 0.83, 95% confidence interval (CI): 0.48-1.44, P : 0.51]. Oxygen desaturation [14/232 (6%) vs 14/230 (6%), OR: 1.01, 95% CI: 0.47-2.17, P : 0.98] and severe coughing [12/232 (5%) vs 10/230 (4%), OR: 0.83, 95% CI: 0.35-1.97, P : 0.68] were the most common PRAE, but did not significantly differ between the groups. The occurrence of PRAE was slightly lower in children with respiratory symptoms who received salbutamol compared with placebo [16/134 (12%) vs 21/142 (15%), OR: 0.93, 95% CI: 0.38-2.26, P : 0.87], but was not significantly different.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Premedication with salbutamol to children aged between 6 and 16&#x2009;years and at high risk of PRAE prior to their surgery did not reduce their risk of PRAE.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ACTRN12612000626864 ( www.anzctr.org.au ).</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramgolam</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physiotherapy and Exercise Science, Curtin University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Child Health Research, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slevin</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>T F E</ForeName><Initials>TFE</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Public Health, Curtin University; Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>B S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058666">Adrenergic beta-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058666" MajorTopicYN="N">Adrenergic beta-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="Y">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">paediatric population</Keyword><Keyword MajorTopicYN="N">perioperative respiratory adverse events</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">salbutamol</Keyword><Keyword MajorTopicYN="N">&#x3b2;-2 agonist</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28974069</ArticleId><ArticleId IdType="doi">10.1093/bja/aex139</ArticleId><ArticleId IdType="pii">S0007-0912(17)33749-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22616954</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1843</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Respirology (Carlton, Vic.)</Title><ISOAbbreviation>Respirology</ISOAbbreviation></Journal><ArticleTitle>Preoperative 6-min walking distance does not predict pulmonary complications in upper abdominal surgery.</ArticleTitle><Pagination><StartPage>1013</StartPage><EndPage>1017</EndPage><MedlinePgn>1013-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1440-1843.2012.02202.x</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Field exercise tests have been increasingly used for pulmonary risk assessment. The 6-min walking distance (6MWD) is a field test commonly employed in clinical practice; however, there is limited evidence supporting its use as a risk assessment method in abdominal surgery. The aim was to assess if the 6MWD can predict the development of post-operative pulmonary complications (PPCs) in patients having upper abdominal surgery (UAS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective cohort study included 137 consecutive subjects undergoing elective UAS. Subjects performed the 6MWD on the day prior to surgery, and their performance were compared with predicted values of 6MWD (p6MWD) using a previously validated formula. PPCs (including pneumonia, tracheobronchitis, atelectasis with clinical repercussions, bronchospasm and acute respiratory failure) were assessed daily by a pulmonologist blinded to the 6MWD results. 6MWD and p6MWD were compared between subjects who developed PPC (PPC group) and those who did not (no PPC group) using Student's t-test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten subjects experienced PPC (7.2%) and no significant difference was observed between the 6MWD obtained in the PPC group and no PPC group (466.0&#x2003;&#xb1;&#x2003;97.0&#x2003;m vs. 485.3&#x2003;&#xb1;&#x2003;107.1&#x2003;m; P&#x2003;=&#x2003;0.57, respectively). There was also no significant difference observed between groups for the p6MWD (100.7&#x2003;&#xb1;&#x2003;29.1% vs. 90.6&#x2003;&#xb1;&#x2003;20.9%; P&#x2003;&gt;&#x2003;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of the present study suggest that the 6-min walking test is not a useful tool to identify subjects with increased risk of developing PPC following UAS.</AbstractText><CopyrightInformation>&#xa9; 2012 The Authors. Respirology &#xa9; 2012 Asian Pacific Society of Respirology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paisani</LastName><ForeName>Denise M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Respiratory Department, Federal University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil. denipaisani@yahoo.com.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>Julio F</ForeName><Initials>JF</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Lunardi</LastName><ForeName>Adriana C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Colluci</LastName><ForeName>Daniela B B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Ilka Lopes</ForeName><Initials>IL</Initials></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Celso R F</ForeName><Initials>CR</Initials></Author><Author ValidYN="Y"><LastName>Chiavegato</LastName><ForeName>Luciana Dias</ForeName><Initials>LD</Initials></Author><Author ValidYN="Y"><LastName>Faresin</LastName><ForeName>Sonia Maria</ForeName><Initials>SM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Respirology</MedlineTA><NlmUniqueID>9616368</NlmUniqueID><ISSNLinking>1323-7799</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22616954</ArticleId><ArticleId IdType="doi">10.1111/j.1440-1843.2012.02202.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30586199</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2125</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of clinical pharmacology</Title><ISOAbbreviation>Br J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.</ArticleTitle><Pagination><StartPage>729</StartPage><EndPage>736</EndPage><MedlinePgn>729-736</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bcp.13847</ELocationID><Abstract><AbstractText Label="AIMS">To demonstrate the noninferiority of extrafine beclomethasone/formoterol fumarate (BDP/FF) dry powder inhaler (DPI) vs. extrafine BDP/FF pressurized metered dose inhaler (pMDI; Foster&#xae; 100/6&#xa0;&#x3bc;g NEXThaler and pMDI, respectively) in the onset of reliever effect after methacholine induced bronchospasm in asthmatic patients, evaluated in terms of forced expiratory volume in 1&#xa0;s (FEV<sub>1</sub> ) at 5&#xa0;min postdose. The DPI provides an alternative device option for patients who cannot use a pMDI properly during an acute asthma attack.</AbstractText><AbstractText Label="METHODS">Sixty-five patients received one inhalation of BDP/FF DPI, BDP/FF pMDI or placebo after methacholine challenge, according to a double-blind, double-dummy, cross-over design. Lung function and Borg dyspnoea score were assessed up to 30&#xa0;min postdose.</AbstractText><AbstractText Label="RESULTS">FEV<sub>1</sub> adjusted mean difference between BDP/FF DPI and BDP/FF pMDI at 5&#xa0;min postdose was 2&#xa0;ml (95% confidence interval: -0.060; 0.065). A similar result was observed at the other time points. Median time to 85% recovery in FEV<sub>1</sub> was 8&#xa0;min for BDP/FF DPI, 7.5&#xa0;min for BDP/FF pMDI and 28&#xa0;min for placebo (P&#xa0;=&#xa0;0.554 DPI vs. pMDI). The Borg score improved after treatment with both BDP/FF DPI and pMDI and the effect was greater than after placebo. Median time to reach 50% recovery was 4.2&#xa0;min for BDP/FF DPI, 4.0&#xa0;min for BDP/FF pMDI and 10.0&#xa0;min for placebo (P&#xa0;=&#xa0;0.609 DPI vs. pMDI).</AbstractText><AbstractText Label="CONCLUSIONS">Extrafine Foster&#xae; NEXThaler, a flow-independent DPI, is comparable to extrafine Foster&#xae; pMDI when administered as reliever therapy after methacholine challenge, thus supporting the maintenance and reliever therapy approach also with Foster&#xae; NEXThaler.</AbstractText><CopyrightInformation>&#xa9; 2018 Chiesi Farmaceutici S.p.A. The British Journal of Clinical Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Dave</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8918-7075</Identifier><AffiliationInfo><Affiliation>Medicines Evaluation Unit, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Frans</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hammersmith Medicines Research ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leaker</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Respiratory Clinical Trials ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2808-4184</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabbal</LastName><ForeName>Sunny</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9604-9807</Identifier><AffiliationInfo><Affiliation>Scottish Centre for Respiratory Research, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collarini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8625-3142</Identifier><AffiliationInfo><Affiliation>Chiesi Farmaceutici SpA, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongelli</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Chiesi Farmaceutici SpA, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Chiesi Farmaceutici SpA, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccinno</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7858-788X</Identifier><AffiliationInfo><Affiliation>Chiesi Farmaceutici SpA, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biondaro</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chiesi Farmaceutici SpA, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipworth</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Scottish Centre for Respiratory Research, Dundee, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Clin Pharmacol</MedlineTA><NlmUniqueID>7503323</NlmUniqueID><ISSNLinking>0306-5251</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011208">Powders</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W5ETF9M2K</RegistryNumber><NameOfSubstance UI="D016210">Methacholine Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>KGZ1SLC28Z</RegistryNumber><NameOfSubstance UI="D001507">Beclomethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>W34SHF8J2K</RegistryNumber><NameOfSubstance UI="D000068759">Formoterol Fumarate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="N">Anti-Asthmatic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001507" MajorTopicYN="N">Beclomethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016084" MajorTopicYN="N">Bronchoconstriction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058995" MajorTopicYN="N">Dry Powder Inhalers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068759" MajorTopicYN="N">Formoterol Fumarate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036501" MajorTopicYN="N">Metered Dose Inhalers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016210" MajorTopicYN="N">Methacholine Chloride</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011208" MajorTopicYN="N">Powders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Trials</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">inhalation</Keyword></KeywordList><CoiStatement>D.S. has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards and research grants from various pharmaceutical companies including Apellis, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Johnson and Johnson, Mundipharma, Novartis, Peptinnovate Pfizer, Pulmatrix, Skypharma, Teva, Therevance and Verona. F.v.d.B. has no competing interests to declare. B.L. has received investigator fees from Chiesi for this and other studies; similar investigator fees were also received from Regeneron Pharmaceuticals, Astra Zeneca, Afimmune, Verona, Moerae Matrix and Hemay Pharmaceutical Pty. Ltd in the last 12&#xa0;months. M.C. has received grants and honoraria for lectures from Chiesi. S.J. has received personal fees and nonfinancial support from Chiesi, personal fees and nonfinancial support from Pfizer, nonfinancial support and other from Napp, personal fees and nonfinancial support from AstraZeneca, nonfinancial support from Teva, nonfinancial support from Meda, personal fees from Boehringer Ingelheim, outside the submitted work. S.C., V.M., L.S., A.P. and S.B. are full&#x2010;time employees at Chiesi Farmaceutici S.p.A.. B.L. and the Scottish Centre for Respiratory Research have received funding in the form of consultancy, advisory boards, research, travel grants, equipment or giving talks from Chiesi Farmaceutici S.p.A., Boerhinger Ingelheim, Teva, Meda Pharma, Mylan, AstraZeneca, Dr Reddys, Cipla, Lupin, Genentech, Sanofi, Jansen, GSK, Novartis, Vectura, Glenmark. 
<i>The clinical trial was sponsored by Chiesi Farmaceutici S.p.A.</i>
 
<i>D.S., F.v.d.B., B.L. and B.L. were the principal investigators of the four clinical sites where the clinical trial was performed. D.S. also acted as coordinating investigator. S.J. was the co&#x2010;investigator at the Scottish Centre for Respiratory Research in Dundee. M.C., S.C., V.M., L.S., A.P. and B.L. were involved in the study design and results interpretation. S.B. and L.S. were involved in data collection and analysis and are responsible for the integrity of the data and accuracy of the data analysis. SGS Belgium NV (Antwerp, Belgium) was responsible for monitoring, data management, statistics, pharmacovigilance and medical writing during the trial. Biomedical Systems (Brussels, Belgium) was responsible for central collection and over&#x2010;reading of the lung function data. The manuscript was written by M.C., S.C., L.S. and A.P. and reviewed and approved by all the authors.</i>
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30586199</ArticleId><ArticleId IdType="pmc">PMC6422816</ArticleId><ArticleId IdType="doi">10.1111/bcp.13847</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Magnoni MS, Latorre M, Bettoncelli G, Sanchez&#x2010;Herrero MG, Lopez A, Calvo E, et al Asthma control in primary care: the results of an observational cross&#x2010;sectional study in Italy and Spain. World Allergy Organ J 2017; 10: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382476</ArticleId><ArticleId IdType="pubmed">28413571</ArticleId></ArticleIdList></Reference><Reference><Citation>GINA . Global strategy for asthma management and prevention (GINA 2017). Glob Initiat Asthma 2017; 147.</Citation></Reference><Reference><Citation>Welsh EJ, Cates CJ. Formoterol versus short&#x2010;acting beta&#x2010;agonists as relief medication for adults and children with asthma. Cochrane Database Syst Rev 2010; 2010: CD008418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034434</ArticleId><ArticleId IdType="pubmed">20824877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, et al Exacerbations of asthma a descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999; 160: 594&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430734</ArticleId></ArticleIdList></Reference><Reference><Citation>Papi A, Corradi M, Pigeon&#x2010;Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, et al Beclometasone&#x2010;formoterol as maintenance and reliever treatment in patients with asthma: a double&#x2010;blind, randomised controlled trial. Lancet Respir Med 2013; 1: 23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24321801</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Corradi M, Bindi E, Baronio R, Petruzzelli S, Paggiaro P. Relief of methacholine&#x2010;induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma. Pulm Pharmacol Ther 2012; 25: 392&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">22842339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanniess F, Scuri M, Vezzoli S, Francisco C, Petruzzelli S. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: a randomised, double&#x2010;blind trial. Pulm Pharmacol Ther 2015; 30: 121&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">25088067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv 2009; 6: 91&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">19236210</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi M, Chrystyn H, Cosio BG, Pirozynski M, Loukides S, Louis R, et al NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma. Expert Opin Drug Deliv 2014; 11: 1497&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">24921434</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuri M, Alfieri V, Giorgio A, Pisi R, Ferrari F, Taverna MC, et al Measurement of the inhalation profile through a novel dry powder inhaler (NEXThaler) in asthmatic patients using acoustic monitoring. Am J Respir Crit Care Med 2013; 187: A1931.</Citation></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al Standardisation of spirometry. Eur Respir J 2005; 26: 319&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society guidelines for methacholine and exercise challenge testing &#x2013;1999. Am J Respir Crit Care Med 1999; 161: 309&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">10619836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0&#x2010;10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 2000; 26: 216&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">10839848</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pubmed">16264058</ArticleId></ArticleIdList></Reference><Reference><Citation>Polosa R, Prosperini G, Magri S, Ciamarra I, Pagano C, Paolino G, et al Bronchodilator response to salbutamol after spontaneous recovery from nonspecific bronchial provocation tests in asthma. Eur Respir J 1998; 11: 1086&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">9648960</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach JR, Bromly CL, Avery AJ, Reid RWEC, Walters EH, Hendrick DJ. Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine&#x2010;induced bronchoconstriction. Pulm Pharmacol 1996; 9: 245&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">9160413</ArticleId></ArticleIdList></Reference><Reference><Citation>Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine&#x2010; induced severe bronchoconstriction. Eur Respir J 1999; 13: 988&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pubmed">10414394</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Noord JA, Smeets JJ, Maesen FPV. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine&#x2010;induced bronchoconstriction. Respir Med 1998; 92: 1346&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">10197228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger P, Ehrlein B, Zier M, Greguletz R. Inspiratory flow resistance of marketed dry powder inhalers (DPI). Eur Respir J 2014; 44 (Suppl. 58).</Citation></Reference><Reference><Citation>Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, et al Effect of flow rate on in vitro aerodynamic performance of NEXThaler(&#xae;) in comparison with Diskus(&#xae;) and Turbohaler(&#xae;) dry powder inhalers. J Aerosol Med Pulm Drug Deliv 2016; 29: 167&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4841907</ArticleId><ArticleId IdType="pubmed">26355743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28936072</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0976-3147</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>Suppl 1</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurosciences in rural practice</Title><ISOAbbreviation>J Neurosci Rural Pract</ISOAbbreviation></Journal><ArticleTitle>Alleviating Stress Response to Tracheal Extubation in Neurosurgical Patients: A Comparative Study of Two Infusion Doses of Dexmedetomidine.</ArticleTitle><Pagination><StartPage>S49</StartPage><EndPage>S56</EndPage><MedlinePgn>S49-S56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jnrp.jnrp_91_17</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tracheal extubation is almost always associated with increase in sympathoadrenal activity may result in hypertension, tachycardia, and arrhythmias. Attempts have been made to oppose the pressor response by the use of various drugs. Dexmedetomidine decreases norepinephrine which reduces the blood pressure and the heart rate (HR). We hypothesize that the infusion of dexmedetomidine may produce more stable hemodynamics during extubation as compared to boluses.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Ninety adult patients aged 18-65 years, the American Society of Anesthesiologists Grade I-II undergoing intracranial surgeries for various neurologic problem at All India Institute of Medical Sciences were enrolled in this randomized controlled trial. Primary.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">(1) To observe the hemodynamic changes (HR and mean arterial pressure [MAP]) and airway responses during tracheal extubation following two infusion doses of dexmedetomidine.</AbstractText><AbstractText Label="SECONDARY OBJECTIVES" NlmCategory="OBJECTIVE">(1) Time to emergence and time to tracheal extubation, (2) Early postoperative complications such as laryngospasm and bronchospasm, and (3) adverse effects of the study drug. Patients were assigned into three groups - (1) Group D<sub>0.2</sub> - 0.2 &#x3bc;g/kg/h diluted to 50 ml, (2) Group D<sub>0.4</sub> - 0.4 &#x3bc;g/kg/h diluted to 50 ml and Group <i>P</i> (Placebo) - 0.9% NS 50 ml. The hemodynamics including the HR and MAP were recorded just before the loading dose of the study drug and then were recorded every 5 min till the infusion was stopped at tracheal extubation and every 1 min till 10 min postextubation. In addition, the airway, respiratory and cardiovascular complications along with postoperative nausea and vomiting, shivering, cough grading, Aldrete score, Ramsay sedation scale, and intraoperative awareness were recorded.</AbstractText><AbstractText Label="STATISTICAL ANALYSIS" NlmCategory="METHODS">Continuous variables such as HR and MAP were analyzed using analysis of variance and categorical variables were analyzed using the Chi-square test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patient demographics were comparable between the three groups. There was a significant reduction in HR and MAP just before extubation and up to 10 min post extubation in the D<sub>0.2</sub> and D<sub>0.4</sub> groups as compared to placebo (<i>P</i> &lt; 0.001) but the difference among the dexmedetomidine groups were not significant. Patients belonging to D<sub>0.2</sub> group emerged faster than D<sub>0.4</sub> group, however, the results were comparable with placebo group. 73.3% patients of the placebo group had tachycardia and hypertension at emergence as compared to only 3.3% patients in the D<sub>0.4</sub> group (<i>P</i> &lt; 0.001). Eighty percentage patients of D<sub>0.2</sub> and 100% patients of D<sub>0.4</sub> group had a significant reduction in cough as compared to placebo (<i>P</i> &lt; 0.001). No patient in either groups had intraoperative awareness, any respiratory complications, or allergic reactions to the study drug. Modified Aldrete scoring and Ramsay sedation scale were comparable in all the three groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine suppresses cough and hemodynamic responses (HR and MAP) to tracheal extubation significantly without delaying emergence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luthra</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabhakar</LastName><ForeName>Hemanshu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rath</LastName><ForeName>Girija Prasad</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Department of Neuroanaesthesiology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci Rural Pract</MedlineTA><NlmUniqueID>101533710</NlmUniqueID><ISSNLinking>0976-3155</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Comparative</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">extubation</Keyword><Keyword MajorTopicYN="N">infusion</Keyword><Keyword MajorTopicYN="N">neurosurgical</Keyword><Keyword MajorTopicYN="N">stress</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28936072</ArticleId><ArticleId IdType="pmc">PMC5602261</ArticleId><ArticleId IdType="doi">10.4103/jnrp.jnrp_91_17</ArticleId><ArticleId IdType="pii">JNRP-8-49</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nishina K, Mikawa K, Maekawa N, Obara H. Attenuation of cardiovascular responses to tracheal extubation with diltiazem. Anesth Analg. 1995;80:1217&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">7762855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii Y, Saitoh Y, Takahashi S, Toyooka H. Combined diltiazem and lidocaine reduces cardiovascular responses to tracheal extubation and anesthesia emergence in hypertensive patients. Can J Anaesth. 1999;46:952&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10522582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikawa K, Nishina K, Maekawa N, Obara H. Attenuation of cardiovascular responses to tracheal extubation: Verapamil versus diltiazem. Anesth Analg. 1996;82:1205&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8638792</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd MM, Warner DS, Sokoll MD, Maktabi MA, Hindman BJ, Scamman FL, et al. A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide. Anesthesiology. 1993;78:1005&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">8512094</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzzi DA, Black S, Losasso TJ, Cucchiara RF. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg. 1990;70:68&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">1967515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cranfield KA, Bromley LM. Minimum alveolar concentration of desflurane for tracheal extubation in deeply anaesthetized, unpremedicated children. Br J Anaesth. 1997;78:370&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">9135353</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KA, Harkin CP, Bailey PL. Postoperative tracheal extubation. Anesth Analg. 1995;80:149&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">7802273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishina K, Mikawa K, Shiga M, Maekawa N, Obara H. Prostaglandin E1 attenuates the hypertensive response to tracheal extubation. Can J Anaesth. 1996;43:678&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">8807172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidwai AV, Bidwai VA, Rogers CR, Stanley TH. Blood-pressure and pulse-rate responses to endotracheal extubation with and without prior injection of lidocaine. Anesthesiology. 1979;51:171&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">453622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee D, Park SY. Lidocaine sprayed down the endotracheal tube attenuates the airway-circulatory reflexes by local anesthesia during emergence and extubation. Anesth Analg. 2003;96:293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505969</ArticleId></ArticleIdList></Reference><Reference><Citation>Unal Y, Zsoylar O, Sariguney D, Arslam M, Yardine RS. The efficacy of esmolol to blunt the haemodynamic response to endotracheal extubation in lumbar disc surgery. Res J Med Sci. 2008;2:99&#x2013;104.</Citation></Reference><Reference><Citation>Lim SH, Chin NM, Tai HY, Wong M, Lin TK. Prophylactic esmolol infusion for the control of cardiovascular responses to extubation after intracranial surgery. Ann Acad Med Singapore. 2000;29:447&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11056773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovac AL, Masiongale A. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation. J Cardiothorac Vasc Anesth. 2007;21:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17289479</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishina K, Mikawa K, Maekawa N, Obara H. Fentanyl attenuates cardiovascular responses to tracheal extubation. Acta Anaesthesiol Scand. 1995;39:85&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7725888</ArticleId></ArticleIdList></Reference><Reference><Citation>Maze M, Scarfini C, Cavaliere F. New agents for sedation in the Intensive Care Unit. Crit Care Med. 2003;18:29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">11762266</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti J, Smith D. Haemodynamic responses to extubation after cardiac surgery with and without continued sedation. Br J Anaesth. 1998;80:834&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771317</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulissian R, Salem MR, Joseph NJ, Braverman B, Cohen HC, Crystal GJ, et al. Hemodynamic responses to endotracheal extubation after coronary artery bypass grafting. Anesth Analg. 1991;73:10&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">1858985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005;57(1 Suppl):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15987564</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Eur J Anaesthesiol. 2008;25:816&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997;52:736&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">9291757</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand. 2005;49:1088&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">1361311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth. 2005;15:1098&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">16324031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanskanen PE, Kytt&#xe4; JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: A double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006;97:658&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">16914460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi Y, Takahashi S. Dexmedetomidine. Masui. 2006;55:856&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16856546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ard JL, Jr, Bekker AY, Doyle WK. Dexmedetomidine in awake craniotomy: A technical note. Surg Neurol. 2005;63:114&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15680647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol. 2004;16:20&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14676565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Koo BN, Jeong JJ, Kim HS, Lee JR. Differential effects of lidocaine and remifentanil on response to the tracheal tube during emergence from general anaesthesia. Br J Anaesth. 2011;106:410&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21205628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brice DD, Hetherington RR, Utting JE. A simple study of awareness and dreaming during anaesthesia. Br J Anaesth. 1970;42:535&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">5423844</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38454342</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Minimal alveolar concentration of sevoflurane in combination with remimazolam in adults during laryngeal mask insertion: an up-down sequential allocation study.</ArticleTitle><Pagination><StartPage>94</StartPage><MedlinePgn>94</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">94</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02468-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Remimazolam is a novel ultrashort-acting intravenous benzodiazepine sedative-hypnotic. The combination of remimazolam and sevoflurane does not increase respiratory sensitivity, produce bronchospasm, or cause other adverse conditions. We aimed to observe the effects of different remimazolam doses on the minimum alveolar concentration (MAC) of sevoflurane at end-expiration during laryngeal mask insertion and evaluate the effect of sex on the efficacy of the combination of remimazolam on the suppression of laryngeal mask insertion in adult patients.</AbstractText><AbstractText Label="METHODS">We included 240 patients undergoing laparoscopic surgery under general anesthesia with elective placement of a laryngeal mask (120 males and 120 females). The patients were randomly divided into four groups according to sex: a control group (randomization for female patients, RF0; randomization for male patients, RM0) and three remimazolam groups (RF1, RM1 / RM2, RF2 / RM3, RF3), with 30 patients in each group. Induction was established by vital capacity rapid inhalation induction (VCRII), using 8% sevoflurane and 100% oxygen (6&#xa0;L/min) in all patients. The (RF1, RM1), (RM2, RF2), and (RM3, RF3) groups were continuously injected with remimazolam at doses of 1, 1.5, and 2.0&#xa0;mg/kg/h, respectively, while the (RM0, RF0) group was injected with an equal volume of normal saline. The end-expiratory concentration of sevoflurane was adjusted to a preset value after the patient's eyelash reflex disappeared. After the end-expiratory concentration of sevoflurane was kept stable for at least 15&#xa0;min, the laryngeal mask was placed, and the patient's physical response to the mask placement was observed immediately and within 30&#xa0;s of placement. The MAC of sevoflurane was measured using the up-and-down sequential method of Dixon.</AbstractText><AbstractText Label="RESULTS">The calculated MAC of end-expiratory sevoflurane during laryngeal mask insertion in adult females was (2.94&#x2009;&#xb1;&#x2009;0.18)%, (2.69&#x2009;&#xb1;&#x2009;0.16)%, (2.32&#x2009;&#xb1;&#x2009;0.16)% and (1.83&#x2009;&#xb1;&#x2009;0.15)% in groups RF0, RF1, RF2&#xa0;and RF3;&#xa0;(2.98&#x2009;&#xb1;&#x2009;0.18)%, (2.80&#x2009;&#xb1;&#x2009;0.19)%, (2.54&#x2009;&#xb1;&#x2009;0.15)% and (2.15&#x2009;&#xb1;&#x2009;0.15)% in male groups RM0, RM1, RM2 and RM3, respectively. The MAC values were significantly lower in the (RF1-RF3, RM1-RM3) group when compared to the (RF0, RM0) group. There was no significant difference between (RF0, RF1) and (RM0, RM1), but the MAC value of the RF2-RF3 group was significantly lower than that of the RM2-RM3 group.</AbstractText><AbstractText Label="CONCLUSIONS">Remimazolam can effectively reduce end-expiratory sevoflurane MAC values during laryngeal mask placement in adults. When remimazolam was measured above 1.5&#xa0;mg/kg/h, the effect of inhibiting laryngeal mask implantation in female patients was stronger than that in male patients. Remimazolam at a dose of 1-2&#xa0;mg/kg/h combined with sevoflurane induction can be safely and effectively used in these patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Clinical Medical College, North Sichuan Medical College, Nanchong Central Hospital, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>HongYu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Clinical Medical College, North Sichuan Medical College, Nanchong Central Hospital, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>LinJi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Clinical Medical College, North Sichuan Medical College, Nanchong Central Hospital, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>PingPing</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>YanXia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>KunPeng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University International Hospital, Beijing, China. liukunpeng@pkuih.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>23YYJCYJ0099</GrantID><Agency>Nanchong Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>23YYJCYJ0099</GrantID><Agency>Nanchong Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>23YYJCYJ0099</GrantID><Agency>Nanchong Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>23YYJCYJ0099</GrantID><Agency>Nanchong Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>23YYJCYJ0099</GrantID><Agency>Nanchong Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>YXJL-2022-0194-0067</GrantID><Agency>Beijing Medical Award Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V4A8U16MB</RegistryNumber><NameOfSubstance UI="C522201">remimazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="Y">Methyl Ethers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="Y">Anesthetics, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laryngeal mask airway</Keyword><Keyword MajorTopicYN="N">Minimum alveolar concentration</Keyword><Keyword MajorTopicYN="N">Remimazolam</Keyword><Keyword MajorTopicYN="N">Sevoflurane</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38454342</ArticleId><ArticleId IdType="pmc">PMC10921704</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02468-y</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02468-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yan CL, Chen Y, Sun P, Qv ZY, Zuo MZ. Preliminary evaluation of SaCoVLM&#x2122; video laryngeal mask airway in airway management for general anesthesia. BMC Anesthesiol. 2022;22:3. doi: 10.1186/s12871-021-01541-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01541-0</ArticleId><ArticleId IdType="pmc">PMC8722220</ArticleId><ArticleId IdType="pubmed">34979936</ArticleId></ArticleIdList></Reference><Reference><Citation>Braude D, Richards M. Rapid sequence Airway (RSA)&#x2014;a novel approach to prehospital airway management. Prehosp Emerg Care. 2007;11:250&#x2013;2. doi: 10.1080/10903120701206032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10903120701206032</ArticleId><ArticleId IdType="pubmed">17454819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickx JFA, De Wolf A, De Wolf A. Special aspects of pharmacokinetics of inhalation anesthesia. Handb Exp Pharmacol. 2008;182:159&#x2013;86. doi: 10.1007/978-3-540-74806-9_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-74806-9_8</ArticleId><ArticleId IdType="pubmed">18175091</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranake A, Mashour GA, Avidan MS. Minimum alveolar concentration: ongoing relevance and clinical utility. Anaesthesia. 2013;68:512&#x2013;22. doi: 10.1111/anae.12168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12168</ArticleId><ArticleId IdType="pubmed">23414556</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui K, St&#xf6;hr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022;36:493&#x2013;505. doi: 10.1007/s00540-022-03079-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-022-03079-y</ArticleId><ArticleId IdType="pubmed">35708787</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patientsv (ASA class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491&#x2013;501. doi: 10.1007/s00540-020-02776-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02776-w</ArticleId><ArticleId IdType="pubmed">32303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida A, Kurata S, Kida K, Tsubokawa T. Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist fumazenil. JA Clin Rep. 2021;7:14. doi: 10.1186/s40981-021-00417-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-021-00417-z</ArticleId><ArticleId IdType="pmc">PMC7847922</ArticleId><ArticleId IdType="pubmed">33517503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick GJ. Remimazolam: nonclinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol. 2021;12:690875. doi: 10.3389/fphar.2021.690875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.690875</ArticleId><ArticleId IdType="pmc">PMC8329483</ArticleId><ArticleId IdType="pubmed">34354587</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevans T, Deering-Rice C, Stockmann C, Rower J, Sakata D, Reilly C. Inhaled remimazolam potentiates inhaled remifentanil in rodents. Anesth Analg. 2017;124:1484&#x2013;90. doi: 10.1213/ANE.0000000000002022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002022</ArticleId><ArticleId IdType="pubmed">28333705</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo YX, Luo K, Jiang PP, Wang D, Wang YZ, Yang XL. Minimal alveolar concentration of sevoflurane in combination with dexmedetomidine in patients with hysteroscopy: an up-down sequential allocation study. Basic Clin Pharmacol Toxicol. 2022;131:364&#x2013;71. doi: 10.1111/bcpt.13777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.13777</ArticleId><ArticleId IdType="pubmed">35968751</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul M, Fisher DM. Are estimates of MAC Reliable? Anesthesiology. 2001;95:1362&#x2013;70. doi: 10.1097/00000542-200112000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200112000-00014</ArticleId><ArticleId IdType="pubmed">11748393</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan MT, Cheng BC, Lee TM, Gin T, Group CT. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25:33&#x2013;42. doi: 10.1097/ANA.0b013e3182712fba.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0b013e3182712fba</ArticleId><ArticleId IdType="pubmed">23027226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Pang Q, Tu A, Wang J, Tu F. Effect of low-dose ketamine on MACBAR of sevoflurane in laparoscopic cholecystectomy: a randomized controlled trial. J Clin Pharm Ther. 2021;46:121&#x2013;7. doi: 10.1111/jcpt.13263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13263</ArticleId><ArticleId IdType="pubmed">32981056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaballos M, Bastida E, Jim&#xe9;nez C, Agust&#xed; S, L&#xf3;pez-Gil MT. Predicted end-tidal sevoflurane concentration for insertion of a laryngeal mask Supreme: a prospective observational study. Eur J Anaesthesiol. 2013;30:170&#x2013;4. doi: 10.1097/EJA.0b013e32835c5512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835c5512</ArticleId><ArticleId IdType="pubmed">23274620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanbo Z, Lu Z, Lu C, Mengguang C, Wei Z. Effect of gender factor on potency of remimazolam inhibiting responses to laryngeal mask airway insertion. Chin J Anesthesiol. 2021;41:1109&#x2013;11.</Citation></Reference><Reference><Citation>Grabowska-Gawe&#x142; A. End-tidal sevoflurane concentrations for laryngeal mask airway insertion and tracheal intubation in children [J] Przegl Lek. 2004;61:783&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15792021</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo JH, Ok SY, Kim SH, Chung JW, Park SY, Kim MG, et al. Comparison of bispectral index and phase lag entropy during general anesthesia: sevoflurane or propofol anesthesia. Medicine. 2022;101:e31191. doi: 10.1097/MD.0000000000031191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000031191</ArticleId><ArticleId IdType="pmc">PMC9646625</ArticleId><ArticleId IdType="pubmed">36343067</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirozu K, Nobukuni K, Tsumura S, Imura K, Nakashima K, Takamori S, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022;36:194&#x2013;200. doi: 10.1007/s00540-021-03030-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-021-03030-7</ArticleId><ArticleId IdType="pubmed">34999964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39844310</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-0525</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Perioperative medicine (London, England)</Title><ISOAbbreviation>Perioper Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>The effect of continuous positive airway pressure (CPAP) application on airway problems in pediatric patients with subglottic stenosis who undergo balloon dilatation.</ArticleTitle><Pagination><StartPage>10</StartPage><MedlinePgn>10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13741-024-00478-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Subglottic stenosis is a significant clinical challenge in pediatric anesthesia, often necessitating interventions that can lead to various postoperative complications. The aim of this study was to determine the effect of prophylactic continuous positive airway pressure (CPAP) application on recovery time and airway complications in pediatric patients with subglottic stenosis undergoing balloon dilatation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective, double-blinded, parallel-group, randomized controlled study was conducted at Health Sciences University &#xdc;mraniye Training and Research Hospital on pediatric patients with subglottic stenosis, aged from 0 to 12&#xa0;years and who underwent elective balloon dilatation under general anesthesia. Patients were randomized in a 1:1 ratio into the CPAP or non-CPAP group. The primary outcome was the duration of recovery time. Secondary outcomes included bronchospasm, the number of desaturation episodes, intubation, tracheostomy, and the need for intensive care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 84 patients were enrolled in this randomized controlled trial, 81 of which received the allocated treatment and were analyzed (non-CPAP n&#x2009;=&#x2009;41, CPAP n&#x2009;=&#x2009;40). Compared to controls, the proportions of bronchospasm, tracheal secretion, need for intensive care, and tracheostomy were consistently lower in the CPAP group, whereas the requirement of intubation was higher. Further, the mean recovery time was significantly shorter in the CPAP group compared to the non-CPAP group (mean difference&#x2009;-&#x2009;3.3&#xa0;min, 95%CI&#x2009;-&#x2009;5.16 to&#x2009;-&#x2009;1.44, p&#x2009;=&#x2009;0.0007). Despite lacking statistical significance, the CPAP group had reduced odds of developing bronchospasm, tracheal secretion, need for intensive care, and tracheostomy, but higher odds of requiring intubation when compared to the controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Prophylactic CPAP application following therapeutic balloon dilatation in pediatric patients who have developed subglottic stenosis due to acquired or congenital causes appears to effectively shorten recovery time and may have a role in decreasing postoperative pulmonary complications; however, more research is recommended to further confirm these findings.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">The protocol for this clinical trial was retrospectively registered on clinicaltrials.gov with registration ID NCT06183515 on 30 November 2023.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tuncel</LastName><ForeName>Zeliha</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, &#xdc;mraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;ksu</LastName><ForeName>&#x15e;enay</ForeName><Initials>&#x15e;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, &#xdc;mraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delig&#xf6;z</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, Haydarpa&#x15f;a Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal Tolga</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albasha</LastName><ForeName>Abdulatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Bushra M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Ayten</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar. saracogluayten@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Aisha Bint Hamad Al-Attiyah Hospital, Hamad Medical Corporation, Doha, Qatar. saracogluayten@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06183515</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perioper Med (Lond)</MedlineTA><NlmUniqueID>101609072</NlmUniqueID><ISSNLinking>2047-0525</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apneic ventilation</Keyword><Keyword MajorTopicYN="N">CPAP</Keyword><Keyword MajorTopicYN="N">Pediatric airway</Keyword><Keyword MajorTopicYN="N">Subglottic stenosis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval consent to participate: The study protocol received ethical approval from the Umraniye Training and Research Hospital Ethics Committee with decision number 35 dated 16th of December 2021 (approval number: B.10.1.TKH.4.34.H.GP.0.01/352). Before the conduct of the study or any study-related procedures, written informed consent was obtained from all legal guardians of the participants. The study was designed following the Declaration of Helsinki defined in 2013. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39844310</ArticleId><ArticleId IdType="pmc">PMC11756109</ArticleId><ArticleId IdType="doi">10.1186/s13741-024-00478-5</ArticleId><ArticleId IdType="pii">10.1186/s13741-024-00478-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Ghaffar HS, Youseff HA, Abdelal FA, Osman MA, Sayed JA, Riad MAF, Abdel-Rady MM. Post-extubation continuous positive airway pressure improves oxygenation after pediatric laparoscopic surgery: A randomized controlled trial. Acta Anaesthesiol Scand. 2019;63(5):620&#x2013;9. 10.1111/aas.13324.</Citation><ArticleIdList><ArticleId IdType="pubmed">30761530</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CM, Lopez Vargas MP, Oropel F, Valente L, Ricci L, Natal M, Suarez Sipmann F, Tusman G. Prevention of atelectasis by continuous positive airway pressure in anaesthetised children: A randomised controlled study. Eur J Anaesthesiol. 2021;38(1):41&#x2013;8. 10.1097/EJA.0000000000001351.</Citation><ArticleIdList><ArticleId IdType="pubmed">33009190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonasso PC, Dassinger MS, Ryan ML, Gowen MS, Burford JM, Smith SD. 24-h and 30-days perioperative mortality in pediatric surgery. J Pedriatr Surg. 2019;54:628&#x2013;30. 10.1016/j.jpedsurg.2018.06.026.</Citation><ArticleIdList><ArticleId IdType="pubmed">30017066</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantarella G, Gaffuri M, Torretta S, Neri S, Ambrosini MT, D&#x2019;Onghia A, Pignataro L, Sandu K. Outcomes of balloon dilation for paediatric laryngeal stenosis. Acta Otorhinolaryngol Ital. 2020;40(5):360&#x2013;7. 10.14639/0392-100X-N0830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726638</ArticleId><ArticleId IdType="pubmed">33299226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Bimonte S, Di Napoli R. Delayed Emergence from Anesthesia: What We Know and How We Act. Local Reg Anesth. 2020;13:195&#x2013;206. 10.2147/LRA.S230728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652217</ArticleId><ArticleId IdType="pubmed">33177867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccozzi A, Pizzi B, Vittori A, Piroli A, Marrocco G, Della Vecchia F, Cascella M, Petrucci E, Marinangeli F. The perioperative anesthetic management of the pediatric patient with special needs: an overview of literature. Children (Basel). 2022;9(10):1438. 10.3390/children9101438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9600107</ArticleId><ArticleId IdType="pubmed">36291372</ArticleId></ArticleIdList></Reference><Reference><Citation>Frykholm P, Disma N, Andersson H, Beck C, Bouvet L, Cercueil E, Elliott E, Hofmann J, Isserman R, Klaucane A, Kuhn F, de Queiroz SM, Rosen D, Rudolph D, Schmidt AR, Schmitz A, Stocki D, S&#xfc;mpelmann R, Stricker PA, Thomas M, Veyckemans F, Afshari A. Pre-operative fasting in children: A guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 2022;39(1):4&#x2013;25. 10.1097/EJA.0000000000001599.</Citation><ArticleIdList><ArticleId IdType="pubmed">34857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gungor A. Balloon dilation of the pediatric airway: potential for disaster. Am J Otolaryngol. 2012;33(1):147&#x2013;9. 10.1016/j.amjoto.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784553</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, Becke K, Hansen TG, J&#xf6;hr M, Leva B, Morton NS, Vermeulen PM, Zielinska M, Boda K, Veyckemans F. APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5:412 &#x2013; 425. 10.1016/S2213-2600(17)30116-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautefort C, Teissier N, Viala P, Van Den Abbeele T. Balloon dilation laryngoplasty for subglottic stenosis in children: eight years&#x2019; experience. Arch Otolaryngol Head Neck Surg. 2012;138(3):235&#x2013;40. 10.1001/archoto.2011.1439.</Citation><ArticleIdList><ArticleId IdType="pubmed">22351854</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys S, von Ungern-Sternberg BS, Skowno J, Williams T, Taylor J, Taverner F, Gibbons K, Burgoyne L, Sommerfield D, Stephens P, Hallett B, Vijayasekaran S, Slee N, Burns H, Sowa M, Davidson A, Schibler A. High-flow oxygen for children&#x2019;s airway surgery: randomised controlled trial protocol (HAMSTER). BMJ Open. 2019;9: e031873. 10.1136/bmjopen-2019-031873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6797255</ArticleId><ArticleId IdType="pubmed">31615801</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer NP, Rotta AT, Essouri S, Fioretto JR, Craven HJ, Whipple EC, Ramnarayan P, Abu-Sultaneh S, Khemani RG. Association of extubation failure rates with high-flow nasal cannula, continuous positive airway pressure, and bilevel positive airway pressure vs conventional oxygen therapy in infants and young children: a systematic review and network meta-analysis. JAMA Pediatr. 2023;177(8):774&#x2013;81. 10.1001/jamapediatrics.2023.1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242512</ArticleId><ArticleId IdType="pubmed">37273226</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Duke T, Chisti MJ, Kepreotes E, Kalinowski V, Li J. Efficacy of high-flow nasal cannula vs standard oxygen therapy or nasal continuous positive airway pressure in children with respiratory distress: a meta-analysis. J Pediatr. 2019;215:199&#x2013;208.e8. 10.1016/j.jpeds.2019.07.059.</Citation><ArticleIdList><ArticleId IdType="pubmed">31570155</ArticleId></ArticleIdList></Reference><Reference><Citation>Misal US, Joshi SA, Shaikh MM. Delayed recovery from anesthesia: a postgraduate educational review. Anesth Essays Res. 2016;10(2):164&#x2013;72. 10.4103/0259-1162.165506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864680</ArticleId><ArticleId IdType="pubmed">27212741</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Hopewell S, Schulz KF, Montori V, G&#xf8;tzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;23(340): c869. 10.1136/bmj.c869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844943</ArticleId><ArticleId IdType="pubmed">20332511</ArticleId></ArticleIdList></Reference><Reference><Citation>Percul C, Lerendegui L, Lobos P, Liberto D, Moldes J, Urquizo MM. Association between subglottic stenosis and endotracheal intubation in tracheostomized pediatric patients. Cir Pediatr. 2023;36(3):110&#x2013;5. 10.54847/cp.2023.03.10.</Citation><ArticleIdList><ArticleId IdType="pubmed">37417214</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell S, Keltie K, Burn J, Cole H, Donne A, Morrison G, Stephenson K, Daniel M, Gupta S, Wyatt M, Patrick H, Sims A. Balloon dilatation for paediatric airway stenosis: Evidence from the UK Airway Intervention Registry. Clin Otolaryngol. 2020;45(3):334&#x2013;41. 10.1111/coa.13492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317836</ArticleId><ArticleId IdType="pubmed">31845458</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMJ 2010 340 c33210.1136/bmj.c332</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva CR, Andrade LB, Maux DA, Bezerra AL, Duarte MC. Effectiveness of prophylactic non-invasive ventilation on respiratory function in the postoperative phase of pediatric cardiac surgery: a randomized controlled trial. Braz J Phys Ther. 2016;20(6):494&#x2013;501. 10.1590/bjpt-rbf.2014.0191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5176203</ArticleId><ArticleId IdType="pubmed">27706462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzuner A, Bas C, Jafarov S, Bahcecitapar M, Aydin E. Respiratory problems and associated factors following endoscopic balloon dilatation procedure in children with acquired subglottic stenos&#x131;s. Eur Arch Otorhinolaryngol. 2022;279(5):2493&#x2013;500. 10.1007/s00405-021-07208-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">35037169</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191&#x2013;4. 10.1001/jama.2013.281053.</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Zeng X, Wang T, Dong B, Wu M, Jia A, Ye L. Early versus delayed postoperative oral hydration in children following general anesthesia: a prospective randomized trial. BMC Anesthesiol. 2020;20(1):174. 10.1186/s12871-020-01086-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7368717</ArticleId><ArticleId IdType="pubmed">32682394</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14978593</PMID><DateCompleted><Year>2004</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0066-782X</ISSN><JournalIssue CitedMedium="Print"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>41</EndPage><MedlinePgn>42-46, 37-41</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the effectiveness of metoprolol in preventing clinically detectable atrial fibrillation (AF) and flutter after coronary artery bypass graft (CABG) surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An open, randomized study was carried out to treat 200 patients who had undergone isolated CABG surgery with extracorporeal circulation. The patients were randomized to either receive metoprolol orally or not to receive the medication in the postoperative period. The outcomes were the detection of sustained atrial AF and flutter, which were symptomatic or required treatment. The patients with the following characteristics were excluded from the study: baseline left ventricular ejection fraction &lt; 35%; previous AF; history of bronchospasm; second- and third-degree atrioventricular blocks, low cardiac output, and heart failure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Arrhythmias occurred in 11 out of 100 patients in the metoprolol group and in 24 out of 100 patients in the control group (P=0.02). The relative risk (RR) was 0.46 (95% CI = 0.24-0.88), and the number necessary to treat (NNT) and avoid the outcome was 8 patients. AF was the arrhythmia most frequently observed (30/35). In 38 patients aged 70 years or more, the arrhythmias occurred in 2 out of 19 patients in the metoprolol group and in 10 out of 19 patients in the control group (c2 Yates: P=0.01). The relative risk was 0.20 (95% CI = 0.05-0.79) and the number necessary to treat was 2 patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metoprolol is effective in preventing AF and flutter in the postoperative period of CABG surgery, and this effect was more evident in the group of elderly patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xfa;cio</LastName><ForeName>Eraldo de Azevedo</ForeName><Initials>Ede A</Initials><AffiliationInfo><Affiliation>Hospital S&#xe3;o Francisco, Santa Casa de Miseric&#xf3;rdia de Porto Alegre, Brasil. eraldoal@cardiol.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Blacher</LastName><ForeName>Celso</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Le&#xe3;es</LastName><ForeName>Paulo E</ForeName><Initials>PE</Initials></Author><Author ValidYN="Y"><LastName>Lucchese</LastName><ForeName>Fernando A</ForeName><Initials>FA</Initials></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Jorge Pinto</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>GEB06NHM23</RegistryNumber><NameOfSubstance UI="D008790">Metoprolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001282" MajorTopicYN="N">Atrial Flutter</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008790" MajorTopicYN="N">Metoprolol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14978593</ArticleId><ArticleId IdType="pii">S0066-782X2004000100004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15114199</PMID><DateCompleted><Year>2004</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-3022</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation.</ArticleTitle><Pagination><StartPage>1052</StartPage><EndPage>1057</EndPage><MedlinePgn>1052-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with bronchial hyperreactivity, airway instrumentation can evoke life-threatening bronchospasm. However, the best strategy for the prevention of bronchospasm has not been defined. Therefore, in a randomized, prospective, placebo-controlled study, the authors tested whether prophylaxis with either combined salbutamol-methylprednisolone or salbutamol alone (1) improves lung function and (2) prevents wheezing after intubation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-one patients with partially reversible airway obstruction (airway resistance &gt; 180%, forced expiratory volume in 1 s [FEV1] &lt; 70% of predicted value, and FEV1 increase &gt; 10% after two puffs of salbutamol), who were naive to anti-obstructive treatment, were randomized to receive daily for 5 days either 3 x 2 puffs (0.2 mg) of salbutamol alone (n = 16) or salbutamol combined with methylprednisolone (40 mg/day orally) (n = 15). Lung function was evaluated daily. Another 10 patients received two puffs of salbutamol 10 min before anesthesia. In all patients, wheezing was assessed before and 5 min after tracheal intubation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Within 1 day, both salbutamol and salbutamol-methylprednisolone treatment significantly improved airway resistance (salbutamol, 4.3+/- 2.0 [SD] to 2.9+/-1.3 mmHg x s x l(-1); salbutamol-methylprednisolone, 5.5+/-2.9 to 3.4+/-1.7 mmHg x s x l(-1)) and FEV1 (salbutamol, 1.79+/-0.49 to 2.12+/-0.61 l; salbutamol-methylprednisolone, 1.58+/-0.66 to 2.04+/-1.05 l) to a steady state, with no difference between groups. However, regardless of whether single-dose salbutamol preinduction or prolonged salbutamol treatment was used, most patients (8 of 10 and 7 of 9) experienced wheezing after intubation. In contrast, only one patient receiving additional methylprednisolone experienced wheezing (P = 0.0058).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">: Pretreatment with either salbutamol alone or salbutamol combined with methylprednisolone significantly and similarly improves lung function within 1 day. However, only combined salbutamol-methylprednisolone pretreatment decreases the incidence of wheezing after tracheal intubation. Therefore, in patients with bronchial hyperreactivity, preoperative treatment with combined corticosteroids and salbutamol minimizes intubation-evoked bronchoconstriction much more effectively than the inhaled beta2-sympathomimetic salbutamol alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silvanus</LastName><ForeName>Marie-Therese</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r An&#xe4;sthesiologie und Intensivmedizin, Universit&#xe4;tsklinikum Essen, Essen, Federal Republic of Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeben</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2004 May;100(5):1047-8. doi: 10.1097/00000542-200405000-00002.</RefSource><PMID Version="1">15114197</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15114199</ArticleId><ArticleId IdType="doi">10.1097/00000542-200405000-00004</ArticleId><ArticleId IdType="pii">00000542-200405000-00004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40396523</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2515-7949</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of perioperative practice</Title><ISOAbbreviation>J Perioper Pract</ISOAbbreviation></Journal><ArticleTitle>Preoperative nebulised lidocaine for children with mild symptoms of upper respiratory tract infections: A randomised controlled trial.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>284</EndPage><MedlinePgn>278-284</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17504589241276651</ELocationID><Abstract><AbstractText>Nebulised lidocaine was previously used in infants and children undergoing flexible bronchoscopy and was safe and beneficial. The aim of this randomised controlled trial was to assess the impact of preoperative nebulised lidocaine on the incidence of perioperative respiratory adverse events in children aged one to five&#x2009;years proposed for ilioinguinal ambulatory surgery while having mild symptoms of upper respiratory tract infection. Patients were randomly allocated to one of the two groups of the study: Group L (lidocaine) received 4&#x2009;mg/kg of nebulised lidocaine 2% (0.2&#x2009;ml/kg), and Group P (placebo) received 0.2&#x2009;ml/kg of normal saline nebulisation, 30&#x2009;minutes before anaesthesia. Nebulised lidocaine reduced the risk of bronchospasm, with p&#x2009;=&#x2009;0.003 and a risk ratio (RR)&#x2009;=&#x2009;0.326 [0.140-0.760], and prolonged oxygen support postoperatively, with p&#x2009;=&#x2009;0.004 and RR&#x2009;=&#x2009;0.222 [0.067-0.732]. It also reduced the risk of hospitalisation, with p&#x2009;=&#x2009;0.001 and RR&#x2009;=&#x2009;0.138 [0.033-0.577]. No side effects for nebulised lidocaine 2% were noted. Preoperative nebulised lidocaine seems to be a safe and efficient premedication for children with upper respiratory tract infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jarraya</LastName><ForeName>Anouar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4488-5491</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammoun</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherif</LastName><ForeName>Olfa</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khcherem</LastName><ForeName>Jaouhar</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhedi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mhiri</LastName><ForeName>Riadh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Perioper Pract</MedlineTA><NlmUniqueID>101271023</NlmUniqueID><ISSNLinking>1750-4589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="Y">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="Y">Lidocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009330" MajorTopicYN="N">Nebulizers and Vaporizers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="Y">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthetics&#x2013;management and care</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Paediatric surgery</Keyword><Keyword MajorTopicYN="N">Patient safety</Keyword><Keyword MajorTopicYN="N">Risk management</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40396523</ArticleId><ArticleId IdType="doi">10.1177/17504589241276651</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31587265</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Respiratory complications after adenotonsillectomy in high-risk children with obstructive sleep apnea: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>292</StartPage><EndPage>300</EndPage><MedlinePgn>292-300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13488</ELocationID><Abstract><AbstractText Label="BACKGROUND">Obstructive sleep apnea (OSA) occurs in 1%-4% of children; adenotonsillectomy is an effective treatment. Mortality/severe brain injury occurs among 0.6/10&#xa0;000 adenotonsillectomies; in children, 60% are secondary to airway/respiratory events. Earlier studies identified that children aged &lt;2&#xa0;years, extremes of weight, with co-morbidities of craniofacial, neuromuscular, cardiac/respiratory disease, or severe OSA are at high risk for adverse post-operative respiratory events (AE). We aimed to: Firstly, investigate which risk factors were associated with AEs either in the post-anesthesia care unit (PACU), pediatric intensive care unit (PICU), or both in this population. Secondly, we investigated factors associated with post-operative PICU AE despite no event in the PACU in order to predict need of post-operative PICU after their PACU stay.</AbstractText><AbstractText Label="METHODS">Retrospective study of children admitted to the PICU after adenotonsillectomy between 08/2006-09/2015. Demographics, risk factors, and occurrence of AE (oxygen saturation &lt;92, stridor, bronchospasm, pneumonia, pulmonary edema, re-intubation) were recorded.</AbstractText><AbstractText Label="RESULTS">During the studied time period 4029 tonsil/adenoid procedures were performed in 3997 children. 179, admitted to the PICU post-operatively, met criteria for analysis. PICU AEs occurred in 59%: 44%-83% in any particular risk category. PACU AEs occurred in 42%. Of those with PACU events: 92% suffered AEs in the PICU; however, 35% of those without a PACU AE still suffered a PICU AE.</AbstractText><AbstractText Label="CONCLUSIONS">Among high-risk children undergoing TA, absence of adverse events in PACU during a 2-hour observation period does not predict absence of subsequent AEs in the PICU.</AbstractText><CopyrightInformation>&#xa9; 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ekstein</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5008-8774</Identifier><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zac</LastName><ForeName>Lilach</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schvartz</LastName><ForeName>Reut</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goren</LastName><ForeName>Or</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiniger</LastName><ForeName>Carolyn F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeRowe</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology Head and Neck and Maxillofacial Surgery, Pediatric Otolaryngology Unit, Tel Aviv Medical Center, Dana-Dwek Children's Hospital, Tel Aviv Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishman</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology Head and Neck and Maxillofacial Surgery, Pediatric Otolaryngology Unit, Tel Aviv Medical Center, Dana-Dwek Children's Hospital, Tel Aviv Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">obstructive sleep apnea</Keyword><Keyword MajorTopicYN="N">pediatric tonsillectomy and adenoidectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31587265</ArticleId><ArticleId IdType="doi">10.1111/aas.13488</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Brown KA. Outcome, risk, and error and the child with obstructive sleep apnea. Paediatr Anaesth. 2011;21:771-780.</Citation></Reference><Reference><Citation>Bhattacharyya N, Lin HW. Changes and consistencies in the epidemiology of pediatric adenotonsillar surgery, 1996-2006. Otolaryngol - Head Neck Surg. 2010;143:680-684.</Citation></Reference><Reference><Citation>Parker NP, Walner DL. Trends in the indications for pediatric tonsillectomy or adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2011;75:282-285.</Citation></Reference><Reference><Citation>Trosman I. Childhood obstructive sleep apnea syndrome: A review of the 2012 American Academy of Pediatrics Guidelines. Pediatr Ann. 2013;42:e205-e209.</Citation></Reference><Reference><Citation>Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368:2366-2376.</Citation></Reference><Reference><Citation>Urquhart D. Investigation and management of childhood sleep apnoea. Hippokratia. 2013;17:196-202.</Citation></Reference><Reference><Citation>Hill CA, Litvak A, Canapari C, et al. A pilot study to identify pre- and peri-operative risk factors for airway complications following adenotonsillectomy for treatment of severe pediatric OSA. Int J Pediatr Otorhinolaryngol. 2011;75:1385-1390.</Citation></Reference><Reference><Citation>McCormick ME, Sheyn A, Haupert M, Thomas R, Folbe AJ. Predicting complications after adenotonsillectomy in children 3 years old and younger. Int J Pediatr Otorhinolaryngol. 2011;75:1391-1394.</Citation></Reference><Reference><Citation>Kieran S, Gorman C, Kirby A, et al. Risk factors for desaturation after tonsillectomy: analysis of 4092 consecutive pediatric cases. Laryngoscope. 2013;123:2554-2559.</Citation></Reference><Reference><Citation>Roland PS, Rosenfeld RM, Brooks LJ, et al. Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol-Head Neck Surg. 2011;145:S1-S15.</Citation></Reference><Reference><Citation>Thongyam A, Marcus CL, Lockman JL, et al. Predictors of perioperative complications in higher risk children after adenotonsillectomy for obstructive sleep apnea: a prospective study. Otolaryngol Head Neck Surg. 2014;151:1046-1054.</Citation></Reference><Reference><Citation>Rosen GM, Muckle RP, Mahowald MW, Goding GS, Ullevig C. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated? Pediatrics. 1994;93:784-788.</Citation></Reference><Reference><Citation>Cohen D, Dor M. Morbidity and mortality of post-tonsillectomy bleeding: analysis of cases. J Laryngol Otol. 2008;122:88-92.</Citation></Reference><Reference><Citation>Tweedie DJ, Bajaj Y, Ifeacho SN, et al. Peri-operative complications after adenotonsillectomy in a UK pediatric tertiary referral centre. Int J Pediatr Otorhinolaryngol. 2012;76:809-815.</Citation></Reference><Reference><Citation>Theilhaber M, Arachchi S, Armstrong DS, Davey MJ, Nixon GM. Routine post-operative intensive care is not necessary for children with obstructive sleep apnea at high risk after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2014;78:744-747.</Citation></Reference><Reference><Citation>Leong AC, Davis JP. Morbidity after adenotonsillectomy for paediatric obstructive sleep apnoea syndrome: waking up to a pragmatic approach. J Laryngol Otol. 2007;121:809-817.</Citation></Reference><Reference><Citation>Rhodes CB, Eid A, Muller G, et al. Postoperative monitoring following adenotonsillectomy for severe obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2018;127:783-790.</Citation></Reference><Reference><Citation>Ye J, Liu H, Zhang G, Huang Z, Huang P, Li Y. Postoperative respiratory complications of adenotonsillectomy for obstructive sleep apnea syndrome in older children: prevalence, risk factors, and impact on clinical outcome. J Otolaryngol Head Neck Surg. 2009;38:49-58.</Citation></Reference><Reference><Citation>Walker P, Whitehead B, Rowley M. Criteria for elective admission to the paediatric intensive care unit following adenotonsillectomy for severe obstructive sleep apnoea. Anaesth Intensive Care. 2004;32:43-46.</Citation></Reference><Reference><Citation>Saur JS, Brietzke SE. Polysomnography results versus clinical factors to predict post-operative respiratory complications following pediatric adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2017;98:136-142.</Citation></Reference><Reference><Citation>Arambula AM, Xie DX, Whigham AS. Respiratory events after adenotonsillectomy requiring escalated admission status in children with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2018;107:31-36.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21854485</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-2712</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2011</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Academic emergency medicine : official journal of the Society for Academic Emergency Medicine</Title><ISOAbbreviation>Acad Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare.</ArticleTitle><Pagination><StartPage>1005</StartPage><EndPage>1009</EndPage><MedlinePgn>1005-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1553-2712.2011.01152.x</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Despite increasing attention to the long-term risks of radiation exposure and contrast-induced nephropathy (CIN), institutional guidelines and patient consent procedures for contrast-enhanced computed tomography (CECT) imaging in the emergency department (ED) setting have focused primarily on more immediate complications, directly attributable to the administration of intravenous (IV) iodinated contrast administration. Thus, this study sought to define the risk of these immediate complications with the overall aim of improving institutional guidelines and patient consent procedures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective, consecutive cohort study of patients undergoing CECT of any body region in the ED, for complications occurring within 1 week of contrast administration, using predefined implicit definitions. Severe complications were defined as any of the following requiring medical or surgical intervention: bronchospasm with acute respiratory failure, airway obstruction, anaphylactoid shock, or acute pulmonary edema. The development of compartment syndrome, lactic acidosis, or pulmonary edema within 1 week of contrast administration was also considered a severe complication.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 633 patients, only five (0.8%, 95% confidence interval [CI] = 0.3% to 1.8%) reported any immediate complications, all of which were classified as minor. No patient developed a reaction meeting the study definition of a severe complication.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The frequency of severe, immediate complications from CECT imaging that includes IV contrast is less than 1%, and the frequency of mild complications is less than 2%. The authors conclude that CECT is associated with a very low rate of severe immediate complications.</AbstractText><CopyrightInformation>&#xa9; 2011 by the Society for Academic Emergency Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Alice M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Tumlin</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Kline</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acad Emerg Med</MedlineTA><NlmUniqueID>9418450</NlmUniqueID><ISSNLinking>1069-6563</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>9679TC07X4</RegistryNumber><NameOfSubstance UI="D007455">Iodine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Acad Emerg Med. 2012 Jan;19(1):110; author reply 111-2. doi: 10.1111/j.1553-2712.2011.01257.x.</RefSource><PMID Version="1">22251195</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007455" MajorTopicYN="N">Iodine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009657" MajorTopicYN="N" Type="Geographic">North Carolina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21854485</ArticleId><ArticleId IdType="doi">10.1111/j.1553-2712.2011.01152.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17273578</PMID><DateCompleted><Year>2007</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1806-3756</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2006</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia</Title><ISOAbbreviation>J Bras Pneumol</ISOAbbreviation></Journal><ArticleTitle>Respiratory muscle evaluation in elective thoracotomies and laparotomies of the upper abdomen.</ArticleTitle><Pagination><StartPage>99</StartPage><EndPage>105</EndPage><MedlinePgn>99-105</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify any possible relation between lower than predicted preoperative respiratory muscle function and the incidence of postoperative respiratory complications and death in elective thoracotomies and laparotomies of the upper abdomen.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted, in which 70 patients over the age of 18 were monitored in two similar hospitals. In the preoperative evaluation performed at admission, patients were classified as presenting respiratory muscle function (as determined by measurement of maximal respiratory pressures) &gt; 75% of the predicted value (n = 50) or &lt; 75% of the predicted value (n = 20). Patients were monitored until discharge. In both groups, the incidence of pneumonia was determined, as was that of acute respiratory failure, bronchospasm, prolonged mechanical ventilation, atelectasis, pleural effusion, pneumothorax and death. A comparative analysis was made between the groups, and relative risk was calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the study sample, the overall incidence of postoperative complications was 22.86% (16/70): 55% (11/20) in the group of patients presenting &lt; 75% of the predicted value; and 10% (5/50) in the group of patients presenting &gt; 75% of the predicted value. Patients in the &lt; 75% of the predicted value group presented a relative risk of 5.5 (95% confidence interval between 2.19 and 13.82).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Respiratory muscle function below the predicted value was found to be related with higher relative risk of postoperative complications in the surgical procedures studied.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellinetti</LastName><ForeName>Laryssa Milenkovich</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Universidade Estadual de Londrina, Londrina, PR, Brasil. laryssa@sercomtel.com.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Jo&#xe3;o Carlos</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Bras Pneumol</MedlineTA><NlmUniqueID>101222274</NlmUniqueID><ISSNLinking>1806-3713</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013908" MajorTopicYN="N">Thoracotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17273578</ArticleId><ArticleId IdType="doi">10.1590/s1806-37132006000200004</ArticleId><ArticleId IdType="pii">S1806-37132006000200004</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>